Athene Holding (ATH-PD) 10-Q 9 May 23 2023 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2023	May 05, 2023
Document Information [Line Items]
Entity Incorporation, State or Country Code	D0
Entity Tax Identification Number	98-0630022
Entity Registrant Name	ATHENE HOLDING LTD
Entity Address, Address Line One	Second Floor, Washington House
Entity Address, City or Town	Hamilton
Entity Address, Postal Zip Code	HM 11
Entity Address, Country	BM
Entity Central Index Key	0001527469
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2023
Entity File Number	001-37963
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31
Amendment Flag	false
Entity Common Stock, Shares Outstanding		203,805,432
City Area Code	441
Local Phone Number	279-8400
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Shell Company	false
Entity Address, Address Line Two	16 Church Street
Preference Share, Series A
Document Information [Line Items]
Title of 12(b) Security	6.35% Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Share, Series A
Trading Symbol	ATHPrA
Security Exchange Name	NYSE
Preference Share, Series B
Document Information [Line Items]
Title of 12(b) Security	5.625% Fixed-Rate Perpetual Non-Cumulative Preference Share, Series B
Trading Symbol	ATHPrB
Security Exchange Name	NYSE
Preference Share, Series C
Document Information [Line Items]
Title of 12(b) Security	6.375% Fixed-Rate Reset Perpetual Non-Cumulative Preference Share, Series C
Trading Symbol	ATHPrC
Security Exchange Name	NYSE
Series D Preferred Stock
Document Information [Line Items]
Title of 12(b) Security	4.875% Fixed-Rate Perpetual Non-Cumulative Preference Share, Series D
Trading Symbol	ATHPrD
Security Exchange Name	NYSE
Series E Preferred Stock
Document Information [Line Items]
Title of 12(b) Security	7.75% Fixed-Rate Reset Perpetual Non-Cumulative Preference Share, Series E
Trading Symbol	ATHPrE
Security Exchange Name	NYSE

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Investments
Available-for-sale securities	$ 118,579	$ 112,225
Investment funds	14,552	14,128
Derivative assets	3,956	3,309
Cash and cash equivalents	13,844	7,779
Restricted cash	1,148	628
Accrued investment income (related party: 2023 – $128 and 2022 – $105)	1,458	1,328
Reinsurance recoverable (portion at fair value: 2023 – $1,470 and 2022 – $1,388)	4,229	4,358
Deferred acquisition costs, deferred sales inducements and value of business acquired	4,836	4,466
Goodwill	4,061	4,058
Other assets (related party: 2023 – $200 and 2022 – $161)	7,916	8,693
Total assets	257,654	243,931
Liabilities
Interest sensitive contract liabilities (related party: 2023 – $11,347 and 2022 – $11,889; portion at fair value: 2023 – $7,626 and 2022 – $6,670)	181,100	173,616
Future policy benefits	42,490	42,110
Market risk benefits	3,203	2,970
Debt	3,650	3,658
Derivative liabilities	1,518	1,646
Payables for collateral on derivatives and securities to repurchase	10,196	6,707
Other liabilities (related party: 2023 – $612 and 2022 – $564)	1,600	1,860
Total liabilities	244,604	233,382
Commitments and Contingencies (Note 14)
Equity
Preferred stock	0	0
Common stock	0	0
Additional paid-in capital	18,139	18,119
Retained deficit	(3,293)	(3,640)
Accumulated other comprehensive loss (related party: 2023 – $(115) and 2022 – $(167))	(6,148)	(7,321)
Total Athene Holding Ltd. shareholders’ equity	8,698	7,158
Noncontrolling interests	4,352	3,391
Total equity	13,050	10,549
Total liabilities and equity	257,654	243,931
Fair Value
Investments
Short-term Investments		1,640
Liabilities
Interest sensitive contract liabilities (related party: 2023 – $11,347 and 2022 – $11,889; portion at fair value: 2023 – $7,626 and 2022 – $6,670)	120,063	111,608
Debt	2,906	2,893
Recurring | Fair Value
Investments
Restricted cash	1,148	628
Reinsurance recoverable (portion at fair value: 2023 – $1,470 and 2022 – $1,388)	1,470	1,388
Other assets (related party: 2023 – $200 and 2022 – $161)	440
Liabilities
Interest sensitive contract liabilities (related party: 2023 – $11,347 and 2022 – $11,889; portion at fair value: 2023 – $7,626 and 2022 – $6,670)	7,626	6,670
Future policy benefits	1,769	1,712
Market risk benefits	3,203	2,970
Derivative liabilities	1,518	1,646
Other liabilities (related party: 2023 – $612 and 2022 – $564)		65
Variable Interest Entities
Investments
Trading securities, at fair value	1,069	1,063
Mortgage loans	2,119	2,055
Investment funds	12,880	12,480
Other investments	99	101
Cash and cash equivalents	654	362
Other assets (related party: 2023 – $200 and 2022 – $161)	111	112
Liabilities
Other liabilities (related party: 2023 – $612 and 2022 – $564)	847	815
Variable Interest Entities | Recurring | Fair Value
Investments
Trading securities, at fair value	1,069	1,063
Mortgage loans	2,119	2,055
Investment funds	12,880	12,480
Other investments	99	101
Consolidated Entity, excluding Affiliated Entity
Investments
Available-for-sale securities	106,713	102,404
Trading securities, at fair value	1,652	1,595
Equity securities (portion at fair value: 2023 – $968 and 2022 – $1,087)	1,368	1,487
Mortgage loans	29,949	27,454
Investment funds	77	79
Policy loans	339	347
Funds withheld at interest	31,084	32,880
Derivative assets	3,956	3,309
Short-term Investments	627	2,160
Other investments	701	773
Total investments	176,466	172,488
Consolidated Entity, excluding Affiliated Entity | Fair Value
Investments
Investment funds	77	79
Policy loans	339	347
Funds withheld at interest	35,375	37,727
Short-term Investments	45
Other investments	200	162
Consolidated Entity, excluding Affiliated Entity | Recurring | Fair Value
Investments
Available-for-sale securities	106,713	102,404
Trading securities, at fair value	1,652	1,595
Equity securities, at fair value	968	1,087
Mortgage loans	29,949	27,454
Derivative assets	3,956	3,309
Short-term Investments	582	520
Other investments	501	611
Related Party
Investments
Available-for-sale securities	11,866	9,821
Trading securities, at fair value	885	878
Equity securities, at fair value	251	279
Mortgage loans	1,324	1,302
Investment funds	1,595	1,569
Funds withheld at interest	9,462	9,808
Short-term Investments	1,043	0
Other investments	338	303
Accrued investment income (related party: 2023 – $128 and 2022 – $105)	128	105
Other assets (related party: 2023 – $200 and 2022 – $161)	200	161
Liabilities
Interest sensitive contract liabilities (related party: 2023 – $11,347 and 2022 – $11,889; portion at fair value: 2023 – $7,626 and 2022 – $6,670)	11,347	11,889
Future policy benefits	1,359	1,353
Market risk benefits	210
Other liabilities (related party: 2023 – $612 and 2022 – $564)	612	564
Equity
Accumulated other comprehensive loss (related party: 2023 – $(115) and 2022 – $(167))	(115)	(167)
Related Party | Fair Value
Investments
Investment funds	561	610
Funds withheld at interest	10,728	11,233
Short-term Investments	1,043
Related Party | Recurring | Fair Value
Investments
Available-for-sale securities	11,866	9,821
Trading securities, at fair value	885	878
Equity securities, at fair value	251	279
Mortgage loans	1,324	1,302
Investment funds	1,034	959
Other investments	338	303
Reinsurance recoverable (portion at fair value: 2023 – $1,470 and 2022 – $1,388)		1,388
Consolidated Entity, Affiliated Entity and VIE Primary Beneficiary
Investments
Trading securities, at fair value	39	0
Mortgage loans	348	342
Investment funds	10,512	10,068
Other investments	73	73
Cash and cash equivalents	45	0
Liabilities
Other liabilities (related party: 2023 – $612 and 2022 – $564)	302	292
Investments, excluding investments in Related Party | Recurring | Fair Value
Investments
Equity securities, at fair value	968	1,087
Short-term Investments	$ 582	$ 520

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Assets
Reinsurance recoverable	$ 4,229	$ 4,358
Other assets	7,916	8,693
AFS securities allowance for credit losses	503	459
Investment funds	14,552	14,128
Cash and cash equivalents	13,844	7,779
Accrued investment income, related party	1,458	1,328
Available-for-sale securities	135,597	131,422
Liabilities and Equity
Interest sensitive contract liabilities	181,100	173,616
Future policy benefits	42,490	42,110
Other liabilities	1,600	1,860
Accumulated other comprehensive loss (related party: 2023 – $(115) and 2022 – $(167))	(6,148)	(7,321)
Related Party
Assets
Other assets	200	161
AFS securities allowance for credit losses	1	1
Equity securities, at fair value	251	279
Mortgage loans, net of allowances	1,324	1,302
Investment funds	1,034	959
Investment funds	1,595	1,569
Short-term Investments, fair value portion	1,043	0
Other investments	338	303
Accrued investment income, related party	128	105
Available-for-sale securities	12,396	10,440
Trading securities, at fair value	885	878
Liabilities and Equity
Interest sensitive contract liabilities	11,347	11,889
Future policy benefits	1,359	1,353
Other liabilities	612	564
Accumulated other comprehensive loss (related party: 2023 – $(115) and 2022 – $(167))	(115)	(167)
Consolidated Entity, excluding Affiliated Entity
Assets
AFS securities allowance for credit losses	502	458
Mortgage loans, net of allowances	29,949	27,454
Investment funds	77	79
Short-term Investments, fair value portion	627	2,160
Other investments	701	773
Available-for-sale securities	123,201	120,982
Trading securities, at fair value	1,652	1,595
Consolidated Entity, Affiliated Entity and VIE Primary Beneficiary
Assets
Mortgage loans, net of allowances	348	342
Investment funds	10,512	10,068
Cash and cash equivalents	45	0
Other investments	73	73
Trading securities, at fair value	39	0
Liabilities and Equity
Other liabilities	302	292
Fair Value
Assets
Short-term Investments, fair value portion		1,640
Liabilities and Equity
Interest sensitive contract liabilities	120,063	111,608
Fair Value | Related Party
Assets
Investment funds	561	610
Short-term Investments, fair value portion	1,043
Fair Value | Consolidated Entity, excluding Affiliated Entity
Assets
Investment funds	77	79
Short-term Investments, fair value portion	45
Other investments	200	162
Recurring | Fair Value
Assets
Reinsurance recoverable	1,470	1,388
Other assets	440
Liabilities and Equity
Interest sensitive contract liabilities	7,626	6,670
Future policy benefits	1,769	1,712
Other liabilities		65
Recurring | Fair Value | Investments, excluding investments in Related Party
Assets
Equity securities, at fair value	968	1,087
Short-term Investments, fair value portion	582	520
Recurring | Fair Value | Related Party
Assets
Reinsurance recoverable		1,388
Equity securities, at fair value	251	279
Mortgage loans, net of allowances	1,324	1,302
Investment funds	1,034	959
Embedded derivative assets, fair value	(1,266)	(1,425)
Other investments	338	303
Trading securities, at fair value	885	878
Recurring | Fair Value | Consolidated Entity, excluding Affiliated Entity
Assets
Equity securities, at fair value	968	1,087
Mortgage loans, net of allowances	29,949	27,454
Embedded derivative assets, fair value	(4,291)	(4,847)
Short-term Investments, fair value portion	582	520
Other investments	501	611
Trading securities, at fair value	$ 1,652	$ 1,595

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income (Loss) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenues
Premiums Earned, Net	$ 96	$ 2,110
Insurance Commissions and Fees	198	166
Net Investment Income	2,407	1,683
Investment related gains (losses)	1,065	(4,212)
Other Income	13	(3)
Total revenues	4,060	(281)
Benefits and expenses
Interest sensitive contract benefits	1,289	(99)
Future policy and other policy benefits	466	2,184
Market risk benefits remeasurement (gains) losses	346	(622)
Amortization of deferred acquisition costs, deferred sales inducements and value of business acquired	138	98
Policy and other operating expenses	435	338
Total benefits and expenses	2,674	1,899
Income (loss) before income taxes	1,386	(2,180)
Income tax expense (benefit)	163	(284)
Net income (loss)	1,223	(1,896)
Less: Net income (loss) attributable to noncontrolling interests	455	(881)
Net income (loss) attributable to Athene Holding Ltd. shareholders	768	(1,015)
Less: Preferred stock dividends	47	35
Net income (loss) available to Athene Holding Ltd. common shareholder	721	(1,050)
Variable Interest Entities
Revenues
Net Investment Income	80	17
Investment related gains (losses)	201	(42)
Consolidated Entity, Affiliated Entity and VIE Primary Beneficiary
Revenues
Net Investment Income	22	1
Investment related gains (losses)	$ 224	$ 7

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Income (Loss) (Parenthetical) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Premiums earned	$ 96	$ 2,110
Product charges	198	166
Net Investment Income	2,407	1,683
Investment expense	228	191
Investment gains (losses), net of offsets	1,065	(4,212)
Interest sensitive contract benefits	1,289	(99)
Future policy and other policy benefits	466	2,184
Remeasurement (gains) losses	2	(3)
Market risk benefits remeasurement (gains) losses	(346)	622
Policy and other operating expenses	435	338
Variable Interest Entities
Net Investment Income	80	17
Investment gains (losses), net of offsets	201	(42)
Related Party
Premiums earned	3	71
Product charges	10	10
Net Investment Income	371	501
Investment expense	222	186
Investment gains (losses), net of offsets	85	(604)
Interest sensitive contract benefits	47	(12)
Future policy and other policy benefits	21	74
Market risk benefits remeasurement (gains) losses	28	(44)
Policy and other operating expenses	30	59
Consolidated Entity, Affiliated Entity and VIE Primary Beneficiary
Net Investment Income	22	1
Investment gains (losses), net of offsets	$ 224	$ 7

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 1,223	$ (1,896)
Other comprehensive income (loss), before tax
Unrealized investment gains (losses) on available-for-sale securities	2,099	(6,697)
Unrealized gains (losses) on hedging instruments	104	(129)
Remeasurement gains (losses) on future policy benefits related to discount rate	(802)	3,562
Remeasurement gains (losses) on market risk benefits related to credit risk	89	397
Foreign currency translation and other adjustments	16	(2)
Other comprehensive income (loss), before tax	1,506	(2,869)
Income tax expense (benefit) related to other comprehensive income (loss)	290	(615)
Other comprehensive income (loss)	1,216	(2,254)
Comprehensive income (loss)	2,439	(4,150)
Less: Comprehensive income (loss) attributable to noncontrolling interests	498	(817)
Comprehensive income (loss) attributable to Athene Holding Ltd. shareholders	$ 1,941	$ (3,333)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Equity - USD ($) $ in Millions	Total	Variable Interest Entities	Preferred stock	Common stock	Additional paid-in capital	Retained deficit	Accumulated other comprehensive income (loss)	Total Athene Holding Ltd. shareholders’ equity (deficit)	Noncontrolling interests	Noncontrolling interests Variable Interest Entities
Beginning Balance at Jan. 01, 2022	$ 22,546		$ 0	$ 0	$ 20,270	$ 0	$ 0	$ 20,270	$ 2,276
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(1,896)					(1,015)		(1,015)	(881)
Other Comprehensive Income (Loss), Net of Tax	(2,254)						(2,318)	(2,318)	64
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition	11				11			11
Dividends, Preferred Stock	(35)					(35)		(35)
Dividends, Common Stock	(188)					(188)		(188)
Dividends	(2,752)				(2,726)	(26)		(2,752)
Contributions from noncontrolling interests	311	$ 1,634							311	$ 1,634
Noncontrolling Interest, Period Increase (Decrease)	(84)								(84)
Ending Balance at Mar. 31, 2022	17,293		0	0	17,555	(1,264)	(2,318)	13,973	3,320
Beginning Balance at Dec. 31, 2022	10,549		0	0	18,119	(3,640)	(7,321)	7,158	3,391
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	1,223					768		768	455
Other Comprehensive Income (Loss), Net of Tax	1,216						1,173	1,173	43
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition	11				11			11
Dividends, Preferred Stock	(47)					(47)		(47)
Dividends, Common Stock	(374)					(374)		(374)
Adjustments to Additional Paid in Capital, Other	9				9			9
Contributions from noncontrolling interests									0
Distributions to noncontrolling interests	(127)								(127)
Noncontrolling Interest, Increase from Business Combination	590								590
Ending Balance at Mar. 31, 2023	$ 13,050		$ 0	$ 0	$ 18,139	$ (3,293)	$ (6,148)	$ 8,698	$ 4,352

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities
Net income (loss)		$ 1,223	$ (1,896)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Amortization of deferred acquisition costs, deferred sales inducements and value of business acquired		138	98
Net amortization of net investment premiums, discounts and other		30	73
Net investment (income) loss (related party: 2023 – $(26) and 2022 – $(199))		(32)	(238)
Net recognized (gains) losses on investments and derivatives (related party: 2023 – $(262) and 2022 – $101)		2,031	(1,825)
Policy acquisition costs deferred		(375)	(214)
Changes in operating assets and liabilities:
Accrued investment income (related party: 2023 – $(23) and 2022 – $10)		(130)	77
Interest sensitive contract liabilities (related party: 2023 – $37 and 2022 – $(20))		2,229	(548)
Future policy benefits, market risk benefits and reinsurance recoverable (related party: 2023 – $11 and 2022 – $1)		64	(776)
Funds withheld assets (related party: 2023 – $(186) and 2022 – $475)		(975)	2,365
Other assets and liabilities		(66)	(611)
Net cash provided by operating activities		75	155
Sales, maturities and repayments of:
Available-for-sale securities (related party: 2023 – $225 and 2022 – $913)		2,461	9,264
Trading securities (related party: 2023 – $1 and 2022 – $51)		60	77
Equity securities		76	87
Mortgage loans (related party: 2023 – $5 and 2022 – $28)		657	985
Investment funds (related party: 2023 – $198 and 2022 – $351)		232	427
Derivative instruments and other investments (related party: 2023 – $0 and 2022 – $44)		396	1,179
Short-term investments (related party: 2023 – $159 and 2022 – $0)		1,888	59
Purchases of:
Available-for-sale securities (related party: 2023 – $(2,161) and 2022 – $(1,055))		(6,668)	(11,100)
Trading securities (related party: 2023 – $0 and 2022 – $(143))		(56)	(173)
Equity securities (related party: 2023 – $0 and 2022 – $(13))		(20)	(59)
Mortgage loans (related party: 2023 – $0 and 2022 – $(167))		(2,930)	(4,258)
Investment funds (related party: 2023 – $(318) and 2022 – $(1,833))		(376)	(1,956)
Derivative instruments and other investments (related party: 2023 – $(43) and 2022 – $(77))		(725)	(736)
Short-term investments (related party: 2023 – $(1,193) and 2022 – $(33))		(1,321)	(129)
Cash Acquired from Acquisition		0	393
Deconsolidation of previously consolidated entities		(51)	0
Other investing activities, net		458	(225)
Net cash used in investing activities		(5,919)	(6,165)
Cash flows from financing activities
Deposits on investment-type policies and contracts (related party: 2023 – $3 and 2022 – $18)		12,006	8,342
Withdrawals on investment-type policies and contracts (related party: 2023 – $(116) and 2022 – $(88))		(2,707)	(2,245)
Capital distributions to noncontrolling interests		(127)	0
Payments for (Proceeds from) Derivative Instrument, Financing Activities		3,489	27
Payments of Ordinary Dividends, Preferred Stock and Preference Stock		(47)	(35)
Payments of Ordinary Dividends, Common Stock		(374)	(938)
Other financing activities, net		(127)	1
Net cash provided by financing activities		12,718	5,463
Effect of exchange rate changes on cash and cash equivalents		3	(4)
Net increase (decrease) in cash and cash equivalents		6,877	(551)
Cash and cash equivalents at beginning of year	[1]	8,769	10,429
Cash and cash equivalents at end of period	[1]	15,646	9,878
Non-cash transactions
Deposits on investment-type policies and contracts through reinsurance agreements (related party: 2023 – $5 and 2022 – $72)		27	563
Withdrawals on investment-type policies and contracts through reinsurance agreements (related party: 2023 – $472 and 2022 – $375)		3,029	1,774
Related Party
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Net investment (income) loss (related party: 2023 – $(26) and 2022 – $(199))		(26)	(199)
Net recognized (gains) losses on investments and derivatives (related party: 2023 – $(262) and 2022 – $101)		262	(101)
Changes in operating assets and liabilities:
Accrued investment income (related party: 2023 – $(23) and 2022 – $10)		(23)	10
Interest sensitive contract liabilities (related party: 2023 – $37 and 2022 – $(20))		37	(20)
Future policy benefits, market risk benefits and reinsurance recoverable (related party: 2023 – $11 and 2022 – $1)		11	1
Funds withheld assets (related party: 2023 – $(186) and 2022 – $475)		(186)	475
Sales, maturities and repayments of:
Available-for-sale securities (related party: 2023 – $225 and 2022 – $913)		225	913
Trading securities (related party: 2023 – $1 and 2022 – $51)		1	51
Mortgage loans (related party: 2023 – $5 and 2022 – $28)		5	28
Investment funds (related party: 2023 – $198 and 2022 – $351)		198	351
Derivative instruments and other investments (related party: 2023 – $0 and 2022 – $44)		0	44
Short-term investments (related party: 2023 – $159 and 2022 – $0)		159	0
Purchases of:
Available-for-sale securities (related party: 2023 – $(2,161) and 2022 – $(1,055))		(2,161)	(1,055)
Trading securities (related party: 2023 – $0 and 2022 – $(143))		0	(143)
Mortgage loans (related party: 2023 – $0 and 2022 – $(167))		0	(167)
Investment funds (related party: 2023 – $(318) and 2022 – $(1,833))		(318)	(1,833)
Derivative instruments and other investments (related party: 2023 – $(43) and 2022 – $(77))		(43)	(77)
Short-term investments (related party: 2023 – $(1,193) and 2022 – $(33))		(1,193)	(33)
Cash flows from financing activities
Deposits on investment-type policies and contracts (related party: 2023 – $3 and 2022 – $18)		3	18
Withdrawals on investment-type policies and contracts (related party: 2023 – $(116) and 2022 – $(88))		(116)	(88)
Non-cash transactions
Deposits on investment-type policies and contracts through reinsurance agreements (related party: 2023 – $5 and 2022 – $72)		5	72
Withdrawals on investment-type policies and contracts through reinsurance agreements (related party: 2023 – $472 and 2022 – $375)		472	375
Variable Interest Entities
Cash flows from financing activities
Capital contributions from noncontrolling interests		605	0
Consolidated Entity, excluding VIE Primary Beneficiary
Cash flows from financing activities
Capital contributions from noncontrolling interests		0	311
Reinsurance Settlements
Non-cash transactions
Transfer to Investments		7	0
Pension Risk Transfer Premiums
Non-cash transactions
Transfer to Investments		0	1,759
Dividend Declared
Non-cash transactions
Payments of Distributions to Affiliates		0	2,145
Related Party | Reinsurance Settlements
Non-cash transactions
Transfer to Investments		$ 64	$ 0
[1] 1 Includes cash and cash equivalents, restricted cash and cash and cash equivalents of consolidated variable interest entities.

Condensed Consolidated Statem_6

Condensed Consolidated Statements of Cash Flows (Parenthetical) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Amortization of deferred acquisition costs, deferred sales inducements and value of business acquired	$ 138	$ 98
Net investment (income) loss	(32)	(238)
Net recognized (gains) losses on investments and derivatives	(2,031)	1,825
Accrued investment income	(130)	77
Policy acquisition costs deferred	(375)	(214)
Interest sensitive contract liabilities	2,229	(548)
Future policy benefits, market risk benefits and reinsurance recoverable	64	(776)
Funds withheld assets	(975)	2,365
Sales, maturities and repayments of:
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale	2,461	9,264
Trading securities (related party: 2023 – $1 and 2022 – $51)	60	77
Mortgage loans (related party: 2023 – $5 and 2022 – $28)	657	985
Investment funds (related party: 2023 – $198 and 2022 – $351)	232	427
Derivative instruments and other investments (related party: 2023 – $0 and 2022 – $44)	396	1,179
Short-term investments	1,888	59
Purchases of:
Payments to Acquire Debt Securities, Available-for-sale	(6,668)	(11,100)
Mortgage loans (related party: 2023 – $0 and 2022 – $(167))	(2,930)	(4,258)
Trading securities	(56)	(173)
Investment funds	(376)	(1,956)
Derivative instruments and other investments (related party: 2023 – $(43) and 2022 – $(77))	(725)	(736)
Short-term investments	(1,321)	(129)
Deposits on investment-type policies and contracts	12,006	8,342
Repayments of Annuities and Investment Certificates	(2,707)	(2,245)
Deposits on investment-type policies and contracts through reinsurance agreements	27	563
Withdrawals on investment-type policies and contracts through reinsurance agreements	3,029	1,774
Payments of Ordinary Dividends, Common Stock	374	938
Related Party
Net investment (income) loss	(26)	(199)
Net recognized (gains) losses on investments and derivatives	(262)	101
Accrued investment income	(23)	10
Interest sensitive contract liabilities	37	(20)
Future policy benefits, market risk benefits and reinsurance recoverable	11	1
Funds withheld assets	(186)	475
Sales, maturities and repayments of:
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale	225	913
Trading securities (related party: 2023 – $1 and 2022 – $51)	1	51
Mortgage loans (related party: 2023 – $5 and 2022 – $28)	5	28
Investment funds (related party: 2023 – $198 and 2022 – $351)	198	351
Derivative instruments and other investments (related party: 2023 – $0 and 2022 – $44)	0	44
Short-term investments	159	0
Purchases of:
Payments to Acquire Debt Securities, Available-for-sale	(2,161)	(1,055)
Mortgage loans (related party: 2023 – $0 and 2022 – $(167))	0	(167)
Trading securities	0	(143)
Investment funds	(318)	(1,833)
Derivative instruments and other investments (related party: 2023 – $(43) and 2022 – $(77))	(43)	(77)
Short-term investments	(1,193)	(33)
Deposits on investment-type policies and contracts	3	18
Repayments of Annuities and Investment Certificates	(116)	(88)
Deposits on investment-type policies and contracts through reinsurance agreements	5	72
Withdrawals on investment-type policies and contracts through reinsurance agreements	472	375
Equity securities | Related Party
Purchases of:
Equity securities	0	(13)
Reinsurance Settlements
Purchases of:
Transfer to Investments	7	0
Reinsurance Settlements | Related Party
Purchases of:
Transfer to Investments	64	0
Pension Risk Transfer Premiums
Purchases of:
Transfer to Investments	$ 0	$ 1,759

Business, Basis of Presentation

Business, Basis of Presentation and Significant Accounting Policies	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Business, Basis of Presentation, and Significant Accounting Policies	1. Business, Basis of Presentation and Significant Accounting Policies Athene Holding Ltd. (AHL), a Bermuda exempted company, together with its subsidiaries (collectively, Athene, we, our, us, or the Company), is a leading financial services company that specializes in issuing, reinsuring and acquiring retirement savings products in the United States (US) and internationally. We are a wholly owned subsidiary of Apollo Global Management, Inc. (AGM, and together with its subsidiaries other than us or our subsidiaries, Apollo). See Note 3 – Business Combination for further information regarding our merger with Apollo. We conduct business primarily through the following consolidated subsidiaries: • Our non-US reinsurance subsidiaries, to which AHL’s other insurance subsidiaries and third-party ceding companies directly and indirectly reinsure a portion of their liabilities, including Athene Life Re Ltd. (ALRe), a Bermuda exempted company, Athene Annuity Re Ltd. (AARe) and Athene Life Re International Ltd. (ALReI); and • Athene USA Corporation, an Iowa corporation (together with its subsidiaries, AUSA). In addition, we consolidate certain variable interest entities (VIEs) for which we have determined we are the primary beneficiary. See Note 6 – Variable Interest Entities for further information on VIEs. Consolidation and Basis of Presentation —We have prepared the accompanying condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (US GAAP) for interim financial information and the United States Securities and Exchange Commission’s rules and regulations for Form 10-Q and Article 10 of Regulation S-X. The accompanying condensed consolidated financial statements are unaudited and reflect all adjustments, consisting only of normal recurring items, considered necessary for fair statement of the results for the interim periods presented. All intercompany accounts and transactions have been eliminated. Interim operating results are not necessarily indicative of the results expected for the entire year. For entities that are consolidated, but not wholly owned, we allocate a portion of the income or loss and corresponding equity to the owners other than us. We include the aggregate of the income or loss and corresponding equity that is not owned by us in noncontrolling interests in the condensed consolidated financial statements. The condensed consolidated balance sheet as of December 31, 2022 has been derived from the audited financial statements, with necessary unaudited adjustments made for the implementation of targeted improvements to the accounting for long-duration contracts, and does not include all of the information and footnotes required by US GAAP for complete financial statements. Therefore, these condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2022. The preparation of financial statements requires the use of management estimates. Actual results may differ from estimates used in preparing the condensed consolidated financial statements. Significant Accounting Policies Reinsurance —We assume and cede insurance and investment contracts under coinsurance, funds withheld coinsurance (funds withheld) and modified coinsurance (modco). We follow reinsurance accounting for transactions that provide indemnification against loss or liability relating to insurance risk (risk transfer). To meet risk transfer requirements, a reinsurance agreement must transfer insurance risk arising from uncertainties about both underwriting and timing risks. Cessions under reinsurance do not discharge our obligations as the primary insurer unless the requirements of assumption reinsurance have been met. We generally have the right of offset on reinsurance contracts, but have elected to present reinsurance settlement amounts due to and from us on a gross basis. For assets and liabilities ceded under reinsurance agreements, we generally apply the same measurement guidance for our directly issued or assumed contracts. Ceded amounts are recorded within reinsurance recoverable on the condensed consolidated balance sheets. For reinsurance of in-force contracts that pass risk transfer, the issue year used for the purpose of measuring the reinsurance recoverable is dependent on the effective date of the reinsurance agreement, which may differ from the issue year for the direct or assumed contract. The issue year informs the locked-in discount rate used for the purposes of interest accretion. This may result in different discount rates used for the direct or assumed reserves and ceded reserves when reinsuring an in-force block of insurance contracts. For flow reinsurance of insurance contracts that pass risk transfer, the contracts have the same cash flow assumptions as the direct or assumed contracts when the terms are consistent between those respective contracts and the ceded reinsurance agreement. When we recognize an immediate loss due to the present value of future benefits and expenses exceeding the present value of future gross premiums, a gain is recognized on the corresponding reinsurance recoverable to the extent it does not result in gain recognition at treaty inception. Likewise, where the direct or assumed reserve has been floored to zero, the corresponding reinsurance recoverable will be consistently set to zero. See – Future Policy Benefits below for further information. Accounting for reinsurance requires the use of assumptions, particularly related to the future performance of the underlying business and the potential impact of counterparty credit risks. We attempt to minimize our counterparty credit risk through the structuring of the terms of our reinsurance agreements, including the use of trusts, and monitor credit ratings of counterparties for signs of declining credit quality. When a ceding company does not report information on a timely basis, we record accruals based on the best available information at the time, which includes the reinsurance agreement terms and historical experience. We periodically compare actual and anticipated experience to the assumptions used to establish reinsurance assets and liabilities. Assets and liabilities assumed or ceded under coinsurance, funds withheld or modco are presented gross on the condensed consolidated balance sheets. For investment contracts, the change in the direct or assumed and ceded reserves are presented net in interest sensitive contract benefits on the condensed consolidated statements of income (loss). For insurance contracts, the change in the direct or assumed and ceded reserves and benefits are presented net in future policy and other policy benefits on the condensed consolidated statements of income (loss), except for changes related to the discount rate which are presented net in other comprehensive income (loss) (OCI) on the condensed consolidated statements of comprehensive income (loss). For market risk benefits, the change in the direct or assumed and ceded reserves are presented net in market risk benefits remeasurement (gains) losses on the condensed consolidated statements of income (loss), except for changes related to instrument-specific credit risk on direct and assumed contracts which are presented net in OCI on the condensed consolidated statements of comprehensive income (loss). For the reinsurance of existing in-force blocks that transfer significant insurance risk, the difference between the assets received or paid and the liabilities assumed or ceded represents the net cost of reinsurance at the inception of the reinsurance agreement. The net cost of reinsurance is amortized on a basis consistent with the methodologies and assumptions used to amortize deferred acquisition costs (DAC) and deferred sales inducements (DSI). Deferred Acquisition Costs, Deferred Sales Inducements and Value of Business Acquired Deferred Acquisition Costs and Deferred Sales Inducements – Costs related directly to the successful acquisition of new, or the renewal of existing, insurance or investment contracts are deferred. These costs consist of commissions and policy issuance costs, as well as sales inducements credited to policyholder account balances, and are included in deferred acquisition costs, deferred sales inducements and value of business acquired on the condensed consolidated balance sheets. These costs are not capitalized until they are incurred. Deferred costs related to universal life-type policies and investment contracts with significant revenue streams from sources other than investment of the policyholder funds are grouped into cohorts based on issue year and contract type and amortized on a constant level basis over the expected term of the related contracts. The cohorts and assumptions used for the amortization of deferred costs are consistent with those used in estimating the related liabilities for these contracts. The constant level basis generally is the initial premium or deposit and is projected based on assumptions related to policyholder behavior, including lapses and mortality, over the expected term of the contracts. Each reporting period, we replace expected experience with actual experience to determine the related amortization expense. Changes to projected experience are recognized in amortization expense prospectively over the remaining contract term. Amortization of DAC and DSI is included in amortization of deferred acquisition costs, deferred sales inducements and value of business acquired on the condensed consolidated statements of income (loss). Deferred costs related to investment contracts without significant revenue streams from sources other than investment of the policyholder funds are amortized using the effective interest method. The effective interest method amortizes the deferred costs by discounting the future liability cash flows at a break-even rate. The break-even rate is solved for such that the present value of future liability cash flows is equal to the net liability at the inception of the contract. The deferred costs represent the difference between the net and gross liability and the change relates to amortization for the period. Value of Business Acquired (VOBA) – We establish VOBA for blocks of insurance contracts acquired through the acquisition of insurance entities and through application of pushdown accounting related to our merger with AGM. We record the fair value of the liabilities assumed in two components: reserves and VOBA. Reserves are established using our best estimate assumptions as of the business combination date. VOBA is the difference between the fair value of the liabilities and the reserves. VOBA can be either positive or negative and is amortized in relation to respective policyholder liabilities. Significant assumptions that impact VOBA amortization are consistent with those that impact the measurement of policyholder liabilities. We perform periodic tests to determine if positive VOBA remains recoverable. If we determine that positive VOBA is not recoverable, we would record a cumulative charge to the current period. Any negative VOBA is recorded to the same financial statement line on the condensed consolidated balance sheets as the associated reserves. Positive VOBA is recorded in deferred acquisition costs, deferred sales inducements and value of business acquired on the condensed consolidated balance sheets. See Note 8 – Deferred Acquisition Costs, Deferred Sales Inducements and Value of Business Acquired for further information. Interest Sensitive Contract Liabilities —Universal life-type policies and investment contracts include traditional deferred annuities, indexed annuities consisting of fixed indexed and index-linked variable annuities in the accumulation phase, funding agreements, immediate annuities without significant mortality risk (which include pension group annuities without life contingencies), universal life insurance, and other investment contracts inclusive of assumed endowments without significant mortality risk. We carry liabilities for traditional deferred annuities, indexed annuities, funding agreements and universal life insurance at the account balances without reduction for potential surrender or withdrawal charges, except for a block of universal life business ceded to Global Atlantic Financial Group Limited (together with its subsidiaries, Global Atlantic), which we carry at fair value. Liabilities for immediate annuities without significant mortality risk are calculated as the present value of future liability cash flows and policy maintenance expenses discounted at contractual interest rates. Certain of our contracts are offered with additional contract features that meet the definition of a market risk benefit. See – Market Risk Benefits below for further information. Unearned revenue liabilities are established when amounts are assessed against the policyholder for services to be provided in future periods. These balances are amortized consistent with the methodologies and assumptions used to amortize DAC and DSI. Changes in interest sensitive contract liabilities, excluding deposits and withdrawals, are recorded in interest sensitive contract benefits or product charges on the condensed consolidated statements of income (loss). Interest sensitive contract liabilities are not reduced for amounts ceded under reinsurance agreements which are reported as reinsurance recoverable on the condensed consolidated balance sheets. Future Policy Benefits —We issue contracts classified as long-duration, which include term and whole life, accident and health, disability, and immediate annuities with life contingencies (which include pension group annuities with life contingencies). Liabilities for nonparticipating long-duration contracts are established as the estimated present value of benefits we expect to pay to or on behalf of the policyholder and related expenses less the present value of the net premiums to be collected, referred to as the net premium ratio. The contracts are grouped into cohorts based on issue year and contract type, with an exception for pension group annuities, which are generally assessed at the group annuity contract level. Contracts with different issuance years are not combined. Contracts acquired in a business combination are grouped into a single cohort by contract type, except for pension group annuities, which follow the group annuity contract level. Liabilities for nonparticipating long-duration contracts are established using accepted actuarial valuation methods which require the use of assumptions related to discount rate, expenses, longevity, mortality, morbidity, persistency and other policyholder behavior. We base certain key assumptions, such as longevity, mortality and morbidity, on industry standard data adjusted to align with actual company experience, if needed. We have elected to use expense assumptions that are locked in at issuance for each cohort. All other cash flow assumptions are established at contract issuance and reviewed annually or more frequently if actual experience suggests a revision is necessary. The effects of changes in cash flow assumptions impacting the net premium ratio are recorded as remeasurement changes in the period in which they are made. As cash flow assumptions are reviewed at least annually, there is no provision for adverse deviation included within the liability. Actual experience is recognized in the period in which the experience arises. Actual experience is then incorporated into the net premium ratio for all products and cohorts on a quarterly basis. When the net premium ratio is revised, whether to incorporate actual experience each reporting period or for the review of cash flow assumptions, the liability is recalculated as of the beginning of the period, discounted at the original contract issuance discount rate, and compared with the carrying amount of the liability as of the same date to determine the current period change. The current period change in the liability is recognized as a remeasurement gain or loss. To the extent the present value of benefits and expenses exceeds the present value of gross premiums, we will cap the net premium ratio at one hundred percent by increasing the corresponding liability and recognizing an immediate loss through the condensed consolidated statements of income (loss). The liability is never recorded at an amount less than zero for the cohort. The liability for nonparticipating long-duration contracts is discounted using an upper-medium grade fixed income instrument yield aligned to the duration of the liability. In determining reference portfolio of instruments, we have used a single A equivalent level rate and maximized the use of observable data to the extent possible for the duration of our liabilities. The discount rate is required to be updated at the end of each reporting period for the remeasurement of the liability but is locked-in for each cohort for the purpose of interest accretion expense. Changes in the value of the liability for nonparticipating long-duration contracts due to changes in the discount rate are recognized as a component of OCI on the condensed consolidated statements of comprehensive income (loss). The change in the liability for the remeasurement gain or loss and all other changes in the liability are recorded in future policy and other policy benefits on the condensed consolidated statements of income (loss). Future policy benefits include liabilities for no-lapse guarantees on universal life insurance and fixed indexed universal life insurance that do not meet the criteria to be classified and accounted for as a market risk benefit. We establish future policy benefits for no-lapse guarantees by estimating the expected value of death benefits paid after policyholder account balances have been exhausted. We recognize these benefits proportionally over the life of the contracts based on total actual and expected assessments. The methods we use to estimate the liabilities have assumptions about policyholder behavior, mortality, expected yield on investments supporting the liability and market conditions affecting policyholder account balance growth. For the liabilities associated with no-lapse guarantees, each reporting period we update expected excess benefits and assessments with actual excess benefits and assessments and adjust the liability balances due to the OCI effects of unrealized investment gains and losses on available-for-sale (AFS) securities. We also periodically revise the key assumptions used in the calculation of the liabilities that result in revisions to the expected excess benefits and assessments. The effects of changes in assumptions are recorded as unlocking in the period in which the changes are made. Changes in the liabilities associated with no-lapse guarantees, other than the adjustment for the OCI effects of unrealized investment gains and losses on AFS securities, are recorded in future policy and other policy benefits on the condensed consolidated statements of income (loss). Future policy benefits are not reduced for amounts ceded under reinsurance agreements which are reported as reinsurance recoverable on the condensed consolidated balance sheets. Market Risk Benefits —Market risk benefits represent contracts or contract features that both provide protection to the contract holder from, and expose the insurance entity to, other-than-nominal capital market risk. We issue and reinsure deferred annuity contracts which contain guaranteed lifetime withdrawal benefits (GLWB) and guaranteed minimum death benefit (GMDB) riders that meet the criteria for, and are classified as, market risk benefits. Market risk benefits are measured at fair value at the contract level and may be recorded as a liability or an asset, which are included in market risk benefits or other assets, respectively, on the condensed consolidated balance sheets. Multiple market risk benefits on a contract are treated as a single, compound market risk benefit. At contract inception, we assess the fees and assessments that are collectible from the policyholder and allocate them to the extent they are attributable to the market risk benefit. These attributed fees are used in the valuation of the market risk benefits and are never negative or exceed total explicit fees collectible from the policyholder. If the fees are sufficient to cover the projected benefits, a non-option based valuation model is used. If the fees are insufficient to cover the projected benefits, an option-based valuation model is used to compute the market risk benefit liability at contract inception, with an equal and offsetting adjustment recognized in interest sensitive contract liabilities. Changes in fair value of market risk benefits are recorded in market risk benefits remeasurement (gains) losses on the condensed consolidated statements of income (loss), excluding portions attributed to changes in instrument-specific credit risk, which are recorded in OCI on the condensed consolidated statements of comprehensive income (loss). Market risk benefits are not reduced for market risk benefits ceded under reinsurance agreements. Ceded market risk benefits are measured at fair value and recorded within reinsurance recoverable on the condensed consolidated balance sheets. Upon annuitization of the contract or the extinguishment of the account balance, the market risk benefit, related annuity contract and unamortized deferred costs are derecognized, including amounts within AOCI. A payout annuity is then established for GLWBs. Recognition of Revenues and Related Expenses —Revenues for universal life-type policies and investment contracts, including surrender and market value adjustments, costs of insurance, policy administration, GMDB, GLWB and no-lapse guarantee charges, are earned when assessed against policyholder account balances during the period. Interest credited to policyholder account balances and the change in fair value of embedded derivatives within fixed indexed annuity contracts is included in interest sensitive contract benefits on the condensed consolidated statements of income (loss). Premiums for long-duration contracts, including products with fixed and guaranteed premiums and benefits, are recognized as revenue when due from policyholders. When premiums are due over a significantly shorter period than the period over which benefits are provided, such as immediate annuities with life contingencies (which includes pension group annuities), a deferred profit liability is established equal to the excess of the gross premium over the net premium. The deferred profit liability is recognized in future policy benefits on the condensed consolidated balance sheets and amortized into income in relation to applicable policyholder liabilities through future policy and other policy benefits on the condensed consolidated statements of income (loss). When the net premium ratio for the corresponding future policy benefit is updated for actual experience and changes to projected cash flow assumptions, the deferred profit liability is retrospectively recalculated from the contract issuance date through the beginning of the current reporting period. The revised deferred profit liability is compared to the beginning of the period carrying amount to determine the change to be recognized as a remeasurement gain or loss within future policy and other policy benefits on the condensed consolidated statements of income (loss). Unlike the related future policy benefit, the deferred profit liability will not be remeasured for changes in discount rates each reporting period. Negative VOBA balances associated with payout contracts involving life contingencies, including pension group annuities, are accounted for in a manner similar to the deferred profit liability. All insurance-related revenue is reported net of reinsurance ceded. Recently Issued Accounting Pronouncements Investments – Equity Method and Joint Ventures (Accounting Standards Update (ASU) 2023-02) The amendments in this update introduce the option of applying the proportional amortization method (PAM) to account for investments made primarily for the purpose of receiving income tax credits or other income tax benefits when certain requirements are met. Currently, PAM only applies to low-income housing tax credit (LIHTC) investments. The guidance is effective for us on January 1, 2024; however, early adoption is permitted. We are currently evaluating the impact of the new pronouncement. Fair Value Measurement — Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (ASU 2022-03) This amendment clarifies guidance that a restriction that is a characteristic of the holding entity, rather than a characteristic of the equity security itself, should not be considered in its fair value measurement. As a result, we are required to measure the fair value of equity securities subject to contractual restrictions attributable to the holding entity on the basis of the market price of the same equity security without those contractual restrictions. Companies are not permitted to recognize a contractual sale restriction attributable to the holding entity as a separate unit of account. The guidance also requires disclosures for these equity securities. The guidance is effective for us on January 1, 2024; however, early adoption is permitted. We will apply the guidance prospectively and recognize in earnings any adjustments required as a result of the adoption. We are currently evaluating the impact of the new pronouncement. Adopted Accounting Pronouncements Insurance – Targeted Improvements to the Accounting for Long-Duration Contracts (ASU 2020-11, ASU 2019-09, ASU 2018-12) These updates amend four key areas pertaining to the accounting and disclosures for long-duration insurance and investment contracts and are commonly referred to as long-duration targeted improvements (LDTI). • The update requires cash flow assumptions used to measure the liability for future policy benefits to be updated at least annually and no longer allows a provision for adverse deviation. The remeasurement of the liability associated with the update of assumptions is required to be recognized in net income. Loss recognition testing is eliminated for traditional and limited-payment contracts. The update also requires the discount rate used in measuring the liability to be an upper-medium grade fixed income instrument yield, which is to be updated at each reporting date. The change in liability due to changes in the discount rate is to be recognized in other comprehensive income. • The update simplifies the amortization of DAC and other balances amortized in proportion to premiums, gross profits or gross margins, requiring such balances to be amortized on a constant level basis over the expected term of the contracts. Deferred costs are required to be written off for unexpected contract terminations but are not subject to impairment testing. • The update requires certain contract features meeting the definition of market risk benefits to be measured at fair value. Among the features included in this definition are GLWB and GMDB riders attached to our annuity products. The change in fair value of the market risk benefits is to be recognized in net income, excluding the portion attributable to changes in instrument-specific credit risk which is recognized in other comprehensive income. • The update also introduces disclosure requirements around the liability for future policy benefits, policyholder account balances, market risk benefits, separate account liabilities and deferred acquisition costs. This includes disaggregated rollforwards of these balances and information about significant inputs, judgments, assumptions and methods used in their measurement. We adopted LDTI as of January 1, 2023 and, for all provisions of the update, applied a retrospective transition approach using a transition date of January 1, 2022, the date of our merger with AGM. At the merger date, VOBA balances were established as the difference between the fair value of the liabilities and the reserves established as of this date. Upon transition to LDTI, the liability for future policy benefits and contractual features that meet the criteria for market risk benefits were adjusted to conform to LDTI, with an offsetting adjustment made to positive or negative VOBA. No adjustments were recorded to AOCI or retained deficit as of the transition date. See Note 2 – Adoption of Accounting Pronouncement for the effects of LDTI adoption on our 2022 condensed consolidated financial statements. Reference Rate Reform (Topic 848) (Accounting Standards Update (ASU) 2022-06, ASU 2021-01, ASU 2020-04) We adopted ASU 2020-04 and ASU 2021-01 and elected to apply certain of the practical expedients related to contract modifications, hedge accounting relationships, and derivative modifications pertaining to discounting, margining, or contract price alignment. The main purpose of the practical expedients is to ease the administrative burden of accounting for contracts impacted by reference rate reform, and these elections did not have, and are not expected to have, a material impact on the consolidated financial statements. ASU 2022-06 amended and deferred the sunset date of Topic 848 from December 31, 2022, to December 31, 2024, after which we will no longer be permitted to apply the expedients provided in Topic 848. We will continue to evaluate the impact of reference rate reform on contract modifications and hedging relationships.

Adoption of Accounting Pronounc

Adoption of Accounting Pronouncement	3 Months Ended
	Mar. 31, 2023
Accounting Changes and Error Corrections [Abstract]
Adoption of Accounting Pronouncement	2. Adoption of Accounting Pronouncement The following table summarizes future policy benefits and changes to the liability: (In millions) Traditional deferred annuities Indexed annuities Payout annuities Reconciling items 1 Total Balance as of January 1, 2022 $ 221 $ 5,389 $ 32,872 $ 8,632 $ 47,114 Change in discount rate assumptions — — 2,406 — 2,406 Adjustment for removal of balances related to market risk benefits (221) (5,389) — — (5,610) Adjustment for offsetting balance in negative VOBA 2 — — — (2,428) (2,428) Adjusted balance as of January 1, 2022 $ — $ — $ 35,278 $ 6,204 $ 41,482 1 Reconciling items primarily include negative VOBA associated with our liability for future policy benefits, as well as reserves for our immaterial lines of business including term and whole life, accident and health and disability, as well as other insurance benefit reserves for our no-lapse guarantees with universal life contracts, all of which are fully ceded. 2 Uneliminated adjustments were recorded to positive VOBA within deferred acquisition costs, deferred sales inducements and value of business acquired on the condensed consolidated balance sheets. Adjustments to the deferred profit liability were not required as these balances were set to zero on the merger date. Since the liability for future policy benefits was measured at fair value on the merger date, there were no instances upon transition in which net premiums exceeded gross premiums which would have required an immediate loss to be recognized in net income. The following table presents the net liability position of market risk benefits: (In millions) Traditional deferred annuities Indexed annuities Total Balance as of January 1, 2022 $ — $ — $ — Adjustment for addition of existing balances 1 221 5,389 5,610 Adjustment to positive VOBA due to fair value adjustment for market risk benefits 2 32 (1,165) (1,133) Adjustment to negative VOBA due to fair value adjustment for market risk benefits 3 — (30) (30) Adjusted balance as of January 1, 2022 $ 253 $ 4,194 $ 4,447 1 Previously recorded within future policy benefits on the condensed consolidated balance sheets. 2 Previously recorded within deferred acquisition costs, deferred sales inducements and value of business acquired on the condensed consolidated balance sheets. 3 Previously recorded within interest sensitive contract liabilities on the condensed consolidated balance sheets. The following table represents market risk benefits by asset and liability positions: (In millions) Asset 1 Liability Net liability Traditional deferred annuities $ — $ 253 $ 253 Indexed annuities 366 4,560 4,194 Adjusted balance as of January 1, 2022 $ 366 $ 4,813 $ 4,447 1 Included in other assets on the condensed consolidated balance sheets. The following table summarizes the change in deferred acquisition costs, deferred sales inducements and value of business acquired: (In millions) VOBA Balance as of January 1, 2022 $ 4,527 Change in discount rate assumptions for future policy benefits (22) Fair value adjustment of market risk benefits (1,133) Adjusted balance as of January 1, 2022 $ 3,372 The following represents the effects of LDTI adoption on the applicable financial statement lines of our condensed consolidated balance sheet: December 31, 2022 (In millions) Reported Adoption Adjusted Assets Reinsurance recoverable $ 4,367 $ (9) $ 4,358 Deferred acquisition costs, deferred sales inducements and value of business acquired 5,576 (1,110) 4,466 Other assets 9,690 (997) 8,693 Total assets $ 246,047 $ (2,116) $ 243,931 Liabilities and Equity Liabilities Interest sensitive contract liabilities $ 173,653 $ (37) $ 173,616 Future policy benefits 55,328 (13,218) 42,110 Market risk benefits — 2,970 2,970 Total liabilities 243,667 (10,285) 233,382 Equity Retained deficit (4,892) 1,252 (3,640) Accumulated other comprehensive income (loss) (12,311) 4,990 (7,321) Total Athene Holding Ltd. shareholders’ equity 916 6,242 7,158 Noncontrolling interests 1,464 1,927 3,391 Total equity 2,380 8,169 10,549 Total liabilities and equity $ 246,047 $ (2,116) $ 243,931 The following represents the effects of LDTI adoption on the applicable financial statement lines of our condensed consolidated statements of income (loss): Three months ended March 31, 2022 (In millions) Reported Adoption Adjusted Revenues Investment related gains (losses) $ (4,200) $ (12) $ (4,212) Total revenues (269) (12) (281) Benefits and expenses Interest sensitive contract benefits (41) (58) (99) Future policy and other policy benefits 2,085 99 2,184 Market risk benefits remeasurement (gains) losses — (622) (622) Amortization of deferred acquisition costs, deferred sales inducements and value of business acquired 125 (27) 98 Policy and other operating expenses 335 3 338 Total benefits and expenses 2,504 (605) 1,899 Income (loss) before income taxes (2,773) 593 (2,180) Income tax expense (benefit) (407) 123 (284) Net income (loss) (2,366) 470 (1,896) Less: Net income (loss) attributable to noncontrolling interests (883) 2 (881) Net income (loss) attributable to Athene Holding Ltd. shareholders (1,483) 468 (1,015) Less: Preferred stock dividends 35 — 35 Net income (loss) available to Athene Holding Ltd. common shareholder $ (1,518) $ 468 $ (1,050) Six months ended June 30, 2022 (In millions) Reported Adoption Adjusted Revenues Total revenues $ 1,526 $ — $ 1,526 Benefits and expenses Interest sensitive contract benefits (662) (90) (752) Future policy and other policy benefits 7,694 266 7,960 Market risk benefits remeasurement (gains) losses — (1,231) (1,231) Amortization of deferred acquisition costs, deferred sales inducements and value of business acquired 250 (44) 206 Policy and other operating expenses 693 2 695 Total benefits and expenses 7,975 (1,097) 6,878 Income (loss) before income taxes (6,449) 1,097 (5,352) Income tax expense (benefit) (891) 229 (662) Net income (loss) (5,558) 868 (4,690) Less: Net loss attributable to noncontrolling interests (1,955) (15) (1,970) Net income (loss) attributable to Athene Holding Ltd. shareholders (3,603) 883 (2,720) Less: Preferred stock dividends 70 — 70 Net income (loss) available to Athene Holding Ltd. common shareholder $ (3,673) $ 883 $ (2,790) Nine months ended September 30, 2022 (In millions) Reported Adoption Adjusted Revenues Investment related gains (losses) $ (12,812) $ 1 $ (12,811) Total revenues 3,835 1 3,836 Benefits and expenses Interest sensitive contract benefits (573) (8) (581) Future policy and other policy benefits 10,988 242 11,230 Market risk benefits remeasurement (gains) losses — (1,689) (1,689) Amortization of deferred acquisition costs, deferred sales inducements and value of business acquired 375 (57) 318 Policy and other operating expenses 1,081 2 1,083 Total benefits and expenses 11,871 (1,510) 10,361 Income (loss) before income taxes (8,036) 1,511 (6,525) Income tax expense (benefit) (1,101) 318 (783) Net income (loss) (6,935) 1,193 (5,742) Less: Net income (loss) attributable to noncontrolling interests (2,431) (4) (2,435) Net income (loss) attributable to Athene Holding Ltd. shareholders (4,504) 1,197 (3,307) Less: Preferred stock dividends 105 — 105 Net income (loss) available to Athene Holding Ltd. common shareholder $ (4,609) $ 1,197 $ (3,412) Year ended December 31, 2022 (In millions) Reported Adoption Adjusted Revenues Total revenues $ 7,623 $ — $ 7,623 Benefits and expenses Interest sensitive contract benefits 541 (3) 538 Future policy and other policy benefits 12,310 155 12,465 Market risk benefits remeasurement (gains) losses — (1,657) (1,657) Amortization of deferred acquisition costs, deferred sales inducements and value of business acquired 509 (65) 444 Policy and other operating expenses 1,493 2 1,495 Total benefits and expenses 14,853 (1,568) 13,285 Income (Loss) before income taxes (7,230) 1,568 (5,662) Income tax expense (benefit) (976) 330 (646) Net income (loss) (6,254) 1,238 (5,016) Less: Net loss attributable to noncontrolling interests (2,092) (14) (2,106) Net income (loss) attributable to Athene Holding Ltd. shareholders (4,162) 1,252 (2,910) Less: Preferred stock dividends 141 — 141 Net income (loss) available to Athene Holding Ltd. common shareholder $ (4,303) $ 1,252 $ (3,051) The following represents the effects of LDTI adoption on the applicable financial statement lines of our condensed consolidated statements of comprehensive income (loss): Three months ended March 31, 2022 (In millions) Reported Adoption Adjusted Net income (loss) $ (2,366) $ 470 $ (1,896) Other comprehensive income (loss), before tax Unrealized investment gains (losses) on available-for-sale securities (6,430) (267) (6,697) Remeasurement gains (losses) on future policy benefits related to discount rate — 3,562 3,562 Remeasurement gains (losses) on market risk benefits related to credit risk — 397 397 Foreign currency translation and other adjustments 4 (6) (2) Other comprehensive income (loss), before tax (6,555) 3,686 (2,869) Income tax expense (benefit) related to other comprehensive income (loss) (1,170) 555 (615) Other comprehensive income (loss) (5,385) 3,131 (2,254) Comprehensive income (loss) (7,751) 3,601 (4,150) Less: Comprehensive income (loss) attributable to noncontrolling interests (1,594) 777 (817) Comprehensive income (loss) attributable to Athene Holding Ltd. shareholders $ (6,157) $ 2,824 $ (3,333) Six months ended June 30, 2022 (In millions) Reported Adoption Adjusted Net income (loss) $ (5,558) $ 868 $ (4,690) Other comprehensive income (loss), before tax Unrealized investment gains (losses) on available-for-sale securities (13,703) (547) (14,250) Remeasurement gains (losses) on future policy benefits related to discount rate — 6,459 6,459 Remeasurement gains (losses) on market risk benefits related to credit risk — 576 576 Foreign currency translation and other adjustments (54) (27) (81) Other comprehensive income (loss), before tax (13,805) 6,461 (7,344) Income tax expense (benefit) related to other comprehensive income (loss) (2,453) 960 (1,493) Other comprehensive income (loss) (11,352) 5,501 (5,851) Comprehensive income (loss) (16,910) 6,369 (10,541) Less: Comprehensive income (loss) attributable to noncontrolling interests (3,520) 1,397 (2,123) Comprehensive income (loss) attributable to Athene Holding Ltd. shareholders $ (13,390) $ 4,972 $ (8,418) Nine months ended September 30, 2022 (In millions) Reported Adoption Adjusted Net income (loss) $ (6,935) $ 1,193 $ (5,742) Other comprehensive income (loss), before tax Unrealized investment gains (losses) on available-for-sale securities (19,414) (764) (20,178) Remeasurement gains (losses) on future policy benefits related to discount rate — 8,833 8,833 Remeasurement gains (losses) on market risk benefits related to credit risk — 524 524 Foreign currency translation and other adjustments (13) (59) (72) Other comprehensive income (loss), before tax (19,555) 8,534 (11,021) Income tax expense (benefit) related to other comprehensive income (loss) (3,444) 1,224 (2,220) Other comprehensive income (loss) (16,111) 7,310 (8,801) Comprehensive income (loss) (23,046) 8,503 (14,543) Less: Comprehensive income (loss) attributable to noncontrolling interests (4,787) 2,024 (2,763) Comprehensive income (loss) attributable to Athene Holding Ltd. shareholders $ (18,259) $ 6,479 $ (11,780) Year ended December 31, 2022 (In millions) Reported Adoption Adjusted Net income (loss) $ (6,254) $ 1,238 $ (5,016) Other comprehensive income (loss), before tax Unrealized investment gains (losses) on available-for-sale securities (17,457) (699) (18,156) Remeasurement gains (losses) on future policy benefits related to discount rate — 8,425 8,425 Remeasurement gains (losses) on market risk benefits related to credit risk — 366 366 Foreign currency translation and other adjustments (16) (11) (27) Other comprehensive income (loss), before tax (17,471) 8,081 (9,390) Income tax expense (benefit) related to other comprehensive income (loss) (3,083) 1,150 (1,933) Other comprehensive income (loss) (14,388) 6,931 (7,457) Comprehensive income (loss) (20,642) 8,169 (12,473) Less: Comprehensive income (loss) attributable to noncontrolling interests (4,169) 1,927 (2,242) Comprehensive income (loss) attributable to Athene Holding Ltd. shareholders $ (16,473) $ 6,242 $ (10,231) We made corresponding adjustments to the condensed consolidated statements of equity for the relevant periods to reflect the changes to net loss and comprehensive loss, as presented above. The following represents the effects of LDTI adoption on the applicable financial statement lines of our condensed consolidated statements of cash flows: Three months ended March 31, 2022 (In millions) Reported Adoption Adjusted Net income (loss) $ (2,366) $ 470 $ (1,896) Adjustments to reconcile net income (loss) to net cash provided by operating activities: Amortization of deferred acquisition costs, deferred sales inducements and value of business acquired 125 (27) 98 Net recognized (gains) losses on investments and derivatives 1,813 12 1,825 Changes in operating assets and liabilities: Interest sensitive contract liabilities (480) (68) (548) Future policy benefits, market risk benefits and reinsurance recoverable (266) (510) (776) Other assets and liabilities (734) 123 (611) Net cash provided by operating activities 155 — 155 Net cash used in investing activities (6,165) — (6,165) Net cash provided by financing activities 5,463 — 5,463 Effect of exchange rate changes on cash and cash equivalents (4) — (4) Net decrease in cash and cash equivalents (551) — (551) Cash and cash equivalents at beginning of year 1 10,429 — 10,429 Cash and cash equivalents at end of period 1 $ 9,878 $ — $ 9,878 1 Includes cash and cash equivalents, restricted cash and cash and cash equivalents of consolidated variable interest entities. Six months ended June 30, 2022 (In millions) Reported Adoption Adjusted Net income (loss) $ (5,558) $ 868 $ (4,690) Adjustments to reconcile net income (loss) to net cash provided by operating activities: Amortization of deferred acquisition costs, deferred sales inducements and value of business acquired 250 (44) 206 Changes in operating assets and liabilities: Interest sensitive contract liabilities (1,604) (120) (1,724) Future policy benefits, market risk benefits and reinsurance recoverable 3,933 (933) 3,000 Other assets and liabilities (1,139) 229 (910) Net cash provided by operating activities 4,726 — 4,726 Net cash used in investing activities (11,719) — (11,719) Net cash provided by financing activities 8,707 — 8,707 Effect of exchange rate changes on cash and cash equivalents (20) — (20) Net increase in cash and cash equivalents 1,694 — 1,694 Cash and cash equivalents at beginning of year 1 10,429 — 10,429 Cash and cash equivalents at end of period 1 $ 12,123 $ — $ 12,123 1 Includes cash and cash equivalents, restricted cash and cash and cash equivalents of consolidated variable interest entities. Nine months ended September 30, 2022 (In millions) Reported Adoption Adjusted Net income (loss) $ (6,935) $ 1,193 $ (5,742) Adjustments to reconcile net income (loss) to net cash provided by operating activities: Amortization of deferred acquisition costs, deferred sales inducements and value of business acquired 375 (57) 318 Net recognized (gains) losses on investments and derivatives 5,958 (1) 5,957 Changes in operating assets and liabilities: Interest sensitive contract liabilities (2,002) (50) (2,052) Future policy benefits, market risk benefits and reinsurance recoverable 5,240 (1,403) 3,837 Other assets and liabilities (1,586) 318 (1,268) Net cash provided by operating activities 6,077 — 6,077 Net cash used in investing activities (22,338) — (22,338) Net cash provided by financing activities 17,115 — 17,115 Effect of exchange rate changes on cash and cash equivalents (18) — (18) Net increase in cash and cash equivalents 836 — 836 Cash and cash equivalents at beginning of year 1 10,429 — 10,429 Cash and cash equivalents at end of period 1 $ 11,265 $ — $ 11,265 1 Includes cash and cash equivalents, restricted cash and cash and cash equivalents of consolidated variable interest entities. Year ended December 31, 2022 (In millions) Reported Adoption Adjusted Net income (loss) $ (6,254) $ 1,238 $ (5,016) Adjustments to reconcile net income (loss) to net cash provided by operating activities: Amortization of deferred acquisition costs, deferred sales inducements and value of business acquired 509 (65) 444 Changes in operating assets and liabilities: Interest sensitive contract liabilities (1,269) (68) (1,337) Future policy benefits, market risk benefits and reinsurance recoverable 5,339 (1,438) 3,901 Other assets and liabilities (1,527) 333 (1,194) Net cash provided by operating activities 6,258 — 6,258 Net cash used in investing activities (34,375) — (34,375) Net cash provided by financing activities 26,472 — 26,472 Effect of exchange rate changes on cash and cash equivalents (15) — (15) Net decrease in cash and cash equivalents (1,660) — (1,660) Cash and cash equivalents at beginning of year 1 10,429 — 10,429 Cash and cash equivalents at end of year 1 $ 8,769 $ — $ 8,769 1 Includes cash and cash equivalents, restricted cash and cash and cash equivalents of consolidated variable interest entities.

Business Combination

Business Combination	3 Months Ended
	Mar. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Business Combination	3. Business Combination On January 1, 2022, we completed our merger with Apollo and are a direct subsidiary of AGM. At the closing of the merger, each issued and outstanding AHL Class A common share (other than shares held by Apollo, the Apollo Operating Group (AOG) or the respective direct or indirect wholly owned subsidiaries of Athene or the AOG) was converted automatically into 1.149 shares of AGM common shares and any cash paid in lieu of fractional AGM common shares. In connection with the merger, AGM issued to AHL Class A common shareholders 158.2 million AGM common shares in exchange for 137.6 million AHL Class A common shares that were issued and outstanding as of the acquisition date, exclusive of the 54.6 million shares previously held by Apollo immediately before the acquisition date. The consideration was calculated based on historical AGM’s December 31, 2021 closing share price multiplied by the AGM common shares issued in the share exchange, as well as the fair value of stock-based compensation awards replaced, fair value of warrants converted to AGM common shares and other equity consideration, and effective settlement of pre-existing relationships and other consideration. The following represents the calculation of consideration: (In millions, except exchange ratio and share price data) Consideration AHL common shares purchased 138 Exchange ratio 1.149 Shares of common stock issued in exchange 158 AGM Class A shares closing price $ 72.43 Total merger consideration at closing $ 11,455 Fair value of estimated RSUs, options and warrants assumed and other equity consideration 699 Effective settlement of pre-existing relationships 896 Total merger consideration 13,050 Fair value of AHL common shares previously held by Apollo and other adjustments 4,554 Total AHL equity value held by AGM 17,604 Fair value of preferred stock 2,666 Noncontrolling interest 2,276 Total AHL equity value $ 22,546 The following represents the calculation of goodwill and fair value amounts recognized: (In millions) Fair value and goodwill calculation Merger consideration $ 13,050 Fair value of AHL common shares previously held by Apollo and other adjustments 4,554 Total AHL equity value held by AGM 17,604 Assets Investments $ 176,015 Cash and cash equivalents 9,479 Restricted cash 796 Investment in related parties 33,863 Reinsurance recoverable 4,977 VOBA 3,372 Other assets 6,115 Assets of consolidated variable interest entities 3,635 Estimated fair value of total assets acquired by AGM 238,252 Liabilities Interest sensitive contract liabilities 160,241 Future policy benefits 41,482 Market risk benefits 4,813 Debt 3,295 Payables for collateral on derivatives and securities to repurchase 7,044 Other liabilities 2,443 Liabilities of consolidated variable interest entities 461 Estimated fair value of total liabilities assumed by AGM 219,779 Identifiable net assets 18,473 Less: Fair value of preferred stock 2,666 Less: Fair value of noncontrolling interests 2,276 Estimated fair value of net assets acquired by AGM, excluding goodwill 13,531 Goodwill attributable to AHL $ 4,073 As part of pushdown accounting, we recorded the calculated goodwill based on the amount that our AHL equity value to be held by AGM exceeded the fair value of identifiable net assets less the amounts attributable to fair values of preferred stock and noncontrolling interests. Goodwill is primarily attributable to the scale, skill sets, operations, and synergies that can be achieved subsequent to the merger. The goodwill recorded is not expected to be deductible for tax purposes. We also recorded VOBA and other identifiable intangible assets. Other identifiable intangible assets are included in other assets on the condensed consolidated balance sheets, as follows: Distribution channels These assets are valued using the excess earnings method, which derives value based on the present value of the cash flow attributable to the distribution channels, less returns for contributory assets. Amortization of these assets is on a straight-line basis. Trade name This represents the Athene trade name and was valued using the relief-from-royalty method considering publicly available third-party trade name royalty rates as well as expected premiums generated by the use of the trade name over its anticipated life. Amortization of this asset is on a straight-line basis. Insurance licenses Licenses are protected through registration and were valued using the market approach based on third-party market transactions from which the prices paid for state insurance licenses could be derived. These assets are not amortized. The fair value and weighted average estimated useful life of identifiable intangible assets consists of the following: Fair value (in millions) Weighted average useful life (in years) VOBA $ 3,372 7 Distribution channels 1,870 18 Trade name 160 20 Insurance licenses 26 Indefinite Total $ 5,428

Investments

Investments	3 Months Ended
	Mar. 31, 2023
Schedule of Investments [Abstract]
Investments	4. Investments AFS Securities — Our AFS investment portfolio includes bonds, collateralized loan obligations (CLO), asset-backed securities (ABS), commercial mortgage-backed securities (CMBS), residential mortgage-backed securities (RMBS) and redeemable preferred stock. Our AFS investment portfolio includes related party investments that are primarily comprised of investments over which Apollo can exercise significant influence. These investments are presented as investments in related parties on the condensed consolidated balance sheets, and are separately disclosed below. The following table represents the amortized cost, allowance for credit losses, gross unrealized gains and losses and fair value of our AFS investments by asset type: March 31, 2023 (In millions) Amortized Cost Allowance for Credit Losses Gross Unrealized Gains Gross Unrealized Losses Fair Value AFS securities US government and agencies $ 3,327 $ — $ 6 $ (630) $ 2,703 US state, municipal and political subdivisions 1,215 — — (249) 966 Foreign governments 1,205 (27) 5 (261) 922 Corporate 75,348 (79) 167 (12,295) 63,141 CLO 18,643 (4) 134 (1,207) 17,566 ABS 11,696 (31) 31 (823) 10,873 CMBS 4,717 (5) 2 (524) 4,190 RMBS 7,050 (356) 197 (539) 6,352 Total AFS securities 123,201 (502) 542 (16,528) 106,713 AFS securities – related parties Corporate 1,180 — 1 (54) 1,127 CLO 3,736 (1) 14 (236) 3,513 ABS 7,480 — 12 (266) 7,226 Total AFS securities – related parties 12,396 (1) 27 (556) 11,866 Total AFS securities including related parties $ 135,597 $ (503) $ 569 $ (17,084) $ 118,579 December 31, 2022 (In millions) Amortized Cost Allowance for Credit Losses Gross Unrealized Gains Gross Unrealized Losses Fair Value AFS securities US government and agencies $ 3,333 $ — $ — $ (756) $ 2,577 US state, municipal and political subdivisions 1,218 — — (291) 927 Foreign governments 1,207 (27) 3 (276) 907 Corporate 74,644 (61) 92 (13,774) 60,901 CLO 17,722 (7) 115 (1,337) 16,493 ABS 11,447 (29) 15 (906) 10,527 CMBS 4,636 (5) 6 (479) 4,158 RMBS 6,775 (329) 64 (596) 5,914 Total AFS securities 120,982 (458) 295 (18,415) 102,404 AFS securities – related parties Corporate 1,028 — 1 (47) 982 CLO 3,346 (1) 10 (276) 3,079 ABS 6,066 — 3 (309) 5,760 Total AFS securities – related parties 10,440 (1) 14 (632) 9,821 Total AFS securities including related parties $ 131,422 $ (459) $ 309 $ (19,047) $ 112,225 The amortized cost and fair value of AFS securities, including related parties, are shown by contractual maturity below: March 31, 2023 (In millions) Amortized Cost Fair Value AFS securities Due in one year or less $ 1,410 $ 1,377 Due after one year through five years 13,421 12,501 Due after five years through ten years 20,917 18,072 Due after ten years 45,347 35,782 CLO, ABS, CMBS and RMBS 42,106 38,981 Total AFS securities 123,201 106,713 AFS securities – related parties Due after one year through five years 735 731 Due after five years through ten years 286 258 Due after ten years 159 138 CLO and ABS 11,216 10,739 Total AFS securities – related parties 12,396 11,866 Total AFS securities including related parties $ 135,597 $ 118,579 Actual maturities can differ from contractual maturities as borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Unrealized Losses on AFS Securities — The following summarizes the fair value and gross unrealized losses for AFS securities, including related parties, for which an allowance for credit losses has not been recorded, aggregated by asset type and length of time the fair value has remained below amortized cost: March 31, 2023 Less than 12 months 12 months or more Total (In millions) Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses AFS securities US government and agencies $ 68 $ (4) $ 2,431 $ (626) $ 2,499 $ (630) US state, municipal and political subdivisions 22 (2) 936 (247) 958 (249) Foreign governments 98 (8) 795 (252) 893 (260) Corporate 10,062 (812) 47,858 (11,472) 57,920 (12,284) CLO 3,038 (92) 11,579 (1,063) 14,617 (1,155) ABS 3,623 (197) 3,938 (492) 7,561 (689) CMBS 1,776 (35) 1,483 (354) 3,259 (389) RMBS 739 (44) 1,846 (258) 2,585 (302) Total AFS securities 19,426 (1,194) 70,866 (14,764) 90,292 (15,958) AFS securities – related parties Corporate 875 (24) 141 (30) 1,016 (54) CLO 1,009 (35) 2,124 (200) 3,133 (235) ABS 2,625 (82) 2,736 (184) 5,361 (266) Total AFS securities – related parties 4,509 (141) 5,001 (414) 9,510 (555) Total AFS securities including related parties $ 23,935 $ (1,335) $ 75,867 $ (15,178) $ 99,802 $ (16,513) December 31, 2022 Less than 12 months 12 months or more Total (In millions) Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses AFS securities US government and agencies $ 2,539 $ (756) $ — $ — $ 2,539 $ (756) US state, municipal and political subdivisions 911 (291) — — 911 (291) Foreign governments 891 (275) — — 891 (275) Corporate 58,256 (13,773) — — 58,256 (13,773) CLO 13,486 (1,277) — — 13,486 (1,277) ABS 8,119 (801) — — 8,119 (801) CMBS 2,650 (427) — — 2,650 (427) RMBS 2,621 (365) — — 2,621 (365) Total AFS securities 89,473 (17,965) — — 89,473 (17,965) AFS securities – related parties Corporate 619 (47) — — 619 (47) CLO 2,752 (273) — — 2,752 (273) ABS 5,487 (308) — — 5,487 (308) Total AFS securities – related parties 8,858 (628) — — 8,858 (628) Total AFS securities including related parties $ 98,331 $ (18,593) $ — $ — $ 98,331 $ (18,593) The following summarizes the number of AFS securities that were in an unrealized loss position, including related parties, for which an allowance for credit losses has not been recorded: March 31, 2023 Unrealized loss position Unrealized loss position 12 months or more AFS securities 8,873 7,387 AFS securities – related parties 194 103 The unrealized losses on AFS securities can primarily be attributed to changes in market interest rates since the application of pushdown accounting or acquisition. We did not recognize the unrealized losses in income, unless as required for hedge accounting, as we intend to hold these securities and it is not more likely than not we will be required to sell a security before the recovery of its amortized cost. Allowance for Credit Losses — The following table summarizes the activity in the allowance for credit losses for AFS securities by asset type: Three months ended March 31, 2023 Additions Reductions (In millions) Beginning balance Initial credit losses Initial credit losses on PCD securities Securities sold during the period Additions (reductions) to previously impaired securities Ending Balance AFS securities Foreign governments $ 27 $ — $ — $ — $ — $ 27 Corporate 61 21 — (6) 3 79 CLO 7 1 — — (4) 4 ABS 29 — — — 2 31 CMBS 5 1 — — (1) 5 RMBS 329 3 28 (4) — 356 Total AFS securities 458 26 28 (10) — 502 AFS securities – related parties, CLO 1 — — — — 1 Total AFS securities including related parties $ 459 $ 26 $ 28 $ (10) $ — $ 503 Three months ended March 31, 2022 Additions Reductions (In millions) January 1, 2022 Initial credit losses Initial credit losses on PCD securities Securities sold during the period Additions (reductions) to previously impaired securities Ending Balance AFS securities Foreign governments $ — $ 66 $ — $ — $ — $ 66 Corporate — 55 — — — 55 CLO — 18 — — — 18 ABS 5 5 — — 1 11 CMBS — 6 — — — 6 RMBS 306 9 — (8) 5 312 Total AFS securities 311 159 — (8) 6 468 AFS securities – related party CLO — 3 — — — 3 ABS — 17 — — — 17 Total AFS securities – related party — 20 — — — 20 Total AFS securities including related parties $ 311 $ 179 $ — $ (8) $ 6 $ 488 Net Investment Income —Net investment income by asset class consists of the following: Three months ended March 31, (In millions) 2023 2022 AFS securities $ 1,469 $ 876 Trading securities 42 63 Equity securities 15 15 Mortgage loans 447 237 Investment funds 43 304 Funds withheld at interest 429 337 Other 190 42 Investment revenue 2,635 1,874 Investment expenses (228) (191) Net investment income $ 2,407 $ 1,683 Investment Related Gains (Losses) —Investment related gains (losses) by asset class consists of the following: Three months ended March 31, (In millions) 2023 2022 AFS securities 1 Gross realized gains on investment activity $ 183 $ 103 Gross realized losses on investment activity (104) (410) Net realized investment gains (losses) on AFS securities 79 (307) Net recognized investment gains (losses) on trading securities 64 (207) Net recognized investment gains (losses) on equity securities (18) 23 Net recognized investment gains (losses) on mortgage loans 277 (796) Derivative gains (losses) 993 (3,041) Provision for credit losses (66) (192) Other gains (losses) (264) 308 Investment related gains (losses) $ 1,065 $ (4,212) 1 Includes the effects of recognized gains or losses on AFS securities associated with designated hedges. Proceeds from sales of AFS securities were $1,140 million and $298 million for the three months ended March 31, 2023 and 2022, respectively. The following table summarizes the change in unrealized gains (losses) on trading and equity securities, including related parties, we held as of the respective period end: Three months ended March 31, (In millions) 2023 2022 Trading securities $ 66 $ (189) Trading securities – related parties 6 (4) Equity securities (23) 17 Equity securities – related parties 3 (5) Repurchase Agreements— The following table summarizes the remaining contractual maturities of our repurchase agreements, which are included in payables for collateral on derivatives and securities to repurchase on the condensed consolidated balance sheets: (In millions) March 31, 2023 December 31, 2022 Less than 30 days $ 1,642 $ 608 30-90 days 2,774 1,268 91 days to 1 year 500 — Greater than 1 year 2,865 2,867 Payables for repurchase agreements $ 7,781 $ 4,743 The following table summarizes the securities pledged as collateral for repurchase agreements: March 31, 2023 December 31, 2022 (In millions) Amortized Cost Fair Value Amortized Cost Fair Value AFS securities US government and agencies $ 2,825 $ 2,261 $ 2,559 $ 1,941 Foreign governments 146 108 146 107 Corporate 5,324 4,425 1,940 1,605 CLO 275 265 273 261 ABS 1,218 1,093 1,243 1,082 Total securities pledged under repurchase agreements $ 9,788 $ 8,152 $ 6,161 $ 4,996 Reverse Repurchase Agreements — As of March 31, 2023 and December 31, 2022, amounts loaned under reverse repurchase agreements were $1,088 million and $1,640 million, respectively, and the fair value of the collateral, comprised primarily of commercial and residential mortgage loans, was $1,475 million and $1,753 million, respectively. Mortgage Loans, including related parties and consolidated VIEs —Mortgage loans includes both commercial and residential loans. In connection with the merger, we elected the fair value option on our mortgage loan portfolio. See Note 7 – Fair Value for further fair value option information. The following represents the mortgage loan portfolio, with fair value option loans presented at unpaid principal balance: (In millions) March 31, 2023 December 31, 2022 Commercial mortgage loans $ 21,743 $ 21,061 Commercial mortgage loans under development 1,020 790 Total commercial mortgage loans 22,763 21,851 Mark to fair value (1,740) (1,743) Commercial mortgage loans 21,023 20,108 Residential mortgage loans 13,211 11,802 Mark to fair value (842) (1,099) Residential mortgage loans 12,369 10,703 Mortgage loans $ 33,392 $ 30,811 We primarily invest in commercial mortgage loans on income producing properties including office and retail buildings, apartments, hotels and industrial properties. We diversify the commercial mortgage loan portfolio by geographic region and property type to reduce concentration risk. We evaluate mortgage loans based on relevant current information to confirm if properties are performing at a consistent and acceptable level to secure the related debt. The distribution of commercial mortgage loans, including those under development, by property type and geographic region, is as follows: March 31, 2023 December 31, 2022 (In millions, except for percentages) Net Carrying Value Percentage of Total Net Carrying Value Percentage of Total Property type Office building $ 4,535 21.6 % $ 4,651 23.1 % Retail 1,450 6.9 % 1,454 7.2 % Apartment 7,506 35.7 % 6,692 33.3 % Hotels 1,873 8.9 % 1,855 9.2 % Industrial 2,242 10.7 % 2,047 10.2 % Other commercial 3,417 16.2 % 3,409 17.0 % Total commercial mortgage loans $ 21,023 100.0 % $ 20,108 100.0 % US region East North Central $ 1,438 6.8 % $ 1,437 7.1 % East South Central 422 2.0 % 413 2.1 % Middle Atlantic 5,561 26.5 % 5,183 25.8 % Mountain 923 4.4 % 898 4.5 % New England 1,071 5.1 % 1,076 5.4 % Pacific 4,033 19.2 % 3,781 18.8 % South Atlantic 2,876 13.6 % 2,756 13.7 % West North Central 225 1.1 % 231 1.1 % West South Central 1,066 5.1 % 1,085 5.4 % Total US region 17,615 83.8 % 16,860 83.9 % International region United Kingdom 1,970 9.4 % 1,898 9.4 % Other international 1 1,438 6.8 % 1,350 6.7 % Total international region 3,408 16.2 % 3,248 16.1 % Total commercial mortgage loans $ 21,023 100.0 % $ 20,108 100.0 % 1 Represents all other countries, with each individual country comprising less than 5% of the portfolio. Our residential mortgage loan portfolio includes first lien residential mortgage loans collateralized by properties in various geographic locations and is summarized by proportion of the portfolio in the following table: March 31, 2023 December 31, 2022 US States California 28.5 % 28.9 % Florida 10.1 % 9.7 % New York 5.8 % 5.6 % New Jersey 5.4 % 5.3 % Arizona 5.0 % 5.1 % Other 1 32.8 % 31.7 % Total US residential mortgage loan percentage 87.6 % 86.3 % International United Kingdom 5.0 % 5.4 % Other 2 7.4 % 8.3 % Total international residential mortgage loan percentage 12.4 % 13.7 % Total residential mortgage loan percentage 100.0 % 100.0 % 1 Represents all other states, with each individual state comprising less than 5% of the portfolio. 2 Represents all other countries, with each individual country comprising less than 5% of the portfolio. Investment Funds —Our investment fund portfolio consists of funds that employ various strategies and include investments in origination platforms, insurance platforms, and equity, hybrid, yield and other funds. Investment funds can meet the definition of VIEs, which are discussed further in Note 6 – Variable Interest Entities . Our investment funds do not specify timing of distributions on the funds’ underlying assets. The following summarizes our investment funds, including related parties and consolidated VIEs: March 31, 2023 December 31, 2022 (In millions, except for percentages) Carrying value Percent of total Carrying value Percent of total Investment funds Equity $ 43 55.8 % $ 46 58.2 % Hybrid 28 36.4 % 32 40.5 % Other 6 7.8 % 1 1.3 % Total investment funds 77 100.0 % 79 100.0 % Investment funds – related parties Strategic origination platforms 35 2.2 % 34 2.2 % Strategic insurance platforms 1,305 81.8 % 1,259 80.2 % Apollo and other fund investments Equity 228 14.3 % 246 15.7 % Yield 5 0.3 % 5 0.3 % Other 22 1.4 % 25 1.6 % Total investment funds – related parties 1,595 100.0 % 1,569 100.0 % Investment funds consolidated VIEs Strategic origination platforms 4,991 38.8 % 4,829 38.7 % Strategic insurance platforms 515 4.0 % 529 4.2 % Apollo and other fund investments Equity 2,815 21.9 % 2,640 21.2 % Hybrid 3,180 24.6 % 3,112 24.9 % Yield 1,091 8.5 % 1,044 8.4 % Other 288 2.2 % 326 2.6 % Total investment funds consolidated VIEs 12,880 100.0 % 12,480 100.0 % Total investment funds including related parties and funds owned by consolidated VIEs $ 14,552 $ 14,128 Non-Consolidated Securities and Investment Funds Fixed maturity securities – We invest in securitization entities as a debt holder or an investor in the residual interest of the securitization vehicle. These entities are deemed VIEs due to insufficient equity within the structure and lack of control by the equity investors over the activities that significantly impact the economics of the entity. In general, we are a debt investor within these entities and, as such, hold a variable interest; however, due to the debt holders’ lack of ability to control the decisions within the trust that significantly impact the entity, and the fact the debt holders are protected from losses due to the subordination of the equity tranche, the debt holders are not deemed the primary beneficiary. Securitization vehicles in which we hold the residual tranche are not consolidated because we do not unilaterally have substantive rights to remove the general partner, or when assessing related party interests, we are not under common control, as defined by US GAAP, with the related parties, nor are substantially all of the activities conducted on our behalf; therefore, we are not deemed the primary beneficiary. Debt investments and investments in the residual tranche of securitization entities are considered debt instruments and are held at fair value on the balance sheet and classified as AFS or trading. Investment funds – Investment funds include non-fixed income, alternative investments in the form of limited partnerships or similar legal structures. Equity securities – We invest in preferred equity securities issued by entities deemed to be VIEs due to insufficient equity within the structure. Our risk of loss associated with our non-consolidated investments depends on the investment. Investment funds, equity securities and trading securities are limited to the carrying value plus unfunded commitments. AFS securities are limited to amortized cost plus unfunded commitments. The following summarizes the carrying value and maximum loss exposure of these non-consolidated investments: March 31, 2023 December 31, 2022 (In millions) Carrying Value Maximum Loss Exposure Carrying Value Maximum Loss Exposure Investment funds $ 77 $ 518 $ 79 $ 340 Investment in related parties – investment funds 1,595 2,251 1,569 2,253 Assets of consolidated VIEs – investment funds 12,880 20,372 12,480 20,278 Investment in fixed maturity securities 39,373 42,555 37,454 40,992 Investment in related parties – fixed maturity securities 11,624 12,101 9,717 10,290 Investment in related parties – equity securities 251 251 279 279 Total non-consolidated investments $ 65,800 $ 78,048 $ 61,578 $ 74,432 Concentrations —The following table represents our investment concentrations in excess of 10% of shareholders’ equity: (In millions) March 31, 2023 Wheels Donlen 1 $ 1,419 PK AirFinance 1 1,334 Athora 1 1,279 Atlas 1 995 AP Tundra 873 MFI Investments 869 (In millions) December 31, 2022 Wheels Donlen 1 $ 1,288 Athora 1 1,232 PK AirFinance 1 999 AP Tundra 896 MFI Investments 878 SoftBank Vision Fund II 789 MidCap 1 788 Cayman Universe 756 1 Related party amounts are representative of single issuer risk and may only include a portion of the total investments associated with a related party. See further discussion of these related parties in Note 13 – Related Parties.

Derivative Instruments

Derivative Instruments	3 Months Ended
	Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	5. Derivative Instruments We use a variety of derivative instruments to manage risks, primarily equity, interest rate, credit, foreign currency and market volatility. See Note 7 – Fair Value for information about the fair value hierarchy for derivatives. The following table presents the notional amount and fair value of derivative instruments: March 31, 2023 December 31, 2022 Notional Amount Fair Value Notional Amount Fair Value (In millions) Assets Liabilities Assets Liabilities Derivatives designated as hedges Foreign currency hedges Swaps 6,678 $ 713 $ 149 6,677 $ 747 $ 154 Forwards 6,380 392 57 6,283 406 52 Interest rate swaps 4,468 — 725 4,468 — 803 Forwards on net investments 217 — 2 216 2 — Interest rate swaps 10,082 10 83 9,332 9 150 Total derivatives designated as hedges 1,115 1,016 1,164 1,159 Derivatives not designated as hedges Equity options 67,730 2,085 106 65,089 1,374 114 Futures 21 56 4 18 33 — Foreign currency swaps 3,863 266 118 3,563 251 112 Interest rate swaps 523 89 1 488 74 — Other swaps 137 4 1 89 — 4 Foreign currency forwards 18,250 341 272 16,376 413 257 Embedded derivatives Funds withheld including related parties (5,557) (67) (6,272) (77) Interest sensitive contract liabilities — 6,747 — 5,841 Total derivatives not designated as hedges (2,716) 7,182 (4,127) 6,251 Total derivatives $ (1,601) $ 8,198 $ (2,963) $ 7,410 Derivatives Designated as Hedges Cash Flow Hedges – We use interest rate swaps to convert floating-rate interest payments to fixed-rate interest payments to reduce exposure to interest rate changes. The interest rate swaps will expire by July 2027. During the three months ended March 31, 2023 and 2022, interest rate swaps recognized in OCI had losses of $73 million and $0 million, respectively. There were no amounts deemed ineffective during the three months ended March 31, 2023 and 2022. As of March 31, 2023, no amounts are expected to be reclassified to income within the next 12 months. Fair Value Hedges – We use foreign currency forward contracts, foreign currency swaps, foreign currency interest rate swaps and interest rate swaps that are designated and accounted for as fair value hedges to hedge certain exposures to foreign currency risk and interest rate risk. The foreign currency forward price is agreed upon at the time of the contract and payment is made at a specified future date. The following represents the carrying amount and the cumulative fair value hedging adjustments included in the hedged assets or liabilities: March 31, 2023 December 31, 2022 (In millions) Carrying amount of the hedged assets or liabilities 1 Cumulative amount of fair value hedging gains (losses) Carrying amount of the hedged assets or liabilities 1 Cumulative amount of fair value hedging gains (losses) AFS securities Foreign currency forwards $ 5,480 $ (431) $ 5,259 $ (217) Foreign currency swaps 4,962 (304) 4,797 (398) Interest sensitive contract liabilities Foreign currency swaps 1,081 (9) 1,081 88 Foreign currency interest rate swaps 4,348 315 4,348 632 Interest rate swaps 7,087 203 6,577 323 1 The carrying amount disclosed for AFS securities is amortized cost. The following is a summary of the gains (losses) related to the derivatives and related hedged items in fair value hedge relationships: Amount Excluded (In millions) Derivatives Hedged Items Net Recognized in income through amortization approach Recognized in income through changes in fair value Three months ended March 31, 2023 Investment related gains (losses) Foreign currency forwards $ (70) $ 73 $ 3 $ 87 $ 4 Foreign currency swaps (59) 64 5 — — Foreign currency interest rate swaps 78 (70) 8 — — Interest rate swaps 102 (104) (2) — — Interest sensitive contract benefits Foreign currency interest rate swaps 15 (15) — — — Three months ended March 31, 2022 Investment related gains (losses) Foreign currency forwards $ 127 $ (126) $ 1 $ 14 $ 1 Foreign currency swaps 91 (95) (4) — — Foreign currency interest rate swaps (159) 197 38 — — Interest rate swaps (72) 75 3 — — Interest sensitive contract benefits Foreign currency interest rate swaps 10 (9) 1 — — The following is a summary of the gains (losses) excluded from the assessment of hedge effectiveness that were recognized in OCI : Three months ended March 31, (In millions) 2023 2022 Foreign currency forwards $ 63 $ (73) Foreign currency swaps 114 (56) Net Investment Hedges – We use foreign currency forwards to hedge the foreign currency exchange rate risk of our investments in subsidiaries that have a reporting currency other than the US dollar. We assess hedge effectiveness based on the changes in forward rates. During the three months ended March 31, 2023 and 2022 , these derivatives had losses of $4 million and gains of $2 million, respectively. These derivatives are included in foreign currency translation and other adjustments on the condensed consolidated statements of comprehensive income (loss). As of March 31, 2023 and December 31, 2022, the cumulative foreign currency translations recorded in AOCI related to these net investment hedges were gains of $26 million and $30 million, respectively. During the three months ended March 31, 2023 and 2022 , there were no amounts deemed ineffective. Derivatives Not Designated as Hedges Equity options – We use equity indexed options to economically hedge fixed indexed annuity products that guarantee the return of principal to the policyholder and credit interest based on a percentage of the gain in a specified market index, primarily the S&P 500. To hedge against adverse changes in equity indices, we enter into contracts to buy equity indexed options. The contracts are net settled in cash based on differentials in the indices at the time of exercise and the strike price. Futures – Futures contracts are purchased to hedge the growth in interest credited to the customer as a direct result of increases in the related indices. We enter into exchange-traded futures with regulated futures commission clearing brokers who are members of a trading exchange. Under exchange-traded futures contracts, we agree to purchase a specified number of contracts with other parties and to post variation margin on a daily basis in an amount equal to the difference in the daily fair values of those contracts. Interest rate swaps – We use interest rate swaps to reduce market risks from interest rate changes and to alter interest rate exposure arising from duration mismatches between assets and liabilities. With an interest rate swap, we agree with another party to exchange the difference between fixed-rate and floating-rate interest amounts tied to an agreed-upon notional principal amount at specified intervals. Other swaps – Other swaps include total return swaps and credit default swaps. We purchase total rate of return swaps to gain exposure and benefit from a reference asset or index without ownership. Credit default swaps provide a measure of protection against the default of an issuer or allow us to gain credit exposure to an issuer or traded index. We use credit default swaps coupled with a bond to synthetically create the characteristics of a reference bond. Embedded derivatives – We have embedded derivatives which are required to be separated from their host contracts and reported as derivatives. Host contracts include reinsurance agreements structured on a modco or funds withheld basis and indexed annuity products. The following is a summary of the gains (losses) related to derivatives not designated as hedges: Three months ended March 31, (In millions) 2023 2022 Equity options $ 350 $ (708) Futures 34 (33) Swaps 33 63 Foreign currency forwards (169) 155 Embedded derivatives on funds withheld 603 (2,520) Amounts recognized in investment related gains (losses) 851 (3,043) Embedded derivatives in indexed annuity products 1 (473) 1,034 Total gains (losses) on derivatives not designated as hedges $ 378 $ (2,009) 1 Included in interest sensitive contract benefits on the condensed consolidated statements of income (loss). Credit Risk —We may be exposed to credit-related losses in the event of counterparty nonperformance on derivative financial instruments. Generally, the current credit exposure of our derivative contracts is the fair value at the reporting date less any collateral received from the counterparty. We manage credit risk related to over-the-counter derivatives by entering into transactions with creditworthy counterparties. Where possible, we maintain collateral arrangements and use master netting agreements that provide for a single net payment from one counterparty to another at each due date and upon termination. We have also established counterparty exposure limits, where possible, in order to evaluate if there is sufficient collateral to support the net exposure. Collateral arrangements typically require the posting of collateral in connection with its derivative instruments. Collateral agreements often contain posting thresholds, some of which may vary depending on the posting party’s financial strength ratings. Additionally, a decrease in our financial strength rating to a specified level can result in settlement of the derivative position. The estimated fair value of our net derivative and other financial assets and liabilities after the application of master netting agreements and collateral were as follows: Gross amounts not offset on the condensed consolidated balance sheets (In millions) Gross amount recognized 1 Financial instruments 2 Collateral (received)/pledged Net amount Off-balance sheet securities collateral 3 Net amount after securities collateral March 31, 2023 Derivative assets $ 3,956 $ (1,456) $ (2,411) $ 89 $ — $ 89 Derivative liabilities (1,518) 1,456 506 444 — 444 December 31, 2022 Derivative assets $ 3,309 $ (1,477) $ (1,952) $ (120) $ — $ (120) Derivative liabilities (1,646) 1,477 478 309 — 309 1 The gross amounts of recognized derivative assets and derivative liabilities are reported on the condensed consolidated balance sheets. As of March 31, 2023 and December 31, 2022, amounts not subject to master netting or similar agreements were immaterial. 2 Represents amounts offsetting derivative assets and derivative liabilities that are subject to an enforceable master netting agreement or similar agreement that are not netted against the gross derivative assets or gross derivative liabilities for presentation on the condensed consolidated balance sheets. 3 For non-cash collateral received, we do not recognize the collateral on our balance sheet unless the obligor (transferor) has defaulted under the terms of the secured contract and is no longer entitled to redeem the pledged asset. Amounts do not include any excess of collateral pledged or received.

Variable Interest Entities

Variable Interest Entities	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Variable Interest Entities	6. Variable Interest Entities We determined that we are required to consolidate certain Apollo-managed investment funds and other Apollo-managed structures. Since the criteria for the primary beneficiary are satisfied by our related party group, we are deemed the primary beneficiary. In addition, we consolidate certain securitization entities where we are deemed the primary beneficiary. No arrangement exists requiring us to provide additional funding in excess of our committed capital investment, liquidity, or the funding of losses or an increase to our loss exposure in excess of our investment in any of the consolidated VIEs. The following summarizes the income statement activity of the consolidated VIEs: Three months ended March 31, (In millions) 2023 2022 Trading securities $ 23 $ — Mortgage loans 24 20 Investment funds 35 (3) Other investments (2) — Net investment income $ 80 $ 17 Net recognized investment gains (losses) on trading securities $ 6 $ — Net recognized investment gains (losses) on mortgage loans 9 (112) Net recognized investment gains (losses) on investment funds 226 70 Other gains (losses) (40) — Investment related gains (losses) $ 201 $ (42)

Fair Value

Fair Value	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value	7. Fair Value Fair value is the price we would receive to sell an asset or pay to transfer a liability (exit price) in an orderly transaction between market participants. We determine fair value based on the following fair value hierarchy: Level 1 – Unadjusted quoted prices for identical assets or liabilities in an active market. Level 2 – Quoted prices for inactive markets or valuation techniques that require observable direct or indirect inputs for substantially the full term of the asset or liability. Level 2 inputs include the following: • Quoted prices for similar assets or liabilities in active markets, • Observable inputs other than quoted market prices, and • Observable inputs derived principally from market data through correlation or other means. Level 3 – Prices or valuation techniques with unobservable inputs significant to the overall fair value estimate. These valuations use critical assumptions not readily available to market participants. Level 3 valuations are based on market standard valuation methodologies, including discounted cash flows, matrix pricing or other similar techniques. Net Asset Value (NAV) – Investment funds are typically measured using NAV as a practical expedient in determining fair value and are not classified in the fair value hierarchy. Our carrying value reflects our pro rata ownership percentage as indicated by NAV in the investment fund financial statements, which we may adjust if we determine NAV is not calculated consistent with investment company fair value principles. The underlying investments of the investment funds may have significant unobservable inputs, which may include but are not limited to, comparable multiples and weighted average cost of capital rates applied in valuation models or a discounted cash flow model. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). If the inputs used to measure fair value fall within different levels of the hierarchy, the category level is based on the lowest priority level input that is significant to the instrument’s fair value measurement. We use a number of valuation sources to determine fair values. Valuation sources can include quoted market prices; third-party commercial pricing services; third-party brokers; industry-standard, vendor modeling software that uses market observable inputs; and other internal modeling techniques based on projected cash flows. We periodically review the assumptions and inputs of third-party commercial pricing services through internal valuation price variance reviews, comparisons to internal pricing models, back testing to recent trades, or monitoring trading volumes. The following represents the hierarchy for our assets and liabilities measured at fair value on a recurring basis: March 31, 2023 (In millions) Total NAV Level 1 Level 2 Level 3 Assets AFS securities US government and agencies $ 2,703 $ — $ 2,697 $ 6 $ — US state, municipal and political subdivisions 966 — — 966 — Foreign governments 922 — — 921 1 Corporate 63,141 — 9 61,510 1,622 CLO 17,566 — — 17,566 — ABS 10,873 — — 5,931 4,942 CMBS 4,190 — — 4,190 — RMBS 6,352 — — 6,114 238 Total AFS securities 106,713 — 2,706 97,204 6,803 Trading securities 1,652 — 24 1,586 42 Equity securities 968 — 273 624 71 Mortgage loans 29,949 — — — 29,949 Funds withheld at interest – embedded derivative (4,291) — — — (4,291) Derivative assets 3,956 — 66 3,890 — Short-term investments 582 — 1 551 30 Other investments 501 — — 215 286 Cash and cash equivalents 13,844 — 13,844 — — Restricted cash 1,148 — 1,148 — — Investments in related parties AFS securities Corporate 1,127 — — 168 959 CLO 3,513 — — 3,015 498 ABS 7,226 — — 221 7,005 Total AFS securities – related parties 11,866 — — 3,404 8,462 Trading securities 885 — — — 885 Equity securities 251 — — — 251 Mortgage loans 1,324 — — — 1,324 Investment funds 1,034 — — — 1,034 Funds withheld at interest – embedded derivative (1,266) — — — (1,266) Other investments 338 — — — 338 Reinsurance recoverable 1,470 — — — 1,470 Other assets 440 — — — 440 Assets of consolidated VIEs Trading securities 1,069 — — 421 648 Mortgage loans 2,119 — — — 2,119 Investment funds 12,880 10,299 — — 2,581 Other investments 99 — — 2 97 Cash and cash equivalents 654 — 654 — — Total assets measured at fair value $ 188,185 $ 10,299 $ 18,716 $ 107,897 $ 51,273 Liabilities Interest sensitive contract liabilities Embedded derivative $ 6,747 $ — $ — $ — $ 6,747 Universal life benefits 879 — — — 879 Future policy benefits AmerUs Life Insurance Company (AmerUs) Closed Block 1,190 — — — 1,190 Indianapolis Life Insurance Company (ILICO) Closed Block and life benefits 579 — — — 579 Market risk benefits 3,203 — — — 3,203 Derivative liabilities 1,518 — 24 1,493 1 Other liabilities 122 — — (67) 189 Total liabilities measured at fair value $ 14,238 $ — $ 24 $ 1,426 $ 12,788 December 31, 2022 (In millions) Total NAV Level 1 Level 2 Level 3 Assets AFS securities US government and agencies $ 2,577 $ — $ 2,570 $ 7 $ — US state, municipal and political subdivisions 927 — — 927 — Foreign governments 907 — — 906 1 Corporate 60,901 — — 59,236 1,665 CLO 16,493 — — 16,493 — ABS 10,527 — — 5,660 4,867 CMBS 4,158 — — 4,158 — RMBS 5,914 — — 5,682 232 Total AFS securities 102,404 — 2,570 93,069 6,765 Trading securities 1,595 — 23 1,519 53 Equity securities 1,087 — 150 845 92 Mortgage loans 27,454 — — — 27,454 Funds withheld at interest – embedded derivative (4,847) — — — (4,847) Derivative assets 3,309 — 42 3,267 — Short-term investments 520 — 29 455 36 Other investments 611 — — 170 441 Cash and cash equivalents 7,779 — 7,779 — — Restricted cash 628 — 628 — — Investments in related parties AFS securities Corporate 982 — — 170 812 CLO 3,079 — — 2,776 303 ABS 5,760 — — 218 5,542 Total AFS securities – related parties 9,821 — — 3,164 6,657 Trading securities 878 — — — 878 Equity securities 279 — — — 279 Mortgage loans 1,302 — — — 1,302 Investment funds 959 — — — 959 Funds withheld at interest – embedded derivative (1,425) — — — (1,425) Other investments 303 — — — 303 Reinsurance recoverable 1,388 — — — 1,388 Other assets 481 — — — 481 Assets of consolidated VIEs Trading securities 1,063 — 5 436 622 Mortgage loans 2,055 — — — 2,055 Investment funds 12,480 10,009 — — 2,471 Other investments 101 — — 2 99 Cash and cash equivalents 362 — 362 — — Total assets measured at fair value $ 170,587 $ 10,009 $ 11,588 $ 102,927 $ 46,063 Liabilities Interest sensitive contract liabilities Embedded derivative $ 5,841 $ — $ — $ — $ 5,841 Universal life benefits 829 — — — 829 Future policy benefits AmerUs Closed Block 1,164 — — — 1,164 ILICO Closed Block and life benefits 548 — — — 548 Market risk benefits 2,970 — — — 2,970 Derivative liabilities 1,646 — 38 1,607 1 Other liabilities 65 — — (77) 142 Total liabilities measured at fair value $ 13,063 $ — $ 38 $ 1,530 $ 11,495 Fair Value Valuation Methods —We used the following valuation methods and assumptions to estimate fair value: AFS and trading securities – We obtain the fair value for most marketable securities without an active market from several commercial pricing services. These are classified as Level 2 assets. The pricing services incorporate a variety of market observable information in their valuation techniques, including benchmark yields, trading activity, credit quality, issuer spreads, bids, offers and other reference data. This category typically includes US and non-US corporate bonds, US agency and government guaranteed securities, CLO, ABS, CMBS and RMBS. We also have fixed maturity securities priced based on indicative broker quotes or by employing market accepted valuation models. For certain fixed maturity securities, the valuation model uses significant unobservable inputs and are included in Level 3 in our fair value hierarchy. Significant unobservable inputs used include: discount rates, issue-specific credit adjustments, material non-public financial information, estimation of future earnings and cash flows, default rate assumptions, liquidity assumptions and indicative quotes from market makers. These inputs are usually considered unobservable, as not all market participants have access to this data. We value privately placed fixed maturity securities based on the credit quality and duration of comparable marketable securities, which may be securities of another issuer with similar characteristics. In some instances, we use a matrix-based pricing model. These models consider the current level of risk-free interest rates, corporate spreads, credit quality of the issuer and cash flow characteristics of the security. We also consider additional factors such as net worth of the borrower, value of collateral, capital structure of the borrower, presence of guarantees and our evaluation of the borrower’s ability to compete in its relevant market. Privately placed fixed maturity securities are classified as Level 2 or 3. Equity securities – Fair values of publicly traded equity securities are based on quoted market prices and classified as Level 1. Other equity securities, typically private equities or equity securities not traded on an exchange, we value based on other sources, such as commercial pricing services or brokers, and are classified as Level 2 or 3. Mortgage loans – We estimate fair value on a monthly basis using discounted cash flow analysis and rates being offered for similar loans to borrowers with similar credit ratings. Loans with similar characteristics are aggregated for purposes of the calculations. The discounted cash flow model uses unobservable inputs, including estimates of discount rates and loan prepayments. Mortgage loans are classified as Level 3. Investment funds – Certain investment funds for which we elected the fair value option are included in Level 3 and are priced based on market accepted valuation models. The valuation models use significant unobservable inputs, which include material non-public financial information, estimation of future distributable earnings and demographic assumptions. These inputs are usually considered unobservable, as not all market participants have access to this data. Other investments – The fair value of other investments are determined using a discounted cash flow model using discount rates for similar investments. Funds withheld at interest embedded derivative – We estimate the fair value of the embedded derivative based on the change in the fair value of the assets supporting the funds withheld payable under modco and funds withheld reinsurance agreements. As a result, the fair value of the embedded derivative is classified as Level 2 or 3 based on the valuation methods used for the assets held supporting the reinsurance agreements. Derivatives – Derivative contracts can be exchange traded or over-the-counter. Exchange-traded derivatives typically fall within Level 1 of the fair value hierarchy depending on trading activity. Over-the-counter derivatives are valued using valuation models or an income approach using third-party broker valuations. Valuation models require a variety of inputs, including contractual terms, market prices, yield curves, credit curves, measures of volatility, prepayment rates and correlation of the inputs. We consider and incorporate counterparty credit risk in the valuation process through counterparty credit rating requirements and monitoring of overall exposure. We also evaluate and include our own nonperformance risk in valuing derivatives. The majority of our derivatives trade in liquid markets; therefore, we can verify model inputs and model selection does not involve significant management judgment. These are typically classified within Level 2 of the fair value hierarchy. Cash and cash equivalents, including restricted cash – The carrying amount for cash equals fair value. We estimate the fair value for cash equivalents based on quoted market prices. These assets are classified as Level 1. Other assets and market risk benefits – Other assets at fair value consists of market risk benefit assets. See Note 9 – Long-duration Contracts for additional information on market risk benefits valuation methodology and additional fair value disclosures. The estimates are classified as Level 3. Interest sensitive contract liabilities embedded derivative – Embedded derivatives related to interest sensitive contract liabilities with fixed indexed annuity products are classified as Level 3. The valuations include significant unobservable inputs associated with economic assumptions and actuarial assumptions for policyholder behavior. AmerUs Closed Block – We elected the fair value option for the future policy benefits liability in the AmerUs Closed Block. Our valuation technique is to set the fair value of policyholder liabilities equal to the fair value of assets. There is an additional component which captures the fair value of the open block’s obligations to the closed block business. This component is the present value of the projected release of required capital and future earnings before income taxes on required capital supporting the AmerUs Closed Block, discounted at a rate which represents a market participant’s required rate of return, less the initial required capital. Unobservable inputs include estimates for these items. The AmerUs Closed Block policyholder liabilities and any corresponding reinsurance recoverable are classified as Level 3. ILICO Closed Block – We elected the fair value option for the ILICO Closed Block. Our valuation technique is to set the fair value of policyholder liabilities equal to the fair value of assets. There is an additional component which captures the fair value of the open block’s obligations to the closed block business. This component uses the present value of future cash flows which include commissions, administrative expenses, reinsurance premiums and benefits, and an explicit cost of capital. The discount rate includes a margin to reflect the business and nonperformance risk. Unobservable inputs include estimates for these items. The ILICO Closed Block policyholder liabilities and corresponding reinsurance recoverable are classified as Level 3. Universal life liabilities and other life benefits – We elected the fair value option for certain blocks of universal and other life business ceded to Global Atlantic. We use a present value of liability cash flows. Unobservable inputs include estimates of mortality, persistency, expenses, premium payments and a risk margin used in the discount rates that reflects the riskiness of the business. These universal life policyholder liabilities and corresponding reinsurance recoverable are classified as Level 3. Other liabilities – Other liabilities includes funds withheld liability, as described above in funds withheld at interest embedded derivative, and a ceded modco agreement of certain inforce funding agreement contracts for which we elected the fair value option. We estimate the fair value of the ceded modco agreement by discounting projected cash flows for net settlements and certain periodic and non-periodic payments. Unobservable inputs include estimates for asset portfolio returns and economic inputs used in the discount rate, including risk margin. Depending on the projected cash flows and other assumptions, the contract may be recorded as an asset or liability. The estimate is classified as Level 3. Fair Value Option — The following represents the gains (losses) recorded for instruments for which we have elected the fair value option, including related parties and consolidated VIEs: Three months ended March 31, (In millions) 2023 2022 Trading securities $ 64 $ (207) Mortgage loans 296 (916) Investment funds 64 20 Future policy benefits (26) 142 Other liabilities (47) — Total gains (losses) $ 351 $ (961) Gains and losses on trading securities and other liabilities are recorded in investment related gains (losses) on the condensed consolidated statements of income (loss). For fair valu e option mortgage loans, we record interest income in net investment income and subsequent changes in fair value in investment related gains (losses) on the condensed consolidated statements of income (loss). Gains and losses related to investment funds, including related party investment funds, are recorded in net investment income on the condensed consolidated statements of income (loss). We record the change in fair value of future policy benefits to future policy and other policy benefits on the condensed consolidated statements of income (loss). The following summarizes information for fair value option mortgage loans, including related parties and consolidated VIEs: (In millions) March 31, 2023 December 31, 2022 Unpaid principal balance $ 35,974 $ 33,653 Mark to fair value (2,582) (2,842) Fair value $ 33,392 $ 30,811 The following represents our commercial mortgage loan portfolio 90 days or more past due and/or in non-accrual status: (In millions) March 31, 2023 December 31, 2022 Unpaid principal balance of commercial mortgage loans 90 days or more past due and/or in non-accrual status $ 198 $ 74 Mark to fair value of commercial mortgage loans 90 days or more past due and/or in non-accrual status (56) (55) Fair value of commercial mortgage loans 90 days or more past due and/or in non-accrual status $ 142 $ 19 Fair value of commercial mortgage loans 90 days or more past due $ 11 $ 2 Fair value of commercial mortgage loans in non-accrual status 131 19 The following represents our residential loan portfolio 90 days or more past due and/or in non-accrual status: (In millions) March 31, 2023 December 31, 2022 Unpaid principal balance of residential mortgage loans 90 days or more past due and/or in non-accrual status $ 483 $ 522 Mark to fair value of residential mortgage loans 90 days or more past due and/or in non-accrual status (50) (50) Fair value of residential mortgage loans 90 days or more past due and/or in non-accrual status $ 433 $ 472 Fair value of residential mortgage loans 90 days or more past due 1 $ 433 $ 472 Fair value of residential mortgage loans in non-accrual status 234 360 1 As of March 31, 2023 and December 31, 2022 includes $199 million and $221 million, respectively, of residential mortgage loans that are guaranteed by US government-sponsored agencies. The following is the estimated amount of gains (losses) included in earnings during the period attributable to changes in instrument-specific credit risk on our mortgage loan portfolio: Three months ended March 31, (In millions) 2023 2022 Mortgage loans $ (3) $ (18) We estimated the portion of gains and losses attributable to changes in instrument-specific credit risk by identifying commercial loans with loan-to-value ratios meeting credit quality criteria, and residential mortgage loans with delinquency status meeting credit quality criteria. Level 3 Financial Instruments — The following are reconciliations for Level 3 assets and liabilities measured at fair value on a recurring basis. Transfers in and out of Level 3 are primarily based on changes in the availability of pricing sources, as described in the valuation methods above. Three months ended March 31, 2023 Total realized and unrealized gains (losses) (In millions) Beginning balance Included in income Included in OCI Net purchases, issuances, sales and settlements Net transfers in (out) Ending balance Total gains (losses) included in earnings 1 Total gains (losses) included in OCI 1 Assets AFS securities Foreign governments $ 1 $ — $ — $ — — $ 1 $ — $ — Corporate 1,665 (1) 12 126 (180) 1,622 — 6 ABS 4,867 — (19) 155 (61) 4,942 — (16) RMBS 232 3 3 — — 238 — 3 Trading securities 53 2 — (4) (9) 42 1 — Equity securities 92 (8) — — (13) 71 (8) — Mortgage loans 27,454 251 — 2,244 — 29,949 251 — Funds withheld at interest – embedded derivative (4,847) 556 — — — (4,291) — — Short-term investments 36 — (2) (30) 26 30 — — Other investments 441 1 — (156) — 286 2 — Investments in related parties AFS securities Corporate 812 1 (7) 153 — 959 — (7) CLO 303 — 10 185 — 498 — 10 ABS 5,542 4 44 1,415 — 7,005 2 42 Trading securities 878 6 — 1 — 885 6 — Equity securities 279 4 — (32) — 251 3 — Mortgage loans 1,302 26 — (4) — 1,324 26 — Investment funds 959 43 — 32 — 1,034 43 — Funds withheld at interest – embedded derivative (1,425) 159 — — — (1,266) — — Other investments 303 (7) — 42 — 338 (7) — Reinsurance recoverable 1,388 82 — — — 1,470 — — Assets of consolidated VIEs Trading securities 622 12 — (2) 16 648 12 — Mortgage loans 2,055 19 — 45 — 2,119 19 — Investment funds 2,471 18 — (8) 100 2,581 18 — Other investments 99 — — (2) — 97 — — Total Level 3 assets $ 45,582 $ 1,171 $ 41 $ 4,160 $ (121) $ 50,833 $ 368 $ 38 Liabilities Interest sensitive contract liabilities Embedded derivative $ (5,841) $ (473) $ — $ (433) $ — $ (6,747) $ — $ — Universal life benefits (829) (50) — — — (879) — — Future policy benefits AmerUs Closed Block (1,164) (26) — — — (1,190) — — ILICO Closed Block and life benefits (548) (31) — — — (579) — — Derivative liabilities (1) — — — — (1) — — Other liabilities (142) (47) — — — (189) — — Total Level 3 liabilities $ (8,525) $ (627) $ — $ (433) $ — $ (9,585) $ — $ — 1 Related to instruments held at end of period. Three months ended March 31, 2022 Total realized and unrealized gains (losses) (In millions) January 1, 2022 Included in income Included in OCI Net purchases, issuances, sales and settlements Net transfers in (out) Ending balance Total gains (losses) included in earnings 1 Total gains (losses) included in OCI 1 Assets AFS securities Foreign governments $ 2 $ — $ — $ — $ — $ 2 $ — $ — Corporate 1,339 (3) (19) 140 42 1,499 — (19) CLO 14 (1) 2 (10) — 5 — 2 ABS 3,619 6 (31) (148) 337 3,783 — (30) CMBS 43 — (17) — (16) 10 — (17) Trading securities 69 (5) — 6 20 90 — — Equity securities 429 9 — — — 438 — — Mortgage loans 21,154 (744) — 3,286 — 23,696 (741) — Investment funds 18 1 — — — 19 1 — Funds withheld at interest – embedded derivative — (1,882) — — — (1,882) — — Short-term investments 29 — — 30 — 59 9 — Investments in related parties AFS securities Corporate 670 (4) 1 94 — 761 — 1 CLO 202 — — 130 — 332 — — ABS 6,445 (17) (10) (145) (1,864) 4,409 — (10) Trading securities 1,771 (5) — (254) (1,260) 252 — — Equity securities 284 (5) — — (113) 166 — — Mortgage loans 1,369 (52) — 139 — 1,456 (52) — Investment funds 2,855 24 — (34) (2,031) 814 24 — Funds withheld at interest – embedded derivative — (570) — — — (570) — — Short-term investments — — — 53 — 53 — — Reinsurance recoverable 1,991 (177) — — — 1,814 — — Assets of consolidated VIEs Mortgage loans 2,152 (120) — (152) — 1,880 (120) — Investment funds 1,297 (5) — 238 9,047 10,577 (5) — Other investments — — — — 1,902 1,902 — — Total Level 3 assets $ 45,752 $ (3,550) $ (74) $ 3,373 $ 6,064 $ 51,565 $ (884) $ (73) Liabilities Interest sensitive contract liabilities Embedded derivative $ (7,408) $ 1,034 $ — $ (111) $ — $ (6,485) $ — $ — Universal life benefits (1,235) 139 — — — (1,096) — — Future policy benefits AmerUs Closed Block (1,520) 142 — — — (1,378) — — ILICO Closed Block and life benefits (742) 38 — — — (704) — — Derivative liabilities (3) — — — — (3) — — Liabilities of consolidated VIEs – debt — — — — (3,645) (3,645) — — Total Level 3 liabilities $ (10,908) $ 1,353 $ — $ (111) $ (3,645) $ (13,311) $ — $ — 1 Related to instruments held at end of period. The following represents the gross components of purchases, issuances, sales and settlements, net, and net transfers in (out) shown above: Three months ended March 31, 2023 (In millions) Purchases Issuances Sales Settlements Net purchases, issuances, sales and settlements Transfers in Transfers out Net transfers in (out) Assets AFS securities Corporate $ 208 $ — $ — $ (82) $ 126 $ 29 $ (209) $ (180) ABS 298 — — (143) 155 215 (276) (61) RMBS 1 — — (1) — — — — Trading securities — — — (4) (4) 5 (14) (9) Equity securities — — — — — — (13) (13) Mortgage loans 2,882 — (32) (606) 2,244 — — — Short-term investments — — — (30) (30) 26 — 26 Other investments 2 — — (158) (156) — — — Investments in related parties AFS securities Corporate 156 — — (3) 153 — — — CLO 185 — — — 185 — — — ABS 1,634 — — (219) 1,415 — — — Trading securities 2 — — (1) 1 — — — Equity securities — — — (32) (32) — — — Mortgage loans — — — (4) (4) — — — Investment funds 32 — — — 32 — — — Other investments 42 — — — 42 — — — Assets of consolidated VIEs Trading securities 10 — (12) — (2) 19 (3) 16 Mortgage loans 46 — — (1) 45 — — — Investment funds — — (8) — (8) 148 (48) 100 Other investments 5 — (7) — (2) — — — Total Level 3 assets $ 5,503 $ — $ (59) $ (1,284) $ 4,160 $ 442 $ (563) $ (121) Liabilities Interest sensitive contract liabilities – embedded derivative $ — $ (577) $ — $ 144 $ (433) $ — $ — $ — Total Level 3 liabilities $ — $ (577) $ — $ 144 $ (433) $ — $ — $ — Three months ended March 31, 2022 (In millions) Purchases Issuances Sales Settlements Net purchases, issuances, sales and settlements Transfers in 1 Transfers out 2 Net transfers in (out) Assets AFS securities Corporate $ 324 $ — $ (168) $ (16) $ 140 $ 43 $ (1) $ 42 CLO — — — (10) (10) — — — ABS 1,489 — (1,450) (187) (148) 338 (1) 337 CMBS — — — — — — (16) (16) Trading securities 6 — — — 6 30 (10) 20 Mortgage loans 4,091 — (82) (723) 3,286 — — — Short-term investments 30 — — — 30 — — — Investments in related parties AFS securities Corporate 315 — (217) (4) 94 — — — CLO 130 — — — 130 — — — ABS 374 — (87) (432) (145) — (1,864) (1,864) Trading securities 29 — (265) (18) (254) (1,260) (1,260) Equity securities — — — — — — (113) (113) Mortgage securities 146 — — (7) 139 — — — Investment funds — — (34) — (34) — (2,031) (2,031) Short-term investments 53 — — — 53 — — — Assets of consolidated VIEs Mortgage loans — — — (152) (152) — — — Investment funds 253 — (15) — 238 10,081 (1,034) 9,047 Other investments — — — — — 1,902 — 1,902 Total Level 3 assets $ 7,240 $ — $ (2,318) $ (1,549) $ 3,373 $ 12,394 $ (6,330) $ 6,064 Liabilities Interest sensitive contract liabilities – embedded derivative $ — $ (260) $ — $ 149 $ (111) $ — $ — $ — Liabilities of consolidated VIEs – debt — — — — — (3,645) — (3,645) Total Level 3 liabilities $ — $ (260) $ — $ 149 $ (111) $ (3,645) $ — $ (3,645) 1 Transfers in includes assets and liabilities of consolidated VIEs that we consolidated effective March 31, 2022 ($10,081 million investment funds, $1,902 million other investments, and $3,645 million debt). 2 Transfers out includes the elimination of investments in related party securities issued by VIEs that we consolidated effective March 31, 2022 ($1,582 million ABS AFS securities, $1,260 million ABS and CLO trading securities, and $113 million equity securities). Significant Unobservable Inputs — Significant unobservable inputs occur when we could not obtain or corroborate the quantitative detail of the inputs. This applies to fixed maturity securities, equity securities, mortgage loans and certain investment funds, as well as embedded derivatives in liabilities. Additional significant unobservable inputs are described below. AFS, trading and equity securities – We use discounted cash flow models to calculate the fair value for certain fixed maturity and equity securities. The discount rate is a significant unobservable input because the credit spread includes adjustments made to the base rate. The base rate represents a market comparable rate for securities with similar characteristics. This excludes assets for which fair value is provided by independent broker quotes, but includes assets for which fair value is provided by affiliated quotes. Mortgage loans – We use discounted cash flow models from independent commercial pricing services to calculate the fair value of our mortgage loan portfolio. The discount rate is a significant unobservable input. This approach uses market transaction information and client portfolio-oriented information, such as prepayments or defaults, to support the valuations. Investment funds – We use various methods of valuing of our investment funds from both independent pricing services and affiliated modeling. Interest sensitive contract liabilities – embedded derivative – Significant unobservable inputs we use in the fixed indexed annuities embedded derivative of the interest sensitive contract liabilities valuation include: 1. Nonperformance risk – For contracts we issue, we use the credit spread, relative to the US Department of the Treasury (US Treasury) curve based on our public credit rating as of the valuation date. This represents our credit risk for use in the estimate of the fair value of embedded derivatives. 2. Option budget – We assume future hedge costs in the derivative’s fair value estimate. The level of option budgets determines the future costs of the options and impacts future policyholder account value growth. 3. Policyholder behavior – We regularly review the full withdrawal (surrender rate) assumptions. These are based on our initial pricing assumptions updated for actual experience. Actual experience may be limited for recently issued products. The following summarizes the unobservable inputs for AFS, trading and equity securities, mortgage loans, investment funds and the embedded derivatives of fixed indexed annuities, including those of consolidated VIEs: March 31, 2023 (In millions, except for percentages and multiples) Fair value Valuation technique Unobservable inputs Minimum Maximum Weighted average Impact of an increase in the input on fair value AFS, trading and equity securities $ 12,271 Discounted cash flow Discount rate 2.0 % 18.7 % 6.7 % 1 Decrease Mortgage loans 33,392 Discounted cash flow Discount rate 2.1 % 22.3 % 6.3 % 1 Decrease Investment funds 650 Discounted cash flow Discount rate 6.4 % 14.7 % 8.4 % Decrease 899 Discounted cash flow / Discount rate / 17.0% /8.5x 17.0% /8.5x 17.0% /8.5x Decrease/Increase 515 Net tangible asset values Implied multiple 1.26x 1.26x 1.26x Increase 517 Reported net asset value Reported net asset value N/A N/A N/A N/A Interest sensitive contract liabilities – fixed indexed annuities embedded derivatives 6,747 Discounted cash flow Nonperformance risk 0.3 % 1.8 % 1.3 % 2 Decrease Option budget 0.5 % 5.7 % 2.0 % 3 Increase Surrender rate 5.2 % 11.7 % 8.1 % 3 Decrease December 31, 2022 (In millions, except for percentages and multiples) Fair value Valuation technique Unobservable inputs Minimum Maximum Weighted average Impact of an increase in the input on fair value AFS, trading and equity securities $ 10,671 Discounted cash flow Discount rate 2.2 % 18.8 % 6.8 % 1 Decrease Mortgage loans 30,811 Discounted cash flow Discount rate 1.5 % 22.1 % 6.3 % 1 Decrease Investment funds 506 Discounted cash flow Discount rate 6.4 % 6.4 % 6.4 % Decrease 873 Discounted cash flow / Discount rate / 16.5% / 9x 16.5% / 9x 16.5% / 9x Decrease/Increase 529 Net tangible asset values Implied multiple 1.26x 1.26x 1.26x Increase 563 Reported net asset value Reported net asset value N/A N/A N/A N/A Interest sensitive contract liabilities – fixed indexed annuities embedded derivatives 5,841 Discounted cash flow Nonperformance risk 0.1 % 1.7 % 1.0 % 2 Decrease Option budget 0.5 % 5.3 % 1.9 % 3 Increase Surrender rate 5.1 % 11.5 % 8.1 % 3 Decrease 1 The discount rate weighted average is calculated based on the relative fair values of the securities or loans. 2 The nonperformance risk weighted average is based on the projected cash flows attributable to the embedded derivative. 3 The option budget and surrender rate weighted averages are calculated based on projected account values. Financial Instruments Without Readily Determinable Fair Values —We have elected the measurement alternative for certain equity securities that do not have a readily determinable fair value. As of March 31, 2023 and December 31, 2022, the carrying amount of the equity securities was $400 million and $400 million, respectively, with no cumulative recorded impairment. Fair Value of Financial Instruments Not Carried at Fair Value — The following represents our financial instruments not carried at fair value on the condensed consolidated balance sheets: March 31, 2023 (In millions) Carrying Value Fair Value NAV Level 1 Level 2 Level 3 Financial assets Investment funds $ 77 $ 77 $ 77 $ — $ — $ — Policy loans 339 339 — — 339 — Funds withheld at interest 35,375 35,375 — — — 35,375 Short-term investments 45 45 — — 45 — Other investments 200 200 — — — 200 Investments in related parties Investment funds 561 561 561 — — — Funds withheld at interest 10,728 10,728 — — — 10,728 Short-term investments 1,043 1,043 — — 1,043 — Total financial assets not carried at fair value

Deferred Acquisition Costs, Def

Deferred Acquisition Costs, Deferred Sales Inducements and Value of Business Acquired	3 Months Ended
	Mar. 31, 2023
Insurance [Abstract]
Deferred Acquisition Costs, Deferred Sales Inducements, and Value of Business Acquired	8. Deferred Acquisition Costs, Deferred Sales Inducements and Value of Business Acquired The following represents a rollforward of DAC and DSI by product, and a rollforward of VOBA. See Note 9 – Long-duration Contracts for more information on our products. Three months ended March 31, 2023 DAC DSI VOBA Total DAC, DSI and VOBA (In millions) Traditional deferred annuities Indexed annuities Funding agreements Other investment-type Indexed annuities Balance at December 31, 2022 $ 304 $ 755 $ 11 $ 9 $ 399 $ 2,988 $ 4,466 Additions 171 203 — 1 133 — 508 Amortization (16) (18) (1) — (10) (93) (138) Balance at March 31, 2023 $ 459 $ 940 $ 10 $ 10 $ 522 $ 2,895 $ 4,836 Three months ended March 31, 2022 DAC DSI VOBA Total DAC, DSI and VOBA (In millions) Traditional deferred annuities Indexed annuities Funding agreements Other investment-type Indexed annuities Balance at January 1, 2022 $ — $ — $ — $ — $ — $ 3,372 $ 3,372 Additions 24 176 11 3 77 — 291 Amortization — (1) (1) — — (96) (98) Balance at March 31, 2022 $ 24 $ 175 $ 10 $ 3 $ 77 $ 3,276 $ 3,565 Deferred costs related to universal life-type policies and investment contracts with significant revenue streams from sources other than investment of the policyholder funds, including traditional deferred annuities and indexed annuities, are amortized on a constant-level basis for a cohort of contracts using initial premium or deposit. Significant inputs and assumptions are required for determining the expected duration of the cohort and involves using accepted actuarial methods to determine decrement rates related to policyholder behavior for lapses, withdrawals (surrenders) and mortality. The assumptions used to determine the amortization of DAC and DSI are consistent with those used to estimate the related liability balance. Deferred costs related to investment contracts without significant revenue streams from sources other than investment of policyholder funds are amortized using the effective interest method, which primarily includes funding agreements. The effective interest method requires inputs to project future cash flows, which for funding agreements includes contractual terms of notional value, periodic interest payments based on either fixed or floating interest rates, and duration. For other investment-type contracts which include immediate annuities and assumed endowments without significant mortality risks, assumptions are required related to policyholder behavior for lapses and withdrawals (surrenders). The expected amortization of VOBA for the next five years is as follows: (In millions) Expected Amortization 2023 1 $ 257 2024 316 2025 289 2026 260 2027 230 2028 200 1 Expected amortization for the remainder of 2023.

Long-duration Contracts

Long-duration Contracts	3 Months Ended
	Mar. 31, 2023
Insurance [Abstract]
Long-duration Contracts	9. Long-duration Contracts Interest sensitive contract liabilities – Interest sensitive contract liabilities primarily include: ▪ traditional deferred annuities, ▪ indexed annuities consisting of fixed indexed and index-linked variable annuities, ▪ funding agreements, and ▪ other investment-type contracts comprising of immediate annuities without significant mortality risk (which includes pension group annuities without life contingencies) and assumed endowments without significant mortality risks. The following represents a rollforward of the policyholder account balance by product within interest sensitive contract liabilities. Where explicit policyholder account balances do not exist, the disaggregated rollforward represents the recorded reserve. Three months ended March 31, 2023 (In millions, except percentages) Traditional deferred annuities Indexed annuities Funding agreements Other investment-type Total Balance at December 31, 2022 $ 43,518 $ 92,660 $ 27,439 $ 4,722 $ 168,339 Deposits 6,700 2,929 1,500 1,033 12,162 Policy charges (1) (158) — — (159) Surrenders and withdrawals (1,818) (2,712) (70) (3) (4,603) Benefit payments (264) (422) (490) (90) (1,266) Interest credited 369 117 206 32 724 Foreign exchange — — 54 (16) 38 Other (54) — 143 (33) 56 Balance at March 31, 2023 $ 48,450 $ 92,414 $ 28,782 $ 5,645 $ 175,291 March 31, 2023 Weighted average crediting rate 3.4 % 2.3 % 2.7 % 2.9 % 2.7 % Net amount at risk $ 423 $ 13,903 $ — $ 66 $ 14,392 Cash surrender value 45,994 84,047 — 2,710 132,751 Three months ended March 31, 2022 (In millions, except percentages) Traditional deferred annuities Indexed annuities Funding agreements Other investment-type Total Balance at January 1, 2022 $ 35,599 $ 89,755 $ 23,623 $ 2,413 $ 151,390 Deposits 918 2,573 4,946 520 8,957 Policy charges (1) (141) — — (142) Surrenders and withdrawals (845) (1,798) — (1) (2,644) Benefit payments (256) (426) (695) (83) (1,460) Interest credited 235 697 125 17 1,074 Foreign exchange — — (100) (14) (114) Other — — (218) — (218) Balance at March 31, 2022 $ 35,650 $ 90,660 $ 27,681 $ 2,852 $ 156,843 March 31, 2022 Weighted average crediting rate 2.7 % 2.0 % 1.8 % 2.2 % 2.1 % Net amount at risk $ 416 $ 10,554 $ — $ 13 $ 10,983 Cash surrender value 34,211 84,265 — 710 119,186 The following is a reconciliation of interest sensitive contract liabilities to the condensed consolidated balance sheets: March 31, (In millions) 2023 2022 Traditional deferred annuities $ 48,450 $ 35,650 Indexed annuities 92,414 90,660 Funding agreements 28,782 27,681 Other investment-type 5,645 2,852 Reconciling items 1 5,809 7,460 Interest sensitive contract liabilities $ 181,100 $ 164,303 1 Reconciling items primarily include embedded derivatives in indexed annuities, unaccreted host contract adjustments on indexed annuities, negative VOBA, sales inducement liabilities, and wholly ceded universal life insurance contracts. The following represents policyholder account balances by range of guaranteed minimum crediting rates, as well as the related range of the difference between rates being credited to policyholders and the respective guaranteed minimums: March 31, 2023 (In millions) At guaranteed minimum 1 basis point – 100 basis points above guaranteed minimum Greater than 100 basis points above guaranteed minimum Total < 2.0% $ 25,571 $ 23,867 $ 80,468 $ 129,906 2.0% – < 4.0% 31,793 1,709 778 34,280 4.0% – < 6.0% 9,625 52 206 9,883 6.0% and greater 1,222 — — 1,222 Total $ 68,211 $ 25,628 $ 81,452 $ 175,291 March 31, 2022 (In millions) At guaranteed minimum 1 basis point – 100 basis points above guaranteed minimum Greater than 100 basis points above guaranteed minimum Total < 2.0% $ 29,040 $ 30,195 $ 57,412 $ 116,647 2.0% – < 4.0% 34,604 925 43 35,572 4.0% – < 6.0% 4,467 11 6 4,484 6.0% and greater 140 — — 140 Total $ 68,251 $ 31,131 $ 57,461 $ 156,843 Future policy benefits – Future policy benefits consist primarily of payout annuities, including single premium immediate annuities with life contingencies (which include pension group annuities with life contingencies). The following is a rollforward of the present value of expected net premiums and expected value of future policy benefits: Payout annuities with life contingencies Three months ended March 31, (In millions) 2023 2022 Present value of expected net premiums Beginning balance $ — $ — Issuances 88 1,994 Net premium collected (88) (1,994) Ending balance $ — $ — Present value of expected future policy benefits Beginning balance $ 36,422 $ 35,278 Effect of changes in discount rate assumptions 8,425 — Beginning balance at original discount rate 44,847 35,278 Effect of actual experience compared to expected experience (29) (47) Adjusted beginning balance 44,818 35,231 Issuances 88 1,994 Interest accrual 346 229 Benefit payments (885) (724) Foreign exchange 8 (19) Ending balance at original discount rate 44,375 36,711 Effect of changes in discount rate assumptions (7,623) (3,562) Ending balance $ 36,752 $ 33,149 The following is a reconciliation of future policy benefits to the condensed consolidated balance sheets: March 31, (In millions) 2023 2022 Payout annuities with life contingencies $ 36,752 $ 33,149 Reconciling items 1 5,738 6,091 Future policy benefits $ 42,490 $ 39,240 1 Reconciling items primarily include the deferred profit liability and negative VOBA associated with our liability for future policy benefits. Additionally, it includes reserves for our immaterial lines of business including term and whole life, accident and health and disability, as well as other insurance benefit reserves for our no-lapse guarantees with universal life contracts, all of which are fully ceded. The following is a reconciliation of premiums to the condensed consolidated statements of income (loss): Three months ended March 31, (In millions) 2023 2022 Payout annuities with life contingencies $ 88 $ 2,098 Reconciling items 1 8 12 Premiums $ 96 $ 2,110 1 Reconciling items premiums related to our immaterial lines of business including term and whole life and accident and health and disability. Gross premiums are recorded within premiums on the condensed consolidated statements of income (loss). Interest expense (accretion) related to future policy benefits was $346 million and $229 million during the three months ended March 31, 2023 and 2022, respectively, and is recorded as a component of policy and other operating expenses on the condensed consolidated statements of income (loss). Significant assumptions and inputs to the calculation of future policy benefits for payout annuities with life contingencies include policyholder demographic data, assumptions for policyholder longevity and policyholder utilization for contracts with deferred lives, and discount rates. We base certain key assumptions related to policyholder behavior on industry standard data adjusted to align with actual company experience, if necessary. At least annually, we review all significant cash flow assumptions and update as necessary, unless emerging experience indicates a more frequent review is necessary. The discount rate reflects market observable inputs from upper-medium grade fixed income instrument yields and is interpolated, where necessary, to conform to the duration of our liabilities. During the three months ended March 31, 2023, future policy benefits for payout annuities with life contingencies increased by $330 million, which was primarily driven by an $802 million change in discount rate assumptions related to a decrease in rates and $346 million of interest accrual, partially offset by $885 million of benefit payments. During the three months ended March 31, 2022, future policy benefits for payout annuities with life contingencies decreased by $2,129 million, which was primarily driven by a $3,562 million change in discount rate assumptions related to an increase in rates and $724 million of benefit payments, partially offset by $1,994 million of pension group annuity issuances and $229 million of interest accrual. The following represents the undiscounted and discounted expected future benefit payments for the liability for future policy benefits. As these relate to payout annuities for single premium immediate annuities with life contingencies, there are no expected future gross premiums. March 31, 2023 March 31, 2022 (In millions) Undiscounted Discounted Undiscounted Discounted Expected future benefit payments $ 63,995 $ 44,375 $ 51,643 $ 36,711 The following represents the weighted-average durations and the weighted-average interest rates of future policy benefits: March 31, 2023 2022 Weighted-average liability duration (in years) 10.1 10.6 Weighted-average interest accretion rate 3.2 % 2.7 % Weighted-average current discount rate 5.3 % 3.7 % Policyholder longevity assumptions represent the main driver of variances from actual experience compared to expected experience. The following is the variance of actual experience compared to expected experience related to policyholder longevity assumptions recorded within future policy benefits: Three months ended March 31, (In millions) 2023 2022 Expected reserve release due to death $ 132 $ 114 Actual reserve release due to death 183 163 Decrease in reserve due to actual experience compared to expected experience $ (51) $ (49) The following is a summary of remeasurement gains (losses) included within future policy and other policy benefits on the condensed consolidated statements of income (loss): Three months ended March 31, (In millions) 2023 2022 Reserves $ 29 $ 47 Deferred profit liability (27) (54) Negative VOBA (4) 10 Total remeasurement gains (losses) $ (2) $ 3 There have been no adverse developments during the three months ended March 31, 2023 and 2022. Market risk benefits – We issue and reinsure traditional deferred and indexed annuity products that contain GLWB and GMDB riders that meet the criteria to be classified as market risk benefits. The following is a rollfoward of net market risk benefit liabilities by product: Three months ended March 31, 2023 (In millions) Traditional deferred annuities Indexed annuities Total Balance at December 31, 2022 $ 170 $ 2,319 $ 2,489 Effect of changes in instrument-specific credit risk 13 353 366 Balance, beginning of period, before changes in instrument specific credit risk 183 2,672 2,855 Issuances — 17 17 Interest accrual 2 32 34 Attributed fees collected 1 84 85 Benefit payments — (6) (6) Effect of changes in interest rates 8 218 226 Effect of changes in equity — (18) (18) Effect of actual behavior compared to expected behavior 2 23 25 Balance, end of period, before changes in instrument specific credit risk 196 3,022 3,218 Effect of changes in the instrument specific credit risk (16) (439) (455) Balance at March 31, 2023 $ 180 $ 2,583 $ 2,763 March 31, 2023 Net amount at risk $ 423 $ 13,903 $ 14,326 Weighted-average attained age of contract holders (in years) 75 69 69 Three months ended March 31, 2022 (In millions) Traditional deferred annuities Indexed annuities Total Balance at January 1, 2022 $ 253 $ 4,194 $ 4,447 Issuances — 16 16 Interest accrual — (2) (2) Attributed fees collected 1 81 82 Benefit payments (1) (11) (12) Effect of changes in interest rates (26) (732) (758) Effect of changes in equity — 55 55 Effect of actual behavior compared to expected behavior 1 12 13 Balance, end of period, before changes in instrument specific credit risk 228 3,613 3,841 Effect of changes in the instrument specific credit risk (13) (384) (397) Balance at March 31, 2022 $ 215 $ 3,229 $ 3,444 March 31, 2022 Net amount at risk $ 416 $ 10,554 $ 10,970 Weighted-average attained age of contract holders (in years) 75 69 69 The following is a reconciliation of market risk benefits to the condensed consolidated balance sheets. Market risk benefit assets are included in other assets on the condensed consolidated balance sheets. March 31, 2023 March 31, 2022 (In millions) Asset Liability Net liability Asset Liability Net liability Traditional deferred annuities $ — $ 180 $ 180 $ — $ 215 $ 215 Indexed annuities 440 3,023 2,583 413 3,642 3,229 Total $ 440 $ 3,203 $ 2,763 $ 413 $ 3,857 $ 3,444 During the three months ended March 31, 2023, net market risk benefit liabilities increased by $274 million, which was primarily driven by a $226 million change in interest rates related to a decrease in rates. During the three months ended March 31, 2022, net market risk benefit liabilities decreased by $1,003 million, which was primarily driven by a $758 million change in interest rates related to an increase in rates and a $397 million change in instrument specific credit risk related to widening of credit spreads, partially offset by $82 million of fees collected from policyholders and $55 million of changes related to equity market performance. The determination of the fair value of market risk benefits requires the use of inputs related to fees and assessments and assumptions in determining the projected benefits in excess of the projected account balance. Judgment is required for both economic and actuarial assumptions, which can be either observable or unobservable, that impact future policyholder account growth. Economic assumptions include interest rates and implied volatilities throughout the duration of the liability. For indexed annuities, assumptions also include projected equity returns which impact cash flows attributable to indexed strategies, implied equity volatilities, expected index credits on the next policy anniversary date and future equity option costs. Assumptions related to the level of option budgets used for determining the future equity option costs and the impact on future policyholder account value growth are considered unobservable inputs. Policyholder behavior assumptions are unobservable inputs and are established using accepted actuarial valuation methods to estimate withdrawals (surrender rate). Assumptions are generally based on industry data and pricing assumptions which are updated for actual experience, if necessary. Actual experience may be limited for recently issued products. All inputs are used to project excess benefits and fees over a range of risk-neutral, stochastic interest rate scenarios. For indexed annuities, stochastic equity return scenarios are also included within the range. A risk margin is incorporated within the discount rate to reflect uncertainty in the projected cash flows such as variations in policyholder behavior, as well as a credit spread to reflect our nonperformance risk, which is considered an unobservable input. The following summarizes the unobservable inputs for market risk benefits: March 31, 2023 (In millions, except for percentages) Fair value Valuation technique Unobservable inputs Minimum Maximum Weighted average Impact of an increase in the input on fair value Market risk benefits, net $ 2,763 Discounted cash flow Nonperformance risk 0.3 % 1.7 % 1.6 % 1 Decrease Option budget 0.5 % 5.6 % 1.7 % 2 Decrease Surrender rate 3.3 % 6.9 % 4.5 % 2 Decrease March 31, 2022 (In millions, except for percentages) Fair value Valuation technique Unobservable inputs Minimum Maximum Weighted average Impact of an increase in the input on fair value Market risk benefits, net $ 3,444 Discounted cash flow Nonperformance risk 0.4 % 2.0 % 1.3 % 1 Decrease Option budget 0.5 % 3.8 % 1.5 % 2 Decrease Surrender rate 3.6 % 6.6 % 4.5 % 2 Decrease 1 The nonperformance risk weighted average is based on the cash flows underlying the market risk benefit reserve. 2 The option budget and surrender rate weighted averages are calculated based on projected account values.

Debt

Debt	3 Months Ended
	Mar. 31, 2023
Debt Disclosure [Abstract]
Debt	10. Debt Liquidity Facility —In the third quarter of 2022, we entered into a revolving credit facility with Wells Fargo Bank, National Association, as administrative agent, which matures on June 30, 2023, subject to additional 364-day extensions (Liquidity Facility). The Liquidity Facility will be used for liquidity and working capital needs to meet short-term cash flow and investment timing differences. The borrowing capacity under the Liquidity Facility is $2.5 billion, with potential increases up to $3.0 billion. The Liquidity Facility contains various standard covenants with which we must comply, including the following: 1. ALRe Minimum Consolidated Net Worth (as defined in the Liquidity Facility) of no less than $9.3 billion; and 2. Restrictions on our ability to incur debt and liens, in each case with certain exceptions. Interest accrues on outstanding borrowings at either the secured overnight financing rate (Adjusted Term SOFR, as defined in the Liquidity Facility) plus a margin or a base rate plus a margin, with applicable margin varying based on ALRe’s Financial Strength Rating (as defined in the Liquidity Facility). On February 7, 2023, we borrowed $1.0 billion from the Liquidity Facility for short-term cash flow needs, which was repaid in the first quarter of 2023. As of March 31, 2023, there were no amounts outstanding under the Liquidity Facility.

Equity

Equity	3 Months Ended
	Mar. 31, 2023
Equity [Abstract]
Equity	11. Equity Acc umulated Other Comprehensive Income (Loss)— The following provides the details and changes in AOCI: (In millions) Unrealized investment gains (losses) on AFS securities without a credit allowance Unrealized investment gains (losses) on AFS securities with a credit allowance Unrealized gains (losses) on hedging instruments Remeasurement gains (losses) on future policy benefits related to discount rate Remeasurement gains (losses) on market risk benefits related to credit risk Foreign currency translation and other adjustments Accumulated other comprehensive income (loss) Balance at December 31, 2022 $ (12,565) $ (334) $ 47 $ 5,256 $ 285 $ (10) $ (7,321) Other comprehensive income (loss) before reclassifications 2,187 (119) 191 (802) 89 16 1,562 Less: Reclassification adjustments for gains (losses) realized 1 (31) — 87 — — — 56 Less: Income tax expense (benefit) 312 14 15 (73) 18 4 290 Less: Other comprehensive income (loss) attributable to noncontrolling interests 220 — 27 (208) 1 3 43 Balance at March 31, 2023 $ (10,879) $ (467) $ 109 $ 4,735 $ 355 $ (1) $ (6,148) 1 Recognized in investment related gains (losses) on the condensed consolidated statements of income (loss). (In millions) Unrealized investment gains (losses) on AFS securities without a credit allowance Unrealized investment gains (losses) on AFS securities with a credit allowance Unrealized gains (losses) on hedging instruments Remeasurement gains (losses) on future policy benefits related to discount rate Remeasurement gains (losses) on market risk benefits related to credit risk Foreign currency translation and other adjustments Accumulated other comprehensive income (loss) Balance at January 1, 2022 $ — $ — $ — $ — $ — $ — $ — Other comprehensive income (loss) before reclassifications 1 (6,645) (97) (129) 3,562 397 (2) (2,914) Less: Reclassification adjustments for gains (losses) realized in net income 1 (38) (7) — — — — (45) Less: Income tax expense (benefit) (1,184) (16) (26) 529 83 (1) (615) Less: Other comprehensive income (loss) attributable to noncontrolling interests (676) (9) (24) 774 5 (6) 64 Balance at March 31, 2022 $ (4,747) $ (65) $ (79) $ 2,259 $ 309 $ 5 $ (2,318) 1 Recognized in investment related gains (losses) on the condensed consolidated statements of income (loss).

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	12. Income Taxes The income tax expense (benefit) was $163 million and $(284) million for the three months ended March 31, 2023 and 2022, respectively. Our effective tax rate in the first quarter of 2023 was 12% compared to 13% in 2022. On August 16, 2022, the US government enacted the Inflation Reduction Act of 2022 (IRA). The IRA contains a number of tax-related provisions including a 15% minimum corporate income tax on certain large corporations as well as an excise tax on stock repurchases. It is unclear how the IRA will be ultimately implemented by the US Department of the Treasury through regulation although the IRS has issued interim guidance relevant to us describing regulations it intends to issue upon which taxpayers are entitled to rely until the issuance of regulations. We are still evaluating the impact of the IRA on our tax liability, which tax liability could also be affected by how the provisions of the IRA are implemented through such regulation. We will continue to evaluate the IRA's impact as further information becomes available.

Related Parties

Related Parties	3 Months Ended
	Mar. 31, 2023
Related Party Transactions [Abstract]
Related Parties	13. Related Parties Apollo Fee structure – Substantially all of our investments are managed by Apollo. Apollo provides us a full suite of services that includes: direct investment management; asset sourcing and allocation; mergers and acquisition sourcing, execution and asset diligence; and strategic support and advice. Apollo also provides certain operational support services for our investment portfolio including investment compliance, tax, legal and risk management support. Apollo has extensive experience managing our investment portfolio and its knowledge of our liability profile enables it to tailor an asset management strategy to fit our specific needs. This strategy has proven responsive to changing market conditions and focuses on earning incremental yield by taking liquidity risk and complexity risk, rather than assuming incremental credit risk. Our partnership has enabled us to take advantage of investment opportunities that would likely not otherwise have been available to us. Under our fee agreement with Apollo, we pay Apollo a base management fee of (1) 0.225% per year on a monthly basis equal to the lesser of (A) $103.4 billion, which represents the aggregate fair market value of substantially all of the assets in substantially all of the accounts of or relating to us (collectively, the Accounts) as of December 31, 2018 (Backbook Value), and (B) the aggregate book value of substantially all of the assets in the Accounts at the end of the respective month, plus (2) 0.15% per year of the amount, if any, by which the aggregate book value of substantially all of the assets in the Accounts at the end of the respective month exceeds the Backbook Value, subject to certain adjustments. Additionally, we pay a sub-allocation fee based on specified asset class tiers ranging from 0.065% to 0.70% of the book value of such assets, with the higher percentages in this range for asset classes that are designed to have more alpha generating abilities. During the three months ended March 31, 2023 and 2022, we incurred management fees, inclusive of the base and sub-allocation fees, of $222 million and $186 million, respectively. Management fees are included within net investment income on the condensed consolidated statements of income (loss). As of March 31, 2023 and December 31, 2022, management fees payable were $85 million and $80 million, respectively, and are included in other liabilities on the condensed consolidated balance sheets. Such amounts include fees incurred attributable to Athene Co-Invest Reinsurance Affiliate Holding Ltd. (together with its subsidiaries, ACRA 1) including all of the noncontrolling interest in ACRA 1. In addition to the assets on our condensed consolidated balance sheets managed by Apollo, Apollo manages the assets underlying our funds withheld receivable. For these assets, the third-party cedants pay Apollo fees based upon the same fee construct we have with Apollo. Such fees directly reduce the settlement payments that we receive from the third-party cedant and, as such, we indirectly pay those fees. Finally, Apollo charges management fees and carried interest on Apollo-managed funds and other entities in which we invest. Neither the fees paid by such third-party cedants nor the fees or carried interest paid by such Apollo-managed funds or other entities are included in the investment management fee amounts noted above. Termination of ACRA 1 investment management agreements (IMA) – Our bye-laws currently provide that, with respect to IMAs covering assets backing reserves and surplus in ACRA 1, whether from internal reinsurance, third-party reinsurance, or inorganic transactions, among us or any of our subsidiaries, on the one hand, and Apollo Insurance Solutions Group LP (ISG), on the other hand, we may not, and will not cause our subsidiaries to, terminate any such IMA with Apollo other than at specified termination dates and with relevant board approvals of independent directors and written notice. Governance – We have a management investment and asset liability committee, which includes members of our senior management and reports to the risk committee of our board of directors. The committee focuses on strategic decisions involving our investment portfolio, such as approving investment limits, new asset classes and our allocation strategy, reviewing large asset transactions, as well as monitoring our credit risk, and the management of our assets and liabilities. AGM owns all of our common stock and James Belardi, our Chief Executive Officer, serves as a member of the board of directors and an executive officer of AGM, and Chief Executive Officer of ISG, which is also a subsidiary of AGM. Mr. Belardi also owns a profit interest in ISG and in connection with such interest receives quarterly distributions equal to 3.35% of base management fees and 4.5% of subadvisory fees, as such fees are defined in our fee agreement with Apollo. Additionally, six of the fourteen members of our board of directors (including Mr. Belardi) are employees of or consultants to Apollo. In order to protect against potential conflicts of interest resulting from transactions into which we have entered and will continue to enter into with the Apollo Group, our bye-laws require us to maintain a conflicts committee comprised solely of directors who are not general partners, directors (other than independent directors of AGM), managers, officers or employees of any member of the Apollo Group. The conflicts committee reviews and approves material transactions between us and the Apollo Group, subject to certain exceptions. Other related party transactions AAA – We consolidate AAA as a VIE. Apollo established AAA for the purpose of providing a single vehicle through which we and third-party investors can participate in a portfolio of alternative investments, which include those managed by Apollo. Additionally, we believe AAA enhances Apollo’s ability to increase alternative assets under management (AUM) by raising capital from third parties, which will allow Athene to achieve greater scale and diversification for alternatives. Third-party investors began to invest in AAA on July 1, 2022. Wheels Donlen – We contributed our limited partnership investment in Athene Freedom Parent, LP (Athene Freedom), for which an Apollo affiliate is the general partner, to AAA during the second quarter of 2022. Athene Freedom indirectly invests in Wheels, Inc. (Wheels) and Donlen, LLC (Donlen). During the fourth quarter of 2022, Athene Freedom also invested in LeasePlan USA, Inc. (LeasePlan). We own securities issued by Wheels, Donlen and LeasePlan of $1,185 million and $1,024 million as of March 31, 2023 and December 31, 2022, respectively, which are held as related party AFS securities on the condensed consolidated balance sheets. MidCap FinCo Designated Activity Company (MidCap Financial) – We have various investments in MidCap Financial including an investment through AAA, senior unsecured notes and redeemable preferred stock. We previously directly held MidCap Financial profit participating notes until contribution to AAA during the second quarter of 2022. We also hold structured securities issued by MidCap Financial affiliates. As of March 31, 2023 and December 31, 2022, we held securities issued by MidCap Financial and its affiliates of $1,481 million and $1,262 million, respectively, which are included in related party AFS or trading securities on the condensed consolidated balance sheets. Athora – We have a cooperation agreement with Athora, pursuant to which, among other things, (1) for a period of 30 days from the receipt of notice of a cession, we have the right of first refusal to reinsure (i) up to 50% of the liabilities ceded from Athora’s reinsurance subsidiaries to Athora Life Re Ltd. and (ii) up to 20% of the liabilities ceded from a third party to any of Athora’s insurance subsidiaries, subject to a limitation in the aggregate of 20% of Athora’s liabilities, (2) Athora agreed to cause its insurance subsidiaries to consider the purchase of certain funding agreements and/or other spread instruments issued by our insurance subsidiaries, subject to a limitation that the fair market value of such funding agreements purchased by any of Athora’s insurance subsidiaries may generally not exceed 3% of the fair market value of such subsidiary’s total assets, (3) we provide Athora with a right of first refusal to pursue acquisition and reinsurance transactions in Europe (other than the United Kingdom (UK)) and (4) Athora provides us and our subsidiaries with a right of first refusal to pursue acquisition and reinsurance transactions in North America and the UK. Notwithstanding the foregoing, pursuant to the cooperation agreement, Athora is only required to use its reasonable best efforts to cause its subsidiaries to adhere to the provisions set forth in the cooperation agreement and therefore Athora’s ability to cause its subsidiaries to act pursuant to the cooperation agreement may be limited by, among other things, legal prohibitions or the inability to obtain the approval of the board of directors or other applicable governing body of the applicable subsidiary, which approval is solely at the discretion of such governing body. As of March 31, 2023 , we have not exercised our right of first refusal to reinsure liabilities ceded to Athora’s insurance or reinsurance subsidiaries. We have investments in Athora’s equity, which we hold as a related party investment fund on the condensed consolidated balance sheets, and non-redeemable preferred equity securities. The following table summarizes our investments in Athora: (In millions) March 31, 2023 December 31, 2022 Investment fund $ 1,034 $ 959 Non-redeemable preferred equity securities 245 273 Total investment in Athora $ 1,279 $ 1,232 Additionally, as of March 31, 2023 and December 31, 2022, we had $60 million and $59 million, respectively, of funding agreements outstanding to Athora . We also have commitments to make additional equity investments in Athora of $526 million as of March 31, 2023. Catalina – We have an investment in Apollo Rose II (B) (Apollo Rose), which we consolidate as a VIE. Apollo Rose has equity interests in Catalina Holdings (Bermuda) Ltd. (Catalina) and is reflected as a related party investment fund in assets of consolidated VIEs on the condensed consolidated balance sheets. During the fourth quarter of 2022, we entered into a strategic modco reinsurance agreement with Catalina General Insurance Ltd., which is a subsidiary of Catalina, to cede certain inforce funding agreements. We elected the fair value option on this agreement and had a liability of $189 million and $142 million as of March 31, 2023 and December 31, 2022, respectively, which is included in other liabilities on the condensed consolidated balance sheets. Venerable – We have coinsurance and modco agreements with Venerable Insurance and Annuity Company (VIAC). VIAC is a related party due to our minority equity investment in its holding company’s parent, VA Capital , which was $235 million and $240 million as of March 31, 2023 and December 31, 2022, respectively. The minority equity investment in VA Capital is included in related party investment funds on the condensed consolidated balance sheets and accounted for as an equity method investment. VA Capital is owned by a consortium of investors, led by affiliates of Apollo, Crestview Partners III Management , LLC and Reverence Capital Partners L.P., and is the parent of Venerable, which is the parent of VIAC. We also have term loans receivable from Venerable due in 2033, which are included in related party other investments on the condensed consolidated balance sheets. The loans are held at fair value and were $338 million and $303 million as of March 31, 2023 and December 31, 2022, respectively. While management views the overall transactions with Venerable as favorable to us, the stated interest rate of 6.257% on the initial term loan to Venerable represented a below-market interest rate, and management considered such rate as part of its evaluation and pricing of the reinsurance transactions. Strategic Partnership – We have an agreement pursuant to which we may invest up to $2.875 billion over three years in funds managed by Apollo entities (Strategic Partnership). This arrangement is intended to permit us to invest across the Apollo alternatives platform into credit-oriented, strategic and other alternative investments in a manner and size that is consistent with our existing investment strategy. Fees for such investments payable by us to Apollo would be more favorable to us than market rates, and consistent with our existing alternative investments, investments made under the Strategic Partnership require approval of ISG and remain subject to our existing governance processes, including approval by our conflicts committee where applicable. During the second quarter of 2022, we contributed the majority of our Strategic Partnership investments to AAA. As of March 31, 2023 and December 31, 2022, we had $1,151 million and $1,046 million, respectively, of investments under the Strategic Partnership and these investments are typically included as consolidated VIEs or related party investment funds on the condensed consolidated balance sheets. PK AirFinance – We have investments in PK AirFinance (PK Air), an aviation lending business with a portfolio of loans (Aviation Loans). The Aviation Loans are generally fully secured by aircraft leases and aircraft and are securitized by a special purpose vehicle (SPV) for which Apollo acts as ABS manager (ABS-SPV). The ABS-SPV issues tranches of senior notes and subordinated notes, which are secured by the Aviation Loans. We have purchased both senior and subordinated notes of PK Air, which are included in related party AFS or trading securities on the condensed consolidated balance sheets. During the first quarter of 2022, we contributed our investment in the subordinated notes to PK Air Holdings, LP (PK Air Holdings) and then contributed PK Air Holdings to AAA during the second quarter of 2022. We had investments in PK Air notes of $1,577 million and $1,183 million as of March 31, 2023 and December 31, 2022, respectively. We also have commitments to make additional investments in PK Air of $1,261 million as of March 31, 2023. Apollo/Athene Dedicated Investment Program (ADIP) – ACRA 1 is partially owned by ADIP, a series of funds managed by Apollo. ALRe currently holds 36.55% of the economic interests in ACRA 1 and all of ACRA 1’s voting interests, with ADIP holding the remaining 63.45% of the economic interests. During the three months ended March 31, 2023 and 2022, we received capital contributions of $0 million and $311 million, respectively, from ADIP, and paid dividends of $127 million and $0 million, respectively, to ADIP. Additionally, as of March 31, 2023 and December 31, 2022 , we had $201 million and $202 million, respectively, of related party payables for contingent investment fees payable by ACRA 1 to Apollo. ACRA 1 is obligated to pay the contingent investment fees on behalf of ADIP and, as such, the balance is attributable to noncontrolling interest. Unsecured Revolving Promissory Note Receivable with AGM – AHL has an unsecured revolving promissory note with AGM which allows AGM to borrow funds from AHL. The note has a borrowing capacity of $500 million. Interest accrues at the US mid-term applicable federal rate per year and has a maturity date of December 13, 2025, or earlier at AHL’s request. The note receivable had an outstanding balance of $123 million and $78 million as of March 31, 2023 and December 31, 2022, respectively . Unsecured Revolving Promissory Note Payable with AGM – AHL has an unsecured revolving promissory note with AGM which allows AHL to borrow funds from AGM. The note has a borrowing capacity of $500 million. Interest accrues at the US mid-term applicable federal rate per year and has a maturity date of December 13, 2025, or earlier at AGM’s request. There was no outstanding balance on the note payable as of March 31, 2023 and December 31, 2022, respectively . Atlas Securitized Products Holdings LP (Atlas) – We have an equity investment in Atlas, an asset-backed specialty lender, through our investment in AAA. A s of March 31, 2023 and December 31, 2022, we had $995 million and $0 million, respectively, of related party AFS securities issued by Atlas. Additionally, we have $1,043 million and $0 million of reverse repurchase agreements issued by Atlas as of March 31, 2023 and December 31, 2022, respectively, which are held as related party short-term investments on the condensed consolidated balance sheets. See Note 14 – Commitments and Contingencies for further information on assurance letters issued in support of Atlas.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	14. Commitments and Contingencies Contingent Commitments —We had commitments to make investments, primarily capital contributions to investment funds, inclusive of related party commitments discussed previously and those of consolidated VIEs, of $19.3 billion as of March 31, 2023. We expect most of our current commitments will be invested over the next five years; however, these commitments could become due any time upon counterparty request. Funding Agreements —We are a member of the Federal Home Loan Bank of Des Moines (FHLB) and, through membership, we have issued funding agreements to the FHLB in exchange for cash advances. As of March 31, 2023 and December 31, 2022, we had $4.9 billion and $3.7 billion, respectively, of FHLB funding agreements outstanding. We are required to provide collateral in excess of the funding agreement amounts outstanding, considering any discounts to the securities posted and prepayment penalties. We have a funding agreement backed notes (FABN) program, which allows Athene Global Funding, a special-purpose, unaffiliated statutory trust, to offer its senior secured medium-term notes. Athene Global Funding uses the net proceeds from each sale to purchase one or more funding agreements from us. As of March 31, 2023 and December 31, 2022, we had $21.1 billion and $21.0 billion, respectively, of board-authorized FABN f unding agreements outstanding . We had $13.5 billion of board-authorized FABN capacity remaining as of March 31, 2023. We also established a secured funding agreement backed repurchase agreement (FABR) program, in which a special-purpose, unaffiliated entity enters into repurchase agreements with a bank and the proceeds of the repurchase agreements are used by the special-purpose entity to purchase funding agreements from us. As of March 31, 2023 and December 31, 2022, we had $3.0 billion and $3.0 billion, respectively, of FABR funding agreements outstanding. Pledged Assets and Funds in Trust (Restricted Assets)— The total restricted assets included on the condensed consolidated balance sheets are as follows: (In millions) March 31, 2023 December 31, 2022 AFS securities $ 17,054 $ 15,366 Trading securities 69 55 Equity securities 71 38 Mortgage loans 7,963 8,849 Investment funds 84 103 Derivative assets 80 65 Short-term investments 131 120 Other investments 215 170 Restricted cash 1,148 628 Total restricted assets $ 26,815 $ 25,394 The restricted assets are primarily related to reinsurance trusts established in accordance with coinsurance agreements and the FHLB and FABR funding agreements described above. Letters of Credit— We have undrawn letters of credit totaling $1,344 million as of March 31, 2023. These letters of credit were issued for our reinsurance program and have expirations through July 28, 2025. Assurance Letter —In February 2023, the Company, Apollo and Credit Suisse AG (CS) undertook the first two closes on a previously announced transaction whereby Atlas, which is owned by AAA, acquired certain assets of the CS Securitized Products Group. Under terms of the transaction, Atlas has agreed to pay CS $3.3 billion, of which $0.4 billion is deferred until February 8, 2026, and $2.9 billion is deferred until February 8, 2028. This deferred purchase price is an obligation first of Atlas, and (as a result of additional guarantees provided by AAA, Apollo Asset Management, Inc. (AAM) and AHL) second of AAA, third of AAM, fourth of AHL and fifth of AARe. AARe and AAM have each issued an assurance letter to CS to guarantee the full amount of $3.3 billion. The fair values of our guarantees related to this transaction are not material to the consolidated financial statements.

Business, Basis of Presentati_2

Business, Basis of Presentation and Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation—We have prepared the accompanying condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (US GAAP) for interim financial information and the United States Securities and Exchange Commission’s rules and regulations for Form 10-Q and Article 10 of Regulation S-X. The accompanying condensed consolidated financial statements are unaudited and reflect all adjustments, consisting only of normal recurring items, considered necessary for fair statement of the results for the interim periods presented. All intercompany accounts and transactions have been eliminated. Interim operating results are not necessarily indicative of the results expected for the entire year.For entities that are consolidated, but not wholly owned, we allocate a portion of the income or loss and corresponding equity to the owners other than us. We include the aggregate of the income or loss and corresponding equity that is not owned by us in noncontrolling interests in the condensed consolidated financial statements.The condensed consolidated balance sheet as of December 31, 2022 has been derived from the audited financial statements, with necessary unaudited adjustments made for the implementation of targeted improvements to the accounting for long-duration contracts, and does not include all of the information and footnotes required by US GAAP for complete financial statements. Therefore, these condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2022.
Consolidation	The accompanying condensed consolidated financial statements are unaudited and reflect all adjustments, consisting only of normal recurring items, considered necessary for fair statement of the results for the interim periods presented. All intercompany accounts and transactions have been eliminated. Interim operating results are not necessarily indicative of the results expected for the entire year.For entities that are consolidated, but not wholly owned, we allocate a portion of the income or loss and corresponding equity to the owners other than us. We include the aggregate of the income or loss and corresponding equity that is not owned by us in noncontrolling interests in the condensed consolidated financial statements.The condensed consolidated balance sheet as of December 31, 2022 has been derived from the audited financial statements, with necessary unaudited adjustments made for the implementation of targeted improvements to the accounting for long-duration contracts, and does not include all of the information and footnotes required by US GAAP for complete financial statements.
Use of Estimates	The preparation of financial statements requires the use of management estimates. Actual results may differ from estimates used in preparing the condensed consolidated financial statements.
Reinsurance	Reinsurance —We assume and cede insurance and investment contracts under coinsurance, funds withheld coinsurance (funds withheld) and modified coinsurance (modco). We follow reinsurance accounting for transactions that provide indemnification against loss or liability relating to insurance risk (risk transfer). To meet risk transfer requirements, a reinsurance agreement must transfer insurance risk arising from uncertainties about both underwriting and timing risks. Cessions under reinsurance do not discharge our obligations as the primary insurer unless the requirements of assumption reinsurance have been met. We generally have the right of offset on reinsurance contracts, but have elected to present reinsurance settlement amounts due to and from us on a gross basis. For assets and liabilities ceded under reinsurance agreements, we generally apply the same measurement guidance for our directly issued or assumed contracts. Ceded amounts are recorded within reinsurance recoverable on the condensed consolidated balance sheets. For reinsurance of in-force contracts that pass risk transfer, the issue year used for the purpose of measuring the reinsurance recoverable is dependent on the effective date of the reinsurance agreement, which may differ from the issue year for the direct or assumed contract. The issue year informs the locked-in discount rate used for the purposes of interest accretion. This may result in different discount rates used for the direct or assumed reserves and ceded reserves when reinsuring an in-force block of insurance contracts. For flow reinsurance of insurance contracts that pass risk transfer, the contracts have the same cash flow assumptions as the direct or assumed contracts when the terms are consistent between those respective contracts and the ceded reinsurance agreement. When we recognize an immediate loss due to the present value of future benefits and expenses exceeding the present value of future gross premiums, a gain is recognized on the corresponding reinsurance recoverable to the extent it does not result in gain recognition at treaty inception. Likewise, where the direct or assumed reserve has been floored to zero, the corresponding reinsurance recoverable will be consistently set to zero. See – Future Policy Benefits below for further information. Accounting for reinsurance requires the use of assumptions, particularly related to the future performance of the underlying business and the potential impact of counterparty credit risks. We attempt to minimize our counterparty credit risk through the structuring of the terms of our reinsurance agreements, including the use of trusts, and monitor credit ratings of counterparties for signs of declining credit quality. When a ceding company does not report information on a timely basis, we record accruals based on the best available information at the time, which includes the reinsurance agreement terms and historical experience. We periodically compare actual and anticipated experience to the assumptions used to establish reinsurance assets and liabilities. Assets and liabilities assumed or ceded under coinsurance, funds withheld or modco are presented gross on the condensed consolidated balance sheets. For investment contracts, the change in the direct or assumed and ceded reserves are presented net in interest sensitive contract benefits on the condensed consolidated statements of income (loss). For insurance contracts, the change in the direct or assumed and ceded reserves and benefits are presented net in future policy and other policy benefits on the condensed consolidated statements of income (loss), except for changes related to the discount rate which are presented net in other comprehensive income (loss) (OCI) on the condensed consolidated statements of comprehensive income (loss). For market risk benefits, the change in the direct or assumed and ceded reserves are presented net in market risk benefits remeasurement (gains) losses on the condensed consolidated statements of income (loss), except for changes related to instrument-specific credit risk on direct and assumed contracts which are presented net in OCI on the condensed consolidated statements of comprehensive income (loss). For the reinsurance of existing in-force blocks that transfer significant insurance risk, the difference between the assets received or paid and the liabilities assumed or ceded represents the net cost of reinsurance at the inception of the reinsurance agreement. The net cost of reinsurance is amortized on a basis consistent with the methodologies and assumptions used to amortize deferred acquisition costs (DAC) and deferred sales inducements (DSI).
Deferred Acquisition Costs and Deferred Sales Inducements	Costs related directly to the successful acquisition of new, or the renewal of existing, insurance or investment contracts are deferred. These costs consist of commissions and policy issuance costs, as well as sales inducements credited to policyholder account balances, and are included in deferred acquisition costs, deferred sales inducements and value of business acquired on the condensed consolidated balance sheets. These costs are not capitalized until they are incurred. Deferred costs related to universal life-type policies and investment contracts with significant revenue streams from sources other than investment of the policyholder funds are grouped into cohorts based on issue year and contract type and amortized on a constant level basis over the expected term of the related contracts. The cohorts and assumptions used for the amortization of deferred costs are consistent with those used in estimating the related liabilities for these contracts. The constant level basis generally is the initial premium or deposit and is projected based on assumptions related to policyholder behavior, including lapses and mortality, over the expected term of the contracts. Each reporting period, we replace expected experience with actual experience to determine the related amortization expense. Changes to projected experience are recognized in amortization expense prospectively over the remaining contract term. Amortization of DAC and DSI is included in amortization of deferred acquisition costs, deferred sales inducements and value of business acquired on the condensed consolidated statements of income (loss). Deferred costs related to investment contracts without significant revenue streams from sources other than investment of the policyholder funds are amortized using the effective interest method. The effective interest method amortizes the deferred costs by discounting the future liability cash flows at a break-even rate. The break-even rate is solved for such that the present value of future liability cash flows is equal to the net liability at the inception of the contract. The deferred costs represent the difference between the net and gross liability and the change relates to amortization for the period.
Deferred Acquisition Costs and Deferred Sales Inducements	Costs related directly to the successful acquisition of new, or the renewal of existing, insurance or investment contracts are deferred. These costs consist of commissions and policy issuance costs, as well as sales inducements credited to policyholder account balances, and are included in deferred acquisition costs, deferred sales inducements and value of business acquired on the condensed consolidated balance sheets. These costs are not capitalized until they are incurred. Deferred costs related to universal life-type policies and investment contracts with significant revenue streams from sources other than investment of the policyholder funds are grouped into cohorts based on issue year and contract type and amortized on a constant level basis over the expected term of the related contracts. The cohorts and assumptions used for the amortization of deferred costs are consistent with those used in estimating the related liabilities for these contracts. The constant level basis generally is the initial premium or deposit and is projected based on assumptions related to policyholder behavior, including lapses and mortality, over the expected term of the contracts. Each reporting period, we replace expected experience with actual experience to determine the related amortization expense. Changes to projected experience are recognized in amortization expense prospectively over the remaining contract term. Amortization of DAC and DSI is included in amortization of deferred acquisition costs, deferred sales inducements and value of business acquired on the condensed consolidated statements of income (loss). Deferred costs related to investment contracts without significant revenue streams from sources other than investment of the policyholder funds are amortized using the effective interest method. The effective interest method amortizes the deferred costs by discounting the future liability cash flows at a break-even rate. The break-even rate is solved for such that the present value of future liability cash flows is equal to the net liability at the inception of the contract. The deferred costs represent the difference between the net and gross liability and the change relates to amortization for the period.
Value of Business Acquired (VOBA)	We establish VOBA for blocks of insurance contracts acquired through the acquisition of insurance entities and through application of pushdown accounting related to our merger with AGM. We record the fair value of the liabilities assumed in two components: reserves and VOBA. Reserves are established using our best estimate assumptions as of the business combination date. VOBA is the difference between the fair value of the liabilities and the reserves. VOBA can be either positive or negative and is amortized in relation to respective policyholder liabilities. Significant assumptions that impact VOBA amortization are consistent with those that impact the measurement of policyholder liabilities. We perform periodic tests to determine if positive VOBA remains recoverable. If we determine that positive VOBA is not recoverable, we would record a cumulative charge to the current period. Any negative VOBA is recorded to the same financial statement line on the condensed consolidated balance sheets as the associated reserves. Positive VOBA is recorded in deferred acquisition costs, deferred sales inducements and value of business acquired on the condensed consolidated balance sheets. See Note 8 – Deferred Acquisition Costs, Deferred Sales Inducements and Value of Business Acquired for further information.
Interest Sensitive Contract Liabilities	Universal life-type policies and investment contracts include traditional deferred annuities, indexed annuities consisting of fixed indexed and index-linked variable annuities in the accumulation phase, funding agreements, immediate annuities without significant mortality risk (which include pension group annuities without life contingencies), universal life insurance, and other investment contracts inclusive of assumed endowments without significant mortality risk. We carry liabilities for traditional deferred annuities, indexed annuities, funding agreements and universal life insurance at the account balances without reduction for potential surrender or withdrawal charges, except for a block of universal life business ceded to Global Atlantic Financial Group Limited (together with its subsidiaries, Global Atlantic), which we carry at fair value. Liabilities for immediate annuities without significant mortality risk are calculated as the present value of future liability cash flows and policy maintenance expenses discounted at contractual interest rates. Certain of our contracts are offered with additional contract features that meet the definition of a market risk benefit. See – Market Risk Benefits below for further information. Unearned revenue liabilities are established when amounts are assessed against the policyholder for services to be provided in future periods. These balances are amortized consistent with the methodologies and assumptions used to amortize DAC and DSI. Changes in interest sensitive contract liabilities, excluding deposits and withdrawals, are recorded in interest sensitive contract benefits or product charges on the condensed consolidated statements of income (loss). Interest sensitive contract liabilities are not reduced for amounts ceded under reinsurance agreements which are reported as reinsurance recoverable on the condensed consolidated balance sheets.
Future Policy Benefits	We issue contracts classified as long-duration, which include term and whole life, accident and health, disability, and immediate annuities with life contingencies (which include pension group annuities with life contingencies). Liabilities for nonparticipating long-duration contracts are established as the estimated present value of benefits we expect to pay to or on behalf of the policyholder and related expenses less the present value of the net premiums to be collected, referred to as the net premium ratio. The contracts are grouped into cohorts based on issue year and contract type, with an exception for pension group annuities, which are generally assessed at the group annuity contract level. Contracts with different issuance years are not combined. Contracts acquired in a business combination are grouped into a single cohort by contract type, except for pension group annuities, which follow the group annuity contract level. Liabilities for nonparticipating long-duration contracts are established using accepted actuarial valuation methods which require the use of assumptions related to discount rate, expenses, longevity, mortality, morbidity, persistency and other policyholder behavior. We base certain key assumptions, such as longevity, mortality and morbidity, on industry standard data adjusted to align with actual company experience, if needed. We have elected to use expense assumptions that are locked in at issuance for each cohort. All other cash flow assumptions are established at contract issuance and reviewed annually or more frequently if actual experience suggests a revision is necessary. The effects of changes in cash flow assumptions impacting the net premium ratio are recorded as remeasurement changes in the period in which they are made. As cash flow assumptions are reviewed at least annually, there is no provision for adverse deviation included within the liability. Actual experience is recognized in the period in which the experience arises. Actual experience is then incorporated into the net premium ratio for all products and cohorts on a quarterly basis. When the net premium ratio is revised, whether to incorporate actual experience each reporting period or for the review of cash flow assumptions, the liability is recalculated as of the beginning of the period, discounted at the original contract issuance discount rate, and compared with the carrying amount of the liability as of the same date to determine the current period change. The current period change in the liability is recognized as a remeasurement gain or loss. To the extent the present value of benefits and expenses exceeds the present value of gross premiums, we will cap the net premium ratio at one hundred percent by increasing the corresponding liability and recognizing an immediate loss through the condensed consolidated statements of income (loss). The liability is never recorded at an amount less than zero for the cohort. The liability for nonparticipating long-duration contracts is discounted using an upper-medium grade fixed income instrument yield aligned to the duration of the liability. In determining reference portfolio of instruments, we have used a single A equivalent level rate and maximized the use of observable data to the extent possible for the duration of our liabilities. The discount rate is required to be updated at the end of each reporting period for the remeasurement of the liability but is locked-in for each cohort for the purpose of interest accretion expense. Changes in the value of the liability for nonparticipating long-duration contracts due to changes in the discount rate are recognized as a component of OCI on the condensed consolidated statements of comprehensive income (loss). The change in the liability for the remeasurement gain or loss and all other changes in the liability are recorded in future policy and other policy benefits on the condensed consolidated statements of income (loss). Future policy benefits include liabilities for no-lapse guarantees on universal life insurance and fixed indexed universal life insurance that do not meet the criteria to be classified and accounted for as a market risk benefit. We establish future policy benefits for no-lapse guarantees by estimating the expected value of death benefits paid after policyholder account balances have been exhausted. We recognize these benefits proportionally over the life of the contracts based on total actual and expected assessments. The methods we use to estimate the liabilities have assumptions about policyholder behavior, mortality, expected yield on investments supporting the liability and market conditions affecting policyholder account balance growth. For the liabilities associated with no-lapse guarantees, each reporting period we update expected excess benefits and assessments with actual excess benefits and assessments and adjust the liability balances due to the OCI effects of unrealized investment gains and losses on available-for-sale (AFS) securities. We also periodically revise the key assumptions used in the calculation of the liabilities that result in revisions to the expected excess benefits and assessments. The effects of changes in assumptions are recorded as unlocking in the period in which the changes are made. Changes in the liabilities associated with no-lapse guarantees, other than the adjustment for the OCI effects of unrealized investment gains and losses on AFS securities, are recorded in future policy and other policy benefits on the condensed consolidated statements of income (loss). Future policy benefits are not reduced for amounts ceded under reinsurance agreements which are reported as reinsurance recoverable on the condensed consolidated balance sheets.
Market Risk Benefits	Market risk benefits represent contracts or contract features that both provide protection to the contract holder from, and expose the insurance entity to, other-than-nominal capital market risk. We issue and reinsure deferred annuity contracts which contain guaranteed lifetime withdrawal benefits (GLWB) and guaranteed minimum death benefit (GMDB) riders that meet the criteria for, and are classified as, market risk benefits. Market risk benefits are measured at fair value at the contract level and may be recorded as a liability or an asset, which are included in market risk benefits or other assets, respectively, on the condensed consolidated balance sheets. Multiple market risk benefits on a contract are treated as a single, compound market risk benefit. At contract inception, we assess the fees and assessments that are collectible from the policyholder and allocate them to the extent they are attributable to the market risk benefit. These attributed fees are used in the valuation of the market risk benefits and are never negative or exceed total explicit fees collectible from the policyholder. If the fees are sufficient to cover the projected benefits, a non-option based valuation model is used. If the fees are insufficient to cover the projected benefits, an option-based valuation model is used to compute the market risk benefit liability at contract inception, with an equal and offsetting adjustment recognized in interest sensitive contract liabilities. Changes in fair value of market risk benefits are recorded in market risk benefits remeasurement (gains) losses on the condensed consolidated statements of income (loss), excluding portions attributed to changes in instrument-specific credit risk, which are recorded in OCI on the condensed consolidated statements of comprehensive income (loss). Market risk benefits are not reduced for market risk benefits ceded under reinsurance agreements. Ceded market risk benefits are measured at fair value and recorded within reinsurance recoverable on the condensed consolidated balance sheets. Upon annuitization of the contract or the extinguishment of the account balance, the market risk benefit, related annuity contract and unamortized deferred costs are derecognized, including amounts within AOCI. A payout annuity is then established for GLWBs.
Recognition of Revenues and Related Expenses	Revenues for universal life-type policies and investment contracts, including surrender and market value adjustments, costs of insurance, policy administration, GMDB, GLWB and no-lapse guarantee charges, are earned when assessed against policyholder account balances during the period. Interest credited to policyholder account balances and the change in fair value of embedded derivatives within fixed indexed annuity contracts is included in interest sensitive contract benefits on the condensed consolidated statements of income (loss). Premiums for long-duration contracts, including products with fixed and guaranteed premiums and benefits, are recognized as revenue when due from policyholders. When premiums are due over a significantly shorter period than the period over which benefits are provided, such as immediate annuities with life contingencies (which includes pension group annuities), a deferred profit liability is established equal to the excess of the gross premium over the net premium. The deferred profit liability is recognized in future policy benefits on the condensed consolidated balance sheets and amortized into income in relation to applicable policyholder liabilities through future policy and other policy benefits on the condensed consolidated statements of income (loss). When the net premium ratio for the corresponding future policy benefit is updated for actual experience and changes to projected cash flow assumptions, the deferred profit liability is retrospectively recalculated from the contract issuance date through the beginning of the current reporting period. The revised deferred profit liability is compared to the beginning of the period carrying amount to determine the change to be recognized as a remeasurement gain or loss within future policy and other policy benefits on the condensed consolidated statements of income (loss). Unlike the related future policy benefit, the deferred profit liability will not be remeasured for changes in discount rates each reporting period. Negative VOBA balances associated with payout contracts involving life contingencies, including pension group annuities, are accounted for in a manner similar to the deferred profit liability. All insurance-related revenue is reported net of reinsurance ceded.
Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements Investments – Equity Method and Joint Ventures (Accounting Standards Update (ASU) 2023-02) The amendments in this update introduce the option of applying the proportional amortization method (PAM) to account for investments made primarily for the purpose of receiving income tax credits or other income tax benefits when certain requirements are met. Currently, PAM only applies to low-income housing tax credit (LIHTC) investments. The guidance is effective for us on January 1, 2024; however, early adoption is permitted. We are currently evaluating the impact of the new pronouncement. Fair Value Measurement — Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (ASU 2022-03) This amendment clarifies guidance that a restriction that is a characteristic of the holding entity, rather than a characteristic of the equity security itself, should not be considered in its fair value measurement. As a result, we are required to measure the fair value of equity securities subject to contractual restrictions attributable to the holding entity on the basis of the market price of the same equity security without those contractual restrictions. Companies are not permitted to recognize a contractual sale restriction attributable to the holding entity as a separate unit of account. The guidance also requires disclosures for these equity securities. The guidance is effective for us on January 1, 2024; however, early adoption is permitted. We will apply the guidance prospectively and recognize in earnings any adjustments required as a result of the adoption. We are currently evaluating the impact of the new pronouncement. Adopted Accounting Pronouncements Insurance – Targeted Improvements to the Accounting for Long-Duration Contracts (ASU 2020-11, ASU 2019-09, ASU 2018-12) These updates amend four key areas pertaining to the accounting and disclosures for long-duration insurance and investment contracts and are commonly referred to as long-duration targeted improvements (LDTI). • The update requires cash flow assumptions used to measure the liability for future policy benefits to be updated at least annually and no longer allows a provision for adverse deviation. The remeasurement of the liability associated with the update of assumptions is required to be recognized in net income. Loss recognition testing is eliminated for traditional and limited-payment contracts. The update also requires the discount rate used in measuring the liability to be an upper-medium grade fixed income instrument yield, which is to be updated at each reporting date. The change in liability due to changes in the discount rate is to be recognized in other comprehensive income. • The update simplifies the amortization of DAC and other balances amortized in proportion to premiums, gross profits or gross margins, requiring such balances to be amortized on a constant level basis over the expected term of the contracts. Deferred costs are required to be written off for unexpected contract terminations but are not subject to impairment testing. • The update requires certain contract features meeting the definition of market risk benefits to be measured at fair value. Among the features included in this definition are GLWB and GMDB riders attached to our annuity products. The change in fair value of the market risk benefits is to be recognized in net income, excluding the portion attributable to changes in instrument-specific credit risk which is recognized in other comprehensive income. • The update also introduces disclosure requirements around the liability for future policy benefits, policyholder account balances, market risk benefits, separate account liabilities and deferred acquisition costs. This includes disaggregated rollforwards of these balances and information about significant inputs, judgments, assumptions and methods used in their measurement. We adopted LDTI as of January 1, 2023 and, for all provisions of the update, applied a retrospective transition approach using a transition date of January 1, 2022, the date of our merger with AGM. At the merger date, VOBA balances were established as the difference between the fair value of the liabilities and the reserves established as of this date. Upon transition to LDTI, the liability for future policy benefits and contractual features that meet the criteria for market risk benefits were adjusted to conform to LDTI, with an offsetting adjustment made to positive or negative VOBA. No adjustments were recorded to AOCI or retained deficit as of the transition date. See Note 2 – Adoption of Accounting Pronouncement for the effects of LDTI adoption on our 2022 condensed consolidated financial statements. Reference Rate Reform (Topic 848) (Accounting Standards Update (ASU) 2022-06, ASU 2021-01, ASU 2020-04) We adopted ASU 2020-04 and ASU 2021-01 and elected to apply certain of the practical expedients related to contract modifications, hedge accounting relationships, and derivative modifications pertaining to discounting, margining, or contract price alignment. The main purpose of the practical expedients is to ease the administrative burden of accounting for contracts impacted by reference rate reform, and these elections did not have, and are not expected to have, a material impact on the consolidated financial statements. ASU 2022-06 amended and deferred the sunset date of Topic 848 from December 31, 2022, to December 31, 2024, after which we will no longer be permitted to apply the expedients provided in Topic 848. We will continue to evaluate the impact of reference rate reform on contract modifications and hedging relationships.

Adoption of Accounting Pronou_2

Adoption of Accounting Pronouncement (Tables)	3 Months Ended
	Mar. 31, 2023
Accounting Changes and Error Corrections [Abstract]
Accounting Standards Update and Change in Accounting Principle	The following represents the effects of LDTI adoption on the applicable financial statement lines of our condensed consolidated balance sheet: December 31, 2022 (In millions) Reported Adoption Adjusted Assets Reinsurance recoverable $ 4,367 $ (9) $ 4,358 Deferred acquisition costs, deferred sales inducements and value of business acquired 5,576 (1,110) 4,466 Other assets 9,690 (997) 8,693 Total assets $ 246,047 $ (2,116) $ 243,931 Liabilities and Equity Liabilities Interest sensitive contract liabilities $ 173,653 $ (37) $ 173,616 Future policy benefits 55,328 (13,218) 42,110 Market risk benefits — 2,970 2,970 Total liabilities 243,667 (10,285) 233,382 Equity Retained deficit (4,892) 1,252 (3,640) Accumulated other comprehensive income (loss) (12,311) 4,990 (7,321) Total Athene Holding Ltd. shareholders’ equity 916 6,242 7,158 Noncontrolling interests 1,464 1,927 3,391 Total equity 2,380 8,169 10,549 Total liabilities and equity $ 246,047 $ (2,116) $ 243,931 The following represents the effects of LDTI adoption on the applicable financial statement lines of our condensed consolidated statements of income (loss): Three months ended March 31, 2022 (In millions) Reported Adoption Adjusted Revenues Investment related gains (losses) $ (4,200) $ (12) $ (4,212) Total revenues (269) (12) (281) Benefits and expenses Interest sensitive contract benefits (41) (58) (99) Future policy and other policy benefits 2,085 99 2,184 Market risk benefits remeasurement (gains) losses — (622) (622) Amortization of deferred acquisition costs, deferred sales inducements and value of business acquired 125 (27) 98 Policy and other operating expenses 335 3 338 Total benefits and expenses 2,504 (605) 1,899 Income (loss) before income taxes (2,773) 593 (2,180) Income tax expense (benefit) (407) 123 (284) Net income (loss) (2,366) 470 (1,896) Less: Net income (loss) attributable to noncontrolling interests (883) 2 (881) Net income (loss) attributable to Athene Holding Ltd. shareholders (1,483) 468 (1,015) Less: Preferred stock dividends 35 — 35 Net income (loss) available to Athene Holding Ltd. common shareholder $ (1,518) $ 468 $ (1,050) Six months ended June 30, 2022 (In millions) Reported Adoption Adjusted Revenues Total revenues $ 1,526 $ — $ 1,526 Benefits and expenses Interest sensitive contract benefits (662) (90) (752) Future policy and other policy benefits 7,694 266 7,960 Market risk benefits remeasurement (gains) losses — (1,231) (1,231) Amortization of deferred acquisition costs, deferred sales inducements and value of business acquired 250 (44) 206 Policy and other operating expenses 693 2 695 Total benefits and expenses 7,975 (1,097) 6,878 Income (loss) before income taxes (6,449) 1,097 (5,352) Income tax expense (benefit) (891) 229 (662) Net income (loss) (5,558) 868 (4,690) Less: Net loss attributable to noncontrolling interests (1,955) (15) (1,970) Net income (loss) attributable to Athene Holding Ltd. shareholders (3,603) 883 (2,720) Less: Preferred stock dividends 70 — 70 Net income (loss) available to Athene Holding Ltd. common shareholder $ (3,673) $ 883 $ (2,790) Nine months ended September 30, 2022 (In millions) Reported Adoption Adjusted Revenues Investment related gains (losses) $ (12,812) $ 1 $ (12,811) Total revenues 3,835 1 3,836 Benefits and expenses Interest sensitive contract benefits (573) (8) (581) Future policy and other policy benefits 10,988 242 11,230 Market risk benefits remeasurement (gains) losses — (1,689) (1,689) Amortization of deferred acquisition costs, deferred sales inducements and value of business acquired 375 (57) 318 Policy and other operating expenses 1,081 2 1,083 Total benefits and expenses 11,871 (1,510) 10,361 Income (loss) before income taxes (8,036) 1,511 (6,525) Income tax expense (benefit) (1,101) 318 (783) Net income (loss) (6,935) 1,193 (5,742) Less: Net income (loss) attributable to noncontrolling interests (2,431) (4) (2,435) Net income (loss) attributable to Athene Holding Ltd. shareholders (4,504) 1,197 (3,307) Less: Preferred stock dividends 105 — 105 Net income (loss) available to Athene Holding Ltd. common shareholder $ (4,609) $ 1,197 $ (3,412) Year ended December 31, 2022 (In millions) Reported Adoption Adjusted Revenues Total revenues $ 7,623 $ — $ 7,623 Benefits and expenses Interest sensitive contract benefits 541 (3) 538 Future policy and other policy benefits 12,310 155 12,465 Market risk benefits remeasurement (gains) losses — (1,657) (1,657) Amortization of deferred acquisition costs, deferred sales inducements and value of business acquired 509 (65) 444 Policy and other operating expenses 1,493 2 1,495 Total benefits and expenses 14,853 (1,568) 13,285 Income (Loss) before income taxes (7,230) 1,568 (5,662) Income tax expense (benefit) (976) 330 (646) Net income (loss) (6,254) 1,238 (5,016) Less: Net loss attributable to noncontrolling interests (2,092) (14) (2,106) Net income (loss) attributable to Athene Holding Ltd. shareholders (4,162) 1,252 (2,910) Less: Preferred stock dividends 141 — 141 Net income (loss) available to Athene Holding Ltd. common shareholder $ (4,303) $ 1,252 $ (3,051) The following represents the effects of LDTI adoption on the applicable financial statement lines of our condensed consolidated statements of comprehensive income (loss): Three months ended March 31, 2022 (In millions) Reported Adoption Adjusted Net income (loss) $ (2,366) $ 470 $ (1,896) Other comprehensive income (loss), before tax Unrealized investment gains (losses) on available-for-sale securities (6,430) (267) (6,697) Remeasurement gains (losses) on future policy benefits related to discount rate — 3,562 3,562 Remeasurement gains (losses) on market risk benefits related to credit risk — 397 397 Foreign currency translation and other adjustments 4 (6) (2) Other comprehensive income (loss), before tax (6,555) 3,686 (2,869) Income tax expense (benefit) related to other comprehensive income (loss) (1,170) 555 (615) Other comprehensive income (loss) (5,385) 3,131 (2,254) Comprehensive income (loss) (7,751) 3,601 (4,150) Less: Comprehensive income (loss) attributable to noncontrolling interests (1,594) 777 (817) Comprehensive income (loss) attributable to Athene Holding Ltd. shareholders $ (6,157) $ 2,824 $ (3,333) Six months ended June 30, 2022 (In millions) Reported Adoption Adjusted Net income (loss) $ (5,558) $ 868 $ (4,690) Other comprehensive income (loss), before tax Unrealized investment gains (losses) on available-for-sale securities (13,703) (547) (14,250) Remeasurement gains (losses) on future policy benefits related to discount rate — 6,459 6,459 Remeasurement gains (losses) on market risk benefits related to credit risk — 576 576 Foreign currency translation and other adjustments (54) (27) (81) Other comprehensive income (loss), before tax (13,805) 6,461 (7,344) Income tax expense (benefit) related to other comprehensive income (loss) (2,453) 960 (1,493) Other comprehensive income (loss) (11,352) 5,501 (5,851) Comprehensive income (loss) (16,910) 6,369 (10,541) Less: Comprehensive income (loss) attributable to noncontrolling interests (3,520) 1,397 (2,123) Comprehensive income (loss) attributable to Athene Holding Ltd. shareholders $ (13,390) $ 4,972 $ (8,418) Nine months ended September 30, 2022 (In millions) Reported Adoption Adjusted Net income (loss) $ (6,935) $ 1,193 $ (5,742) Other comprehensive income (loss), before tax Unrealized investment gains (losses) on available-for-sale securities (19,414) (764) (20,178) Remeasurement gains (losses) on future policy benefits related to discount rate — 8,833 8,833 Remeasurement gains (losses) on market risk benefits related to credit risk — 524 524 Foreign currency translation and other adjustments (13) (59) (72) Other comprehensive income (loss), before tax (19,555) 8,534 (11,021) Income tax expense (benefit) related to other comprehensive income (loss) (3,444) 1,224 (2,220) Other comprehensive income (loss) (16,111) 7,310 (8,801) Comprehensive income (loss) (23,046) 8,503 (14,543) Less: Comprehensive income (loss) attributable to noncontrolling interests (4,787) 2,024 (2,763) Comprehensive income (loss) attributable to Athene Holding Ltd. shareholders $ (18,259) $ 6,479 $ (11,780) Year ended December 31, 2022 (In millions) Reported Adoption Adjusted Net income (loss) $ (6,254) $ 1,238 $ (5,016) Other comprehensive income (loss), before tax Unrealized investment gains (losses) on available-for-sale securities (17,457) (699) (18,156) Remeasurement gains (losses) on future policy benefits related to discount rate — 8,425 8,425 Remeasurement gains (losses) on market risk benefits related to credit risk — 366 366 Foreign currency translation and other adjustments (16) (11) (27) Other comprehensive income (loss), before tax (17,471) 8,081 (9,390) Income tax expense (benefit) related to other comprehensive income (loss) (3,083) 1,150 (1,933) Other comprehensive income (loss) (14,388) 6,931 (7,457) Comprehensive income (loss) (20,642) 8,169 (12,473) Less: Comprehensive income (loss) attributable to noncontrolling interests (4,169) 1,927 (2,242) Comprehensive income (loss) attributable to Athene Holding Ltd. shareholders $ (16,473) $ 6,242 $ (10,231) The following represents the effects of LDTI adoption on the applicable financial statement lines of our condensed consolidated statements of cash flows: Three months ended March 31, 2022 (In millions) Reported Adoption Adjusted Net income (loss) $ (2,366) $ 470 $ (1,896) Adjustments to reconcile net income (loss) to net cash provided by operating activities: Amortization of deferred acquisition costs, deferred sales inducements and value of business acquired 125 (27) 98 Net recognized (gains) losses on investments and derivatives 1,813 12 1,825 Changes in operating assets and liabilities: Interest sensitive contract liabilities (480) (68) (548) Future policy benefits, market risk benefits and reinsurance recoverable (266) (510) (776) Other assets and liabilities (734) 123 (611) Net cash provided by operating activities 155 — 155 Net cash used in investing activities (6,165) — (6,165) Net cash provided by financing activities 5,463 — 5,463 Effect of exchange rate changes on cash and cash equivalents (4) — (4) Net decrease in cash and cash equivalents (551) — (551) Cash and cash equivalents at beginning of year 1 10,429 — 10,429 Cash and cash equivalents at end of period 1 $ 9,878 $ — $ 9,878 1 Includes cash and cash equivalents, restricted cash and cash and cash equivalents of consolidated variable interest entities.
Liability for Future Policy Benefit, Activity	The following table summarizes future policy benefits and changes to the liability: (In millions) Traditional deferred annuities Indexed annuities Payout annuities Reconciling items 1 Total Balance as of January 1, 2022 $ 221 $ 5,389 $ 32,872 $ 8,632 $ 47,114 Change in discount rate assumptions — — 2,406 — 2,406 Adjustment for removal of balances related to market risk benefits (221) (5,389) — — (5,610) Adjustment for offsetting balance in negative VOBA 2 — — — (2,428) (2,428) Adjusted balance as of January 1, 2022 $ — $ — $ 35,278 $ 6,204 $ 41,482 1 Reconciling items primarily include negative VOBA associated with our liability for future policy benefits, as well as reserves for our immaterial lines of business including term and whole life, accident and health and disability, as well as other insurance benefit reserves for our no-lapse guarantees with universal life contracts, all of which are fully ceded. 2 Uneliminated adjustments were recorded to positive VOBA within deferred acquisition costs, deferred sales inducements and value of business acquired on the condensed consolidated balance sheets. The following is a rollforward of the present value of expected net premiums and expected value of future policy benefits: Payout annuities with life contingencies Three months ended March 31, (In millions) 2023 2022 Present value of expected net premiums Beginning balance $ — $ — Issuances 88 1,994 Net premium collected (88) (1,994) Ending balance $ — $ — Present value of expected future policy benefits Beginning balance $ 36,422 $ 35,278 Effect of changes in discount rate assumptions 8,425 — Beginning balance at original discount rate 44,847 35,278 Effect of actual experience compared to expected experience (29) (47) Adjusted beginning balance 44,818 35,231 Issuances 88 1,994 Interest accrual 346 229 Benefit payments (885) (724) Foreign exchange 8 (19) Ending balance at original discount rate 44,375 36,711 Effect of changes in discount rate assumptions (7,623) (3,562) Ending balance $ 36,752 $ 33,149 The following is a reconciliation of premiums to the condensed consolidated statements of income (loss): Three months ended March 31, (In millions) 2023 2022 Payout annuities with life contingencies $ 88 $ 2,098 Reconciling items 1 8 12 Premiums $ 96 $ 2,110 1 Reconciling items premiums related to our immaterial lines of business including term and whole life and accident and health and disability. The following represents the undiscounted and discounted expected future benefit payments for the liability for future policy benefits. As these relate to payout annuities for single premium immediate annuities with life contingencies, there are no expected future gross premiums. March 31, 2023 March 31, 2022 (In millions) Undiscounted Discounted Undiscounted Discounted Expected future benefit payments $ 63,995 $ 44,375 $ 51,643 $ 36,711 The following represents the weighted-average durations and the weighted-average interest rates of future policy benefits: March 31, 2023 2022 Weighted-average liability duration (in years) 10.1 10.6 Weighted-average interest accretion rate 3.2 % 2.7 % Weighted-average current discount rate 5.3 % 3.7 %
Market Risk Benefit, Activity	The following table presents the net liability position of market risk benefits: (In millions) Traditional deferred annuities Indexed annuities Total Balance as of January 1, 2022 $ — $ — $ — Adjustment for addition of existing balances 1 221 5,389 5,610 Adjustment to positive VOBA due to fair value adjustment for market risk benefits 2 32 (1,165) (1,133) Adjustment to negative VOBA due to fair value adjustment for market risk benefits 3 — (30) (30) Adjusted balance as of January 1, 2022 $ 253 $ 4,194 $ 4,447 1 Previously recorded within future policy benefits on the condensed consolidated balance sheets. 2 Previously recorded within deferred acquisition costs, deferred sales inducements and value of business acquired on the condensed consolidated balance sheets. 3 Previously recorded within interest sensitive contract liabilities on the condensed consolidated balance sheets. The following table represents market risk benefits by asset and liability positions: (In millions) Asset 1 Liability Net liability Traditional deferred annuities $ — $ 253 $ 253 Indexed annuities 366 4,560 4,194 Adjusted balance as of January 1, 2022 $ 366 $ 4,813 $ 4,447 1 Included in other assets on the condensed consolidated balance sheets. The following is a rollfoward of net market risk benefit liabilities by product: Three months ended March 31, 2023 (In millions) Traditional deferred annuities Indexed annuities Total Balance at December 31, 2022 $ 170 $ 2,319 $ 2,489 Effect of changes in instrument-specific credit risk 13 353 366 Balance, beginning of period, before changes in instrument specific credit risk 183 2,672 2,855 Issuances — 17 17 Interest accrual 2 32 34 Attributed fees collected 1 84 85 Benefit payments — (6) (6) Effect of changes in interest rates 8 218 226 Effect of changes in equity — (18) (18) Effect of actual behavior compared to expected behavior 2 23 25 Balance, end of period, before changes in instrument specific credit risk 196 3,022 3,218 Effect of changes in the instrument specific credit risk (16) (439) (455) Balance at March 31, 2023 $ 180 $ 2,583 $ 2,763 March 31, 2023 Net amount at risk $ 423 $ 13,903 $ 14,326 Weighted-average attained age of contract holders (in years) 75 69 69 Three months ended March 31, 2022 (In millions) Traditional deferred annuities Indexed annuities Total Balance at January 1, 2022 $ 253 $ 4,194 $ 4,447 Issuances — 16 16 Interest accrual — (2) (2) Attributed fees collected 1 81 82 Benefit payments (1) (11) (12) Effect of changes in interest rates (26) (732) (758) Effect of changes in equity — 55 55 Effect of actual behavior compared to expected behavior 1 12 13 Balance, end of period, before changes in instrument specific credit risk 228 3,613 3,841 Effect of changes in the instrument specific credit risk (13) (384) (397) Balance at March 31, 2022 $ 215 $ 3,229 $ 3,444 March 31, 2022 Net amount at risk $ 416 $ 10,554 $ 10,970 Weighted-average attained age of contract holders (in years) 75 69 69 The following is a reconciliation of market risk benefits to the condensed consolidated balance sheets. Market risk benefit assets are included in other assets on the condensed consolidated balance sheets. March 31, 2023 March 31, 2022 (In millions) Asset Liability Net liability Asset Liability Net liability Traditional deferred annuities $ — $ 180 $ 180 $ — $ 215 $ 215 Indexed annuities 440 3,023 2,583 413 3,642 3,229 Total $ 440 $ 3,203 $ 2,763 $ 413 $ 3,857 $ 3,444
Deferred Acquisition Costs	The following table summarizes the change in deferred acquisition costs, deferred sales inducements and value of business acquired: (In millions) VOBA Balance as of January 1, 2022 $ 4,527 Change in discount rate assumptions for future policy benefits (22) Fair value adjustment of market risk benefits (1,133) Adjusted balance as of January 1, 2022 $ 3,372 The following represents a rollforward of DAC and DSI by product, and a rollforward of VOBA. See Note 9 – Long-duration Contracts for more information on our products. Three months ended March 31, 2023 DAC DSI VOBA Total DAC, DSI and VOBA (In millions) Traditional deferred annuities Indexed annuities Funding agreements Other investment-type Indexed annuities Balance at December 31, 2022 $ 304 $ 755 $ 11 $ 9 $ 399 $ 2,988 $ 4,466 Additions 171 203 — 1 133 — 508 Amortization (16) (18) (1) — (10) (93) (138) Balance at March 31, 2023 $ 459 $ 940 $ 10 $ 10 $ 522 $ 2,895 $ 4,836 Three months ended March 31, 2022 DAC DSI VOBA Total DAC, DSI and VOBA (In millions) Traditional deferred annuities Indexed annuities Funding agreements Other investment-type Indexed annuities Balance at January 1, 2022 $ — $ — $ — $ — $ — $ 3,372 $ 3,372 Additions 24 176 11 3 77 — 291 Amortization — (1) (1) — — (96) (98) Balance at March 31, 2022 $ 24 $ 175 $ 10 $ 3 $ 77 $ 3,276 $ 3,565

Business Combination (Tables)

Business Combination (Tables)	3 Months Ended
	Mar. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Schedule of Business Acquisitions, by Acquisition	(In millions, except exchange ratio and share price data) Consideration AHL common shares purchased 138 Exchange ratio 1.149 Shares of common stock issued in exchange 158 AGM Class A shares closing price $ 72.43 Total merger consideration at closing $ 11,455 Fair value of estimated RSUs, options and warrants assumed and other equity consideration 699 Effective settlement of pre-existing relationships 896 Total merger consideration 13,050 Fair value of AHL common shares previously held by Apollo and other adjustments 4,554 Total AHL equity value held by AGM 17,604 Fair value of preferred stock 2,666 Noncontrolling interest 2,276 Total AHL equity value $ 22,546 The following represents the calculation of goodwill and fair value amounts recognized: (In millions) Fair value and goodwill calculation Merger consideration $ 13,050 Fair value of AHL common shares previously held by Apollo and other adjustments 4,554 Total AHL equity value held by AGM 17,604 Assets Investments $ 176,015 Cash and cash equivalents 9,479 Restricted cash 796 Investment in related parties 33,863 Reinsurance recoverable 4,977 VOBA 3,372 Other assets 6,115 Assets of consolidated variable interest entities 3,635 Estimated fair value of total assets acquired by AGM 238,252 Liabilities Interest sensitive contract liabilities 160,241 Future policy benefits 41,482 Market risk benefits 4,813 Debt 3,295 Payables for collateral on derivatives and securities to repurchase 7,044 Other liabilities 2,443 Liabilities of consolidated variable interest entities 461 Estimated fair value of total liabilities assumed by AGM 219,779 Identifiable net assets 18,473 Less: Fair value of preferred stock 2,666 Less: Fair value of noncontrolling interests 2,276 Estimated fair value of net assets acquired by AGM, excluding goodwill 13,531 Goodwill attributable to AHL $ 4,073
Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination	The fair value and weighted average estimated useful life of identifiable intangible assets consists of the following: Fair value (in millions) Weighted average useful life (in years) VOBA $ 3,372 7 Distribution channels 1,870 18 Trade name 160 20 Insurance licenses 26 Indefinite Total $ 5,428

Investments (Tables)

Investments (Tables)	3 Months Ended
	Mar. 31, 2023
Schedule of Investments [Abstract]
Debt Securities, Available-for-sale, Allowance for Credit Loss	Allowance for Credit Losses — The following table summarizes the activity in the allowance for credit losses for AFS securities by asset type: Three months ended March 31, 2023 Additions Reductions (In millions) Beginning balance Initial credit losses Initial credit losses on PCD securities Securities sold during the period Additions (reductions) to previously impaired securities Ending Balance AFS securities Foreign governments $ 27 $ — $ — $ — $ — $ 27 Corporate 61 21 — (6) 3 79 CLO 7 1 — — (4) 4 ABS 29 — — — 2 31 CMBS 5 1 — — (1) 5 RMBS 329 3 28 (4) — 356 Total AFS securities 458 26 28 (10) — 502 AFS securities – related parties, CLO 1 — — — — 1 Total AFS securities including related parties $ 459 $ 26 $ 28 $ (10) $ — $ 503 Three months ended March 31, 2022 Additions Reductions (In millions) January 1, 2022 Initial credit losses Initial credit losses on PCD securities Securities sold during the period Additions (reductions) to previously impaired securities Ending Balance AFS securities Foreign governments $ — $ 66 $ — $ — $ — $ 66 Corporate — 55 — — — 55 CLO — 18 — — — 18 ABS 5 5 — — 1 11 CMBS — 6 — — — 6 RMBS 306 9 — (8) 5 312 Total AFS securities 311 159 — (8) 6 468 AFS securities – related party CLO — 3 — — — 3 ABS — 17 — — — 17 Total AFS securities – related party — 20 — — — 20 Total AFS securities including related parties $ 311 $ 179 $ — $ (8) $ 6 $ 488
Available-for-sale Securities	The following table represents the amortized cost, allowance for credit losses, gross unrealized gains and losses and fair value of our AFS investments by asset type: March 31, 2023 (In millions) Amortized Cost Allowance for Credit Losses Gross Unrealized Gains Gross Unrealized Losses Fair Value AFS securities US government and agencies $ 3,327 $ — $ 6 $ (630) $ 2,703 US state, municipal and political subdivisions 1,215 — — (249) 966 Foreign governments 1,205 (27) 5 (261) 922 Corporate 75,348 (79) 167 (12,295) 63,141 CLO 18,643 (4) 134 (1,207) 17,566 ABS 11,696 (31) 31 (823) 10,873 CMBS 4,717 (5) 2 (524) 4,190 RMBS 7,050 (356) 197 (539) 6,352 Total AFS securities 123,201 (502) 542 (16,528) 106,713 AFS securities – related parties Corporate 1,180 — 1 (54) 1,127 CLO 3,736 (1) 14 (236) 3,513 ABS 7,480 — 12 (266) 7,226 Total AFS securities – related parties 12,396 (1) 27 (556) 11,866 Total AFS securities including related parties $ 135,597 $ (503) $ 569 $ (17,084) $ 118,579 December 31, 2022 (In millions) Amortized Cost Allowance for Credit Losses Gross Unrealized Gains Gross Unrealized Losses Fair Value AFS securities US government and agencies $ 3,333 $ — $ — $ (756) $ 2,577 US state, municipal and political subdivisions 1,218 — — (291) 927 Foreign governments 1,207 (27) 3 (276) 907 Corporate 74,644 (61) 92 (13,774) 60,901 CLO 17,722 (7) 115 (1,337) 16,493 ABS 11,447 (29) 15 (906) 10,527 CMBS 4,636 (5) 6 (479) 4,158 RMBS 6,775 (329) 64 (596) 5,914 Total AFS securities 120,982 (458) 295 (18,415) 102,404 AFS securities – related parties Corporate 1,028 — 1 (47) 982 CLO 3,346 (1) 10 (276) 3,079 ABS 6,066 — 3 (309) 5,760 Total AFS securities – related parties 10,440 (1) 14 (632) 9,821 Total AFS securities including related parties $ 131,422 $ (459) $ 309 $ (19,047) $ 112,225 The following summarizes the number of AFS securities that were in an unrealized loss position, including related parties, for which an allowance for credit losses has not been recorded: March 31, 2023 Unrealized loss position Unrealized loss position 12 months or more AFS securities 8,873 7,387 AFS securities – related parties 194 103
Available-for-sale Securities by Contractual Maturity	The amortized cost and fair value of AFS securities, including related parties, are shown by contractual maturity below: March 31, 2023 (In millions) Amortized Cost Fair Value AFS securities Due in one year or less $ 1,410 $ 1,377 Due after one year through five years 13,421 12,501 Due after five years through ten years 20,917 18,072 Due after ten years 45,347 35,782 CLO, ABS, CMBS and RMBS 42,106 38,981 Total AFS securities 123,201 106,713 AFS securities – related parties Due after one year through five years 735 731 Due after five years through ten years 286 258 Due after ten years 159 138 CLO and ABS 11,216 10,739 Total AFS securities – related parties 12,396 11,866 Total AFS securities including related parties $ 135,597 $ 118,579
Fair Values and Unrealized Losses on Available-for-sale Securities	The following summarizes the fair value and gross unrealized losses for AFS securities, including related parties, for which an allowance for credit losses has not been recorded, aggregated by asset type and length of time the fair value has remained below amortized cost: March 31, 2023 Less than 12 months 12 months or more Total (In millions) Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses AFS securities US government and agencies $ 68 $ (4) $ 2,431 $ (626) $ 2,499 $ (630) US state, municipal and political subdivisions 22 (2) 936 (247) 958 (249) Foreign governments 98 (8) 795 (252) 893 (260) Corporate 10,062 (812) 47,858 (11,472) 57,920 (12,284) CLO 3,038 (92) 11,579 (1,063) 14,617 (1,155) ABS 3,623 (197) 3,938 (492) 7,561 (689) CMBS 1,776 (35) 1,483 (354) 3,259 (389) RMBS 739 (44) 1,846 (258) 2,585 (302) Total AFS securities 19,426 (1,194) 70,866 (14,764) 90,292 (15,958) AFS securities – related parties Corporate 875 (24) 141 (30) 1,016 (54) CLO 1,009 (35) 2,124 (200) 3,133 (235) ABS 2,625 (82) 2,736 (184) 5,361 (266) Total AFS securities – related parties 4,509 (141) 5,001 (414) 9,510 (555) Total AFS securities including related parties $ 23,935 $ (1,335) $ 75,867 $ (15,178) $ 99,802 $ (16,513) December 31, 2022 Less than 12 months 12 months or more Total (In millions) Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses AFS securities US government and agencies $ 2,539 $ (756) $ — $ — $ 2,539 $ (756) US state, municipal and political subdivisions 911 (291) — — 911 (291) Foreign governments 891 (275) — — 891 (275) Corporate 58,256 (13,773) — — 58,256 (13,773) CLO 13,486 (1,277) — — 13,486 (1,277) ABS 8,119 (801) — — 8,119 (801) CMBS 2,650 (427) — — 2,650 (427) RMBS 2,621 (365) — — 2,621 (365) Total AFS securities 89,473 (17,965) — — 89,473 (17,965) AFS securities – related parties Corporate 619 (47) — — 619 (47) CLO 2,752 (273) — — 2,752 (273) ABS 5,487 (308) — — 5,487 (308) Total AFS securities – related parties 8,858 (628) — — 8,858 (628) Total AFS securities including related parties $ 98,331 $ (18,593) $ — $ — $ 98,331 $ (18,593)
Net Investment Income	Net Investment Income —Net investment income by asset class consists of the following: Three months ended March 31, (In millions) 2023 2022 AFS securities $ 1,469 $ 876 Trading securities 42 63 Equity securities 15 15 Mortgage loans 447 237 Investment funds 43 304 Funds withheld at interest 429 337 Other 190 42 Investment revenue 2,635 1,874 Investment expenses (228) (191) Net investment income $ 2,407 $ 1,683
Investment Related Gains (Losses)	Investment Related Gains (Losses) —Investment related gains (losses) by asset class consists of the following: Three months ended March 31, (In millions) 2023 2022 AFS securities 1 Gross realized gains on investment activity $ 183 $ 103 Gross realized losses on investment activity (104) (410) Net realized investment gains (losses) on AFS securities 79 (307) Net recognized investment gains (losses) on trading securities 64 (207) Net recognized investment gains (losses) on equity securities (18) 23 Net recognized investment gains (losses) on mortgage loans 277 (796) Derivative gains (losses) 993 (3,041) Provision for credit losses (66) (192) Other gains (losses) (264) 308 Investment related gains (losses) $ 1,065 $ (4,212) 1 Includes the effects of recognized gains or losses on AFS securities associated with designated hedges. The following table summarizes the change in unrealized gains (losses) on trading and equity securities, including related parties, we held as of the respective period end: Three months ended March 31, (In millions) 2023 2022 Trading securities $ 66 $ (189) Trading securities – related parties 6 (4) Equity securities (23) 17 Equity securities – related parties 3 (5)
Mortgage Loans, Net	Mortgage loans includes both commercial and residential loans. In connection with the merger, we elected the fair value option on our mortgage loan portfolio. See Note 7 – Fair Value for further fair value option information. The following represents the mortgage loan portfolio, with fair value option loans presented at unpaid principal balance: (In millions) March 31, 2023 December 31, 2022 Commercial mortgage loans $ 21,743 $ 21,061 Commercial mortgage loans under development 1,020 790 Total commercial mortgage loans 22,763 21,851 Mark to fair value (1,740) (1,743) Commercial mortgage loans 21,023 20,108 Residential mortgage loans 13,211 11,802 Mark to fair value (842) (1,099) Residential mortgage loans 12,369 10,703 Mortgage loans $ 33,392 $ 30,811 The distribution of commercial mortgage loans, including those under development, by property type and geographic region, is as follows: March 31, 2023 December 31, 2022 (In millions, except for percentages) Net Carrying Value Percentage of Total Net Carrying Value Percentage of Total Property type Office building $ 4,535 21.6 % $ 4,651 23.1 % Retail 1,450 6.9 % 1,454 7.2 % Apartment 7,506 35.7 % 6,692 33.3 % Hotels 1,873 8.9 % 1,855 9.2 % Industrial 2,242 10.7 % 2,047 10.2 % Other commercial 3,417 16.2 % 3,409 17.0 % Total commercial mortgage loans $ 21,023 100.0 % $ 20,108 100.0 % US region East North Central $ 1,438 6.8 % $ 1,437 7.1 % East South Central 422 2.0 % 413 2.1 % Middle Atlantic 5,561 26.5 % 5,183 25.8 % Mountain 923 4.4 % 898 4.5 % New England 1,071 5.1 % 1,076 5.4 % Pacific 4,033 19.2 % 3,781 18.8 % South Atlantic 2,876 13.6 % 2,756 13.7 % West North Central 225 1.1 % 231 1.1 % West South Central 1,066 5.1 % 1,085 5.4 % Total US region 17,615 83.8 % 16,860 83.9 % International region United Kingdom 1,970 9.4 % 1,898 9.4 % Other international 1 1,438 6.8 % 1,350 6.7 % Total international region 3,408 16.2 % 3,248 16.1 % Total commercial mortgage loans $ 21,023 100.0 % $ 20,108 100.0 % 1 Represents all other countries, with each individual country comprising less than 5% of the portfolio. Our residential mortgage loan portfolio includes first lien residential mortgage loans collateralized by properties in various geographic locations and is summarized by proportion of the portfolio in the following table: March 31, 2023 December 31, 2022 US States California 28.5 % 28.9 % Florida 10.1 % 9.7 % New York 5.8 % 5.6 % New Jersey 5.4 % 5.3 % Arizona 5.0 % 5.1 % Other 1 32.8 % 31.7 % Total US residential mortgage loan percentage 87.6 % 86.3 % International United Kingdom 5.0 % 5.4 % Other 2 7.4 % 8.3 % Total international residential mortgage loan percentage 12.4 % 13.7 % Total residential mortgage loan percentage 100.0 % 100.0 % 1 Represents all other states, with each individual state comprising less than 5% of the portfolio. 2 Represents all other countries, with each individual country comprising less than 5% of the portfolio.
Investment Funds	The following summarizes our investment funds, including related parties and consolidated VIEs: March 31, 2023 December 31, 2022 (In millions, except for percentages) Carrying value Percent of total Carrying value Percent of total Investment funds Equity $ 43 55.8 % $ 46 58.2 % Hybrid 28 36.4 % 32 40.5 % Other 6 7.8 % 1 1.3 % Total investment funds 77 100.0 % 79 100.0 % Investment funds – related parties Strategic origination platforms 35 2.2 % 34 2.2 % Strategic insurance platforms 1,305 81.8 % 1,259 80.2 % Apollo and other fund investments Equity 228 14.3 % 246 15.7 % Yield 5 0.3 % 5 0.3 % Other 22 1.4 % 25 1.6 % Total investment funds – related parties 1,595 100.0 % 1,569 100.0 % Investment funds consolidated VIEs Strategic origination platforms 4,991 38.8 % 4,829 38.7 % Strategic insurance platforms 515 4.0 % 529 4.2 % Apollo and other fund investments Equity 2,815 21.9 % 2,640 21.2 % Hybrid 3,180 24.6 % 3,112 24.9 % Yield 1,091 8.5 % 1,044 8.4 % Other 288 2.2 % 326 2.6 % Total investment funds consolidated VIEs 12,880 100.0 % 12,480 100.0 % Total investment funds including related parties and funds owned by consolidated VIEs $ 14,552 $ 14,128
Schedule of Variable Interest Entities	The following summarizes the carrying value and maximum loss exposure of these non-consolidated investments: March 31, 2023 December 31, 2022 (In millions) Carrying Value Maximum Loss Exposure Carrying Value Maximum Loss Exposure Investment funds $ 77 $ 518 $ 79 $ 340 Investment in related parties – investment funds 1,595 2,251 1,569 2,253 Assets of consolidated VIEs – investment funds 12,880 20,372 12,480 20,278 Investment in fixed maturity securities 39,373 42,555 37,454 40,992 Investment in related parties – fixed maturity securities 11,624 12,101 9,717 10,290 Investment in related parties – equity securities 251 251 279 279 Total non-consolidated investments $ 65,800 $ 78,048 $ 61,578 $ 74,432 The following summarizes the income statement activity of the consolidated VIEs: Three months ended March 31, (In millions) 2023 2022 Trading securities $ 23 $ — Mortgage loans 24 20 Investment funds 35 (3) Other investments (2) — Net investment income $ 80 $ 17 Net recognized investment gains (losses) on trading securities $ 6 $ — Net recognized investment gains (losses) on mortgage loans 9 (112) Net recognized investment gains (losses) on investment funds 226 70 Other gains (losses) (40) — Investment related gains (losses) $ 201 $ (42)
Schedule of Repurchase Agreements	The following table summarizes the remaining contractual maturities of our repurchase agreements, which are included in payables for collateral on derivatives and securities to repurchase on the condensed consolidated balance sheets: (In millions) March 31, 2023 December 31, 2022 Less than 30 days $ 1,642 $ 608 30-90 days 2,774 1,268 91 days to 1 year 500 — Greater than 1 year 2,865 2,867 Payables for repurchase agreements $ 7,781 $ 4,743 The following table summarizes the securities pledged as collateral for repurchase agreements: March 31, 2023 December 31, 2022 (In millions) Amortized Cost Fair Value Amortized Cost Fair Value AFS securities US government and agencies $ 2,825 $ 2,261 $ 2,559 $ 1,941 Foreign governments 146 108 146 107 Corporate 5,324 4,425 1,940 1,605 CLO 275 265 273 261 ABS 1,218 1,093 1,243 1,082 Total securities pledged under repurchase agreements $ 9,788 $ 8,152 $ 6,161 $ 4,996
Schedules of Concentration of Risk, by Risk Factor	The following table represents our investment concentrations in excess of 10% of shareholders’ equity: (In millions) March 31, 2023 Wheels Donlen 1 $ 1,419 PK AirFinance 1 1,334 Athora 1 1,279 Atlas 1 995 AP Tundra 873 MFI Investments 869 (In millions) December 31, 2022 Wheels Donlen 1 $ 1,288 Athora 1 1,232 PK AirFinance 1 999 AP Tundra 896 MFI Investments 878 SoftBank Vision Fund II 789 MidCap 1 788 Cayman Universe 756 1 Related party amounts are representative of single issuer risk and may only include a portion of the total investments associated with a related party. See further discussion of these related parties in Note 13 – Related Parties.

Derivative Instruments (Tables)

Derivative Instruments (Tables)	3 Months Ended
	Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Notional Amount and Fair Value of Derivative Instruments	The following table presents the notional amount and fair value of derivative instruments: March 31, 2023 December 31, 2022 Notional Amount Fair Value Notional Amount Fair Value (In millions) Assets Liabilities Assets Liabilities Derivatives designated as hedges Foreign currency hedges Swaps 6,678 $ 713 $ 149 6,677 $ 747 $ 154 Forwards 6,380 392 57 6,283 406 52 Interest rate swaps 4,468 — 725 4,468 — 803 Forwards on net investments 217 — 2 216 2 — Interest rate swaps 10,082 10 83 9,332 9 150 Total derivatives designated as hedges 1,115 1,016 1,164 1,159 Derivatives not designated as hedges Equity options 67,730 2,085 106 65,089 1,374 114 Futures 21 56 4 18 33 — Foreign currency swaps 3,863 266 118 3,563 251 112 Interest rate swaps 523 89 1 488 74 — Other swaps 137 4 1 89 — 4 Foreign currency forwards 18,250 341 272 16,376 413 257 Embedded derivatives Funds withheld including related parties (5,557) (67) (6,272) (77) Interest sensitive contract liabilities — 6,747 — 5,841 Total derivatives not designated as hedges (2,716) 7,182 (4,127) 6,251 Total derivatives $ (1,601) $ 8,198 $ (2,963) $ 7,410
Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]	The following represents the carrying amount and the cumulative fair value hedging adjustments included in the hedged assets or liabilities: March 31, 2023 December 31, 2022 (In millions) Carrying amount of the hedged assets or liabilities 1 Cumulative amount of fair value hedging gains (losses) Carrying amount of the hedged assets or liabilities 1 Cumulative amount of fair value hedging gains (losses) AFS securities Foreign currency forwards $ 5,480 $ (431) $ 5,259 $ (217) Foreign currency swaps 4,962 (304) 4,797 (398) Interest sensitive contract liabilities Foreign currency swaps 1,081 (9) 1,081 88 Foreign currency interest rate swaps 4,348 315 4,348 632 Interest rate swaps 7,087 203 6,577 323 1 The carrying amount disclosed for AFS securities is amortized cost. The following is a summary of the gains (losses) related to the derivatives and related hedged items in fair value hedge relationships: Amount Excluded (In millions) Derivatives Hedged Items Net Recognized in income through amortization approach Recognized in income through changes in fair value Three months ended March 31, 2023 Investment related gains (losses) Foreign currency forwards $ (70) $ 73 $ 3 $ 87 $ 4 Foreign currency swaps (59) 64 5 — — Foreign currency interest rate swaps 78 (70) 8 — — Interest rate swaps 102 (104) (2) — — Interest sensitive contract benefits Foreign currency interest rate swaps 15 (15) — — — Three months ended March 31, 2022 Investment related gains (losses) Foreign currency forwards $ 127 $ (126) $ 1 $ 14 $ 1 Foreign currency swaps 91 (95) (4) — — Foreign currency interest rate swaps (159) 197 38 — — Interest rate swaps (72) 75 3 — — Interest sensitive contract benefits Foreign currency interest rate swaps 10 (9) 1 — — The following is a summary of the gains (losses) excluded from the assessment of hedge effectiveness that were recognized in OCI : Three months ended March 31, (In millions) 2023 2022 Foreign currency forwards $ 63 $ (73) Foreign currency swaps 114 (56)
Gains (Losses) Related to Derivatives Not Designated as Hedges	The following is a summary of the gains (losses) related to derivatives not designated as hedges: Three months ended March 31, (In millions) 2023 2022 Equity options $ 350 $ (708) Futures 34 (33) Swaps 33 63 Foreign currency forwards (169) 155 Embedded derivatives on funds withheld 603 (2,520) Amounts recognized in investment related gains (losses) 851 (3,043) Embedded derivatives in indexed annuity products 1 (473) 1,034 Total gains (losses) on derivatives not designated as hedges $ 378 $ (2,009) 1 Included in interest sensitive contract benefits on the condensed consolidated statements of income (loss).
Estimated Fair Value of Net Derivative and Other Financial Assets	The estimated fair value of our net derivative and other financial assets and liabilities after the application of master netting agreements and collateral were as follows: Gross amounts not offset on the condensed consolidated balance sheets (In millions) Gross amount recognized 1 Financial instruments 2 Collateral (received)/pledged Net amount Off-balance sheet securities collateral 3 Net amount after securities collateral March 31, 2023 Derivative assets $ 3,956 $ (1,456) $ (2,411) $ 89 $ — $ 89 Derivative liabilities (1,518) 1,456 506 444 — 444 December 31, 2022 Derivative assets $ 3,309 $ (1,477) $ (1,952) $ (120) $ — $ (120) Derivative liabilities (1,646) 1,477 478 309 — 309 1 The gross amounts of recognized derivative assets and derivative liabilities are reported on the condensed consolidated balance sheets. As of March 31, 2023 and December 31, 2022, amounts not subject to master netting or similar agreements were immaterial. 2 Represents amounts offsetting derivative assets and derivative liabilities that are subject to an enforceable master netting agreement or similar agreement that are not netted against the gross derivative assets or gross derivative liabilities for presentation on the condensed consolidated balance sheets. 3 For non-cash collateral received, we do not recognize the collateral on our balance sheet unless the obligor (transferor) has defaulted under the terms of the secured contract and is no longer entitled to redeem the pledged asset. Amounts do not include any excess of collateral pledged or received.
Estimated Fair Value of Net Derivative and Other Financial Liabilities	The estimated fair value of our net derivative and other financial assets and liabilities after the application of master netting agreements and collateral were as follows: Gross amounts not offset on the condensed consolidated balance sheets (In millions) Gross amount recognized 1 Financial instruments 2 Collateral (received)/pledged Net amount Off-balance sheet securities collateral 3 Net amount after securities collateral March 31, 2023 Derivative assets $ 3,956 $ (1,456) $ (2,411) $ 89 $ — $ 89 Derivative liabilities (1,518) 1,456 506 444 — 444 December 31, 2022 Derivative assets $ 3,309 $ (1,477) $ (1,952) $ (120) $ — $ (120) Derivative liabilities (1,646) 1,477 478 309 — 309 1 The gross amounts of recognized derivative assets and derivative liabilities are reported on the condensed consolidated balance sheets. As of March 31, 2023 and December 31, 2022, amounts not subject to master netting or similar agreements were immaterial. 2 Represents amounts offsetting derivative assets and derivative liabilities that are subject to an enforceable master netting agreement or similar agreement that are not netted against the gross derivative assets or gross derivative liabilities for presentation on the condensed consolidated balance sheets. 3 For non-cash collateral received, we do not recognize the collateral on our balance sheet unless the obligor (transferor) has defaulted under the terms of the secured contract and is no longer entitled to redeem the pledged asset. Amounts do not include any excess of collateral pledged or received.

Organization, Consolidation and

Organization, Consolidation and Presentation of Financial Statements (Tables)	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Variable Interest Entities	The following summarizes the carrying value and maximum loss exposure of these non-consolidated investments: March 31, 2023 December 31, 2022 (In millions) Carrying Value Maximum Loss Exposure Carrying Value Maximum Loss Exposure Investment funds $ 77 $ 518 $ 79 $ 340 Investment in related parties – investment funds 1,595 2,251 1,569 2,253 Assets of consolidated VIEs – investment funds 12,880 20,372 12,480 20,278 Investment in fixed maturity securities 39,373 42,555 37,454 40,992 Investment in related parties – fixed maturity securities 11,624 12,101 9,717 10,290 Investment in related parties – equity securities 251 251 279 279 Total non-consolidated investments $ 65,800 $ 78,048 $ 61,578 $ 74,432 The following summarizes the income statement activity of the consolidated VIEs: Three months ended March 31, (In millions) 2023 2022 Trading securities $ 23 $ — Mortgage loans 24 20 Investment funds 35 (3) Other investments (2) — Net investment income $ 80 $ 17 Net recognized investment gains (losses) on trading securities $ 6 $ — Net recognized investment gains (losses) on mortgage loans 9 (112) Net recognized investment gains (losses) on investment funds 226 70 Other gains (losses) (40) — Investment related gains (losses) $ 201 $ (42)

Fair Value (Tables)

Fair Value (Tables)	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Assets and Liabilities Measured at Fair Value on Recurring Basis	The following represents the hierarchy for our assets and liabilities measured at fair value on a recurring basis: March 31, 2023 (In millions) Total NAV Level 1 Level 2 Level 3 Assets AFS securities US government and agencies $ 2,703 $ — $ 2,697 $ 6 $ — US state, municipal and political subdivisions 966 — — 966 — Foreign governments 922 — — 921 1 Corporate 63,141 — 9 61,510 1,622 CLO 17,566 — — 17,566 — ABS 10,873 — — 5,931 4,942 CMBS 4,190 — — 4,190 — RMBS 6,352 — — 6,114 238 Total AFS securities 106,713 — 2,706 97,204 6,803 Trading securities 1,652 — 24 1,586 42 Equity securities 968 — 273 624 71 Mortgage loans 29,949 — — — 29,949 Funds withheld at interest – embedded derivative (4,291) — — — (4,291) Derivative assets 3,956 — 66 3,890 — Short-term investments 582 — 1 551 30 Other investments 501 — — 215 286 Cash and cash equivalents 13,844 — 13,844 — — Restricted cash 1,148 — 1,148 — — Investments in related parties AFS securities Corporate 1,127 — — 168 959 CLO 3,513 — — 3,015 498 ABS 7,226 — — 221 7,005 Total AFS securities – related parties 11,866 — — 3,404 8,462 Trading securities 885 — — — 885 Equity securities 251 — — — 251 Mortgage loans 1,324 — — — 1,324 Investment funds 1,034 — — — 1,034 Funds withheld at interest – embedded derivative (1,266) — — — (1,266) Other investments 338 — — — 338 Reinsurance recoverable 1,470 — — — 1,470 Other assets 440 — — — 440 Assets of consolidated VIEs Trading securities 1,069 — — 421 648 Mortgage loans 2,119 — — — 2,119 Investment funds 12,880 10,299 — — 2,581 Other investments 99 — — 2 97 Cash and cash equivalents 654 — 654 — — Total assets measured at fair value $ 188,185 $ 10,299 $ 18,716 $ 107,897 $ 51,273 Liabilities Interest sensitive contract liabilities Embedded derivative $ 6,747 $ — $ — $ — $ 6,747 Universal life benefits 879 — — — 879 Future policy benefits AmerUs Life Insurance Company (AmerUs) Closed Block 1,190 — — — 1,190 Indianapolis Life Insurance Company (ILICO) Closed Block and life benefits 579 — — — 579 Market risk benefits 3,203 — — — 3,203 Derivative liabilities 1,518 — 24 1,493 1 Other liabilities 122 — — (67) 189 Total liabilities measured at fair value $ 14,238 $ — $ 24 $ 1,426 $ 12,788 December 31, 2022 (In millions) Total NAV Level 1 Level 2 Level 3 Assets AFS securities US government and agencies $ 2,577 $ — $ 2,570 $ 7 $ — US state, municipal and political subdivisions 927 — — 927 — Foreign governments 907 — — 906 1 Corporate 60,901 — — 59,236 1,665 CLO 16,493 — — 16,493 — ABS 10,527 — — 5,660 4,867 CMBS 4,158 — — 4,158 — RMBS 5,914 — — 5,682 232 Total AFS securities 102,404 — 2,570 93,069 6,765 Trading securities 1,595 — 23 1,519 53 Equity securities 1,087 — 150 845 92 Mortgage loans 27,454 — — — 27,454 Funds withheld at interest – embedded derivative (4,847) — — — (4,847) Derivative assets 3,309 — 42 3,267 — Short-term investments 520 — 29 455 36 Other investments 611 — — 170 441 Cash and cash equivalents 7,779 — 7,779 — — Restricted cash 628 — 628 — — Investments in related parties AFS securities Corporate 982 — — 170 812 CLO 3,079 — — 2,776 303 ABS 5,760 — — 218 5,542 Total AFS securities – related parties 9,821 — — 3,164 6,657 Trading securities 878 — — — 878 Equity securities 279 — — — 279 Mortgage loans 1,302 — — — 1,302 Investment funds 959 — — — 959 Funds withheld at interest – embedded derivative (1,425) — — — (1,425) Other investments 303 — — — 303 Reinsurance recoverable 1,388 — — — 1,388 Other assets 481 — — — 481 Assets of consolidated VIEs Trading securities 1,063 — 5 436 622 Mortgage loans 2,055 — — — 2,055 Investment funds 12,480 10,009 — — 2,471 Other investments 101 — — 2 99 Cash and cash equivalents 362 — 362 — — Total assets measured at fair value $ 170,587 $ 10,009 $ 11,588 $ 102,927 $ 46,063 Liabilities Interest sensitive contract liabilities Embedded derivative $ 5,841 $ — $ — $ — $ 5,841 Universal life benefits 829 — — — 829 Future policy benefits AmerUs Closed Block 1,164 — — — 1,164 ILICO Closed Block and life benefits 548 — — — 548 Market risk benefits 2,970 — — — 2,970 Derivative liabilities 1,646 — 38 1,607 1 Other liabilities 65 — — (77) 142 Total liabilities measured at fair value $ 13,063 $ — $ 38 $ 1,530 $ 11,495
Summary of Fair Value Option	The following represents the gains (losses) recorded for instruments for which we have elected the fair value option, including related parties and consolidated VIEs: Three months ended March 31, (In millions) 2023 2022 Trading securities $ 64 $ (207) Mortgage loans 296 (916) Investment funds 64 20 Future policy benefits (26) 142 Other liabilities (47) — Total gains (losses) $ 351 $ (961) The following summarizes information for fair value option mortgage loans, including related parties and consolidated VIEs: (In millions) March 31, 2023 December 31, 2022 Unpaid principal balance $ 35,974 $ 33,653 Mark to fair value (2,582) (2,842) Fair value $ 33,392 $ 30,811 The following represents our commercial mortgage loan portfolio 90 days or more past due and/or in non-accrual status: (In millions) March 31, 2023 December 31, 2022 Unpaid principal balance of commercial mortgage loans 90 days or more past due and/or in non-accrual status $ 198 $ 74 Mark to fair value of commercial mortgage loans 90 days or more past due and/or in non-accrual status (56) (55) Fair value of commercial mortgage loans 90 days or more past due and/or in non-accrual status $ 142 $ 19 Fair value of commercial mortgage loans 90 days or more past due $ 11 $ 2 Fair value of commercial mortgage loans in non-accrual status 131 19 The following represents our residential loan portfolio 90 days or more past due and/or in non-accrual status: (In millions) March 31, 2023 December 31, 2022 Unpaid principal balance of residential mortgage loans 90 days or more past due and/or in non-accrual status $ 483 $ 522 Mark to fair value of residential mortgage loans 90 days or more past due and/or in non-accrual status (50) (50) Fair value of residential mortgage loans 90 days or more past due and/or in non-accrual status $ 433 $ 472 Fair value of residential mortgage loans 90 days or more past due 1 $ 433 $ 472 Fair value of residential mortgage loans in non-accrual status 234 360 1 As of March 31, 2023 and December 31, 2022 includes $199 million and $221 million, respectively, of residential mortgage loans that are guaranteed by US government-sponsored agencies. The following is the estimated amount of gains (losses) included in earnings during the period attributable to changes in instrument-specific credit risk on our mortgage loan portfolio: Three months ended March 31, (In millions) 2023 2022 Mortgage loans $ (3) $ (18)
Reconciliation of Level 3 Assets Measured on a Recurring Basis	The following are reconciliations for Level 3 assets and liabilities measured at fair value on a recurring basis. Transfers in and out of Level 3 are primarily based on changes in the availability of pricing sources, as described in the valuation methods above. Three months ended March 31, 2023 Total realized and unrealized gains (losses) (In millions) Beginning balance Included in income Included in OCI Net purchases, issuances, sales and settlements Net transfers in (out) Ending balance Total gains (losses) included in earnings 1 Total gains (losses) included in OCI 1 Assets AFS securities Foreign governments $ 1 $ — $ — $ — — $ 1 $ — $ — Corporate 1,665 (1) 12 126 (180) 1,622 — 6 ABS 4,867 — (19) 155 (61) 4,942 — (16) RMBS 232 3 3 — — 238 — 3 Trading securities 53 2 — (4) (9) 42 1 — Equity securities 92 (8) — — (13) 71 (8) — Mortgage loans 27,454 251 — 2,244 — 29,949 251 — Funds withheld at interest – embedded derivative (4,847) 556 — — — (4,291) — — Short-term investments 36 — (2) (30) 26 30 — — Other investments 441 1 — (156) — 286 2 — Investments in related parties AFS securities Corporate 812 1 (7) 153 — 959 — (7) CLO 303 — 10 185 — 498 — 10 ABS 5,542 4 44 1,415 — 7,005 2 42 Trading securities 878 6 — 1 — 885 6 — Equity securities 279 4 — (32) — 251 3 — Mortgage loans 1,302 26 — (4) — 1,324 26 — Investment funds 959 43 — 32 — 1,034 43 — Funds withheld at interest – embedded derivative (1,425) 159 — — — (1,266) — — Other investments 303 (7) — 42 — 338 (7) — Reinsurance recoverable 1,388 82 — — — 1,470 — — Assets of consolidated VIEs Trading securities 622 12 — (2) 16 648 12 — Mortgage loans 2,055 19 — 45 — 2,119 19 — Investment funds 2,471 18 — (8) 100 2,581 18 — Other investments 99 — — (2) — 97 — — Total Level 3 assets $ 45,582 $ 1,171 $ 41 $ 4,160 $ (121) $ 50,833 $ 368 $ 38 Liabilities Interest sensitive contract liabilities Embedded derivative $ (5,841) $ (473) $ — $ (433) $ — $ (6,747) $ — $ — Universal life benefits (829) (50) — — — (879) — — Future policy benefits AmerUs Closed Block (1,164) (26) — — — (1,190) — — ILICO Closed Block and life benefits (548) (31) — — — (579) — — Derivative liabilities (1) — — — — (1) — — Other liabilities (142) (47) — — — (189) — — Total Level 3 liabilities $ (8,525) $ (627) $ — $ (433) $ — $ (9,585) $ — $ — 1 Related to instruments held at end of period. Three months ended March 31, 2022 Total realized and unrealized gains (losses) (In millions) January 1, 2022 Included in income Included in OCI Net purchases, issuances, sales and settlements Net transfers in (out) Ending balance Total gains (losses) included in earnings 1 Total gains (losses) included in OCI 1 Assets AFS securities Foreign governments $ 2 $ — $ — $ — $ — $ 2 $ — $ — Corporate 1,339 (3) (19) 140 42 1,499 — (19) CLO 14 (1) 2 (10) — 5 — 2 ABS 3,619 6 (31) (148) 337 3,783 — (30) CMBS 43 — (17) — (16) 10 — (17) Trading securities 69 (5) — 6 20 90 — — Equity securities 429 9 — — — 438 — — Mortgage loans 21,154 (744) — 3,286 — 23,696 (741) — Investment funds 18 1 — — — 19 1 — Funds withheld at interest – embedded derivative — (1,882) — — — (1,882) — — Short-term investments 29 — — 30 — 59 9 — Investments in related parties AFS securities Corporate 670 (4) 1 94 — 761 — 1 CLO 202 — — 130 — 332 — — ABS 6,445 (17) (10) (145) (1,864) 4,409 — (10) Trading securities 1,771 (5) — (254) (1,260) 252 — — Equity securities 284 (5) — — (113) 166 — — Mortgage loans 1,369 (52) — 139 — 1,456 (52) — Investment funds 2,855 24 — (34) (2,031) 814 24 — Funds withheld at interest – embedded derivative — (570) — — — (570) — — Short-term investments — — — 53 — 53 — — Reinsurance recoverable 1,991 (177) — — — 1,814 — — Assets of consolidated VIEs Mortgage loans 2,152 (120) — (152) — 1,880 (120) — Investment funds 1,297 (5) — 238 9,047 10,577 (5) — Other investments — — — — 1,902 1,902 — — Total Level 3 assets $ 45,752 $ (3,550) $ (74) $ 3,373 $ 6,064 $ 51,565 $ (884) $ (73) Liabilities Interest sensitive contract liabilities Embedded derivative $ (7,408) $ 1,034 $ — $ (111) $ — $ (6,485) $ — $ — Universal life benefits (1,235) 139 — — — (1,096) — — Future policy benefits AmerUs Closed Block (1,520) 142 — — — (1,378) — — ILICO Closed Block and life benefits (742) 38 — — — (704) — — Derivative liabilities (3) — — — — (3) — — Liabilities of consolidated VIEs – debt — — — — (3,645) (3,645) — — Total Level 3 liabilities $ (10,908) $ 1,353 $ — $ (111) $ (3,645) $ (13,311) $ — $ — 1 Related to instruments held at end of period.
Gross Components of Purchases, Sales, Issuances and Settlements, net	The following represents the gross components of purchases, issuances, sales and settlements, net, and net transfers in (out) shown above: Three months ended March 31, 2023 (In millions) Purchases Issuances Sales Settlements Net purchases, issuances, sales and settlements Transfers in Transfers out Net transfers in (out) Assets AFS securities Corporate $ 208 $ — $ — $ (82) $ 126 $ 29 $ (209) $ (180) ABS 298 — — (143) 155 215 (276) (61) RMBS 1 — — (1) — — — — Trading securities — — — (4) (4) 5 (14) (9) Equity securities — — — — — — (13) (13) Mortgage loans 2,882 — (32) (606) 2,244 — — — Short-term investments — — — (30) (30) 26 — 26 Other investments 2 — — (158) (156) — — — Investments in related parties AFS securities Corporate 156 — — (3) 153 — — — CLO 185 — — — 185 — — — ABS 1,634 — — (219) 1,415 — — — Trading securities 2 — — (1) 1 — — — Equity securities — — — (32) (32) — — — Mortgage loans — — — (4) (4) — — — Investment funds 32 — — — 32 — — — Other investments 42 — — — 42 — — — Assets of consolidated VIEs Trading securities 10 — (12) — (2) 19 (3) 16 Mortgage loans 46 — — (1) 45 — — — Investment funds — — (8) — (8) 148 (48) 100 Other investments 5 — (7) — (2) — — — Total Level 3 assets $ 5,503 $ — $ (59) $ (1,284) $ 4,160 $ 442 $ (563) $ (121) Liabilities Interest sensitive contract liabilities – embedded derivative $ — $ (577) $ — $ 144 $ (433) $ — $ — $ — Total Level 3 liabilities $ — $ (577) $ — $ 144 $ (433) $ — $ — $ — Three months ended March 31, 2022 (In millions) Purchases Issuances Sales Settlements Net purchases, issuances, sales and settlements Transfers in 1 Transfers out 2 Net transfers in (out) Assets AFS securities Corporate $ 324 $ — $ (168) $ (16) $ 140 $ 43 $ (1) $ 42 CLO — — — (10) (10) — — — ABS 1,489 — (1,450) (187) (148) 338 (1) 337 CMBS — — — — — — (16) (16) Trading securities 6 — — — 6 30 (10) 20 Mortgage loans 4,091 — (82) (723) 3,286 — — — Short-term investments 30 — — — 30 — — — Investments in related parties AFS securities Corporate 315 — (217) (4) 94 — — — CLO 130 — — — 130 — — — ABS 374 — (87) (432) (145) — (1,864) (1,864) Trading securities 29 — (265) (18) (254) (1,260) (1,260) Equity securities — — — — — — (113) (113) Mortgage securities 146 — — (7) 139 — — — Investment funds — — (34) — (34) — (2,031) (2,031) Short-term investments 53 — — — 53 — — — Assets of consolidated VIEs Mortgage loans — — — (152) (152) — — — Investment funds 253 — (15) — 238 10,081 (1,034) 9,047 Other investments — — — — — 1,902 — 1,902 Total Level 3 assets $ 7,240 $ — $ (2,318) $ (1,549) $ 3,373 $ 12,394 $ (6,330) $ 6,064 Liabilities Interest sensitive contract liabilities – embedded derivative $ — $ (260) $ — $ 149 $ (111) $ — $ — $ — Liabilities of consolidated VIEs – debt — — — — — (3,645) — (3,645) Total Level 3 liabilities $ — $ (260) $ — $ 149 $ (111) $ (3,645) $ — $ (3,645) 1 Transfers in includes assets and liabilities of consolidated VIEs that we consolidated effective March 31, 2022 ($10,081 million investment funds, $1,902 million other investments, and $3,645 million debt). 2 Transfers out includes the elimination of investments in related party securities issued by VIEs that we consolidated effective March 31, 2022 ($1,582 million ABS AFS securities, $1,260 million ABS and CLO trading securities, and $113 million equity securities).
Summary of the Unobservable Inputs for the Embedded Derivative of Fixed Indexed Annuities	The following summarizes the unobservable inputs for AFS, trading and equity securities, mortgage loans, investment funds and the embedded derivatives of fixed indexed annuities, including those of consolidated VIEs: March 31, 2023 (In millions, except for percentages and multiples) Fair value Valuation technique Unobservable inputs Minimum Maximum Weighted average Impact of an increase in the input on fair value AFS, trading and equity securities $ 12,271 Discounted cash flow Discount rate 2.0 % 18.7 % 6.7 % 1 Decrease Mortgage loans 33,392 Discounted cash flow Discount rate 2.1 % 22.3 % 6.3 % 1 Decrease Investment funds 650 Discounted cash flow Discount rate 6.4 % 14.7 % 8.4 % Decrease 899 Discounted cash flow / Discount rate / 17.0% /8.5x 17.0% /8.5x 17.0% /8.5x Decrease/Increase 515 Net tangible asset values Implied multiple 1.26x 1.26x 1.26x Increase 517 Reported net asset value Reported net asset value N/A N/A N/A N/A Interest sensitive contract liabilities – fixed indexed annuities embedded derivatives 6,747 Discounted cash flow Nonperformance risk 0.3 % 1.8 % 1.3 % 2 Decrease Option budget 0.5 % 5.7 % 2.0 % 3 Increase Surrender rate 5.2 % 11.7 % 8.1 % 3 Decrease December 31, 2022 (In millions, except for percentages and multiples) Fair value Valuation technique Unobservable inputs Minimum Maximum Weighted average Impact of an increase in the input on fair value AFS, trading and equity securities $ 10,671 Discounted cash flow Discount rate 2.2 % 18.8 % 6.8 % 1 Decrease Mortgage loans 30,811 Discounted cash flow Discount rate 1.5 % 22.1 % 6.3 % 1 Decrease Investment funds 506 Discounted cash flow Discount rate 6.4 % 6.4 % 6.4 % Decrease 873 Discounted cash flow / Discount rate / 16.5% / 9x 16.5% / 9x 16.5% / 9x Decrease/Increase 529 Net tangible asset values Implied multiple 1.26x 1.26x 1.26x Increase 563 Reported net asset value Reported net asset value N/A N/A N/A N/A Interest sensitive contract liabilities – fixed indexed annuities embedded derivatives 5,841 Discounted cash flow Nonperformance risk 0.1 % 1.7 % 1.0 % 2 Decrease Option budget 0.5 % 5.3 % 1.9 % 3 Increase Surrender rate 5.1 % 11.5 % 8.1 % 3 Decrease 1 The discount rate weighted average is calculated based on the relative fair values of the securities or loans. 2 The nonperformance risk weighted average is based on the projected cash flows attributable to the embedded derivative. 3 The option budget and surrender rate weighted averages are calculated based on projected account values. The following summarizes the unobservable inputs for market risk benefits: March 31, 2023 (In millions, except for percentages) Fair value Valuation technique Unobservable inputs Minimum Maximum Weighted average Impact of an increase in the input on fair value Market risk benefits, net $ 2,763 Discounted cash flow Nonperformance risk 0.3 % 1.7 % 1.6 % 1 Decrease Option budget 0.5 % 5.6 % 1.7 % 2 Decrease Surrender rate 3.3 % 6.9 % 4.5 % 2 Decrease March 31, 2022 (In millions, except for percentages) Fair value Valuation technique Unobservable inputs Minimum Maximum Weighted average Impact of an increase in the input on fair value Market risk benefits, net $ 3,444 Discounted cash flow Nonperformance risk 0.4 % 2.0 % 1.3 % 1 Decrease Option budget 0.5 % 3.8 % 1.5 % 2 Decrease Surrender rate 3.6 % 6.6 % 4.5 % 2 Decrease 1 The nonperformance risk weighted average is based on the cash flows underlying the market risk benefit reserve. 2 The option budget and surrender rate weighted averages are calculated based on projected account values.
Summary of Financial Instruments Not Carried at Fair Value on the Balance Sheet	The following represents our financial instruments not carried at fair value on the condensed consolidated balance sheets: March 31, 2023 (In millions) Carrying Value Fair Value NAV Level 1 Level 2 Level 3 Financial assets Investment funds $ 77 $ 77 $ 77 $ — $ — $ — Policy loans 339 339 — — 339 — Funds withheld at interest 35,375 35,375 — — — 35,375 Short-term investments 45 45 — — 45 — Other investments 200 200 — — — 200 Investments in related parties Investment funds 561 561 561 — — — Funds withheld at interest 10,728 10,728 — — — 10,728 Short-term investments 1,043 1,043 — — 1,043 — Total financial assets not carried at fair value $ 48,368 $ 48,368 $ 638 $ — $ 1,427 $ 46,303 Financial liabilities Interest sensitive contract liabilities $ 131,873 $ 120,063 $ — $ — $ — $ 120,063 Debt 3,650 2,906 — — 2,906 — Securities to repurchase 7,781 7,781 — — 7,781 — Funds withheld liability 346 346 — — 346 — Total financial liabilities not carried at fair value $ 143,650 $ 131,096 $ — $ — $ 11,033 $ 120,063 December 31, 2022 (In millions) Carrying Value Fair Value NAV Level 1 Level 2 Level 3 Financial assets Investment funds $ 79 $ 79 $ 79 $ — $ — $ — Policy loans 347 347 — — 347 — Funds withheld at interest 37,727 37,727 — — — 37,727 Short-term investments 1,640 1,640 — — 1,614 26 Other investments 162 162 — — — 162 Investments in related parties Investment funds 610 610 610 — — — Funds withheld at interest 11,233 11,233 — — — 11,233 Total financial assets not carried at fair value $ 51,798 $ 51,798 $ 689 $ — $ 1,961 $ 49,148 Financial liabilities Interest sensitive contract liabilities $ 125,101 $ 111,608 $ — $ — $ — $ 111,608 Debt 3,658 2,893 — — 2,893 — Securities to repurchase 4,743 4,743 — — 4,743 — Funds withheld liability 360 360 — — 360 — Total financial liabilities not carried at fair value $ 133,862 $ 119,604 $ — $ — $ 7,996 $ 111,608

Deferred Acquisition Costs, D_2

Deferred Acquisition Costs, Deferred Sales Inducements and Value of Business Acquired (Tables)	3 Months Ended
	Mar. 31, 2023
Insurance [Abstract]
Deferred Acquisition Costs	The following table summarizes the change in deferred acquisition costs, deferred sales inducements and value of business acquired: (In millions) VOBA Balance as of January 1, 2022 $ 4,527 Change in discount rate assumptions for future policy benefits (22) Fair value adjustment of market risk benefits (1,133) Adjusted balance as of January 1, 2022 $ 3,372 The following represents a rollforward of DAC and DSI by product, and a rollforward of VOBA. See Note 9 – Long-duration Contracts for more information on our products. Three months ended March 31, 2023 DAC DSI VOBA Total DAC, DSI and VOBA (In millions) Traditional deferred annuities Indexed annuities Funding agreements Other investment-type Indexed annuities Balance at December 31, 2022 $ 304 $ 755 $ 11 $ 9 $ 399 $ 2,988 $ 4,466 Additions 171 203 — 1 133 — 508 Amortization (16) (18) (1) — (10) (93) (138) Balance at March 31, 2023 $ 459 $ 940 $ 10 $ 10 $ 522 $ 2,895 $ 4,836 Three months ended March 31, 2022 DAC DSI VOBA Total DAC, DSI and VOBA (In millions) Traditional deferred annuities Indexed annuities Funding agreements Other investment-type Indexed annuities Balance at January 1, 2022 $ — $ — $ — $ — $ — $ 3,372 $ 3,372 Additions 24 176 11 3 77 — 291 Amortization — (1) (1) — — (96) (98) Balance at March 31, 2022 $ 24 $ 175 $ 10 $ 3 $ 77 $ 3,276 $ 3,565
Deferred Sales Inducements	The following represents a rollforward of DAC and DSI by product, and a rollforward of VOBA. See Note 9 – Long-duration Contracts for more information on our products. Three months ended March 31, 2023 DAC DSI VOBA Total DAC, DSI and VOBA (In millions) Traditional deferred annuities Indexed annuities Funding agreements Other investment-type Indexed annuities Balance at December 31, 2022 $ 304 $ 755 $ 11 $ 9 $ 399 $ 2,988 $ 4,466 Additions 171 203 — 1 133 — 508 Amortization (16) (18) (1) — (10) (93) (138) Balance at March 31, 2023 $ 459 $ 940 $ 10 $ 10 $ 522 $ 2,895 $ 4,836 Three months ended March 31, 2022 DAC DSI VOBA Total DAC, DSI and VOBA (In millions) Traditional deferred annuities Indexed annuities Funding agreements Other investment-type Indexed annuities Balance at January 1, 2022 $ — $ — $ — $ — $ — $ 3,372 $ 3,372 Additions 24 176 11 3 77 — 291 Amortization — (1) (1) — — (96) (98) Balance at March 31, 2022 $ 24 $ 175 $ 10 $ 3 $ 77 $ 3,276 $ 3,565
Present Value of Future Insurance Profits	The expected amortization of VOBA for the next five years is as follows: (In millions) Expected Amortization 2023 1 $ 257 2024 316 2025 289 2026 260 2027 230 2028 200 1 Expected amortization for the remainder of 2023.

Long-duration Contracts (Tables

Long-duration Contracts (Tables)	3 Months Ended
	Mar. 31, 2023
Insurance [Abstract]
Policyholder Account Balance	The following represents a rollforward of the policyholder account balance by product within interest sensitive contract liabilities. Where explicit policyholder account balances do not exist, the disaggregated rollforward represents the recorded reserve. Three months ended March 31, 2023 (In millions, except percentages) Traditional deferred annuities Indexed annuities Funding agreements Other investment-type Total Balance at December 31, 2022 $ 43,518 $ 92,660 $ 27,439 $ 4,722 $ 168,339 Deposits 6,700 2,929 1,500 1,033 12,162 Policy charges (1) (158) — — (159) Surrenders and withdrawals (1,818) (2,712) (70) (3) (4,603) Benefit payments (264) (422) (490) (90) (1,266) Interest credited 369 117 206 32 724 Foreign exchange — — 54 (16) 38 Other (54) — 143 (33) 56 Balance at March 31, 2023 $ 48,450 $ 92,414 $ 28,782 $ 5,645 $ 175,291 March 31, 2023 Weighted average crediting rate 3.4 % 2.3 % 2.7 % 2.9 % 2.7 % Net amount at risk $ 423 $ 13,903 $ — $ 66 $ 14,392 Cash surrender value 45,994 84,047 — 2,710 132,751 Three months ended March 31, 2022 (In millions, except percentages) Traditional deferred annuities Indexed annuities Funding agreements Other investment-type Total Balance at January 1, 2022 $ 35,599 $ 89,755 $ 23,623 $ 2,413 $ 151,390 Deposits 918 2,573 4,946 520 8,957 Policy charges (1) (141) — — (142) Surrenders and withdrawals (845) (1,798) — (1) (2,644) Benefit payments (256) (426) (695) (83) (1,460) Interest credited 235 697 125 17 1,074 Foreign exchange — — (100) (14) (114) Other — — (218) — (218) Balance at March 31, 2022 $ 35,650 $ 90,660 $ 27,681 $ 2,852 $ 156,843 March 31, 2022 Weighted average crediting rate 2.7 % 2.0 % 1.8 % 2.2 % 2.1 % Net amount at risk $ 416 $ 10,554 $ — $ 13 $ 10,983 Cash surrender value 34,211 84,265 — 710 119,186
Policyholder Account Balance and Liability for Unpaid Claims and Claims Adjustment Expense	The following is a reconciliation of interest sensitive contract liabilities to the condensed consolidated balance sheets: March 31, (In millions) 2023 2022 Traditional deferred annuities $ 48,450 $ 35,650 Indexed annuities 92,414 90,660 Funding agreements 28,782 27,681 Other investment-type 5,645 2,852 Reconciling items 1 5,809 7,460 Interest sensitive contract liabilities $ 181,100 $ 164,303 1 Reconciling items primarily include embedded derivatives in indexed annuities, unaccreted host contract adjustments on indexed annuities, negative VOBA, sales inducement liabilities, and wholly ceded universal life insurance contracts. The following is a reconciliation of future policy benefits to the condensed consolidated balance sheets: March 31, (In millions) 2023 2022 Payout annuities with life contingencies $ 36,752 $ 33,149 Reconciling items 1 5,738 6,091 Future policy benefits $ 42,490 $ 39,240 1 Reconciling items primarily include the deferred profit liability and negative VOBA associated with our liability for future policy benefits. Additionally, it includes reserves for our immaterial lines of business including term and whole life, accident and health and disability, as well as other insurance benefit reserves for our no-lapse guarantees with universal life contracts, all of which are fully ceded.
Policyholder Account Balance, Guaranteed Minimum Crediting Rate	The following represents policyholder account balances by range of guaranteed minimum crediting rates, as well as the related range of the difference between rates being credited to policyholders and the respective guaranteed minimums: March 31, 2023 (In millions) At guaranteed minimum 1 basis point – 100 basis points above guaranteed minimum Greater than 100 basis points above guaranteed minimum Total < 2.0% $ 25,571 $ 23,867 $ 80,468 $ 129,906 2.0% – < 4.0% 31,793 1,709 778 34,280 4.0% – < 6.0% 9,625 52 206 9,883 6.0% and greater 1,222 — — 1,222 Total $ 68,211 $ 25,628 $ 81,452 $ 175,291 March 31, 2022 (In millions) At guaranteed minimum 1 basis point – 100 basis points above guaranteed minimum Greater than 100 basis points above guaranteed minimum Total < 2.0% $ 29,040 $ 30,195 $ 57,412 $ 116,647 2.0% – < 4.0% 34,604 925 43 35,572 4.0% – < 6.0% 4,467 11 6 4,484 6.0% and greater 140 — — 140 Total $ 68,251 $ 31,131 $ 57,461 $ 156,843
Liability for Future Policy Benefit, Activity	The following table summarizes future policy benefits and changes to the liability: (In millions) Traditional deferred annuities Indexed annuities Payout annuities Reconciling items 1 Total Balance as of January 1, 2022 $ 221 $ 5,389 $ 32,872 $ 8,632 $ 47,114 Change in discount rate assumptions — — 2,406 — 2,406 Adjustment for removal of balances related to market risk benefits (221) (5,389) — — (5,610) Adjustment for offsetting balance in negative VOBA 2 — — — (2,428) (2,428) Adjusted balance as of January 1, 2022 $ — $ — $ 35,278 $ 6,204 $ 41,482 1 Reconciling items primarily include negative VOBA associated with our liability for future policy benefits, as well as reserves for our immaterial lines of business including term and whole life, accident and health and disability, as well as other insurance benefit reserves for our no-lapse guarantees with universal life contracts, all of which are fully ceded. 2 Uneliminated adjustments were recorded to positive VOBA within deferred acquisition costs, deferred sales inducements and value of business acquired on the condensed consolidated balance sheets. The following is a rollforward of the present value of expected net premiums and expected value of future policy benefits: Payout annuities with life contingencies Three months ended March 31, (In millions) 2023 2022 Present value of expected net premiums Beginning balance $ — $ — Issuances 88 1,994 Net premium collected (88) (1,994) Ending balance $ — $ — Present value of expected future policy benefits Beginning balance $ 36,422 $ 35,278 Effect of changes in discount rate assumptions 8,425 — Beginning balance at original discount rate 44,847 35,278 Effect of actual experience compared to expected experience (29) (47) Adjusted beginning balance 44,818 35,231 Issuances 88 1,994 Interest accrual 346 229 Benefit payments (885) (724) Foreign exchange 8 (19) Ending balance at original discount rate 44,375 36,711 Effect of changes in discount rate assumptions (7,623) (3,562) Ending balance $ 36,752 $ 33,149 The following is a reconciliation of premiums to the condensed consolidated statements of income (loss): Three months ended March 31, (In millions) 2023 2022 Payout annuities with life contingencies $ 88 $ 2,098 Reconciling items 1 8 12 Premiums $ 96 $ 2,110 1 Reconciling items premiums related to our immaterial lines of business including term and whole life and accident and health and disability. The following represents the undiscounted and discounted expected future benefit payments for the liability for future policy benefits. As these relate to payout annuities for single premium immediate annuities with life contingencies, there are no expected future gross premiums. March 31, 2023 March 31, 2022 (In millions) Undiscounted Discounted Undiscounted Discounted Expected future benefit payments $ 63,995 $ 44,375 $ 51,643 $ 36,711 The following represents the weighted-average durations and the weighted-average interest rates of future policy benefits: March 31, 2023 2022 Weighted-average liability duration (in years) 10.1 10.6 Weighted-average interest accretion rate 3.2 % 2.7 % Weighted-average current discount rate 5.3 % 3.7 %
Additional Liability, Long-Duration Insurance	The following is the variance of actual experience compared to expected experience related to policyholder longevity assumptions recorded within future policy benefits: Three months ended March 31, (In millions) 2023 2022 Expected reserve release due to death $ 132 $ 114 Actual reserve release due to death 183 163 Decrease in reserve due to actual experience compared to expected experience $ (51) $ (49) The following is a summary of remeasurement gains (losses) included within future policy and other policy benefits on the condensed consolidated statements of income (loss): Three months ended March 31, (In millions) 2023 2022 Reserves $ 29 $ 47 Deferred profit liability (27) (54) Negative VOBA (4) 10 Total remeasurement gains (losses) $ (2) $ 3
Market Risk Benefit, Activity	The following table presents the net liability position of market risk benefits: (In millions) Traditional deferred annuities Indexed annuities Total Balance as of January 1, 2022 $ — $ — $ — Adjustment for addition of existing balances 1 221 5,389 5,610 Adjustment to positive VOBA due to fair value adjustment for market risk benefits 2 32 (1,165) (1,133) Adjustment to negative VOBA due to fair value adjustment for market risk benefits 3 — (30) (30) Adjusted balance as of January 1, 2022 $ 253 $ 4,194 $ 4,447 1 Previously recorded within future policy benefits on the condensed consolidated balance sheets. 2 Previously recorded within deferred acquisition costs, deferred sales inducements and value of business acquired on the condensed consolidated balance sheets. 3 Previously recorded within interest sensitive contract liabilities on the condensed consolidated balance sheets. The following table represents market risk benefits by asset and liability positions: (In millions) Asset 1 Liability Net liability Traditional deferred annuities $ — $ 253 $ 253 Indexed annuities 366 4,560 4,194 Adjusted balance as of January 1, 2022 $ 366 $ 4,813 $ 4,447 1 Included in other assets on the condensed consolidated balance sheets. The following is a rollfoward of net market risk benefit liabilities by product: Three months ended March 31, 2023 (In millions) Traditional deferred annuities Indexed annuities Total Balance at December 31, 2022 $ 170 $ 2,319 $ 2,489 Effect of changes in instrument-specific credit risk 13 353 366 Balance, beginning of period, before changes in instrument specific credit risk 183 2,672 2,855 Issuances — 17 17 Interest accrual 2 32 34 Attributed fees collected 1 84 85 Benefit payments — (6) (6) Effect of changes in interest rates 8 218 226 Effect of changes in equity — (18) (18) Effect of actual behavior compared to expected behavior 2 23 25 Balance, end of period, before changes in instrument specific credit risk 196 3,022 3,218 Effect of changes in the instrument specific credit risk (16) (439) (455) Balance at March 31, 2023 $ 180 $ 2,583 $ 2,763 March 31, 2023 Net amount at risk $ 423 $ 13,903 $ 14,326 Weighted-average attained age of contract holders (in years) 75 69 69 Three months ended March 31, 2022 (In millions) Traditional deferred annuities Indexed annuities Total Balance at January 1, 2022 $ 253 $ 4,194 $ 4,447 Issuances — 16 16 Interest accrual — (2) (2) Attributed fees collected 1 81 82 Benefit payments (1) (11) (12) Effect of changes in interest rates (26) (732) (758) Effect of changes in equity — 55 55 Effect of actual behavior compared to expected behavior 1 12 13 Balance, end of period, before changes in instrument specific credit risk 228 3,613 3,841 Effect of changes in the instrument specific credit risk (13) (384) (397) Balance at March 31, 2022 $ 215 $ 3,229 $ 3,444 March 31, 2022 Net amount at risk $ 416 $ 10,554 $ 10,970 Weighted-average attained age of contract holders (in years) 75 69 69 The following is a reconciliation of market risk benefits to the condensed consolidated balance sheets. Market risk benefit assets are included in other assets on the condensed consolidated balance sheets. March 31, 2023 March 31, 2022 (In millions) Asset Liability Net liability Asset Liability Net liability Traditional deferred annuities $ — $ 180 $ 180 $ — $ 215 $ 215 Indexed annuities 440 3,023 2,583 413 3,642 3,229 Total $ 440 $ 3,203 $ 2,763 $ 413 $ 3,857 $ 3,444
Summary of the Unobservable Inputs for the Embedded Derivative of Fixed Indexed Annuities	The following summarizes the unobservable inputs for AFS, trading and equity securities, mortgage loans, investment funds and the embedded derivatives of fixed indexed annuities, including those of consolidated VIEs: March 31, 2023 (In millions, except for percentages and multiples) Fair value Valuation technique Unobservable inputs Minimum Maximum Weighted average Impact of an increase in the input on fair value AFS, trading and equity securities $ 12,271 Discounted cash flow Discount rate 2.0 % 18.7 % 6.7 % 1 Decrease Mortgage loans 33,392 Discounted cash flow Discount rate 2.1 % 22.3 % 6.3 % 1 Decrease Investment funds 650 Discounted cash flow Discount rate 6.4 % 14.7 % 8.4 % Decrease 899 Discounted cash flow / Discount rate / 17.0% /8.5x 17.0% /8.5x 17.0% /8.5x Decrease/Increase 515 Net tangible asset values Implied multiple 1.26x 1.26x 1.26x Increase 517 Reported net asset value Reported net asset value N/A N/A N/A N/A Interest sensitive contract liabilities – fixed indexed annuities embedded derivatives 6,747 Discounted cash flow Nonperformance risk 0.3 % 1.8 % 1.3 % 2 Decrease Option budget 0.5 % 5.7 % 2.0 % 3 Increase Surrender rate 5.2 % 11.7 % 8.1 % 3 Decrease December 31, 2022 (In millions, except for percentages and multiples) Fair value Valuation technique Unobservable inputs Minimum Maximum Weighted average Impact of an increase in the input on fair value AFS, trading and equity securities $ 10,671 Discounted cash flow Discount rate 2.2 % 18.8 % 6.8 % 1 Decrease Mortgage loans 30,811 Discounted cash flow Discount rate 1.5 % 22.1 % 6.3 % 1 Decrease Investment funds 506 Discounted cash flow Discount rate 6.4 % 6.4 % 6.4 % Decrease 873 Discounted cash flow / Discount rate / 16.5% / 9x 16.5% / 9x 16.5% / 9x Decrease/Increase 529 Net tangible asset values Implied multiple 1.26x 1.26x 1.26x Increase 563 Reported net asset value Reported net asset value N/A N/A N/A N/A Interest sensitive contract liabilities – fixed indexed annuities embedded derivatives 5,841 Discounted cash flow Nonperformance risk 0.1 % 1.7 % 1.0 % 2 Decrease Option budget 0.5 % 5.3 % 1.9 % 3 Increase Surrender rate 5.1 % 11.5 % 8.1 % 3 Decrease 1 The discount rate weighted average is calculated based on the relative fair values of the securities or loans. 2 The nonperformance risk weighted average is based on the projected cash flows attributable to the embedded derivative. 3 The option budget and surrender rate weighted averages are calculated based on projected account values. The following summarizes the unobservable inputs for market risk benefits: March 31, 2023 (In millions, except for percentages) Fair value Valuation technique Unobservable inputs Minimum Maximum Weighted average Impact of an increase in the input on fair value Market risk benefits, net $ 2,763 Discounted cash flow Nonperformance risk 0.3 % 1.7 % 1.6 % 1 Decrease Option budget 0.5 % 5.6 % 1.7 % 2 Decrease Surrender rate 3.3 % 6.9 % 4.5 % 2 Decrease March 31, 2022 (In millions, except for percentages) Fair value Valuation technique Unobservable inputs Minimum Maximum Weighted average Impact of an increase in the input on fair value Market risk benefits, net $ 3,444 Discounted cash flow Nonperformance risk 0.4 % 2.0 % 1.3 % 1 Decrease Option budget 0.5 % 3.8 % 1.5 % 2 Decrease Surrender rate 3.6 % 6.6 % 4.5 % 2 Decrease 1 The nonperformance risk weighted average is based on the cash flows underlying the market risk benefit reserve. 2 The option budget and surrender rate weighted averages are calculated based on projected account values.

Equity (Tables)

Equity (Tables)	3 Months Ended
	Mar. 31, 2023
Equity [Abstract]
Accumulated Other Comprehensive Income	The following provides the details and changes in AOCI: (In millions) Unrealized investment gains (losses) on AFS securities without a credit allowance Unrealized investment gains (losses) on AFS securities with a credit allowance Unrealized gains (losses) on hedging instruments Remeasurement gains (losses) on future policy benefits related to discount rate Remeasurement gains (losses) on market risk benefits related to credit risk Foreign currency translation and other adjustments Accumulated other comprehensive income (loss) Balance at December 31, 2022 $ (12,565) $ (334) $ 47 $ 5,256 $ 285 $ (10) $ (7,321) Other comprehensive income (loss) before reclassifications 2,187 (119) 191 (802) 89 16 1,562 Less: Reclassification adjustments for gains (losses) realized 1 (31) — 87 — — — 56 Less: Income tax expense (benefit) 312 14 15 (73) 18 4 290 Less: Other comprehensive income (loss) attributable to noncontrolling interests 220 — 27 (208) 1 3 43 Balance at March 31, 2023 $ (10,879) $ (467) $ 109 $ 4,735 $ 355 $ (1) $ (6,148) 1 Recognized in investment related gains (losses) on the condensed consolidated statements of income (loss). (In millions) Unrealized investment gains (losses) on AFS securities without a credit allowance Unrealized investment gains (losses) on AFS securities with a credit allowance Unrealized gains (losses) on hedging instruments Remeasurement gains (losses) on future policy benefits related to discount rate Remeasurement gains (losses) on market risk benefits related to credit risk Foreign currency translation and other adjustments Accumulated other comprehensive income (loss) Balance at January 1, 2022 $ — $ — $ — $ — $ — $ — $ — Other comprehensive income (loss) before reclassifications 1 (6,645) (97) (129) 3,562 397 (2) (2,914) Less: Reclassification adjustments for gains (losses) realized in net income 1 (38) (7) — — — — (45) Less: Income tax expense (benefit) (1,184) (16) (26) 529 83 (1) (615) Less: Other comprehensive income (loss) attributable to noncontrolling interests (676) (9) (24) 774 5 (6) 64 Balance at March 31, 2022 $ (4,747) $ (65) $ (79) $ 2,259 $ 309 $ 5 $ (2,318) 1 Recognized in investment related gains (losses) on the condensed consolidated statements of income (loss).

Related Parties (Tables)

Related Parties (Tables)	3 Months Ended
	Mar. 31, 2023
Related Party Transactions [Abstract]
Schedule of Related Party Transactions	The following table summarizes our investments in Athora: (In millions) March 31, 2023 December 31, 2022 Investment fund $ 1,034 $ 959 Non-redeemable preferred equity securities 245 273 Total investment in Athora $ 1,279 $ 1,232

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Restricted Pledged Assets and Funds in Trust	The total restricted assets included on the condensed consolidated balance sheets are as follows: (In millions) March 31, 2023 December 31, 2022 AFS securities $ 17,054 $ 15,366 Trading securities 69 55 Equity securities 71 38 Mortgage loans 7,963 8,849 Investment funds 84 103 Derivative assets 80 65 Short-term investments 131 120 Other investments 215 170 Restricted cash 1,148 628 Total restricted assets $ 26,815 $ 25,394

Business, Basis of Presentati_3

Business, Basis of Presentation and Significant Accounting Policies Narrative (Details)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Net premium ratio cap (in percent)	100%

Adoption of Accounting Pronou_3

Adoption of Accounting Pronouncement - Future Policy Benefits and Changes to the Liability (Details) $ in Millions	Jan. 01, 2022 USD ($)
Policyholder Account Balance [Roll Forward]
Balance as of January 1, 2022	$ 47,114
Change in discount rate assumptions	2,406
Adjustment for removal of balances related to market risk benefits	(5,610)
Adjustment for offsetting balance in negative VOBA	(2,428)
Adjusted balance as of January 1, 2022	41,482
Traditional deferred annuities
Policyholder Account Balance [Roll Forward]
Balance as of January 1, 2022	221
Change in discount rate assumptions	0
Adjustment for removal of balances related to market risk benefits	(221)
Adjustment for offsetting balance in negative VOBA	0
Adjusted balance as of January 1, 2022	0
Indexed annuities
Policyholder Account Balance [Roll Forward]
Balance as of January 1, 2022	5,389
Change in discount rate assumptions	0
Adjustment for removal of balances related to market risk benefits	(5,389)
Adjustment for offsetting balance in negative VOBA	0
Adjusted balance as of January 1, 2022	0
Payout annuities with life contingencies
Policyholder Account Balance [Roll Forward]
Balance as of January 1, 2022	32,872
Change in discount rate assumptions	2,406
Adjustment for removal of balances related to market risk benefits	0
Adjustment for offsetting balance in negative VOBA	0
Adjusted balance as of January 1, 2022	35,278
Reconciling items
Policyholder Account Balance [Roll Forward]
Balance as of January 1, 2022	8,632
Change in discount rate assumptions	0
Adjustment for removal of balances related to market risk benefits	0
Adjustment for offsetting balance in negative VOBA	(2,428)
Adjusted balance as of January 1, 2022	$ 6,204

Adoption of Accounting Pronou_4

Adoption of Accounting Pronouncement - Market Risk Benefit (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022	Jan. 01, 2022
Market Risk Benefit [Roll Forward]
Beginning Balance	$ 3,218	$ (2,489)	$ 3,841	$ 4,447
Reported
Market Risk Benefit [Roll Forward]
Beginning Balance				0
Adjustment for addition of existing balances
Market Risk Benefit [Roll Forward]
Beginning Balance				5,610
Adjustment to positive VOBA due to fair value adjustment for market risk benefits
Market Risk Benefit [Roll Forward]
Beginning Balance				(1,133)
Adjustment to negative VOBA due to fair value adjustment for market risk benefits
Market Risk Benefit [Roll Forward]
Beginning Balance				(30)
Traditional deferred annuities
Market Risk Benefit [Roll Forward]
Beginning Balance	196	(170)	228	253
Traditional deferred annuities | Reported
Market Risk Benefit [Roll Forward]
Beginning Balance				0
Traditional deferred annuities | Adjustment for addition of existing balances
Market Risk Benefit [Roll Forward]
Beginning Balance				221
Traditional deferred annuities | Adjustment to positive VOBA due to fair value adjustment for market risk benefits
Market Risk Benefit [Roll Forward]
Beginning Balance				32
Traditional deferred annuities | Adjustment to negative VOBA due to fair value adjustment for market risk benefits
Market Risk Benefit [Roll Forward]
Beginning Balance				0
Indexed annuities
Market Risk Benefit [Roll Forward]
Beginning Balance	$ 3,022	$ (2,319)	$ 3,613	4,194
Indexed annuities | Reported
Market Risk Benefit [Roll Forward]
Beginning Balance				0
Indexed annuities | Adjustment for addition of existing balances
Market Risk Benefit [Roll Forward]
Beginning Balance				5,389
Indexed annuities | Adjustment to positive VOBA due to fair value adjustment for market risk benefits
Market Risk Benefit [Roll Forward]
Beginning Balance				(1,165)
Indexed annuities | Adjustment to negative VOBA due to fair value adjustment for market risk benefits
Market Risk Benefit [Roll Forward]
Beginning Balance				$ (30)

Adoption of Accounting Pronou_5

Adoption of Accounting Pronouncement - Market Risk Benefits by Asset and Liability Positions (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022	Jan. 01, 2022
Market Risk Benefit [Line Items]
Asset	$ 440		$ 413
Liability	3,203	$ 2,970	3,857
Net liability	(2,763)	(2,855)	(3,444)
Reported
Market Risk Benefit [Line Items]
Asset				$ 366
Liability		0		4,813
Net liability				4,447
Traditional deferred annuities
Market Risk Benefit [Line Items]
Asset	0		0
Liability	180		215
Net liability	(180)	(183)	(215)
Traditional deferred annuities | Reported
Market Risk Benefit [Line Items]
Asset				0
Liability				253
Net liability				253
Indexed annuities
Market Risk Benefit [Line Items]
Asset	440		413
Liability	3,023		3,642
Net liability	$ (2,583)	$ (2,672)	$ (3,229)
Indexed annuities | Reported
Market Risk Benefit [Line Items]
Asset				366
Liability				4,560
Net liability				$ 4,194

Adoption of Accounting Pronou_6

Adoption of Accounting Pronouncement - Deferred Acquisition Costs (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
VOBA
Beginning balance	$ 2,988	$ 3,276	$ 3,372
Ending balance	$ 2,895	$ 2,988	3,276
Reported
VOBA
Beginning balance			4,527
Change in discount rate assumptions for future policy benefits
VOBA
Beginning balance			(22)
Fair value adjustment of market risk benefits
VOBA
Beginning balance			$ (1,133)

Adoption of Accounting Pronou_7

Adoption of Accounting Pronouncement - Balance Sheet (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022	Jan. 01, 2022
Assets
Reinsurance recoverable	$ 4,229	$ 4,358
Deferred acquisition costs, deferred sales inducements and value of business acquired	4,836	4,466	$ 3,565	$ 3,372
Other assets	7,916	8,693
Total assets	257,654	243,931
Liabilities
Interest sensitive contract liabilities	181,100	173,616	164,303
Future policy benefits	42,490	42,110	39,240
Market risk benefits	3,203	2,970	3,857
Total liabilities	244,604	233,382
Equity
Retained deficit	(3,293)	(3,640)
Accumulated other comprehensive income (loss)	(6,148)	(7,321)	(2,318)	0
Total Athene Holding Ltd. shareholders’ equity	8,698	7,158
Noncontrolling interests	4,352	3,391
Total equity	13,050	10,549	$ 17,293	22,546
Total liabilities and equity	$ 257,654	243,931
Reported
Assets
Reinsurance recoverable		4,367
Deferred acquisition costs, deferred sales inducements and value of business acquired		5,576
Other assets		9,690
Total assets		246,047
Liabilities
Interest sensitive contract liabilities		173,653
Future policy benefits		55,328
Market risk benefits		0		$ 4,813
Total liabilities		243,667
Equity
Retained deficit		(4,892)
Accumulated other comprehensive income (loss)		(12,311)
Total Athene Holding Ltd. shareholders’ equity		916
Noncontrolling interests		1,464
Total equity		2,380
Total liabilities and equity		246,047
Adoption
Assets
Reinsurance recoverable		(9)
Deferred acquisition costs, deferred sales inducements and value of business acquired		(1,110)
Other assets		(997)
Total assets		(2,116)
Liabilities
Interest sensitive contract liabilities		(37)
Future policy benefits		(13,218)
Market risk benefits		2,970
Total liabilities		(10,285)
Equity
Retained deficit		1,252
Accumulated other comprehensive income (loss)		4,990
Total Athene Holding Ltd. shareholders’ equity		6,242
Noncontrolling interests		1,927
Total equity		8,169
Total liabilities and equity		$ (2,116)

Adoption of Accounting Pronou_8

Adoption of Accounting Pronouncement - Income Statement (Details) - USD ($) $ in Millions	3 Months Ended			6 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2022	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022
Revenues
Investment related gains (losses)	$ 1,065		$ (4,212)		$ (12,811)
Total revenues	4,060		(281)	$ 1,526	3,836	$ 7,623
Benefits and expenses
Interest sensitive contract benefits	1,289		(99)	(752)	(581)	538
Future policy and other policy benefits	466		2,184	7,960	11,230	12,465
Market risk benefits remeasurement (gains) losses	346		(622)	1,231	(1,689)	(1,657)
Amortization of deferred acquisition costs, deferred sales inducements and value of business acquired	138		98	206	318	444
Policy and other operating expenses	435		338	695	1,083	1,495
Total benefits and expenses	2,674		1,899	6,878	10,361	13,285
Income (loss) before income taxes	1,386		(2,180)	(5,352)	(6,525)	(5,662)
Income tax expense (benefit)	163		(284)	(662)	(783)	(646)
Net income (loss)	1,223	$ (1,896)	(1,896)	(4,690)	(5,742)	(5,016)
Less: Net income (loss) attributable to noncontrolling interests	455		(881)	(1,970)	(2,435)	(2,106)
Net income (loss) attributable to Athene Holding Ltd. shareholders	768		(1,015)	(2,720)	(3,307)	(2,910)
Less: Preferred stock dividends	47		35	70	105	141
Net income (loss) available to Athene Holding Ltd. common shareholder	$ 721		(1,050)	(2,790)	(3,412)	(3,051)
Reported
Revenues
Investment related gains (losses)			(4,200)		(12,812)
Total revenues			(269)	1,526	3,835	7,623
Benefits and expenses
Interest sensitive contract benefits			(41)	(662)	(573)	541
Future policy and other policy benefits			2,085	7,694	10,988	12,310
Market risk benefits remeasurement (gains) losses			0	0	0	0
Amortization of deferred acquisition costs, deferred sales inducements and value of business acquired			125	250	375	509
Policy and other operating expenses			335	693	1,081	1,493
Total benefits and expenses			2,504	7,975	11,871	14,853
Income (loss) before income taxes			(2,773)	(6,449)	(8,036)	(7,230)
Income tax expense (benefit)			(407)	(891)	(1,101)	(976)
Net income (loss)			(2,366)	(5,558)	(6,935)	(6,254)
Less: Net income (loss) attributable to noncontrolling interests			(883)	(1,955)	(2,431)	(2,092)
Net income (loss) attributable to Athene Holding Ltd. shareholders			(1,483)	(3,603)	(4,504)	(4,162)
Less: Preferred stock dividends			35	70	105	141
Net income (loss) available to Athene Holding Ltd. common shareholder			(1,518)	(3,673)	(4,609)	(4,303)
Adoption
Revenues
Investment related gains (losses)			(12)		1
Total revenues			(12)	0	1	0
Benefits and expenses
Interest sensitive contract benefits			(58)	(90)	(8)	(3)
Future policy and other policy benefits			99	266	242	155
Market risk benefits remeasurement (gains) losses			(622)	1,231	(1,689)	(1,657)
Amortization of deferred acquisition costs, deferred sales inducements and value of business acquired			(27)	(44)	(57)	(65)
Policy and other operating expenses			3	2	2	2
Total benefits and expenses			(605)	(1,097)	(1,510)	(1,568)
Income (loss) before income taxes			593	1,097	1,511	1,568
Income tax expense (benefit)			123	229	318	330
Net income (loss)			470	868	1,193	1,238
Less: Net income (loss) attributable to noncontrolling interests			2	(15)	(4)	(14)
Net income (loss) attributable to Athene Holding Ltd. shareholders			468	883	1,197	1,252
Less: Preferred stock dividends			0	0	0	0
Net income (loss) available to Athene Holding Ltd. common shareholder			$ 468	$ 883	$ 1,197	$ 1,252

Adoption of Accounting Pronou_9

Adoption of Accounting Pronouncement - Other Comprehensive Income (Details) - USD ($) $ in Millions	3 Months Ended			6 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2022	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Net income (loss)	$ 1,223	$ (1,896)	$ (1,896)	$ (4,690)	$ (5,742)	$ (5,016)
Other comprehensive income (loss), before tax
Unrealized investment gains (losses) on available-for-sale securities	2,099		(6,697)	(14,250)	(20,178)	(18,156)
Remeasurement gains (losses) on future policy benefits related to discount rate	(802)		3,562	6,459	8,833	8,425
Remeasurement gains (losses) on market risk benefits related to credit risk	89		397	576	524	366
Foreign currency translation and other adjustments	16		(2)	(81)	(72)	(27)
Other comprehensive income (loss), before tax	1,506		(2,869)	(7,344)	(11,021)	(9,390)
Income tax expense (benefit) related to other comprehensive income (loss)	290	(615)	(615)	(1,493)	(2,220)	(1,933)
Other comprehensive income (loss)	1,216	$ (2,254)	(2,254)	(5,851)	(8,801)	(7,457)
Comprehensive income (loss)	2,439		(4,150)	(10,541)	(14,543)	(12,473)
Less: Comprehensive income (loss) attributable to noncontrolling interests	498		(817)	(2,123)	(2,763)	(2,242)
Comprehensive income (loss) attributable to Athene Holding Ltd. shareholders	$ 1,941		(3,333)	(8,418)	(11,780)	(10,231)
Adoption
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Net income (loss)			470	868	1,193	1,238
Other comprehensive income (loss), before tax
Unrealized investment gains (losses) on available-for-sale securities			(267)	(547)	(764)	(699)
Remeasurement gains (losses) on future policy benefits related to discount rate			3,562	6,459	8,833	8,425
Remeasurement gains (losses) on market risk benefits related to credit risk			397	576	524	366
Foreign currency translation and other adjustments			(6)	(27)	(59)	(11)
Other comprehensive income (loss), before tax			3,686	6,461	8,534	8,081
Income tax expense (benefit) related to other comprehensive income (loss)			555	960	1,224	1,150
Other comprehensive income (loss)			3,131	5,501	7,310	6,931
Comprehensive income (loss)			3,601	6,369	8,503	8,169
Less: Comprehensive income (loss) attributable to noncontrolling interests			777	1,397	2,024	1,927
Comprehensive income (loss) attributable to Athene Holding Ltd. shareholders			2,824	4,972	6,479	6,242
Reported
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Net income (loss)			(2,366)	(5,558)	(6,935)	(6,254)
Other comprehensive income (loss), before tax
Unrealized investment gains (losses) on available-for-sale securities			(6,430)	(13,703)	(19,414)	(17,457)
Remeasurement gains (losses) on future policy benefits related to discount rate			0	0	0	0
Remeasurement gains (losses) on market risk benefits related to credit risk			0	0	0	0
Foreign currency translation and other adjustments			4	(54)	(13)	(16)
Other comprehensive income (loss), before tax			(6,555)	(13,805)	(19,555)	(17,471)
Income tax expense (benefit) related to other comprehensive income (loss)			(1,170)	(2,453)	(3,444)	(3,083)
Other comprehensive income (loss)			(5,385)	(11,352)	(16,111)	(14,388)
Comprehensive income (loss)			(7,751)	(16,910)	(23,046)	(20,642)
Less: Comprehensive income (loss) attributable to noncontrolling interests			(1,594)	(3,520)	(4,787)	(4,169)
Comprehensive income (loss) attributable to Athene Holding Ltd. shareholders			$ (6,157)	$ (13,390)	$ (18,259)	$ (16,473)

Adoption of Accounting Prono_10

Adoption of Accounting Pronouncement - Statement of Cash Flows (Details) - USD ($) $ in Millions		3 Months Ended						6 Months Ended	9 Months Ended	12 Months Ended
		Mar. 31, 2023		Mar. 31, 2022		Mar. 31, 2022		Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Net income (loss)		$ 1,223		$ (1,896)		$ (1,896)		$ (4,690)	$ (5,742)	$ (5,016)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Amortization of deferred acquisition costs, deferred sales inducements and value of business acquired		138				98		206	318	444
Net recognized (gains) losses on investments and derivatives		(2,031)				1,825			5,957
Changes in operating assets and liabilities:
Interest sensitive contract liabilities		2,229				(548)		(1,724)	(2,052)	(1,337)
Future policy benefits, market risk benefits and reinsurance recoverable		64				(776)		3,000	3,837	3,901
Other assets and liabilities		(66)				(611)		(910)	(1,268)	(1,194)
Net cash provided by operating activities		75				155		4,726	6,077	6,258
Net cash used in investing activities		(5,919)				(6,165)		(11,719)	(22,338)	(34,375)
Net cash provided by financing activities		12,718				5,463		8,707	17,115	26,472
Effect of exchange rate changes on cash and cash equivalents		3				(4)		(20)	(18)	(15)
Net increase (decrease) in cash and cash equivalents		6,877				(551)		1,694	836	(1,660)
Cash and cash equivalents at beginning of year	[1]	8,769				10,429		10,429	10,429	10,429
Cash and cash equivalents at end of period		15,646	[1]	9,878	[1]	9,878	[1]	12,123	11,265	8,769	[1]
Reported
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Net income (loss)						(2,366)		(5,558)	(6,935)	(6,254)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Amortization of deferred acquisition costs, deferred sales inducements and value of business acquired						125		250	375	509
Net recognized (gains) losses on investments and derivatives						1,813			5,958
Changes in operating assets and liabilities:
Interest sensitive contract liabilities						(480)		(1,604)	(2,002)	(1,269)
Future policy benefits, market risk benefits and reinsurance recoverable						(266)		3,933	5,240	5,339
Other assets and liabilities						(734)		(1,139)	(1,586)	(1,527)
Net cash provided by operating activities						155		4,726	6,077	6,258
Net cash used in investing activities						(6,165)		(11,719)	(22,338)	(34,375)
Net cash provided by financing activities						5,463		8,707	17,115	26,472
Effect of exchange rate changes on cash and cash equivalents						(4)		(20)	(18)	(15)
Net increase (decrease) in cash and cash equivalents						(551)		1,694	836	(1,660)
Cash and cash equivalents at beginning of year		8,769				10,429		10,429	10,429	10,429
Cash and cash equivalents at end of period				9,878		9,878		12,123	11,265	8,769
Adoption
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Net income (loss)						470		868	1,193	1,238
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Amortization of deferred acquisition costs, deferred sales inducements and value of business acquired						(27)		(44)	(57)	(65)
Net recognized (gains) losses on investments and derivatives						12			(1)
Changes in operating assets and liabilities:
Interest sensitive contract liabilities						(68)		(120)	(50)	(68)
Future policy benefits, market risk benefits and reinsurance recoverable						(510)		(933)	(1,403)	(1,438)
Other assets and liabilities						123		229	318	333
Net cash provided by operating activities						0		0	0	0
Net cash used in investing activities						0		0	0	0
Net cash provided by financing activities						0		0	0	0
Effect of exchange rate changes on cash and cash equivalents						0		0	0	0
Net increase (decrease) in cash and cash equivalents						0		0	0	0
Cash and cash equivalents at beginning of year		$ 0				0		0	0	0
Cash and cash equivalents at end of period				$ 0		$ 0		$ 0	$ 0	$ 0
[1] 1 Includes cash and cash equivalents, restricted cash and cash and cash equivalents of consolidated variable interest entities.

Business Combination - Addition

Business Combination - Additional Information (Details) - Apollo Global Management , Inc.	Jan. 01, 2022 shares
Business Acquisition [Line Items]
Business Acquisition, Share Conversion Rate	1.149
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	158,200,000
Apollo
Business Acquisition [Line Items]
Common Stock, Shares, Outstanding and Previously Held	54,600,000
Common Class A
Business Acquisition [Line Items]
Common stock outstanding (in shares)	137,600,000

Business Combination - Consider

Business Combination - Consideration Calculation (Details) $ / shares in Units, shares in Millions, $ in Millions	Jan. 01, 2022 USD ($) $ / shares shares	Mar. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Mar. 31, 2022 USD ($)
Business Acquisition [Line Items]
Total equity	$ 22,546	$ 13,050	$ 10,549	$ 17,293
Apollo Global Management , Inc.
Business Acquisition [Line Items]
Business Combination, Share Exchange Ratio	1.149
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares | shares	158.2
Share Price | $ / shares	$ 72.43
Business Combination, Consideration Transferred prior to Adjustments	$ 11,455
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable	699
Business Combination, Consideration Transferred, Other	896
Business Combination, Consideration Transferred	13,050
Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value	4,554
Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination	17,604
Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value	$ 2,276
Apollo Global Management , Inc. | Common Class A
Business Acquisition [Line Items]
Common stock outstanding (in shares) | shares	137.6
Apollo Global Management , Inc. | Preferred stock
Business Acquisition [Line Items]
Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value	$ 2,666

Business Combination - Fair Val

Business Combination - Fair Value and Goodwill Calculation (Details) - USD ($) $ in Millions	Jan. 01, 2022	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
Business Acquisition [Line Items]
Cash and cash equivalents		$ 13,844	$ 7,779
Restricted cash		1,148	628
Reinsurance recoverable		4,229	4,358
Business Combination, Consideration Transferred, Liabilities Incurred	$ 3,372	2,895	2,988	$ 3,276
Interest sensitive contract liabilities		181,100	173,616	164,303
Payout annuities with life contingencies		42,490	42,110	39,240
Liability		3,203	2,970	3,857
Payables for collateral on derivatives and securities to repurchase		10,196	6,707
Goodwill		4,061	4,058
Related Party
Business Acquisition [Line Items]
Interest sensitive contract liabilities		11,347	11,889
Payout annuities with life contingencies		1,359	1,353
Liability		210		$ 195
Variable Interest Entities
Business Acquisition [Line Items]
Cash and cash equivalents		$ 654	$ 362
Apollo Global Management , Inc.
Business Acquisition [Line Items]
Business Combination, Consideration Transferred	13,050
Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value	4,554
Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination	17,604
Investments	176,015
Cash and cash equivalents	9,479
Restricted cash	796
Reinsurance recoverable	4,977
Business Combination, Consideration Transferred, Liabilities Incurred	3,372
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets	6,115
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets	238,252
Interest sensitive contract liabilities	160,241
Payout annuities with life contingencies	41,482
Liability	4,813
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt	3,295
Payables for collateral on derivatives and securities to repurchase	7,044
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other	2,443
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Liabilities	219,779
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net	18,473
Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value	2,276
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest	13,531
Goodwill	4,073
Apollo Global Management , Inc. | Preferred stock
Business Acquisition [Line Items]
Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value	2,666
Apollo Global Management , Inc. | Related Party
Business Acquisition [Line Items]
Investments	33,863
Apollo Global Management , Inc. | Variable Interest Entities
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets	3,635
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other	$ 461

Business Combination - Fair V_2

Business Combination - Fair Value of Intangible Assets (Details) - Apollo Global Management , Inc. $ in Millions	Jan. 01, 2022 USD ($)
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets	$ 5,428
Licensing Agreements
Business Acquisition [Line Items]
Indefinite-lived Intangible Assets Acquired	26
Insurance Contracts Acquired in Business Combination
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	$ 3,372
Finite-Lived Intangible Asset, Useful Life	7 years
Distribution Rights
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	$ 1,870
Finite-Lived Intangible Asset, Useful Life	18 years
Trade Names
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	$ 160
Finite-Lived Intangible Asset, Useful Life	20 years

Investments - Schedule of AFS S

Investments - Schedule of AFS Securities (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022	Jan. 01, 2022
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities	$ 135,597	$ 131,422
AFS securities allowance for credit losses	(503)	(459)	$ (488)	$ (311)
Gross Unrealized Gains	569	309
Gross Unrealized Losses	(17,084)	(19,047)
Available-for-sale securities	118,579	112,225
Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities	123,201	120,982
AFS securities allowance for credit losses	(502)	(458)	(468)	(311)
Gross Unrealized Gains	542	295
Gross Unrealized Losses	(16,528)	(18,415)
Available-for-sale securities	$ 106,713	$ 102,404
Carrying Amount, Assets, Percent of Total	100%	100%
Related Party
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities	$ 12,396	$ 10,440
AFS securities allowance for credit losses	(1)	(1)	(20)	0
Gross Unrealized Gains	27	14
Gross Unrealized Losses	(556)	(632)
Available-for-sale securities	$ 11,866	$ 9,821
Carrying Amount, Assets, Percent of Total	100%	100%
U.S. government and agencies | Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities	$ 3,327	$ 3,333
AFS securities allowance for credit losses	0	0
Gross Unrealized Gains	6	0
Gross Unrealized Losses	(630)	(756)
Available-for-sale securities	2,703	2,577
US state, municipal and political subdivisions | Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities	1,215	1,218
AFS securities allowance for credit losses	0	0
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(249)	(291)
Available-for-sale securities	966	927
Foreign governments | Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities	1,205	1,207
AFS securities allowance for credit losses	(27)	(27)	(66)	0
Gross Unrealized Gains	5	3
Gross Unrealized Losses	(261)	(276)
Available-for-sale securities	922	907
Corporate | Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities	75,348	74,644
AFS securities allowance for credit losses	(79)	(61)	(55)	0
Gross Unrealized Gains	167	92
Gross Unrealized Losses	(12,295)	(13,774)
Available-for-sale securities	63,141	60,901
Corporate | Related Party
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities	1,180	1,028
AFS securities allowance for credit losses	0	0
Gross Unrealized Gains	1	1
Gross Unrealized Losses	(54)	(47)
Available-for-sale securities	1,127	982
CLO | Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities	18,643	17,722
AFS securities allowance for credit losses	(4)	(7)	(18)	0
Gross Unrealized Gains	134	115
Gross Unrealized Losses	(1,207)	(1,337)
Available-for-sale securities	17,566	16,493
CLO | Related Party
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities	3,736	3,346
AFS securities allowance for credit losses	(1)	(1)	(3)	0
Gross Unrealized Gains	14	10
Gross Unrealized Losses	(236)	(276)
Available-for-sale securities	3,513	3,079
ABS | Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities	11,696	11,447
AFS securities allowance for credit losses	(31)	(29)	(11)	(5)
Gross Unrealized Gains	31	15
Gross Unrealized Losses	(823)	(906)
Available-for-sale securities	10,873	10,527
ABS | Related Party
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities	7,480	6,066
AFS securities allowance for credit losses	0	0	(17)	0
Gross Unrealized Gains	12	3
Gross Unrealized Losses	(266)	(309)
Available-for-sale securities	7,226	5,760
CMBS | Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities	4,717	4,636
AFS securities allowance for credit losses	(5)	(5)	(6)	0
Gross Unrealized Gains	2	6
Gross Unrealized Losses	(524)	(479)
Available-for-sale securities	4,190	4,158
RMBS | Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities	7,050	6,775
AFS securities allowance for credit losses	(356)	(329)	$ (312)	$ (306)
Gross Unrealized Gains	197	64
Gross Unrealized Losses	(539)	(596)
Available-for-sale securities	$ 6,352	$ 5,914

Investments - Maturities of AFS

Investments - Maturities of AFS Securities (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Amortized Cost
Amortized Cost	$ 135,597	$ 131,422
Fair Value
Total AFS fixed maturity securities	118,579	112,225
Consolidated Entity, excluding Affiliated Entity
Amortized Cost
Due in one year or less	1,410
Due after one year through five years	13,421
Due after five years through ten years	20,917
Due after ten years	45,347
CLO, ABS, CMBS and RMBS	42,106
Amortized Cost	123,201	120,982
Fair Value
Due in one year or less	1,377
Due after one year through five years	12,501
Due after five years through ten years	18,072
Due after ten years	35,782
CLO, ABS, CMBS and RMBS	38,981
Total AFS fixed maturity securities	106,713	102,404
Related Party
Amortized Cost
Due after one year through five years	735
Due after five years through ten years	286
Due after ten years	159
CLO, ABS, CMBS and RMBS	11,216
Amortized Cost	12,396	10,440
Fair Value
Due after one year through five years	731
Due after five years through ten years	258
Due after ten years	138
CLO, ABS, CMBS and RMBS	10,739
Total AFS fixed maturity securities	$ 11,866	$ 9,821

Investments - Unrealized Losses

Investments - Unrealized Losses on AFS Securities (Details) $ in Millions	Mar. 31, 2023 USD ($) security	Dec. 31, 2022 USD ($)
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 months	$ 23,935	$ 98,331
Fair Value, 12 months or greater	75,867	0
Total	99,802	98,331
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(1,335)	(18,593)
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(15,178)	0
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	(16,513)	(18,593)
Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 months	19,426	89,473
Fair Value, 12 months or greater	70,866	0
Total	90,292	89,473
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(1,194)	(17,965)
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(14,764)	0
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	$ (15,958)	(17,965)
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions | security	7,387
Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | security	8,873
Related Party
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 months	$ 4,509	8,858
Fair Value, 12 months or greater	5,001	0
Total	9,510	8,858
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(141)	(628)
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(414)	0
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	$ (555)	(628)
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions | security	103
Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | security	194
U.S. government and agencies | Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 months	$ 68	2,539
Fair Value, 12 months or greater	2,431	0
Total	2,499	2,539
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(4)	(756)
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(626)	0
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	(630)	(756)
US state, municipal and political subdivisions | Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 months	22	911
Fair Value, 12 months or greater	936	0
Total	958	911
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(2)	(291)
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(247)	0
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	(249)	(291)
Foreign governments | Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 months	98	891
Fair Value, 12 months or greater	795	0
Total	893	891
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(8)	(275)
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(252)	0
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	(260)	(275)
Corporate | Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 months	10,062	58,256
Fair Value, 12 months or greater	47,858	0
Total	57,920	58,256
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(812)	(13,773)
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(11,472)	0
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	(12,284)	(13,773)
Corporate | Related Party
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 months	875	619
Fair Value, 12 months or greater	141	0
Total	1,016	619
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(24)	(47)
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(30)	0
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	(54)	(47)
CLO | Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 months	3,038	13,486
Fair Value, 12 months or greater	11,579	0
Total	14,617	13,486
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(92)	(1,277)
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(1,063)	0
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	(1,155)	(1,277)
CLO | Related Party
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 months	1,009	2,752
Fair Value, 12 months or greater	2,124	0
Total	3,133	2,752
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(35)	(273)
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(200)	0
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	(235)	(273)
ABS | Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 months	3,623	8,119
Fair Value, 12 months or greater	3,938	0
Total	7,561	8,119
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(197)	(801)
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(492)	0
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	(689)	(801)
ABS | Related Party
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 months	2,625	5,487
Fair Value, 12 months or greater	2,736	0
Total	5,361	5,487
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(82)	(308)
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(184)	0
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	(266)	(308)
CMBS | Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 months	1,776	2,650
Fair Value, 12 months or greater	1,483	0
Total	3,259	2,650
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(35)	(427)
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(354)	0
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	(389)	(427)
RMBS | Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale [Line Items]
Fair Value, Less than 12 months	739	2,621
Fair Value, 12 months or greater	1,846	0
Total	2,585	2,621
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(44)	(365)
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(258)	0
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss	$ (302)	$ (365)

Investments - Allowance for Cre

Investments - Allowance for Credit Losses Rollforward (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance	$ 459
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded	26	$ 179
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase	28	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold	(10)	(8)
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)	0	6
Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance	458
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded	26	159
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase	28	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold	(10)	(8)
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)	0	6
Related Party
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance	1
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded		20
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase		0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold		0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)		0
Foreign governments | Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance	27
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded	0	66
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase	0	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold	0	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)	0	0
Corporate | Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance	61
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded	21	55
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase	0	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold	(6)	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)	3	0
Corporate | Related Party
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance	0
CLO | Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance	7
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded	1	18
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase	0	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold	0	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)	(4)	0
CLO | Related Party
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance	1
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded	0	3
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase	0	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold	0	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)	0	0
ABS | Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance	29
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded	0	5
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase	0	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold	0	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)	2	1
ABS | Related Party
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded		17
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase		0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold		0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)		0
CMBS | Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance	5
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded	1	6
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase	0	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold	0	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)	(1)	0
RMBS | Consolidated Entity, excluding Affiliated Entity
Debt Securities, Available-for-sale, Allowance for Credit Loss [Roll Forward]
Debt Securities, Available-for-sale, Allowance for Credit Loss, Beginning Balance	329
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded	3	9
Debt Securities, Available-for-sale, Allowance for Credit Loss, Purchased with Credit Deterioration, Increase	28	0
Debt Securities, Available-for-sale, Allowance for Credit Loss, Securities Sold	(4)	(8)
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not to Sell before Recovery, Credit Loss, Previously Recorded, Expense (Reversal)	$ 0	$ 5

Investments - Net Investment In

Investments - Net Investment Income (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Net Investment Income [Line Items]
Investment revenue	$ 2,635	$ 1,874
Investment funds	14,552		$ 14,128
Investment expenses	(228)	(191)
Net investment income	2,407	1,683
Trading securities
Net Investment Income [Line Items]
Investment revenue	42	63
Equity securities
Net Investment Income [Line Items]
Investment revenue	15	15
Mortgage loans
Net Investment Income [Line Items]
Investment revenue	447	237
Investment funds
Net Investment Income [Line Items]
Investment expenses	43	304
Funds withheld at interest
Net Investment Income [Line Items]
Investment revenue	429	337
Other
Net Investment Income [Line Items]
Investment revenue	190	42
Available-for-sale Securities
Net Investment Income [Line Items]
Investment revenue	$ 1,469	$ 876

Investments - Investment Relate

Investments - Investment Related Gains (Losses) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Sep. 30, 2022
Gain (Loss) on Securities [Line Items]
Gross realized gains on investment activity	$ 183	$ 103
Gross realized losses on investment activity	(104)	(410)
Net realized investment gains (losses) on AFS securities	79	(307)
Net recognized investment gains (losses) on trading securities	64	(207)
Net recognized investment gains (losses) on equity securities	(18)	23
Investment related gains (losses)	1,065	(4,212)	$ (12,811)
Derivative gains (losses)	993	(3,041)
Provision for Loan, Lease, and Other Losses	(66)	(192)
Other gains (losses)	(264)	308
Mortgage loans
Gain (Loss) on Securities [Line Items]
Investment related gains (losses)	$ 277	$ (796)

Investments - Unrealized gains

Investments - Unrealized gains (losses) recognized in income (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Gain (Loss) on Securities [Line Items]
Proceeds from Sale of Debt Securities, Available-for-sale	$ 1,140	$ 298
Consolidated Entity, excluding Affiliated Entity
Gain (Loss) on Securities [Line Items]
Debt Securities, Trading, Unrealized Gain (Loss)	66	(189)
Equity Securities, FV-NI, Unrealized Gain (Loss)	(23)	17
Related Party
Gain (Loss) on Securities [Line Items]
Debt Securities, Trading, Unrealized Gain (Loss)	6	(4)
Equity Securities, FV-NI, Unrealized Gain (Loss)	$ 3	$ (5)

Investments - Mortgage Loans, N

Investments - Mortgage Loans, Net (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Loans and Leases Receivable Disclosure [Line Items]
Mortgage Loans	$ 33,392	$ 30,811
Mortgage loans
Loans and Leases Receivable Disclosure [Line Items]
Mark to fair value	(2,582)	(2,842)
Commercial mortgage loans
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	21,023	20,108
Mark to fair value	(1,740)	(1,743)
Investment Owned, Balance, Principal Amount	22,763	21,851
Commercial mortgage loans | Commercial mortgage loans
Loans and Leases Receivable Disclosure [Line Items]
Investment Owned, Balance, Principal Amount	21,743	21,061
Commercial mortgage loans | Commercial mortgage loans under development
Loans and Leases Receivable Disclosure [Line Items]
Investment Owned, Balance, Principal Amount	1,020	790
Residential mortgage loans
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, before allowance for credit losses	13,211	11,802
Mortgage loans, net of allowances	12,369	10,703
Mark to fair value	$ (842)	$ (1,099)

Investments - Mortgage Loans,_2

Investments - Mortgage Loans, Net by Property Type and Geographic Region (Details) - Commercial mortgage loans - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 21,023	$ 20,108
Property Type Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	100%	100%
Geographic Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	100%	100%
Total U.S. Region
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 17,615	$ 16,860
Total U.S. Region | Geographic Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	83.80%	83.90%
East North Central
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 1,438	$ 1,437
East North Central | Geographic Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	6.80%	7.10%
East South Central
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 422	$ 413
East South Central | Geographic Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	2%	2.10%
Middle Atlantic
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 5,561	$ 5,183
Middle Atlantic | Geographic Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	26.50%	25.80%
Mountain
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 923	$ 898
Mountain | Geographic Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	4.40%	4.50%
New England
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 1,071	$ 1,076
New England | Geographic Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	5.10%	5.40%
Pacific
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 4,033	$ 3,781
Pacific | Geographic Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	19.20%	18.80%
South Atlantic
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 2,876	$ 2,756
South Atlantic | Geographic Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	13.60%	13.70%
West North Central
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 225	$ 231
West North Central | Geographic Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	1.10%	1.10%
West South Central
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 1,066	$ 1,085
West South Central | Geographic Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	5.10%	5.40%
UNITED KINGDOM
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 1,970	$ 1,898
UNITED KINGDOM | Geographic Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	9.40%	9.40%
Other
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 1,438	$ 1,350
Other | Geographic Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	6.80%	6.70%
International
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 3,408	$ 3,248
International | Geographic Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	16.20%	16.10%
Hotels
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 1,873	$ 1,855
Hotels | Property Type Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	8.90%	9.20%
Retail
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 1,450	$ 1,454
Retail | Property Type Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	6.90%	7.20%
Office building
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 4,535	$ 4,651
Office building | Property Type Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	21.60%	23.10%
Industrial
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 2,242	$ 2,047
Industrial | Property Type Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	10.70%	10.20%
Apartment
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 7,506	$ 6,692
Apartment | Property Type Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	35.70%	33.30%
Other commercial
Loans and Leases Receivable Disclosure [Line Items]
Mortgage loans, net of allowances	$ 3,417	$ 3,409
Other commercial | Property Type Concentration Risk | Mortgage Loans, Net
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	16.20%	17%

Investments - Mortgage Loans, R

Investments - Mortgage Loans, Residential by State (Details) - Geographic Concentration Risk - Residential mortgage loans - Mortgage Loans, Net	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	100%	100%
California
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	28.50%	28.90%
Florida
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	10.10%	9.70%
NEW YORK
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	5.80%	5.60%
Other U.S. States
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	32.80%	31.70%
Total U.S. Region
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	87.60%	86.30%
IRELAND
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	5%
UNITED KINGDOM
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk		5.40%
Other
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	7.40%	8.30%
International
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	12.40%	13.70%
NEW JERSEY
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	5.40%	5.30%
ARIZONA
Loans and Leases Receivable Disclosure [Line Items]
Percentage concentration risk	5%	5.10%

Investments - Investment Funds

Investments - Investment Funds (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 14,552	$ 14,128
Consolidated Entity, excluding Affiliated Entity
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 77	$ 79
Carrying Amount, Assets, Percent of Total	100%	100%
Variable Interest Entities
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 12,880	$ 12,480
Carrying Amount, Assets, Percent of Total	100%	100%
Related Party
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 1,595	$ 1,569
Carrying Amount, Assets, Percent of Total	100%	100%
Other fund | Consolidated Entity, excluding Affiliated Entity
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 6	$ 1
Carrying Amount, Assets, Percent of Total	7.80%	1.30%
Other fund | Variable Interest Entities
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 288	$ 326
Carrying Amount, Assets, Percent of Total	2.20%	2.60%
Other fund | Related Party
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 22	$ 25
Carrying Amount, Assets, Percent of Total	1.40%	1.60%
Hybrid Funds | Consolidated Entity, excluding Affiliated Entity
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 28	$ 32
Carrying Amount, Assets, Percent of Total	36.40%	40.50%
Hybrid Funds | Variable Interest Entities
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 3,180	$ 3,112
Carrying Amount, Assets, Percent of Total	24.60%	24.90%
Yield Fund | Variable Interest Entities
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 1,091	$ 1,044
Carrying Amount, Assets, Percent of Total	8.50%	8.40%
Yield Fund | Related Party
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 5	$ 5
Carrying Amount, Assets, Percent of Total	0.30%	0.30%
Strategic Origination Platforms | Variable Interest Entities
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 4,991	$ 4,829
Carrying Amount, Assets, Percent of Total	38.80%	38.70%
Strategic Origination Platforms | Related Party
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 35	$ 34
Carrying Amount, Assets, Percent of Total	2.20%	2.20%
Strategic Insurance Platforms | Variable Interest Entities
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 515	$ 529
Carrying Amount, Assets, Percent of Total	4%	4.20%
Strategic Insurance Platforms | Related Party
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 1,305	$ 1,259
Carrying Amount, Assets, Percent of Total	81.80%	80.20%
Equity Funds | Consolidated Entity, excluding Affiliated Entity
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 43	$ 46
Carrying Amount, Assets, Percent of Total	55.80%	58.20%
Equity Funds | Variable Interest Entities
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 2,815	$ 2,640
Carrying Amount, Assets, Percent of Total	21.90%	21.20%
Equity Funds | Related Party
Schedule of Equity Method Investments [Line Items]
Investment funds	$ 228	$ 246
Carrying Amount, Assets, Percent of Total	14.30%	15.70%

Investments - Summary of Maximu

Investments - Summary of Maximum Loss Exposure (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Variable Interest Entity [Line Items]
Assets	$ 257,654	$ 243,931
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	78,048	74,432
Variable Interest Entity, Not Primary Beneficiary [Member]
Variable Interest Entity [Line Items]
Assets	65,800	61,578
Variable Interest Entity, Not Primary Beneficiary [Member] | Investment funds
Variable Interest Entity [Line Items]
Assets	12,880	12,480
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	20,372	20,278
Variable Interest Entity, Not Primary Beneficiary, Consolidated Entity Exclude Affiliated | Investment funds
Variable Interest Entity [Line Items]
Assets	77	79
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	518	340
Variable Interest Entity, Not Primary Beneficiary, Consolidated Entity Exclude Affiliated | AFS securities
Variable Interest Entity [Line Items]
Assets	39,373	37,454
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	42,555	40,992
Variable Interest Entity, Not Primary Beneficiary, Affiliated Entity | Investment funds
Variable Interest Entity [Line Items]
Assets	1,595	1,569
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	2,251	2,253
Variable Interest Entity, Not Primary Beneficiary, Affiliated Entity | AFS securities
Variable Interest Entity [Line Items]
Assets	11,624	9,717
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	12,101	10,290
Variable Interest Entity, Not Primary Beneficiary, Affiliated Entity | Equity securities
Variable Interest Entity [Line Items]
Assets	251	279
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	$ 251	$ 279

Investments - Repurchase Agreem

Investments - Repurchase Agreements (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Schedule of Repurchase Agreements [Line Items]
Payables for repurchase agreements	$ 7,781	$ 4,743
Amortized Cost	9,788	6,161
Fair Value	8,152	4,996
Less than 30 days
Schedule of Repurchase Agreements [Line Items]
Payables for repurchase agreements	1,642	608
30-90 days
Schedule of Repurchase Agreements [Line Items]
Payables for repurchase agreements	2,774	1,268
91 days to 1 year
Schedule of Repurchase Agreements [Line Items]
Payables for repurchase agreements	500	0
Greater than 1 year
Schedule of Repurchase Agreements [Line Items]
Payables for repurchase agreements	2,865	2,867
Available-for-sale Securities | Corporate
Schedule of Repurchase Agreements [Line Items]
Amortized Cost	5,324	1,940
Fair Value	4,425	1,605
Available-for-sale Securities | U.S. government and agencies
Schedule of Repurchase Agreements [Line Items]
Amortized Cost	2,825	2,559
Fair Value	2,261	1,941
Available-for-sale Securities | Collateralized Loan Obligations
Schedule of Repurchase Agreements [Line Items]
Amortized Cost	275	273
Fair Value	265	261
Available-for-sale Securities | Foreign governments
Schedule of Repurchase Agreements [Line Items]
Amortized Cost	146	146
Fair Value	108	107
Available-for-sale Securities | ABS
Schedule of Repurchase Agreements [Line Items]
Amortized Cost	1,218	1,243
Fair Value	$ 1,093	$ 1,082

Investments - Narrative (Detail

Investments - Narrative (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Amounts loaned under reverse repurchase agreements	$ 1,088	$ 1,640
Fair value of collateral	$ 1,475	$ 1,753

Investments - Concentration of

Investments - Concentration of Equity (Details) - Stockholders' Equity, Total - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Wheels Donlen
Concentration Risk [Line Items]
Investments	$ 1,419	$ 1,288
PK AirFinance
Concentration Risk [Line Items]
Investments	1,334	999
Athora
Concentration Risk [Line Items]
Investments	1,279	1,232
Atlas
Concentration Risk [Line Items]
Investments	995
AP Tundra
Concentration Risk [Line Items]
Investments	873	896
MFI Investments
Concentration Risk [Line Items]
Investments	$ 869	878
SoftBank Vision Fund II
Concentration Risk [Line Items]
Investments		789
MidCap
Concentration Risk [Line Items]
Investments		788
Cayman Universe
Concentration Risk [Line Items]
Investments		$ 756

Derivative Instruments - Summar

Derivative Instruments - Summary of Notional and Fair Value of Derivative Assets and Liabilities (Details) $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($)	Mar. 31, 2022 USD ($)	Dec. 31, 2022 USD ($)
Derivative [Line Items]
Derivative assets, fair value	$ 3,956		$ 3,309
Derivative liabilities, fair value	1,518		1,646
Total derivative liabilities	8,198		7,410
Derivative Asset, Including Embedded Derivatives	(1,601)		(2,963)
Derivatives designated as hedges
Derivative [Line Items]
Derivative assets, fair value	1,115		1,164
Derivative liabilities, fair value	$ 1,016		$ 1,159
Derivatives designated as hedges | Foreign currency swaps
Derivative [Line Items]
Notional Amount	6,678		6,677
Derivative assets, fair value	$ 713		$ 747
Derivative liabilities, fair value	$ 149		$ 154
Derivatives designated as hedges | Interest rate swaps
Derivative [Line Items]
Notional Amount	10,082		9,332
Derivative assets, fair value	$ 10		$ 9
Derivative liabilities, fair value	$ 83		$ 150
Derivatives designated as hedges | Foreign currency forwards
Derivative [Line Items]
Notional Amount	6,380		6,283
Derivative assets, fair value	$ 392		$ 406
Derivative liabilities, fair value	$ 57		$ 52
Derivatives designated as hedges | Cross Currency Interest Rate Contract
Derivative [Line Items]
Notional Amount	4,468		4,468
Derivative assets, fair value	$ 0		$ 0
Derivative liabilities, fair value	725		803
Derivatives not designated as hedges
Derivative [Line Items]
Total derivative liabilities	7,182		6,251
Derivative Asset, Including Embedded Derivatives	$ (2,716)		$ (4,127)
Derivatives not designated as hedges | Foreign currency swaps
Derivative [Line Items]
Notional Amount	3,863		3,563
Derivative assets, fair value	$ 266		$ 251
Derivative liabilities, fair value	$ 118		$ 112
Derivatives not designated as hedges | Interest rate swaps
Derivative [Line Items]
Notional Amount	523		488
Derivative assets, fair value	$ 89		$ 74
Derivative liabilities, fair value	$ 1		$ 0
Derivatives not designated as hedges | Equity options
Derivative [Line Items]
Notional Amount	67,730		65,089
Derivative assets, fair value	$ 2,085		$ 1,374
Derivative liabilities, fair value	$ 106		$ 114
Derivatives not designated as hedges | Futures
Derivative [Line Items]
Notional Amount	21		18
Derivative assets, fair value	$ 56		$ 33
Derivative liabilities, fair value	$ 4		$ 0
Derivatives not designated as hedges | Foreign currency forwards
Derivative [Line Items]
Notional Amount	18,250		16,376
Derivative assets, fair value	$ 341		$ 413
Derivative liabilities, fair value	272		257
Derivatives not designated as hedges | Embedded derivatives | Funds withheld
Derivative [Line Items]
Embedded derivative assets, fair value	5,557		(6,272)
Embedded derivative liabilities, fair value	(67)		(77)
Derivatives not designated as hedges | Embedded derivatives | Interest sensitive contract liabilities
Derivative [Line Items]
Embedded derivative assets, fair value	0		0
Embedded derivative liabilities, fair value	$ 6,747		$ 5,841
Derivatives not designated as hedges | Other swaps
Derivative [Line Items]
Notional Amount	137		89
Derivative assets, fair value	$ 4		$ 0
Derivative liabilities, fair value	$ 1		$ 4
Net Investment Hedging [Member] | Derivatives designated as hedges | Foreign currency forwards
Derivative [Line Items]
Notional Amount	217		216
Derivative assets, fair value	$ 0		$ 2
Derivative liabilities, fair value	2		$ 0
Fair Value Hedging [Member] | Derivatives designated as hedges | Foreign currency swaps
Derivative [Line Items]
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net, Recorded in Other Comprehensive Income	114	$ (56)
Fair Value Hedging [Member] | Derivatives designated as hedges | Foreign currency swaps | Investment related gains (losses)
Derivative [Line Items]
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	0	0
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	(59)	91
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	64	(95)
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)	5	(4)
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach	0	0
Fair Value Hedging [Member] | Derivatives designated as hedges | Interest rate swaps | Investment related gains (losses)
Derivative [Line Items]
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	0	0
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	102	(72)
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	(104)	75
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)	(2)	3
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach	0	0
Fair Value Hedging [Member] | Derivatives designated as hedges | Foreign currency forwards
Derivative [Line Items]
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net, Recorded in Other Comprehensive Income	63	(73)
Fair Value Hedging [Member] | Derivatives designated as hedges | Foreign currency forwards | Investment related gains (losses)
Derivative [Line Items]
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	4	1
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	(70)	127
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	73	(126)
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)	3	1
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach	87	14
Fair Value Hedging [Member] | Derivatives designated as hedges | Cross Currency Interest Rate Contract | Investment related gains (losses)
Derivative [Line Items]
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	0	0
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	78	(159)
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	(70)	197
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)	8	38
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach	0	0
Fair Value Hedging [Member] | Derivatives designated as hedges | Cross Currency Interest Rate Contract | Interest sensitive contract benefits
Derivative [Line Items]
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	0	0
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	15	10
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	(15)	(9)
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)	0	1
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach	$ 0	$ 0

Derivative Instruments - Gains

Derivative Instruments - Gains (Losses) on Derivatives Not Designated as Hedging (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Derivative [Line Items]
Total gains (losses) for derivatives not designated as hedges	$ 378	$ (2,009)
Investment related gains (losses)
Derivative [Line Items]
Total gains (losses) for derivatives not designated as hedges	851	(3,043)
Investment related gains (losses) | Equity options
Derivative [Line Items]
Total gains (losses) for derivatives not designated as hedges	350	(708)
Investment related gains (losses) | Futures
Derivative [Line Items]
Total gains (losses) for derivatives not designated as hedges	34	(33)
Investment related gains (losses) | Swaps
Derivative [Line Items]
Total gains (losses) for derivatives not designated as hedges	33	63
Investment related gains (losses) | Foreign currency forwards
Derivative [Line Items]
Total gains (losses) for derivatives not designated as hedges	(169)	155
Investment related gains (losses) | Embedded derivatives
Derivative [Line Items]
Total gains (losses) for derivatives not designated as hedges	603	(2,520)
Interest sensitive contract benefits | Embedded derivatives
Derivative [Line Items]
Total gains (losses) for derivatives not designated as hedges	(473)	1,034
Fair Value Hedging [Member] | Derivatives designated as hedges | Investment related gains (losses) | Foreign currency swaps
Derivative [Line Items]
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	(59)	91
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	64	(95)
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)	5	(4)
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach	0	0
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	0	0
Fair Value Hedging [Member] | Derivatives designated as hedges | Investment related gains (losses) | Interest rate swaps
Derivative [Line Items]
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	102	(72)
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	(104)	75
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)	(2)	3
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach	0	0
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	0	0
Fair Value Hedging [Member] | Derivatives designated as hedges | Investment related gains (losses) | Foreign currency forwards
Derivative [Line Items]
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	(70)	127
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	73	(126)
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)	3	1
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach	87	14
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	4	1
Fair Value Hedging [Member] | Derivatives designated as hedges | Investment related gains (losses) | Cross Currency Interest Rate Contract
Derivative [Line Items]
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	78	(159)
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	(70)	197
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)	8	38
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach	0	0
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	0	0
Fair Value Hedging [Member] | Derivatives designated as hedges | Interest sensitive contract benefits | Cross Currency Interest Rate Contract
Derivative [Line Items]
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	15	10
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	(15)	(9)
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)	0	1
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach	0	0
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	$ 0	$ 0

Derivative Instruments - Offset

Derivative Instruments - Offsetting Assets and Liabilities (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Derivative assets
Gross amount recognized	$ 3,956	$ 3,309
Financial instruments	(1,456)	(1,477)
Collateral (received)/pledged	(2,411)	(1,952)
Off-balance sheet securities collateral	0	0
Derivative Liability, Collateral, Right to Reclaim Cash, Offset	0	0
Derivative liabilities
Gross amount recognized	(1,518)	(1,646)
Financial instruments	1,456	1,477
Collateral (received)/pledged	506	478
Derivative Asset, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election	89	(120)
Derivative Liability, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election	444	309
Derivative Asset, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election, Excluding Obligation to Return Securities	89	(120)
Derivative Liability, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election, Excluding Right to Reclaim Securities	444	309
Derivatives designated as hedges
Derivative assets
Gross amount recognized	1,115	1,164
Derivative liabilities
Gross amount recognized	(1,016)	(1,159)
Foreign currency forwards | Derivatives designated as hedges
Derivative assets
Gross amount recognized	392	406
Derivative liabilities
Gross amount recognized	(57)	(52)
Foreign currency swaps | Derivatives designated as hedges
Derivative assets
Gross amount recognized	713	747
Derivative liabilities
Gross amount recognized	(149)	(154)
Cross Currency Interest Rate Contract | Derivatives designated as hedges
Derivative assets
Gross amount recognized	0	0
Derivative liabilities
Gross amount recognized	(725)	(803)
Interest rate swaps | Derivatives designated as hedges
Derivative assets
Gross amount recognized	10	9
Derivative liabilities
Gross amount recognized	(83)	(150)
Interest sensitive contract liabilities | Foreign currency swaps | Fair Value Hedging [Member] | Derivatives designated as hedges
Derivative [Line Items]
Derivative, Amount of Hedged Item	1,081	1,081
Hedged Asset, Fair Value Hedge, Cumulative Increase (Decrease)	(9)	88
Interest sensitive contract liabilities | Cross Currency Interest Rate Contract | Fair Value Hedging [Member] | Derivatives designated as hedges
Derivative [Line Items]
Derivative, Amount of Hedged Item	4,348	4,348
Hedged Asset, Fair Value Hedge, Cumulative Increase (Decrease)	315	632
Interest sensitive contract liabilities | Interest rate swaps | Fair Value Hedging [Member] | Derivatives designated as hedges
Derivative [Line Items]
Derivative, Amount of Hedged Item	7,087	6,577
Hedged Asset, Fair Value Hedge, Cumulative Increase (Decrease)	203	323
AFS securities | Foreign currency forwards | Fair Value Hedging [Member] | Derivatives designated as hedges
Derivative [Line Items]
Derivative, Amount of Hedged Item	5,480	5,259
Hedged Asset, Fair Value Hedge, Cumulative Increase (Decrease)	(431)	(217)
AFS securities | Foreign currency swaps | Fair Value Hedging [Member] | Derivatives designated as hedges
Derivative [Line Items]
Derivative, Amount of Hedged Item	4,962	4,797
Hedged Asset, Fair Value Hedge, Cumulative Increase (Decrease)	$ (304)	$ (398)

Derivative Instruments - Narrat

Derivative Instruments - Narrative (Details) - USD ($)	3 Months Ended		6 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022
Derivative [Line Items]
Other Comprehensive Income (Loss), before Tax	$ 1,506,000,000	$ (2,869,000,000)	$ (7,344,000,000)	$ (11,021,000,000)	$ (9,390,000,000)
Derivatives used in Net Investment Hedge, Net of Tax	26,000,000				30,000,000
Amount of Ineffectiveness on Net Investment Hedges	0	0
Cash flow hedges | Derivatives designated as hedges | Foreign currency swaps
Derivative [Line Items]
Gain (Loss) on Foreign Currency Cash Flow Hedge Ineffectiveness	0	0
Cash flow hedges | Derivatives designated as hedges | Interest rate swaps
Derivative [Line Items]
Foreign currency swap gains (losses)	(73,000,000)	0
Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months	0
Fair Value Hedging [Member] | Derivatives designated as hedges | Foreign currency swaps
Derivative [Line Items]
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net, Recorded in Other Comprehensive Income	114,000,000	(56,000,000)
Fair Value Hedging [Member] | Derivatives designated as hedges | Foreign currency swaps | Investment related gains (losses)
Derivative [Line Items]
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	(59,000,000)	91,000,000
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	64,000,000	(95,000,000)
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)	5,000,000	(4,000,000)
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	0	0
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach	0	0
Fair Value Hedging [Member] | Derivatives designated as hedges | Foreign currency swaps | Interest sensitive contract liabilities
Derivative [Line Items]
Hedged Asset, Fair Value Hedge, Cumulative Increase (Decrease)	(9,000,000)				88,000,000
Fair Value Hedging [Member] | Derivatives designated as hedges | Interest rate swaps | Investment related gains (losses)
Derivative [Line Items]
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	102,000,000	(72,000,000)
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	(104,000,000)	75,000,000
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)	(2,000,000)	3,000,000
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	0	0
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach	0	0
Fair Value Hedging [Member] | Derivatives designated as hedges | Interest rate swaps | Interest sensitive contract liabilities
Derivative [Line Items]
Hedged Asset, Fair Value Hedge, Cumulative Increase (Decrease)	203,000,000				323,000,000
Fair Value Hedging [Member] | Derivatives designated as hedges | Foreign currency forwards
Derivative [Line Items]
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net, Recorded in Other Comprehensive Income	63,000,000	(73,000,000)
Fair Value Hedging [Member] | Derivatives designated as hedges | Foreign currency forwards | Investment related gains (losses)
Derivative [Line Items]
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	(70,000,000)	127,000,000
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	73,000,000	(126,000,000)
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)	3,000,000	1,000,000
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	4,000,000	1,000,000
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach	87,000,000	14,000,000
Fair Value Hedging [Member] | Derivatives designated as hedges | Net Investment Hedging [Member]
Derivative [Line Items]
Other Comprehensive Income (Loss), before Tax	(4,000,000)	2,000,000
Fair Value Hedging [Member] | Derivatives designated as hedges | Cross Currency Interest Rate Contract | Investment related gains (losses)
Derivative [Line Items]
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	78,000,000	(159,000,000)
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	(70,000,000)	197,000,000
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)	8,000,000	38,000,000
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	0	0
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach	0	0
Fair Value Hedging [Member] | Derivatives designated as hedges | Cross Currency Interest Rate Contract | Interest sensitive contract benefits
Derivative [Line Items]
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	15,000,000	10,000,000
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	(15,000,000)	(9,000,000)
Derivative, Fair Value Hedge, Included in Effectiveness, Gain (Loss)	0	1,000,000
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	0	0
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Amortization Approach	0	$ 0
Fair Value Hedging [Member] | Derivatives designated as hedges | Cross Currency Interest Rate Contract | Interest sensitive contract liabilities
Derivative [Line Items]
Hedged Asset, Fair Value Hedge, Cumulative Increase (Decrease)	$ 315,000,000				$ 632,000,000

Variable Interest Entities (Det

Variable Interest Entities (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Sep. 30, 2022
Variable Interest Entity [Line Items]
Investment revenue	$ (2,635)	$ (1,874)
Net Investment Income	2,407	1,683
Investment related gains (losses)	1,065	(4,212)	$ (12,811)
Other gains (losses)	(264)	308
Mortgage loans
Variable Interest Entity [Line Items]
Investment related gains (losses)	277	(796)
Mortgage loans
Variable Interest Entity [Line Items]
Investment revenue	(447)	(237)
Investment funds
Variable Interest Entity [Line Items]
Investment expenses	43	304
Other
Variable Interest Entity [Line Items]
Investment revenue	(190)	(42)
Trading securities
Variable Interest Entity [Line Items]
Investment revenue	(42)	(63)
Variable Interest Entities
Variable Interest Entity [Line Items]
Net Investment Income	80	17
Investment related gains (losses)	201	(42)
Other gains (losses)	(40)	0
Variable Interest Entities | Mortgage loans
Variable Interest Entity [Line Items]
Investment related gains (losses)	9	(112)
Variable Interest Entities | Investment funds
Variable Interest Entity [Line Items]
Investment related gains (losses)	226	70
Variable Interest Entities | Mortgage loans
Variable Interest Entity [Line Items]
Investment revenue	(24)	(20)
Variable Interest Entities | Investment funds
Variable Interest Entity [Line Items]
Investment expenses	35	(3)
Variable Interest Entities | Other
Variable Interest Entity [Line Items]
Investment expenses	(2)	0
Variable Interest Entities | Trading securities
Variable Interest Entity [Line Items]
Investment revenue	(23)	0
Investment related gains (losses)	$ 6	$ 0

Fair Value - Assets and Liabili

Fair Value - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
Assets
Available-for-sale securities	$ 118,579	$ 112,225
Investment funds	14,552	14,128
Derivative assets	3,956	3,309
Restricted cash	1,148	628
Reinsurance recoverable	4,229	4,358
Other assets (related party: 2023 – $200 and 2022 – $161)	7,916	8,693
Liabilities
Interest sensitive contract liabilities	181,100	173,616	$ 164,303
Future policy benefits	42,490	42,110	39,240
Market risk benefits	3,203	2,970	3,857
Derivative liabilities	1,518	1,646
Other liabilities	1,600	1,860
Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	106,713	102,404
Trading securities, at fair value	1,652	1,595
Mortgage loans	29,949	27,454
Investment funds	77	79
Funds withheld at interest	(31,084)	(32,880)
Derivative assets	3,956	3,309
Short-term investments	627	2,160
Other investments	701	773
Related Party
Assets
Available-for-sale securities	11,866	9,821
Trading securities, at fair value	885	878
Equity securities, at fair value	251	279
Mortgage loans	1,324	1,302
Investment funds	1,595	1,569
Funds withheld at interest	(9,462)	(9,808)
Short-term investments	1,043	0
Other investments	338	303
Other assets (related party: 2023 – $200 and 2022 – $161)	200	161
Liabilities
Interest sensitive contract liabilities	11,347	11,889
Future policy benefits	1,359	1,353
Market risk benefits	210		$ 195
Other liabilities	612	564
Variable Interest Entities
Assets
Trading securities, at fair value	1,069	1,063
Mortgage loans	2,119	2,055
Investment funds	12,880	12,480
Other investments	99	101
Other assets (related party: 2023 – $200 and 2022 – $161)	111	112
Liabilities
Other liabilities	847	815
U.S. government and agencies | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	2,703	2,577
US state, municipal and political subdivisions | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	966	927
Foreign governments | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	922	907
Corporate | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	63,141	60,901
Corporate | Related Party
Assets
Available-for-sale securities	1,127	982
CLO | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	17,566	16,493
CLO | Related Party
Assets
Available-for-sale securities	3,513	3,079
ABS | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	10,873	10,527
ABS | Related Party
Assets
Available-for-sale securities	7,226	5,760
CMBS | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	4,190	4,158
RMBS | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	6,352	5,914
Level 3
Assets
Available-for-sale securities	12,271	10,671
Mortgage loans	33,392	30,811
Recurring | Level 1
Assets
Cash and cash equivalents	13,844	7,779
Restricted cash	1,148	628
Reinsurance recoverable	0
Other assets (related party: 2023 – $200 and 2022 – $161)	0
Total assets measured at fair value	18,716	11,588
Liabilities
Market risk benefits	0	0
Derivative liabilities	24	38
Other liabilities		0
Total liabilities measured at fair value	24	38
Recurring | Level 1 | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	2,706	2,570
Trading securities, at fair value	24	23
Equity securities, at fair value	273	150
Mortgage loans	0	0
Derivative assets	66	42
Short-term investments	1	29
Other investments	0	0
Recurring | Level 1 | Related Party
Assets
Available-for-sale securities	0	0
Trading securities, at fair value	0	0
Equity securities, at fair value	0	0
Mortgage loans	0	0
Investment funds	0	0
Other investments	0	0
Reinsurance recoverable		0
Recurring | Level 1 | Variable Interest Entities
Assets
Trading securities, at fair value	0	5
Mortgage loans	0	0
Investment funds	0	0
Other investments	0	0
Cash and cash equivalents	654	362
Recurring | Level 1 | Related Party
Assets
Other assets (related party: 2023 – $200 and 2022 – $161)		0
Recurring | Level 1 | Universal life
Liabilities
Interest sensitive contract liabilities	0	0
Recurring | Level 1 | AmerUs Closed Block
Liabilities
Future policy benefits	0	0
Recurring | Level 1 | ILICO Closed Block and life benefits
Liabilities
Future policy benefits	0	0
Recurring | Level 1 | Embedded derivatives
Liabilities
Interest sensitive contract liabilities	0	0
Recurring | Level 1 | Embedded derivatives | Consolidated Entity, excluding Affiliated Entity
Assets
Funds withheld at interest		0
Recurring | Level 1 | Embedded derivatives | Related Party
Assets
Funds withheld at interest		0
Recurring | Level 1 | U.S. government and agencies | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	2,697	2,570
Recurring | Level 1 | US state, municipal and political subdivisions | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring | Level 1 | Foreign governments | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring | Level 1 | Corporate | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	9	0
Recurring | Level 1 | Corporate | Related Party
Assets
Available-for-sale securities	0	0
Recurring | Level 1 | CLO | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring | Level 1 | CLO | Related Party
Assets
Available-for-sale securities	0	0
Recurring | Level 1 | ABS | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring | Level 1 | ABS | Related Party
Assets
Available-for-sale securities	0	0
Recurring | Level 1 | CMBS | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring | Level 1 | RMBS | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring | Level 2
Assets
Cash and cash equivalents	0	0
Restricted cash	0	0
Reinsurance recoverable	0
Other assets (related party: 2023 – $200 and 2022 – $161)	0
Total assets measured at fair value	107,897	102,927
Liabilities
Market risk benefits	0	0
Derivative liabilities	1,493	1,607
Other liabilities	(67)	(77)
Total liabilities measured at fair value	1,426	1,530
Recurring | Level 2 | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	97,204	93,069
Trading securities, at fair value	1,586	1,519
Equity securities, at fair value	624	845
Mortgage loans	0	0
Derivative assets	3,890	3,267
Short-term investments	551	455
Other investments	215	170
Recurring | Level 2 | Related Party
Assets
Available-for-sale securities	3,404	3,164
Trading securities, at fair value	0	0
Equity securities, at fair value	0	0
Mortgage loans	0	0
Investment funds	0	0
Other investments	0	0
Reinsurance recoverable		0
Recurring | Level 2 | Variable Interest Entities
Assets
Trading securities, at fair value	421	436
Mortgage loans	0	0
Investment funds	0	0
Other investments	2	2
Cash and cash equivalents	0	0
Recurring | Level 2 | Related Party
Assets
Other assets (related party: 2023 – $200 and 2022 – $161)		0
Recurring | Level 2 | Universal life
Liabilities
Interest sensitive contract liabilities	0	0
Recurring | Level 2 | AmerUs Closed Block
Liabilities
Future policy benefits	0	0
Recurring | Level 2 | ILICO Closed Block and life benefits
Liabilities
Future policy benefits	0	0
Recurring | Level 2 | Embedded derivatives
Liabilities
Interest sensitive contract liabilities	0	0
Recurring | Level 2 | Embedded derivatives | Consolidated Entity, excluding Affiliated Entity
Assets
Funds withheld at interest		0
Recurring | Level 2 | Embedded derivatives | Related Party
Assets
Funds withheld at interest		0
Recurring | Level 2 | U.S. government and agencies | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	6	7
Recurring | Level 2 | US state, municipal and political subdivisions | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	966	927
Recurring | Level 2 | Foreign governments | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	921	906
Recurring | Level 2 | Corporate | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	61,510	59,236
Recurring | Level 2 | Corporate | Related Party
Assets
Available-for-sale securities	168	170
Recurring | Level 2 | CLO | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	17,566	16,493
Recurring | Level 2 | CLO | Related Party
Assets
Available-for-sale securities	3,015	2,776
Recurring | Level 2 | ABS | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	5,931	5,660
Recurring | Level 2 | ABS | Related Party
Assets
Available-for-sale securities	221	218
Recurring | Level 2 | CMBS | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	4,190	4,158
Recurring | Level 2 | RMBS | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	6,114	5,682
Recurring | Level 3
Assets
Cash and cash equivalents	0	0
Restricted cash	0	0
Reinsurance recoverable	1,470
Other assets (related party: 2023 – $200 and 2022 – $161)	440
Total assets measured at fair value	51,273	46,063
Liabilities
Market risk benefits	3,203	2,970
Derivative liabilities	1	1
Other liabilities	189	142
Total liabilities measured at fair value	12,788	11,495
Recurring | Level 3 | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	6,803	6,765
Trading securities, at fair value	42	53
Equity securities, at fair value	71	92
Mortgage loans	29,949	27,454
Derivative assets	0	0
Short-term investments	30	36
Other investments	286	441
Recurring | Level 3 | Related Party
Assets
Available-for-sale securities	8,462	6,657
Trading securities, at fair value	885	878
Equity securities, at fair value	251	279
Mortgage loans	1,324	1,302
Investment funds	1,034	959
Other investments	338	303
Reinsurance recoverable		1,388
Recurring | Level 3 | Variable Interest Entities
Assets
Trading securities, at fair value	648	622
Mortgage loans	2,119	2,055
Investment funds	2,581	2,471
Other investments	97	99
Cash and cash equivalents	0	0
Recurring | Level 3 | Related Party
Assets
Other assets (related party: 2023 – $200 and 2022 – $161)		481
Recurring | Level 3 | Universal life
Liabilities
Interest sensitive contract liabilities	879	829
Recurring | Level 3 | AmerUs Closed Block
Liabilities
Future policy benefits	1,190	1,164
Recurring | Level 3 | ILICO Closed Block and life benefits
Liabilities
Future policy benefits	579	548
Recurring | Level 3 | Embedded derivatives
Liabilities
Interest sensitive contract liabilities	6,747	5,841
Recurring | Level 3 | Embedded derivatives | Consolidated Entity, excluding Affiliated Entity
Assets
Funds withheld at interest		4,847
Recurring | Level 3 | Embedded derivatives | Related Party
Assets
Funds withheld at interest		(1,425)
Recurring | Level 3 | U.S. government and agencies | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring | Level 3 | US state, municipal and political subdivisions | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring | Level 3 | Foreign governments | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	1	1
Recurring | Level 3 | Corporate | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	1,622	1,665
Recurring | Level 3 | Corporate | Related Party
Assets
Available-for-sale securities	959	812
Recurring | Level 3 | CLO | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring | Level 3 | CLO | Related Party
Assets
Available-for-sale securities	498	303
Recurring | Level 3 | ABS | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	4,942	4,867
Recurring | Level 3 | ABS | Related Party
Assets
Available-for-sale securities	7,005	5,542
Recurring | Level 3 | CMBS | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring | Level 3 | RMBS | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	238	232
Recurring | NAV
Assets
Cash and cash equivalents	0	0
Restricted cash	0	0
Reinsurance recoverable	0
Other assets (related party: 2023 – $200 and 2022 – $161)	0
Total assets measured at fair value	10,299	10,009
Liabilities
Market risk benefits	0	0
Derivative liabilities	0	0
Other liabilities		0
Total liabilities measured at fair value	0	0
Recurring | NAV | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Trading securities, at fair value	0	0
Equity securities, at fair value	0	0
Mortgage loans	0	0
Derivative assets	0	0
Short-term investments	0	0
Other investments	0	0
Recurring | NAV | Related Party
Assets
Available-for-sale securities	0	0
Trading securities, at fair value	0	0
Equity securities, at fair value	0	0
Mortgage loans	0	0
Investment funds	0	0
Other investments	0	0
Reinsurance recoverable		0
Recurring | NAV | Variable Interest Entities
Assets
Trading securities, at fair value	0	0
Mortgage loans	0	0
Investment funds	10,299	10,009
Other investments	0	0
Cash and cash equivalents	0	0
Recurring | NAV | Related Party
Assets
Other assets (related party: 2023 – $200 and 2022 – $161)		0
Recurring | NAV | Universal life
Liabilities
Interest sensitive contract liabilities	0	0
Recurring | NAV | AmerUs Closed Block
Liabilities
Future policy benefits	0	0
Recurring | NAV | ILICO Closed Block and life benefits
Liabilities
Future policy benefits	0	0
Recurring | NAV | Embedded derivatives
Liabilities
Interest sensitive contract liabilities	0	0
Recurring | NAV | Embedded derivatives | Consolidated Entity, excluding Affiliated Entity
Assets
Funds withheld at interest		0
Recurring | NAV | Embedded derivatives | Related Party
Assets
Funds withheld at interest		0
Recurring | NAV | U.S. government and agencies | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring | NAV | US state, municipal and political subdivisions | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring | NAV | Foreign governments | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring | NAV | Corporate | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring | NAV | Corporate | Related Party
Assets
Available-for-sale securities	0	0
Recurring | NAV | CLO | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring | NAV | CLO | Related Party
Assets
Available-for-sale securities	0	0
Recurring | NAV | ABS | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring | NAV | ABS | Related Party
Assets
Available-for-sale securities	0	0
Recurring | NAV | CMBS | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Recurring | NAV | RMBS | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	0	0
Fair Value
Assets
Short-term investments		1,640
Total assets measured at fair value	48,368	51,798
Liabilities
Interest sensitive contract liabilities	120,063	111,608
Fair Value | Consolidated Entity, excluding Affiliated Entity
Assets
Investment funds	77	79
Funds withheld at interest	(35,375)	(37,727)
Short-term investments	45
Other investments	200	162
Fair Value | Related Party
Assets
Investment funds	561	610
Funds withheld at interest	(10,728)	(11,233)
Short-term investments	1,043
Fair Value | Level 1
Assets
Short-term investments		0
Total assets measured at fair value	0	0
Liabilities
Interest sensitive contract liabilities	0	0
Fair Value | Level 1 | Consolidated Entity, excluding Affiliated Entity
Assets
Investment funds	0	0
Funds withheld at interest	0	0
Short-term investments	0
Other investments	0	0
Fair Value | Level 1 | Related Party
Assets
Investment funds	0	0
Funds withheld at interest	0	0
Short-term investments	0
Fair Value | Level 2
Assets
Short-term investments		1,614
Total assets measured at fair value	1,427	1,961
Liabilities
Interest sensitive contract liabilities	0	0
Fair Value | Level 2 | Consolidated Entity, excluding Affiliated Entity
Assets
Investment funds	0	0
Funds withheld at interest	0	0
Short-term investments	45
Other investments	0	0
Fair Value | Level 2 | Related Party
Assets
Investment funds	0	0
Funds withheld at interest	0	0
Short-term investments	1,043
Fair Value | Level 3
Assets
Short-term investments		26
Total assets measured at fair value	46,303	49,148
Liabilities
Interest sensitive contract liabilities	120,063	111,608
Fair Value | Level 3 | Consolidated Entity, excluding Affiliated Entity
Assets
Investment funds	0	0
Funds withheld at interest	(35,375)	(37,727)
Short-term investments	0
Other investments	200	162
Fair Value | Level 3 | Related Party
Assets
Investment funds	0	0
Funds withheld at interest	(10,728)	(11,233)
Short-term investments	0
Fair Value | NAV
Assets
Total assets measured at fair value	638	689
Liabilities
Interest sensitive contract liabilities	0	0
Fair Value | NAV | Consolidated Entity, excluding Affiliated Entity
Assets
Investment funds	77	79
Funds withheld at interest	0	0
Short-term investments	0	0
Other investments	0	0
Fair Value | NAV | Related Party
Assets
Investment funds	561	610
Funds withheld at interest	0	0
Short-term investments	0
Fair Value | Recurring
Assets
Cash and cash equivalents	13,844	7,779
Restricted cash	1,148	628
Reinsurance recoverable	1,470	1,388
Other assets (related party: 2023 – $200 and 2022 – $161)	440
Total assets measured at fair value	188,185	170,587
Liabilities
Interest sensitive contract liabilities	7,626	6,670
Future policy benefits	1,769	1,712
Market risk benefits	3,203	2,970
Derivative liabilities	1,518	1,646
Other liabilities		65
Total liabilities measured at fair value	14,238	13,063
Fair Value | Recurring | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	106,713	102,404
Trading securities, at fair value	1,652	1,595
Equity securities, at fair value	968	1,087
Mortgage loans	29,949	27,454
Embedded derivative assets, fair value	(4,291)	(4,847)
Derivative assets	3,956	3,309
Short-term investments	582	520
Other investments	501	611
Fair Value | Recurring | Related Party
Assets
Available-for-sale securities	11,866	9,821
Trading securities, at fair value	885	878
Equity securities, at fair value	251	279
Mortgage loans	1,324	1,302
Investment funds	1,034	959
Embedded derivative assets, fair value	(1,266)	(1,425)
Other investments	338	303
Reinsurance recoverable		1,388
Fair Value | Recurring | Variable Interest Entities
Assets
Trading securities, at fair value	1,069	1,063
Mortgage loans	2,119	2,055
Investment funds	12,880	12,480
Other investments	99	101
Cash and cash equivalents	654	362
Fair Value | Recurring | Related Party
Assets
Other assets (related party: 2023 – $200 and 2022 – $161)		481
Fair Value | Recurring | Universal life
Liabilities
Interest sensitive contract liabilities	879	829
Fair Value | Recurring | AmerUs Closed Block
Liabilities
Future policy benefits	1,190	1,164
Fair Value | Recurring | ILICO Closed Block and life benefits
Liabilities
Future policy benefits	579	548
Fair Value | Recurring | Embedded derivatives
Liabilities
Interest sensitive contract liabilities	6,747	5,841
Fair Value | Recurring | Embedded derivatives | Consolidated Entity, excluding Affiliated Entity
Assets
Funds withheld at interest		4,847
Fair Value | Recurring | Embedded derivatives | Related Party
Assets
Funds withheld at interest		(1,425)
Fair Value | Recurring | U.S. government and agencies | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	2,703	2,577
Fair Value | Recurring | US state, municipal and political subdivisions | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	966	927
Fair Value | Recurring | Foreign governments | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	922	907
Fair Value | Recurring | Corporate | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	63,141	60,901
Fair Value | Recurring | Corporate | Related Party
Assets
Available-for-sale securities	1,127	982
Fair Value | Recurring | CLO | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	17,566	16,493
Fair Value | Recurring | CLO | Related Party
Assets
Available-for-sale securities	3,513	3,079
Fair Value | Recurring | ABS | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	10,873	10,527
Fair Value | Recurring | ABS | Related Party
Assets
Available-for-sale securities	7,226	5,760
Fair Value | Recurring | CMBS | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	4,190	4,158
Fair Value | Recurring | RMBS | Consolidated Entity, excluding Affiliated Entity
Assets
Available-for-sale securities	6,352	$ 5,914
Funds withheld at interest | Recurring | Level 1
Liabilities
Other liabilities	0
Funds withheld at interest | Recurring | Level 1 | Embedded derivatives | Consolidated Entity, excluding Affiliated Entity
Assets
Embedded derivative assets, fair value	0
Funds withheld at interest | Recurring | Level 1 | Embedded derivatives | Related Party
Assets
Embedded derivative assets, fair value	0
Funds withheld at interest | Recurring | Level 2 | Embedded derivatives | Consolidated Entity, excluding Affiliated Entity
Assets
Embedded derivative assets, fair value	0
Funds withheld at interest | Recurring | Level 2 | Embedded derivatives | Related Party
Assets
Embedded derivative assets, fair value	0
Funds withheld at interest | Recurring | Level 3 | Embedded derivatives | Consolidated Entity, excluding Affiliated Entity
Assets
Embedded derivative assets, fair value	(4,291)
Funds withheld at interest | Recurring | Level 3 | Embedded derivatives | Related Party
Assets
Embedded derivative assets, fair value	(1,266)
Funds withheld at interest | Recurring | NAV
Liabilities
Other liabilities	0
Funds withheld at interest | Recurring | NAV | Embedded derivatives | Consolidated Entity, excluding Affiliated Entity
Assets
Embedded derivative assets, fair value	0
Funds withheld at interest | Recurring | NAV | Embedded derivatives | Related Party
Assets
Embedded derivative assets, fair value	0
Funds withheld at interest | Fair Value | Recurring
Liabilities
Other liabilities	122
Funds withheld at interest | Fair Value | Recurring | Embedded derivatives | Consolidated Entity, excluding Affiliated Entity
Assets
Embedded derivative assets, fair value	(4,291)
Funds withheld at interest | Fair Value | Recurring | Embedded derivatives | Related Party
Assets
Embedded derivative assets, fair value	$ (1,266)

Fair Value - Fair Value Option

Fair Value - Fair Value Option (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Fair Value, Option, Quantitative Disclosures [Line Items]
Total gains (losses)	$ 351	$ (961)
Mortgage loans
Fair Value, Option, Quantitative Disclosures [Line Items]
Total gains (losses)	296	(916)
Unpaid principal balance	35,974		$ 33,653
Mark to fair value	(2,582)		(2,842)
Fair value	33,392		30,811
Fair Value, Option, Credit Risk, Gains (Losses) on Assets	(3)	(18)
Future policy benefits
Fair Value, Option, Quantitative Disclosures [Line Items]
Total gains (losses)	(47)	0
Residential mortgage loans
Fair Value, Option, Quantitative Disclosures [Line Items]
Fair value option, loans, 90 days or more past due	433		472
Fair Value, Option, Loans Held as Assets, Aggregate Amount in Nonaccrual Status	234		360
Unpaid principal balance	483		522
Fair value	433		472
Fair Value, Option, Loans Held as Assets, Aggregate Difference	(50)		(50)
Residential mortgage loans | Loans Insured or Guaranteed by US Government Authorities
Fair Value, Option, Quantitative Disclosures [Line Items]
Fair value option, loans, 90 days or more past due	199		221
Mortgage loans
Fair Value, Option, Quantitative Disclosures [Line Items]
Fair value option, loans, 90 days or more past due	11		2
Fair Value, Option, Loans Held as Assets, Aggregate Amount in Nonaccrual Status	131		19
Unpaid principal balance	198		74
Fair value	142		19
Fair Value, Option, Loans Held as Assets, Aggregate Difference	(56)		$ (55)
Investment related gains (losses) | Trading securities
Fair Value, Option, Quantitative Disclosures [Line Items]
Total gains (losses)	64	(207)
Net investment income | Investment funds
Fair Value, Option, Quantitative Disclosures [Line Items]
Total gains (losses)	64	20
Future policy and other policy benefits | Future policy benefits
Fair Value, Option, Quantitative Disclosures [Line Items]
Total gains (losses)	$ (26)	$ 142

Fair Value - Reconciliation of

Fair Value - Reconciliation of Level 3 Financial Instruments (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Assets
Beginning balance	$ 45,582
Total realized and unrealized gains (losses) included in income	1,171	$ (3,550)
Total realized and unrealized gains (losses) included in OCI	41	(74)
Purchases, issuances, sales and settlements, net	4,160	3,373
Transfers in	(121)	6,064
Transfers (out)	563	6,330
Ending balance	50,833	51,565
Total gains (losses) included in earnings1	368	(884)
Total gains (losses) included in OCI1	38	(73)
Liabilities
Beginning balance	(8,525)
Total realized and unrealized gains (losses) included in income	(627)	1,353
Total realized and unrealized gains (losses) included in OCI	0	0
Purchases, issuances, sales and settlements, net	433	111
Transfers in	0	(3,645)
Transfers (out)	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	442	12,394
Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3	0	(3,645)
Ending balance	(9,585)	(13,311)
Total gains (losses) included in earnings1	0	0
Total gains (losses) included in OCI1	0	0
Reinsurance recoverable
Assets
Beginning balance	1,388
Total realized and unrealized gains (losses) included in income	82	(177)
Total realized and unrealized gains (losses) included in OCI	0	0
Purchases, issuances, sales and settlements, net	0	0
Transfers in	0	0
Ending balance	1,470	1,814
Total gains (losses) included in earnings1	0	0
Total gains (losses) included in OCI1	0	0
Short-term investments | Consolidated Entity, excluding Affiliated Entity
Assets
Beginning balance	36
Total realized and unrealized gains (losses) included in income	0	0
Total realized and unrealized gains (losses) included in OCI	(2)	0
Purchases, issuances, sales and settlements, net	(30)	30
Transfers in	26	0
Ending balance	30	59
Total gains (losses) included in earnings1	0	9
Total gains (losses) included in OCI1	0	0
Short-term investments | Investments, excluding investments in Related Party
Assets
Purchases, issuances, sales and settlements, net	(30)	30
Transfers in	26	0
Transfers (out)	0	0
Liabilities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	26	0
Mortgage loans | Consolidated Entity, excluding Affiliated Entity
Assets
Beginning balance	27,454
Total realized and unrealized gains (losses) included in income	251	(744)
Total realized and unrealized gains (losses) included in OCI	0	0
Purchases, issuances, sales and settlements, net	2,244	3,286
Transfers in	0	0
Transfers (out)		0
Ending balance	29,949	23,696
Total gains (losses) included in earnings1	251	(741)
Total gains (losses) included in OCI1	0	0
Liabilities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3		0
Mortgage loans | Related Party
Assets
Beginning balance	1,302
Total realized and unrealized gains (losses) included in income	26	(52)
Total realized and unrealized gains (losses) included in OCI	0	0
Purchases, issuances, sales and settlements, net	(4)	139
Transfers in	0	0
Transfers (out)	0	0
Ending balance	1,324	1,456
Total gains (losses) included in earnings1	26	(52)
Total gains (losses) included in OCI1	0	0
Liabilities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0	0
Mortgage loans | Variable Interest Entities
Assets
Beginning balance	2,055
Total realized and unrealized gains (losses) included in income	19	(120)
Total realized and unrealized gains (losses) included in OCI	0	0
Purchases, issuances, sales and settlements, net	45	(152)
Transfers in	0	0
Transfers (out)	0	0
Ending balance	2,119	1,880
Total gains (losses) included in earnings1	19	(120)
Total gains (losses) included in OCI1	0	0
Liabilities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0	0
Mortgage loans | Investments, excluding investments in Related Party
Assets
Purchases, issuances, sales and settlements, net	2,244
Transfers in	0
Transfers (out)	0
Liabilities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0
Investment funds | Related Party
Assets
Purchases, issuances, sales and settlements, net	32
Transfers in	0
Transfers (out)	0
Liabilities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0
Other | Consolidated Entity, excluding Affiliated Entity
Assets
Beginning balance	441
Total realized and unrealized gains (losses) included in income	1
Total realized and unrealized gains (losses) included in OCI	0
Purchases, issuances, sales and settlements, net	(156)
Transfers in	0
Ending balance	286
Total gains (losses) included in earnings1	2
Total gains (losses) included in OCI1	0
Other | Related Party
Assets
Beginning balance	303
Total realized and unrealized gains (losses) included in income	(7)
Total realized and unrealized gains (losses) included in OCI	0
Purchases, issuances, sales and settlements, net	42
Transfers in	0
Transfers (out)	0
Ending balance	338
Total gains (losses) included in earnings1	(7)
Total gains (losses) included in OCI1	0
Liabilities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0
Other | Variable Interest Entities
Assets
Beginning balance	99
Total realized and unrealized gains (losses) included in income	0	0
Total realized and unrealized gains (losses) included in OCI	0	0
Purchases, issuances, sales and settlements, net	(2)	0
Transfers in	0	1,902
Transfers (out)	0	0
Ending balance	97	1,902
Total gains (losses) included in earnings1	0	0
Total gains (losses) included in OCI1	0	0
Liabilities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0	1,902
Other | Investments, excluding investments in Related Party
Assets
Purchases, issuances, sales and settlements, net	(156)
Transfers in	0
Transfers (out)	0
Liabilities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0
Equity securities | Consolidated Entity, excluding Affiliated Entity
Assets
Beginning balance	92
Total realized and unrealized gains (losses) included in income	(8)	9
Total realized and unrealized gains (losses) included in OCI	0	0
Purchases, issuances, sales and settlements, net	0	0
Transfers in	(13)	0
Ending balance	71	438
Total gains (losses) included in earnings1	(8)	0
Total gains (losses) included in OCI1	0	0
Equity securities | Related Party
Assets
Beginning balance	279
Total realized and unrealized gains (losses) included in income	4	(5)
Total realized and unrealized gains (losses) included in OCI	0	0
Purchases, issuances, sales and settlements, net	(32)	0
Transfers in	0	(113)
Transfers (out)	0	113
Ending balance	251	166
Total gains (losses) included in earnings1	3	0
Total gains (losses) included in OCI1	0	0
Liabilities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0	0
Equity securities | Variable Interest Entities
Assets
Transfers (out)		113
Equity securities | Investments, excluding investments in Related Party
Assets
Purchases, issuances, sales and settlements, net	0
Transfers in	(13)
Transfers (out)	13
Liabilities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0
Trading securities | Consolidated Entity, excluding Affiliated Entity
Assets
Beginning balance	53
Total realized and unrealized gains (losses) included in income	2	(5)
Total realized and unrealized gains (losses) included in OCI	0	0
Purchases, issuances, sales and settlements, net	(4)	6
Transfers in	(9)	20
Transfers (out)		10
Ending balance	42	90
Total gains (losses) included in earnings1	1	0
Total gains (losses) included in OCI1	0	0
Liabilities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3		30
Trading securities | Related Party
Assets
Beginning balance	878
Total realized and unrealized gains (losses) included in income	6	(5)
Total realized and unrealized gains (losses) included in OCI	0	0
Purchases, issuances, sales and settlements, net	1	(254)
Transfers in	0	(1,260)
Transfers (out)	0	1,260
Ending balance	885	252
Total gains (losses) included in earnings1	6	0
Total gains (losses) included in OCI1	0	0
Liabilities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0
Trading securities | Variable Interest Entities
Assets
Beginning balance	622
Total realized and unrealized gains (losses) included in income	12
Total realized and unrealized gains (losses) included in OCI	0
Purchases, issuances, sales and settlements, net	(2)
Transfers in	16
Transfers (out)	3	1,260
Ending balance	648
Total gains (losses) included in earnings1	12
Total gains (losses) included in OCI1	0
Liabilities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	19
Trading securities | Investments, excluding investments in Related Party
Assets
Purchases, issuances, sales and settlements, net	(4)
Transfers in	(9)
Transfers (out)	14
Liabilities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	5
Investment funds | Consolidated Entity, excluding Affiliated Entity
Assets
Total realized and unrealized gains (losses) included in income		1
Total realized and unrealized gains (losses) included in OCI		0
Purchases, issuances, sales and settlements, net		0
Transfers in		0
Ending balance		19
Total gains (losses) included in earnings1		1
Total gains (losses) included in OCI1		0
Investment funds | Related Party
Assets
Beginning balance	959
Total realized and unrealized gains (losses) included in income	43	24
Total realized and unrealized gains (losses) included in OCI	0	0
Purchases, issuances, sales and settlements, net	32	(34)
Transfers in	0	(2,031)
Ending balance	1,034	814
Total gains (losses) included in earnings1	43	24
Total gains (losses) included in OCI1	0	0
Investment funds | Variable Interest Entities
Assets
Beginning balance	2,471
Total realized and unrealized gains (losses) included in income	18	(5)
Total realized and unrealized gains (losses) included in OCI	0	0
Purchases, issuances, sales and settlements, net	(8)	238
Transfers in	100	9,047
Transfers (out)	48	1,034
Ending balance	2,581	10,577
Total gains (losses) included in earnings1	18	(5)
Total gains (losses) included in OCI1	0	0
Liabilities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	148	10,081
Embedded derivatives | Funds withheld at interest | Consolidated Entity, excluding Affiliated Entity
Assets
Beginning balance	(4,847)
Total realized and unrealized gains (losses) included in income	556	(1,882)
Total realized and unrealized gains (losses) included in OCI	0	0
Purchases, issuances, sales and settlements, net	0	0
Transfers in	0	0
Ending balance	(4,291)	(1,882)
Total gains (losses) included in earnings1	0	0
Total gains (losses) included in OCI1	0	0
Embedded derivatives | Funds withheld at interest | Related Party
Assets
Beginning balance	(1,425)
Total realized and unrealized gains (losses) included in income	159	(570)
Total realized and unrealized gains (losses) included in OCI	0	0
Purchases, issuances, sales and settlements, net	0	0
Transfers in	0	0
Ending balance	(1,266)	(570)
Total gains (losses) included in earnings1	0	0
Total gains (losses) included in OCI1	0	0
Related Party | Short-term investments
Assets
Total realized and unrealized gains (losses) included in income		0
Total realized and unrealized gains (losses) included in OCI		0
Purchases, issuances, sales and settlements, net		53
Transfers in		0
Ending balance		53
Total gains (losses) included in earnings1		0
Total gains (losses) included in OCI1		0
Related Party | Investment funds | Related Party
Assets
Transfers (out)		2,031
Liabilities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3		0
RMBS | AFS securities | Consolidated Entity, excluding Affiliated Entity
Assets
Beginning balance	232
Total realized and unrealized gains (losses) included in income	3
Total realized and unrealized gains (losses) included in OCI	3
Purchases, issuances, sales and settlements, net	0
Transfers in	0
Ending balance	238
Total gains (losses) included in earnings1	0
Total gains (losses) included in OCI1	3
ABS | AFS securities | Consolidated Entity, excluding Affiliated Entity
Assets
Beginning balance	4,867
Total realized and unrealized gains (losses) included in income	0	6
Total realized and unrealized gains (losses) included in OCI	(19)	(31)
Purchases, issuances, sales and settlements, net	155	(148)
Transfers in	(61)	337
Transfers (out)		1
Ending balance	4,942	3,783
Total gains (losses) included in earnings1	0	0
Total gains (losses) included in OCI1	(16)	(30)
Liabilities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3		338
ABS | AFS securities | Related Party
Assets
Beginning balance	5,542
Total realized and unrealized gains (losses) included in income	4	(17)
Total realized and unrealized gains (losses) included in OCI	44	(10)
Purchases, issuances, sales and settlements, net	1,415	(145)
Transfers in	0	(1,864)
Transfers (out)		1,864
Ending balance	7,005	4,409
Total gains (losses) included in earnings1	2	0
Total gains (losses) included in OCI1	42	(10)
Liabilities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3		0
CLO | AFS securities | Consolidated Entity, excluding Affiliated Entity
Assets
Total realized and unrealized gains (losses) included in income		(1)
Total realized and unrealized gains (losses) included in OCI		2
Purchases, issuances, sales and settlements, net		(10)
Transfers in		0
Transfers (out)		0
Ending balance		5
Total gains (losses) included in earnings1		0
Total gains (losses) included in OCI1		2
Liabilities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3		0
CLO | AFS securities | Related Party
Assets
Beginning balance	303
Total realized and unrealized gains (losses) included in income	0
Total realized and unrealized gains (losses) included in OCI	10
Purchases, issuances, sales and settlements, net	185
Transfers in	0
Ending balance	498
Total gains (losses) included in earnings1	0
Total gains (losses) included in OCI1	10
CLO | Related Party | AFS securities
Assets
Total realized and unrealized gains (losses) included in income		0
Total realized and unrealized gains (losses) included in OCI		0
Purchases, issuances, sales and settlements, net		130
Transfers in		0
Transfers (out)		0
Ending balance		332
Total gains (losses) included in earnings1		0
Total gains (losses) included in OCI1		0
Liabilities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3		0
Corporate | AFS securities | Consolidated Entity, excluding Affiliated Entity
Assets
Beginning balance	1,665
Total realized and unrealized gains (losses) included in income	(1)	(3)
Total realized and unrealized gains (losses) included in OCI	12	(19)
Purchases, issuances, sales and settlements, net	126	140
Transfers in	(180)	42
Transfers (out)		1
Ending balance	1,622	1,499
Total gains (losses) included in earnings1	0	0
Total gains (losses) included in OCI1	6	(19)
Liabilities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3		43
Corporate | AFS securities | Related Party
Assets
Beginning balance	812
Total realized and unrealized gains (losses) included in income	1	(4)
Total realized and unrealized gains (losses) included in OCI	(7)	1
Purchases, issuances, sales and settlements, net	153	94
Transfers in	0	0
Transfers (out)		0
Ending balance	959	761
Total gains (losses) included in earnings1	0	0
Total gains (losses) included in OCI1	(7)	1
Liabilities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3		0
CMBS | AFS securities | Consolidated Entity, excluding Affiliated Entity
Assets
Total realized and unrealized gains (losses) included in income		0
Total realized and unrealized gains (losses) included in OCI		(17)
Purchases, issuances, sales and settlements, net		0
Transfers in		(16)
Ending balance		10
Total gains (losses) included in earnings1		0
Total gains (losses) included in OCI1		(17)
CMBS | AFS securities | Investments, excluding investments in Related Party
Assets
Purchases, issuances, sales and settlements, net		0
Transfers in		(16)
Transfers (out)		16
Liabilities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3		0
Foreign governments | AFS securities | Consolidated Entity, excluding Affiliated Entity
Assets
Beginning balance	1
Total realized and unrealized gains (losses) included in income	0	0
Total realized and unrealized gains (losses) included in OCI	0	0
Purchases, issuances, sales and settlements, net	0	0
Transfers in	0	0
Ending balance	1	2
Total gains (losses) included in earnings1	0	0
Total gains (losses) included in OCI1	0	0
AFS and ABO | AFS securities | Variable Interest Entities
Assets
Transfers (out)		1,582
Derivative Financial Instruments, Liabilities
Liabilities
Beginning balance	(1)
Total realized and unrealized gains (losses) included in income	0	0
Total realized and unrealized gains (losses) included in OCI	0	0
Purchases, issuances, sales and settlements, net	0	0
Transfers in	0	0
Ending balance	(1)	(3)
Total gains (losses) included in earnings1	0	0
Total gains (losses) included in OCI1	0	0
Interest sensitive contract liabilities | Embedded derivatives
Liabilities
Beginning balance	(5,841)
Total realized and unrealized gains (losses) included in income	(473)	1,034
Total realized and unrealized gains (losses) included in OCI	0	0
Purchases, issuances, sales and settlements, net	433	111
Transfers in	0	0
Transfers (out)	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3	0	0
Ending balance	(6,747)	(6,485)
Total gains (losses) included in earnings1	0	0
Total gains (losses) included in OCI1	0	0
Other liabilities
Liabilities
Beginning balance	(142)
Total realized and unrealized gains (losses) included in income	(47)
Total realized and unrealized gains (losses) included in OCI	0
Purchases, issuances, sales and settlements, net	0
Transfers in	0
Ending balance	(189)
Total gains (losses) included in earnings1	0
Total gains (losses) included in OCI1	0
Liabilities of consolidated VIEs – debt
Liabilities
Total realized and unrealized gains (losses) included in income		0
Total realized and unrealized gains (losses) included in OCI		0
Purchases, issuances, sales and settlements, net		0
Transfers in		(3,645)
Transfers (out)		0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3		(3,645)
Ending balance		(3,645)
Total gains (losses) included in earnings1		0
Total gains (losses) included in OCI1		0
Universal life | Interest sensitive contract liabilities
Liabilities
Beginning balance	(829)
Total realized and unrealized gains (losses) included in income	(50)	139
Total realized and unrealized gains (losses) included in OCI	0	0
Purchases, issuances, sales and settlements, net	0	0
Transfers in	0	0
Ending balance	(879)	(1,096)
Total gains (losses) included in earnings1	0	0
Total gains (losses) included in OCI1	0	0
AmerUs Closed Block | Future policy benefits
Liabilities
Beginning balance	(1,164)
Total realized and unrealized gains (losses) included in income	(26)	142
Total realized and unrealized gains (losses) included in OCI	0	0
Purchases, issuances, sales and settlements, net	0	0
Transfers in	0	0
Ending balance	(1,190)	(1,378)
Total gains (losses) included in earnings1	0	0
Total gains (losses) included in OCI1	0	0
ILICO Closed Block and life benefits | Future policy benefits
Liabilities
Beginning balance	(548)
Total realized and unrealized gains (losses) included in income	(31)	38
Total realized and unrealized gains (losses) included in OCI	0	0
Purchases, issuances, sales and settlements, net	0	0
Transfers in	0	0
Ending balance	(579)	(704)
Total gains (losses) included in earnings1	0	0
Total gains (losses) included in OCI1	$ 0	$ 0

Fair Value - Gross Components o

Fair Value - Gross Components of Purchases, Sales, Issuances and Settlements, net (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Jan. 01, 2022
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	$ 5,503	$ 7,240
Issuances	0	0
Sales	(59)	(2,318)
Settlements	(1,284)	(1,549)
Purchases, (Sales), Issuances, (Settlements)	4,160	3,373
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	442	12,394
Transfers (out)	(563)	(6,330)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	121	(6,064)
Purchases	0	0
Issuances	(577)	(260)
Sales	0	0
Settlements	(144)	(149)
Purchases, (Sales), Issuances, (Settlements), Liabilities	(433)	(111)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3	0	(3,645)
Transfers (out)	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net	0	(3,645)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	50,833	51,565	$ 45,582	$ 45,752
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	9,585	13,311	8,525	10,908
Short-term investments | Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases		53
Issuances		0
Sales		0
Settlements		0
Purchases, (Sales), Issuances, (Settlements)		53
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3		0
Transfers (out)		0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net		0
Trading securities | Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases		6
Issuances		0
Sales		0
Settlements		0
Purchases, (Sales), Issuances, (Settlements)	(4)	6
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3		30
Transfers (out)		(10)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	9	(20)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	42	90	53	69
Trading securities | Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	2	29
Issuances	0	0
Sales	0	(265)
Settlements	(1)	(18)
Purchases, (Sales), Issuances, (Settlements)	1	(254)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0
Transfers (out)	0	(1,260)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	1,260
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	885	252	878	1,771
Trading securities | Variable Interest Entities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	10
Issuances	0
Sales	(12)
Settlements	0
Purchases, (Sales), Issuances, (Settlements)	(2)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	19
Transfers (out)	(3)	(1,260)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	(16)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	648		622
Trading securities | Investments, excluding investments in Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	0
Issuances	0
Sales	0
Settlements	(4)
Purchases, (Sales), Issuances, (Settlements)	(4)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	5
Transfers (out)	(14)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	9
Equity securities | Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements)	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	13	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	71	438	92	429
Equity securities | Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	0	0
Issuances	0	0
Sales	0	0
Settlements	(32)	0
Purchases, (Sales), Issuances, (Settlements)	(32)	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0	0
Transfers (out)	0	(113)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	113
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	251	166	279	284
Equity securities | Variable Interest Entities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Transfers (out)		(113)
Equity securities | Investments, excluding investments in Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	0
Issuances	0
Sales	0
Settlements	0
Purchases, (Sales), Issuances, (Settlements)	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0
Transfers (out)	(13)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	13
Investment funds | Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements)		0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net		0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value		19		18
Investment funds | Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases		0
Issuances		0
Sales		(34)
Settlements		0
Purchases, (Sales), Issuances, (Settlements)	32	(34)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	2,031
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	1,034	814	959	2,855
Investment funds | Variable Interest Entities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	0	253
Issuances	0	0
Sales	(8)	(15)
Settlements	0	0
Purchases, (Sales), Issuances, (Settlements)	(8)	238
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	148	10,081
Transfers (out)	(48)	(1,034)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	(100)	(9,047)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	2,581	10,577	2,471	1,297
Investment funds | Related Party | Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3		0
Transfers (out)		(2,031)
Foreign governments | AFS securities | Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements)	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	1	2	1	2
Corporate | Available-for-sale Securities | Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	208
Issuances	0
Sales	0
Settlements	(82)
Purchases, (Sales), Issuances, (Settlements)	126
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	29
Transfers (out)	(209)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	180
Corporate | Available-for-sale Securities | Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	156
Issuances	0
Sales	0
Settlements	(3)
Purchases, (Sales), Issuances, (Settlements)	153
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0
Transfers (out)	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0
Corporate | AFS securities | Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases		324
Issuances		0
Sales		(168)
Settlements		(16)
Purchases, (Sales), Issuances, (Settlements)	126	140
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3		43
Transfers (out)		(1)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	180	(42)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	1,622	1,499	1,665	1,339
Corporate | AFS securities | Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases		315
Issuances		0
Sales		(217)
Settlements		(4)
Purchases, (Sales), Issuances, (Settlements)	153	94
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3		0
Transfers (out)		0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	959	761	812	670
CLO | Available-for-sale Securities | Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	185
Issuances	0
Sales	0
Settlements	0
Purchases, (Sales), Issuances, (Settlements)	185
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0
Transfers (out)	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0
CLO | AFS securities | Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases		0
Issuances		0
Sales		0
Settlements		(10)
Purchases, (Sales), Issuances, (Settlements)		(10)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3		0
Transfers (out)		0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net		0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value		5		14
CLO | AFS securities | Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements)	185
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	498		303
CLO | AFS securities | Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases		130
Issuances		0
Sales		0
Settlements		0
Purchases, (Sales), Issuances, (Settlements)		130
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3		0
Transfers (out)		0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net		0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value		332		202
RMBS | Available-for-sale Securities | Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	1
Issuances	0
Sales	0
Settlements	(1)
Purchases, (Sales), Issuances, (Settlements)	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0
Transfers (out)	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0
RMBS | AFS securities | Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements)	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	238		232
ABS | Available-for-sale Securities | Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	298
Issuances	0
Sales	0
Settlements	(143)
Purchases, (Sales), Issuances, (Settlements)	155
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	215
Transfers (out)	(276)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	61
ABS | Available-for-sale Securities | Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	1,634
Issuances	0
Sales	0
Settlements	(219)
Purchases, (Sales), Issuances, (Settlements)	1,415
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0
Transfers (out)	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0
ABS | AFS securities | Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases		1,489
Issuances		0
Sales		(1,450)
Settlements		(187)
Purchases, (Sales), Issuances, (Settlements)	155	(148)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3		338
Transfers (out)		(1)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	61	(337)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	4,942	3,783	4,867	3,619
ABS | AFS securities | Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases		374
Issuances		0
Sales		(87)
Settlements		(432)
Purchases, (Sales), Issuances, (Settlements)	1,415	(145)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3		0
Transfers (out)		(1,864)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	1,864
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	7,005	4,409	5,542	6,445
CMBS | AFS securities | Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements)		0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net		16
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value		10		43
CMBS | AFS securities | Investments, excluding investments in Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases		0
Issuances		0
Sales		0
Settlements		0
Purchases, (Sales), Issuances, (Settlements)		0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3		0
Transfers (out)		(16)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net		16
Mortgage loans | Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases		4,091
Issuances		0
Sales		(82)
Settlements		(723)
Purchases, (Sales), Issuances, (Settlements)	2,244	3,286
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3		0
Transfers (out)		0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	29,949	23,696	27,454	21,154
Mortgage loans | Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	0	146
Issuances	0	0
Sales	0	0
Settlements	(4)	(7)
Purchases, (Sales), Issuances, (Settlements)	(4)	139
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0	0
Transfers (out)	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	1,324	1,456	1,302	1,369
Mortgage loans | Variable Interest Entities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	46	0
Issuances	0	0
Sales	0	0
Settlements	(1)	(152)
Purchases, (Sales), Issuances, (Settlements)	45	(152)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0	0
Transfers (out)	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	2,119	1,880	2,055	2,152
Mortgage loans | Investments, excluding investments in Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	2,882
Issuances	0
Sales	(32)
Settlements	(606)
Purchases, (Sales), Issuances, (Settlements)	2,244
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0
Transfers (out)	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0
Short-term investments | Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements)	(30)	30
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	(26)	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	30	59	36	29
Short-term investments | Investments, excluding investments in Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	0	30
Issuances	0	0
Sales	0	0
Settlements	(30)	0
Purchases, (Sales), Issuances, (Settlements)	(30)	30
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	26	0
Transfers (out)	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	(26)	0
Short-term investments | Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements)		53
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net		0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value		53		0
Investment funds | Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	32
Issuances	0
Sales	0
Settlements	0
Purchases, (Sales), Issuances, (Settlements)	32
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0
Transfers (out)	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0
Reinsurance recoverable
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements)	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	1,470	1,814	1,388	1,991
Other | Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements)	(156)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	286		441
Other | Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	42
Issuances	0
Sales	0
Settlements	0
Purchases, (Sales), Issuances, (Settlements)	42
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0
Transfers (out)	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	338		303
Other | Variable Interest Entities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	5	0
Issuances	0	0
Sales	(7)	0
Settlements	0	0
Purchases, (Sales), Issuances, (Settlements)	(2)	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0	1,902
Transfers (out)	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	(1,902)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	97	1,902	99	0
Other | Investments, excluding investments in Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	2
Issuances	0
Sales	0
Settlements	(158)
Purchases, (Sales), Issuances, (Settlements)	(156)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0
Transfers (out)	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0
Embedded derivatives | Funds withheld at interest | Consolidated Entity, excluding Affiliated Entity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements)	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	(4,291)	(1,882)	(4,847)	0
Embedded derivatives | Funds withheld at interest | Related Party
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements)	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	(1,266)	(570)	(1,425)	0
Interest sensitive contract liabilities | Universal life
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements), Liabilities	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	879	1,096	829	1,235
Interest sensitive contract liabilities | Embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases	0	0
Issuances	(577)	(260)
Sales	0	0
Settlements	(144)	(149)
Purchases, (Sales), Issuances, (Settlements), Liabilities	(433)	(111)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3	0	0
Transfers (out)	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	6,747	6,485	5,841	7,408
Derivative Financial Instruments, Liabilities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements), Liabilities	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	1	3	1	3
Future policy benefits | AmerUs Closed Block
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements), Liabilities	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	1,190	1,378	1,164	1,520
Future policy benefits | ILICO Closed Block and life benefits
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements), Liabilities	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net	0	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	579	704	548	742
Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases, (Sales), Issuances, (Settlements), Liabilities	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	$ 189		$ 142
Liabilities of consolidated VIEs – debt
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Purchases		0
Issuances		0
Sales		0
Settlements		0
Purchases, (Sales), Issuances, (Settlements), Liabilities		0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3		(3,645)
Transfers (out)		0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net		(3,645)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value		$ 3,645		$ 0

Fair Value - Summary of Unobser

Fair Value - Summary of Unobservable Inputs for the Embedded Derivatives of Interest Sensitive Contract Liabilities (Details) $ in Millions	Mar. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale securities	$ 118,579	$ 112,225
Investment funds	14,552	14,128
Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale securities	12,271	10,671
Mortgage loans, net of allowances	33,392	30,811
Level 3 | Discounted cash flow
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment funds	650	506
Level 3 | Discounted cash flow/guideline public equity
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment funds	899	873
Level 3 | Net tangible asset values
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment funds	515	529
Level 3 | Reported net asset value
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment funds	$ 517	$ 563
Nonperformance risk | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability, measurement input	0.003	0.001
Nonperformance risk | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability, measurement input	0.018	0.017
Nonperformance risk | Weighted average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability, measurement input	0.013	0.010
Option budget | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability, measurement input	0.005	0.005
Option budget | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability, measurement input	0.057	0.053
Option budget | Weighted average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability, measurement input	0.020	0.019
Surrender rate | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability, measurement input	0.052	0.051
Surrender rate | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability, measurement input	0.117	0.115
Surrender rate | Weighted average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability, measurement input	0.081	0.081
Measurement Input, Discount Rate [Member] | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt Securities, Available-for-sale, Measurement Input	0.020	0.022
Mortgage loans, Measurement Input	0.021	0.015
Investment funds, measurement input	0.064	0.064
Measurement Input, Discount Rate [Member] | Minimum | Discounted cash flow/guideline public equity
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment funds, measurement input	0.170	0.165
Measurement Input, Discount Rate [Member] | Minimum | Measurement Input, Implied Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment funds, measurement input	1.26	1.26
Measurement Input, Discount Rate [Member] | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt Securities, Available-for-sale, Measurement Input	0.187	0.188
Mortgage loans, Measurement Input	0.223	0.221
Investment funds, measurement input	0.147	0.064
Measurement Input, Discount Rate [Member] | Maximum | Discounted cash flow/guideline public equity
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment funds, measurement input	0.170	0.165
Measurement Input, Discount Rate [Member] | Maximum | Measurement Input, Implied Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment funds, measurement input	1.26	1.26
Measurement Input, Discount Rate [Member] | Weighted average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt Securities, Available-for-sale, Measurement Input	0.067	0.068
Mortgage loans, Measurement Input	0.063	0.063
Investment funds, measurement input	0.084	0.064
Measurement Input, Discount Rate [Member] | Weighted average | Discounted cash flow/guideline public equity
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment funds, measurement input	0.170	0.165
Measurement Input, Discount Rate [Member] | Weighted average | Measurement Input, Implied Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment funds, measurement input	1.26	1.26
Measurement Input, P/E Ratio | Minimum | Discounted cash flow/guideline public equity
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment funds, measurement input	8.5	9
Measurement Input, P/E Ratio | Maximum | Discounted cash flow/guideline public equity
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment funds, measurement input	8.5	9
Measurement Input, P/E Ratio | Weighted average | Discounted cash flow/guideline public equity
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment funds, measurement input	8.5	9
Embedded derivatives | Interest sensitive contract liabilities | Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Total liabilities measured at fair value	$ 6,747	$ 5,841

Fair Value - Financial Instrume

Fair Value - Financial Instruments Not Carried at Fair Value (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
Fair Value
Assets
Short-term investments		$ 1,640
Total assets measured at fair value	$ 48,368	51,798
Liabilities
Interest sensitive contract liabilities	120,063	111,608
Debt	2,906	2,893
Securities Sold under Agreements to Repurchase	7,781	4,743
Funds withheld liability	346	360
Total liabilities not carried at fair value	131,096	119,604
Fair Value | Consolidated Entity, excluding Affiliated Entity
Assets
Investment funds	77	79
Policy loans	339	347
Funds withheld at interest	35,375	37,727
Other investments	200	162
Short-term investments	45
Fair Value | Related Party
Assets
Investment funds	561	610
Funds withheld at interest	10,728	11,233
Short-term investments	1,043
Carrying Value
Assets
Short-term investments		1,640
Total assets measured at fair value	48,368	51,798
Liabilities
Interest sensitive contract liabilities	131,873	125,101
Debt	3,650	3,658
Securities Sold under Agreements to Repurchase	7,781	4,743
Funds withheld liability	346	360
Total liabilities not carried at fair value	143,650	133,862
Carrying Value | Consolidated Entity, excluding Affiliated Entity
Assets
Investment funds	77	79
Policy loans	339	347
Funds withheld at interest	35,375	37,727
Other investments	200	162
Short-term investments	45
Carrying Value | Related Party
Assets
Investment funds	561	610
Funds withheld at interest	10,728	11,233
Short-term investments	1,043
Investment funds	14,552	14,128
Liabilities
Interest sensitive contract liabilities	181,100	173,616	$ 164,303
Debt	3,650	3,658
Consolidated Entity, excluding Affiliated Entity
Assets
Investment funds	77	79
Policy loans	339	347
Funds withheld at interest	31,084	32,880
Other investments	701	773
Short-term investments	627	2,160
Related Party
Assets
Investment funds	1,595	1,569
Funds withheld at interest	9,462	9,808
Other investments	338	303
Short-term investments	1,043	0
Liabilities
Interest sensitive contract liabilities	11,347	11,889
Variable Interest Entities
Assets
Investment funds	12,880	12,480
Other investments	99	101
Level 1 | Fair Value
Assets
Short-term investments		0
Total assets measured at fair value	0	0
Liabilities
Interest sensitive contract liabilities	0	0
Debt	0	0
Securities Sold under Agreements to Repurchase	0	0
Funds withheld liability	0	0
Total liabilities not carried at fair value	0	0
Level 1 | Fair Value | Consolidated Entity, excluding Affiliated Entity
Assets
Investment funds	0	0
Policy loans	0	0
Funds withheld at interest	0	0
Other investments	0	0
Short-term investments	0
Level 1 | Fair Value | Related Party
Assets
Investment funds	0	0
Funds withheld at interest	0	0
Short-term investments	0
Level 3 | Fair Value
Assets
Short-term investments		26
Total assets measured at fair value	46,303	49,148
Liabilities
Interest sensitive contract liabilities	120,063	111,608
Debt	0	0
Securities Sold under Agreements to Repurchase	0	0
Funds withheld liability	0	0
Total liabilities not carried at fair value	120,063	111,608
Level 3 | Fair Value | Consolidated Entity, excluding Affiliated Entity
Assets
Investment funds	0	0
Policy loans	0	0
Funds withheld at interest	35,375	37,727
Other investments	200	162
Short-term investments	0
Level 3 | Fair Value | Related Party
Assets
Investment funds	0	0
Funds withheld at interest	10,728	11,233
Short-term investments	0
NAV | Fair Value
Assets
Total assets measured at fair value	638	689
Liabilities
Interest sensitive contract liabilities	0	0
Debt	0	0
Securities Sold under Agreements to Repurchase	0	0
Funds withheld liability	0	0
Total liabilities not carried at fair value	0	0
NAV | Fair Value | Consolidated Entity, excluding Affiliated Entity
Assets
Investment funds	77	79
Policy loans	0	0
Funds withheld at interest	0	0
Other investments	0	0
Short-term investments	0	0
NAV | Fair Value | Related Party
Assets
Investment funds	561	610
Funds withheld at interest	0	0
Short-term investments	0
Level 2 | Fair Value
Assets
Short-term investments		1,614
Total assets measured at fair value	1,427	1,961
Liabilities
Interest sensitive contract liabilities	0	0
Debt	2,906	2,893
Securities Sold under Agreements to Repurchase	7,781	4,743
Funds withheld liability	346	360
Total liabilities not carried at fair value	11,033	7,996
Level 2 | Fair Value | Consolidated Entity, excluding Affiliated Entity
Assets
Investment funds	0	0
Policy loans	339	347
Funds withheld at interest	0	0
Other investments	0	0
Short-term investments	45
Level 2 | Fair Value | Related Party
Assets
Investment funds	0	0
Funds withheld at interest	0	$ 0
Short-term investments	$ 1,043

Fair Value - Narrative (Details

Fair Value - Narrative (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Carrying amount of equity securities	$ 400,000,000	$ 400,000,000
Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount	$ 0	$ 0

Deferred Acquisition Costs, D_3

Deferred Acquisition Costs, Deferred Sales Inducements and Value of Business Acquired - Roll Forward of DAC, DSI, and VOBA (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
VOBA
Beginning balance	$ 2,988	$ 3,372
Additions	0	0
Amortization	(93)	(96)
Ending balance	2,895	3,276
Total
Beginning balance	4,466	3,372
Additions	508	291
Amortization	(138)	(98)
Ending balance	4,836	3,565
Traditional deferred annuities
DAC
Beginning balance	304	0
Additions	171	24
Amortization	(16)	0
Ending balance	459	24
Indexed annuities
DAC
Beginning balance	755	0
Additions	203	176
Amortization	(18)	(1)
Ending balance	940	175
DSI
Beginning balance	399	0
Additions	133	77
Amortization	(10)	0
Ending balance	522	77
Funding agreements
DAC
Beginning balance	11	0
Additions	0	11
Amortization	(1)	(1)
Ending balance	10	10
Other investment-type
DAC
Beginning balance	9	0
Additions	1	3
Amortization	0	0
Ending balance	$ 10	$ 3

Deferred Acquisition Costs, D_4

Deferred Acquisition Costs, Deferred Sales Inducements and Value of Business Acquired - Expected Amortization (Details) $ in Millions	Mar. 31, 2023 USD ($)
Insurance [Abstract]
2023	$ 257
2024	316
2025	289
2026	260
2027	230
2028	$ 200

Long-duration Contracts - Polic

Long-duration Contracts - Policyholder Account Balance Rollforward (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Policyholder Account Balance [Roll Forward]
Beginning balance	$ 168,339	$ 151,390
Deposits	12,162	8,957
Policy charges	(159)	(142)
Surrenders and withdrawals	(4,603)	(2,644)
Benefit payments	(1,266)	(1,460)
Interest credited	724	1,074
Foreign exchange	38	(114)
Other	56	(218)
Ending balance	$ 175,291	$ 156,843
Weighted average crediting rate	2.70%	2.10%
Net amount at risk	$ 14,392	$ 10,983
Cash surrender value	132,751	119,186
Traditional deferred annuities
Policyholder Account Balance [Roll Forward]
Beginning balance	43,518	35,599
Deposits	6,700	918
Policy charges	(1)	(1)
Surrenders and withdrawals	(1,818)	(845)
Benefit payments	(264)	(256)
Interest credited	369	235
Foreign exchange	0	0
Other	(54)	0
Ending balance	$ 48,450	$ 35,650
Weighted average crediting rate	3.40%	2.70%
Net amount at risk	$ 423	$ 416
Cash surrender value	45,994	34,211
Indexed annuities
Policyholder Account Balance [Roll Forward]
Beginning balance	92,660	89,755
Deposits	2,929	2,573
Policy charges	(158)	(141)
Surrenders and withdrawals	(2,712)	(1,798)
Benefit payments	(422)	(426)
Interest credited	117	697
Foreign exchange	0	0
Other	0	0
Ending balance	$ 92,414	$ 90,660
Weighted average crediting rate	2.30%	2%
Net amount at risk	$ 13,903	$ 10,554
Cash surrender value	84,047	84,265
Funding agreements
Policyholder Account Balance [Roll Forward]
Beginning balance	27,439	23,623
Deposits	1,500	4,946
Policy charges	0	0
Surrenders and withdrawals	(70)	0
Benefit payments	(490)	(695)
Interest credited	206	125
Foreign exchange	54	(100)
Other	143	(218)
Ending balance	$ 28,782	$ 27,681
Weighted average crediting rate	2.70%	1.80%
Net amount at risk	$ 0	$ 0
Cash surrender value	0	0
Other investment-type
Policyholder Account Balance [Roll Forward]
Beginning balance	4,722	2,413
Deposits	1,033	520
Policy charges	0	0
Surrenders and withdrawals	(3)	(1)
Benefit payments	(90)	(83)
Interest credited	32	17
Foreign exchange	(16)	(14)
Other	(33)	0
Ending balance	$ 5,645	$ 2,852
Weighted average crediting rate	2.90%	2.20%
Net amount at risk	$ 66	$ 13
Cash surrender value	$ 2,710	$ 710

Long-duration Contracts - Recon

Long-duration Contracts - Reconciliation of Account Balance Within Interest Sensitive Contract Benefits (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
Liability for Future Policy Benefit, Activity [Line Items]
Interest sensitive contract liabilities	$ 181,100	$ 173,616	$ 164,303
Traditional deferred annuities
Liability for Future Policy Benefit, Activity [Line Items]
Interest sensitive contract liabilities	48,450		35,650
Indexed annuities
Liability for Future Policy Benefit, Activity [Line Items]
Interest sensitive contract liabilities	92,414		90,660
Funding agreements
Liability for Future Policy Benefit, Activity [Line Items]
Interest sensitive contract liabilities	28,782		27,681
Other investment-type
Liability for Future Policy Benefit, Activity [Line Items]
Interest sensitive contract liabilities	5,645		2,852
Reconciling items
Liability for Future Policy Benefit, Activity [Line Items]
Interest sensitive contract liabilities	$ 5,809		$ 7,460

Long-duration Contracts - Accou

Long-duration Contracts - Account Balances by Guaranteed Minimum Interest Rates (Details) $ in Millions	Mar. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Mar. 31, 2022 USD ($)	Jan. 01, 2022 USD ($)
Policyholder Account Balance [Line Items]
Total	$ 175,291	$ 168,339	$ 156,843	$ 151,390
Less than 2.0%
Policyholder Account Balance [Line Items]
Total	$ 129,906		$ 116,647
Less than 2.0% | Maximum
Policyholder Account Balance [Line Items]
Range of guaranteed minimum credit ratings (in percent)	2%		2%
2.0% to 4.0%
Policyholder Account Balance [Line Items]
Total	$ 34,280		$ 35,572
2.0% to 4.0% | Maximum
Policyholder Account Balance [Line Items]
Range of guaranteed minimum credit ratings (in percent)	4%		4%
2.0% to 4.0% | Minimum
Policyholder Account Balance [Line Items]
Range of guaranteed minimum credit ratings (in percent)	2%		2%
4.0% to 6.0%
Policyholder Account Balance [Line Items]
Total	$ 9,883		$ 4,484
Range of guaranteed minimum credit ratings (in percent)			6%
4.0% to 6.0% | Maximum
Policyholder Account Balance [Line Items]
Range of guaranteed minimum credit ratings (in percent)	6%
4.0% to 6.0% | Minimum
Policyholder Account Balance [Line Items]
Range of guaranteed minimum credit ratings (in percent)	4%		4%
6.0% and greater
Policyholder Account Balance [Line Items]
Total	$ 1,222		$ 140
6.0% and greater | Minimum
Policyholder Account Balance [Line Items]
Range of guaranteed minimum credit ratings (in percent)	6%		6%
At guaranteed minimum
Policyholder Account Balance [Line Items]
Total	$ 68,211		$ 68,251
At guaranteed minimum | Less than 2.0%
Policyholder Account Balance [Line Items]
Total	25,571		29,040
At guaranteed minimum | 2.0% to 4.0%
Policyholder Account Balance [Line Items]
Total	31,793		34,604
At guaranteed minimum | 4.0% to 6.0%
Policyholder Account Balance [Line Items]
Total	9,625		4,467
At guaranteed minimum | 6.0% and greater
Policyholder Account Balance [Line Items]
Total	1,222		140
1 basis point – 100 basis points above guaranteed minimum
Policyholder Account Balance [Line Items]
Total	$ 25,628		$ 31,131
1 basis point – 100 basis points above guaranteed minimum | Maximum
Policyholder Account Balance [Line Items]
Policyholder account balance above guaranteed minimum crediting rate	100		100
1 basis point – 100 basis points above guaranteed minimum | Minimum
Policyholder Account Balance [Line Items]
Policyholder account balance above guaranteed minimum crediting rate	1		1
1 basis point – 100 basis points above guaranteed minimum | Less than 2.0%
Policyholder Account Balance [Line Items]
Total	$ 23,867		$ 30,195
1 basis point – 100 basis points above guaranteed minimum | 2.0% to 4.0%
Policyholder Account Balance [Line Items]
Total	1,709		925
1 basis point – 100 basis points above guaranteed minimum | 4.0% to 6.0%
Policyholder Account Balance [Line Items]
Total	52		11
1 basis point – 100 basis points above guaranteed minimum | 6.0% and greater
Policyholder Account Balance [Line Items]
Total	0		0
Greater than 100 basis points above guaranteed minimum
Policyholder Account Balance [Line Items]
Total	$ 81,452		$ 57,461
Greater than 100 basis points above guaranteed minimum | Minimum
Policyholder Account Balance [Line Items]
Policyholder account balance above guaranteed minimum crediting rate	100		100
Greater than 100 basis points above guaranteed minimum | Less than 2.0%
Policyholder Account Balance [Line Items]
Total	$ 80,468		$ 57,412
Greater than 100 basis points above guaranteed minimum | 2.0% to 4.0%
Policyholder Account Balance [Line Items]
Total	778		43
Greater than 100 basis points above guaranteed minimum | 4.0% to 6.0%
Policyholder Account Balance [Line Items]
Total	206		6
Greater than 100 basis points above guaranteed minimum | 6.0% and greater
Policyholder Account Balance [Line Items]
Total	$ 0		$ 0

Long-duration Contracts - Balan

Long-duration Contracts - Balances of and Changes in Liability for Future Policy Benefits (Details) - Payout annuities with life contingencies - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Jan. 01, 2022
(In millions)
Beginning balance	$ 0	$ 0
Issuances	88	1,994
Net premium collected	(88)	(1,994)
Ending balance	0	0
Present value of expected future policy benefits
Beginning balance	36,422	35,278
Effect of changes in discount rate assumptions	7,623	3,562	$ 8,425	$ 0
Beginning balance at original discount rate	44,375	36,711	44,847	35,278
Effect of actual experience compared to expected experience			(29)	(47)
Adjusted beginning balance			$ 44,818	$ 35,231
Issuances	88	1,994
Interest accrual	346	229
Benefit payments	(885)	(724)
Foreign exchange	8	(19)
Ending balance at original discount rate	44,375	36,711
Ending balance	$ 36,752	$ 33,149

Long-duration Contracts - Rec_2

Long-duration Contracts - Reconciliation of Future Policy Benefits (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefits	$ 42,490	$ 42,110	$ 39,240
Payout annuities with life contingencies
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefits	36,752		33,149
Reconciling items
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefits	$ 5,738		$ 6,091

Long-duration Contracts - Premi

Long-duration Contracts - Premium Reconciliation (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Liability for Future Policy Benefit, Activity [Line Items]
Premiums	$ 96	$ 2,110
Payout annuities with life contingencies
Liability for Future Policy Benefit, Activity [Line Items]
Premiums	88	2,098
Reconciling items
Liability for Future Policy Benefit, Activity [Line Items]
Premiums	$ 8	$ 12

Long-duration Contracts - Narra

Long-duration Contracts - Narrative (Details) - USD ($) $ in Millions	3 Months Ended			6 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2022	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022	Jan. 01, 2022
Additional Liability, Long-Duration Insurance [Line Items]
Future policy benefit, interest expense	$ 346		$ 229
Market risk benefit, period increase (decrease)	274		(1,003)
Effect of changes in interest rates	(226)		758
Effect of changes in instrument-specific credit risk	455	$ (397)	(397)			$ (366)
Attributed fees collected	85		82
Effect of changes in equity	(18)		55
Remeasurement gains (losses) on future policy benefits related to discount rate	(802)		3,562	$ 6,459	$ 8,833	8,425
Remeasurement gains (losses) on market risk benefits related to credit risk	89		397	$ 576	$ 524	366
Payout annuities with life contingencies
Additional Liability, Long-Duration Insurance [Line Items]
Favorable (unfavorable) movements	330		(2,129)
Interest accrual	346	229
Benefit payments	(885)	(724)
Effect of changes in discount rate assumptions	7,623	3,562	3,562			$ 8,425	$ 0
Issuances	88	$ 1,994
Remeasurement gains (losses) on future policy benefits related to discount rate	$ (802)		$ 3,562

Long-duration Contracts - Disco

Long-duration Contracts - Discounted Future Gross Premiums (Details) - USD ($) $ in Millions	Mar. 31, 2023	Mar. 31, 2022
Insurance [Abstract]
Expected future benefit payments, Undiscounted	$ 63,995	$ 51,643
Expected future benefit payments, Discounted	$ 44,375	$ 36,711

Long-duration Contracts - Weigh

Long-duration Contracts - Weighted Average Durations and Interest Rates (Details)	Mar. 31, 2023	Mar. 31, 2022
Insurance [Abstract]
Weighted-average liability duration (in years)	10 years 1 month 6 days	10 years 7 months 6 days
Weighted-average interest accretion rate	3.20%	2.70%
Weighted-average current discount rate	5.30%	3.70%

Long-duration Contracts - Varia

Long-duration Contracts - Variance of Actual Experience Compared to Expected Experience (Details) - USD ($) $ in Millions	Mar. 31, 2023	Mar. 31, 2022
Insurance [Abstract]
Expected reserve release due to death	$ 132	$ 114
Actual reserve release due to death	183	163
Decrease in reserve due to actual experience compared to expected experience	$ (51)	$ (49)

Long-duration Contracts - Remea

Long-duration Contracts - Remeasurement Gain (Loss) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Insurance [Abstract]
Reserves	$ 29	$ 47
Deferred profit liability	(27)	(54)
Negative VOBA	(4)	10
Total remeasurement gains (losses)	$ (2)	$ 3

Long-duration Contracts - Marke

Long-duration Contracts - Market Risk Benefits (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Market Risk Benefit [Roll Forward]
Beginning Balance	$ (2,489)
Effect of changes in instrument-specific credit risk	455	$ (397)	$ (366)
Balance, beginning of period, before changes in instrument specific credit risk	2,855
Issuances	17	16
Interest accrual	34	(2)
Attributed fees collected	85	82
Benefit payments	(6)	(12)
Effect of changes in interest rates	226	(758)
Effect of changes in equity	(18)	55
Effect of actual behavior compared to expected behavior	25	13
Balance at March 31, 2023	2,763	3,444
Ending Balance	3,218	3,841
Net amount at risk	$ 14,326	$ 10,970
Weighted-average attained age of contract holders (in years)	69 years	69 years
Traditional deferred annuities
Market Risk Benefit [Roll Forward]
Beginning Balance	$ (170)
Effect of changes in instrument-specific credit risk	16	$ (13)	(13)
Balance, beginning of period, before changes in instrument specific credit risk	183
Issuances	0	0
Interest accrual	2	0
Attributed fees collected	1	1
Benefit payments	0	(1)
Effect of changes in interest rates	8	(26)
Effect of changes in equity	0	0
Effect of actual behavior compared to expected behavior	2	1
Balance at March 31, 2023	180	215
Ending Balance	196	228
Net amount at risk	$ 423	$ 416
Weighted-average attained age of contract holders (in years)	75 years	75 years
Indexed annuities
Market Risk Benefit [Roll Forward]
Beginning Balance	$ (2,319)
Effect of changes in instrument-specific credit risk	439	$ (384)	$ (353)
Balance, beginning of period, before changes in instrument specific credit risk	2,672
Issuances	17	16
Interest accrual	32	(2)
Attributed fees collected	84	81
Benefit payments	(6)	(11)
Effect of changes in interest rates	218	(732)
Effect of changes in equity	(18)	55
Effect of actual behavior compared to expected behavior	23	12
Balance at March 31, 2023	2,583	3,229
Ending Balance	3,022	3,613
Net amount at risk	$ 13,903	$ 10,554
Weighted-average attained age of contract holders (in years)	69 years	69 years

Long-duration Contracts - Mar_2

Long-duration Contracts - Market Risk Reconciliation (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
Market Risk Benefit [Line Items]
Asset	$ 440		$ 413
Liability	3,203	$ 2,970	3,857
Net liability	2,763	2,855	3,444
Traditional deferred annuities
Market Risk Benefit [Line Items]
Asset	0		0
Liability	180		215
Net liability	180	183	215
Indexed annuities
Market Risk Benefit [Line Items]
Asset	440		413
Liability	3,023		3,642
Net liability	$ 2,583	$ 2,672	$ 3,229

Long-duration Contracts - Signi

Long-duration Contracts - Significant Inputs and Assumptions (Details) $ in Millions	Mar. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Mar. 31, 2022 USD ($)
Market Risk Benefit [Line Items]
Net liability	$ 2,763	$ 2,855	$ 3,444
Nonperformance risk | Discounted cash flow | Minimum
Market Risk Benefit [Line Items]
Market risk benefit, measurement input (in percent)	0.003		0.004
Nonperformance risk | Discounted cash flow | Maximum
Market Risk Benefit [Line Items]
Market risk benefit, measurement input (in percent)	0.017		0.020
Nonperformance risk | Discounted cash flow | Weighted average
Market Risk Benefit [Line Items]
Market risk benefit, measurement input (in percent)	0.016		0.013
Option budget | Discounted cash flow | Minimum
Market Risk Benefit [Line Items]
Market risk benefit, measurement input (in percent)	0.005		0.005
Option budget | Discounted cash flow | Maximum
Market Risk Benefit [Line Items]
Market risk benefit, measurement input (in percent)	0.056		0.038
Option budget | Discounted cash flow | Weighted average
Market Risk Benefit [Line Items]
Market risk benefit, measurement input (in percent)	0.017		0.015
Surrender rate | Discounted cash flow | Minimum
Market Risk Benefit [Line Items]
Market risk benefit, measurement input (in percent)	0.033		0.036
Surrender rate | Discounted cash flow | Maximum
Market Risk Benefit [Line Items]
Market risk benefit, measurement input (in percent)	0.069		0.066
Surrender rate | Discounted cash flow | Weighted average
Market Risk Benefit [Line Items]
Market risk benefit, measurement input (in percent)	0.045		0.045

Debt - Narrative (Details)

Debt - Narrative (Details) - Liquidity Facility - USD ($)	3 Months Ended
	Sep. 30, 2022	Mar. 31, 2023	Feb. 07, 2023
Line of Credit Facility [Line Items]
Extension period (in years)	364 days
Line of Credit Facility, Current Borrowing Capacity		$ 2,500,000,000
Maximum borrowing capacity		3,000,000,000
Line of Credit Facility, Fair Value of Amount Outstanding		0	$ 1,000,000,000
Athene Life Re Ltd.
Line of Credit Facility [Line Items]
Line of Credit Facility, Covenant Terms, Consolidated Net Worth Requirement, Amount		$ 9,300,000,000

Equity - Accumulated Other Comp

Equity - Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	3 Months Ended			6 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2022	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	$ (7,321)	$ 0
Other comprehensive income (loss) before reclassifications	1,562	(2,914)
Less: Reclassification adjustments for gains (losses) realized	56	(45)
Less: Income tax expense (benefit)	290	(615)	$ (615)	$ (1,493)	$ (2,220)	$ (1,933)
Less: Other comprehensive income (loss) attributable to noncontrolling interests	(43)	(64)
Ending balance	(6,148)	(2,318)	(2,318)			(7,321)
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Noncontrolling Interest [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	(12,565)	0
Less: Other comprehensive income (loss) attributable to noncontrolling interests	(220)	676
Ending balance	(10,879)	(4,747)	(4,747)			(12,565)
AOCI, Gain (Loss), Debt Securities, Available-for-sale, with Allowance for Credit Loss, Parent [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	(334)	0
Ending balance	(467)	(65)	(65)			(334)
DAC, DSI, VOBA, future policy benefits and dividends payable to policyholders adjustments on AFS securities
Accumulated Other Comprehensive Income (Loss) [Line Items]
Ending balance	109	(79)	(79)
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	47	0
Ending balance						47
AOCI, Accumulated Gain (Loss), Debt Securities, with credit allowance, portion attributable to NCI [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Less: Other comprehensive income (loss) attributable to noncontrolling interests	0	9
Accumulated Foreign Currency Adjustment and Other Attributable to Parent [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	(10)	0
Ending balance	(1)	5	5			(10)
AOCI, Gain (Loss), Debt Securities, Available-for-sale, with Allowance for Credit Loss, Including Noncontrolling Interest [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	2,187	(6,645)
Less: Reclassification adjustments for gains (losses) realized	(31)	(38)
Less: Income tax expense (benefit)	312	(1,184)
AOCI, Gain (Loss), Debt Securities, Available-for-sale, with Allowance for Credit Loss, Including Noncontrolling Interest [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	(119)	(97)
Less: Reclassification adjustments for gains (losses) realized	0	(7)
Less: Income tax expense (benefit)	14	(16)
Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	191	(129)
Less: Reclassification adjustments for gains (losses) realized	87	0
Less: Income tax expense (benefit)	15	(26)
Accumulated Foreign Currency Adjustment and Other Including Portion Attributable to Noncontrolling Interest [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	16	(2)
Less: Reclassification adjustments for gains (losses) realized	0	0
Less: Income tax expense (benefit)	4	(1)
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Noncontrolling Interest [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Less: Other comprehensive income (loss) attributable to noncontrolling interests	(27)	24
Accumulated Foreign Currency Adjustment and Other Attributable to Noncontrolling Interest [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Less: Other comprehensive income (loss) attributable to noncontrolling interests	(3)	6
Remeasurement gains (losses) on future policy benefits related to discount rate
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	5,256	0
Other comprehensive income (loss) before reclassifications	(802)	3,562
Less: Reclassification adjustments for gains (losses) realized	0	0
Less: Income tax expense (benefit)	(73)	529
Less: Other comprehensive income (loss) attributable to noncontrolling interests	208	(774)
Ending balance	4,735	2,259	2,259			5,256
Remeasurement gains (losses) on market risk benefits related to credit risk
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	285	0
Other comprehensive income (loss) before reclassifications	89	397
Less: Reclassification adjustments for gains (losses) realized	0	0
Less: Income tax expense (benefit)	18	83
Less: Other comprehensive income (loss) attributable to noncontrolling interests	(1)	(5)
Ending balance	$ 355	$ 309	$ 309			$ 285

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Income tax expense (benefit)	$ 163	$ (284)	$ (662)	$ (783)	$ (646)
Effective income tax rate (percent)	12%	(13.00%)

Related Parties - Summary of In

Related Parties - Summary of Investments (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Related Party Transaction [Line Items]
Investment funds	$ 14,552	$ 14,128
Related Party
Related Party Transaction [Line Items]
Investment funds	1,595	1,569
Related Party | Athora
Related Party Transaction [Line Items]
Investment funds	1,034	959
Equity Securities, FV-NI	245	273
Investments	$ 1,279	$ 1,232

Related Parties - Narrative (De

Related Parties - Narrative (Details)	3 Months Ended
	Mar. 31, 2023 USD ($) board_member	Mar. 31, 2022 USD ($)	Mar. 31, 2022 USD ($)	Feb. 08, 2023 USD ($)	Dec. 31, 2022 USD ($)
Related Party Transaction [Line Items]
Backbook Value	$ 103,400,000,000
Management Fee, Percent	0.0335
Number of board of directors that are employees of Apollo | board_member	6
Number of board of directors | board_member	14
Investment funds	$ 14,552,000,000				$ 14,128,000,000
Contributions from noncontrolling interests		$ 311,000,000
Interest sensitive contract liabilities	181,100,000,000	164,303,000,000	$ 164,303,000,000		173,616,000,000
Available-for-sale securities	118,579,000,000				112,225,000,000
Other liabilities	1,600,000,000				1,860,000,000
Distributions to noncontrolling interests	(127,000,000)
Venerable
Related Party Transaction [Line Items]
Equity investment method	235,000,000				240,000,000
Noncontrolling interests
Related Party Transaction [Line Items]
Contributions from noncontrolling interests	0	$ 311,000,000	311,000,000
Distributions to noncontrolling interests	(127,000,000)		0
Related Party | Management fees associated with investment funds
Related Party Transaction [Line Items]
Expenses from transactions with related parties	222,000,000		$ 186,000,000
Contingent Investment Fees
Related Party Transaction [Line Items]
Due to other related parties	$ 201,000,000				202,000,000
Athora | Related Party
Related Party Transaction [Line Items]
Day from receipt of notice of a cession	30 days
Athora | Related Party | Maximum
Related Party Transaction [Line Items]
Liabilities ceded (in percent)	0.50
Percentage of liabilities (in percent)	0.20
Percent of refusal to reinsure liabilities ceded from a third party (in percent)	0.20
Percent of fair market value of total assets of subsidiary (in percent)	0.03
Investments
Related Party Transaction [Line Items]
Investment commitment	$ 19,300,000,000
Private equity
Related Party Transaction [Line Items]
Management Fee, Percent	0.045
Related Party
Related Party Transaction [Line Items]
Investment commitment				$ 3,300,000,000
Other investments	$ 338,000,000				303,000,000
Investment funds	1,595,000,000				1,569,000,000
Interest sensitive contract liabilities	11,347,000,000				11,889,000,000
Available-for-sale securities	11,866,000,000				9,821,000,000
Other liabilities	612,000,000				564,000,000
Related Party | Management fees associated with investment funds
Related Party Transaction [Line Items]
Due to related parties	85,000,000				80,000,000
Related Party | MidCap affiliates
Related Party Transaction [Line Items]
Available-for-sale securities	$ 1,481,000,000				1,262,000,000
Related Party | Apollo | Sub-allocated assets
Related Party Transaction [Line Items]
Base Management Fee	0.225%
Incremental Fee	0.15%
Related Party | Apollo | Sub-allocated assets | Minimum
Related Party Transaction [Line Items]
Sub-allocation Fee	0.065%
Related Party | Apollo | Sub-allocated assets | Maximum
Related Party Transaction [Line Items]
Sub-allocation Fee	0.70%
Related Party | Athora
Related Party Transaction [Line Items]
Investment funds	$ 1,034,000,000				959,000,000
Equity Securities, FV-NI	245,000,000				273,000,000
Investments	$ 1,279,000,000				1,232,000,000
Related Party | Venerable
Related Party Transaction [Line Items]
Investment Interest Rate	6.257%
Related Party | Apollo Athene Strategic Partnership Advisors, LLC
Related Party Transaction [Line Items]
Investment funds	$ 1,151,000,000				1,046,000,000
Strategic Partnership Capacity	$ 2,875,000,000
Investment period of funds (in years)	3 years
Related Party | PK AirFinance
Related Party Transaction [Line Items]
Debt Securities	$ 1,577,000,000				1,183,000,000
Related Party | Catalina Holdings (Bermuda) Ltd
Related Party Transaction [Line Items]
Other liabilities	189,000,000				142,000,000
Related Party | Atals
Related Party Transaction [Line Items]
Available-for-sale securities	995,000,000				0
Related Party | Wheels Donlen
Related Party Transaction [Line Items]
Available-for-sale securities	1,185,000,000				1,024,000,000
Related Party | Funding agreements | Athora
Related Party Transaction [Line Items]
Interest sensitive contract liabilities	60,000,000				59,000,000
Related Party | Investments | Athora
Related Party Transaction [Line Items]
Investment commitment	526,000,000
Related Party | Investments | PK AirFinance
Related Party Transaction [Line Items]
Investment commitment	1,261,000,000
Related Party | Private equity | Venerable
Related Party Transaction [Line Items]
Other investments	338,000,000				303,000,000
Related Party | Repurchase Agreements | Atals
Related Party Transaction [Line Items]
Investments	1,043,000,000				0
Parent Company | Apollo Global Management , Inc.
Related Party Transaction [Line Items]
Maximum borrowing capacity	500,000,000
Long-Term Line of Credit	0				0
Parent Company | Apollo Global Management , Inc. | Revolving Credit Facility
Related Party Transaction [Line Items]
Revolving note receivable, borrowing capacity	500,000,000
Intercompany Note Receivable	$ 123,000,000				$ 78,000,000
ACRA
Related Party Transaction [Line Items]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners	63.45%
Noncontrolling Interest, Ownership Percentage by Parent	36.55%

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($)	Feb. 23, 2023 close	Feb. 08, 2023 USD ($)	Dec. 31, 2022 USD ($)	Mar. 31, 2022 USD ($)
Other Commitments [Line Items]
Investment period (in years)	5 years
Advances from FHLB	$ 4,900			$ 3,700
Letters of Credit Outstanding, Amount	1,344
Interest sensitive contract liabilities	181,100			173,616	$ 164,303
Number of closes | close		2
Related Party
Other Commitments [Line Items]
Investment commitment			$ 3,300
Interest sensitive contract liabilities	11,347			11,889
Other Commitment, to be Paid, Year Three			400
Other Commitment, to be Paid, Year Five			$ 2,900
Investments
Other Commitments [Line Items]
Investment commitment	19,300
Funding Agreement Backed Repurchase Agreements [Member]
Other Commitments [Line Items]
Interest sensitive contract liabilities	3,000			3,000
Athene Global Funding | Funding agreements
Other Commitments [Line Items]
Maximum borrowing capacity	13,500
Interest sensitive contract liabilities	$ 21,100			$ 21,000

Commitments and Contingencies_2

Commitments and Contingencies - Pledged Assets and Funds in Trust (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
AFS securities	$ 17,054	$ 15,366
Debt Securities, Trading, Restricted	69	55
Equity securities	71	38
Investment funds	84	103
Derivative assets pledged as collateral	80	65
Other investments	215	170
Restricted cash	1,148	628
Total restricted assets	26,815	25,394
Other Commitments [Line Items]
Short-term investments	131	120
Asset Pledged as Collateral
Commitments and Contingencies Disclosure [Abstract]
Mortgage loans, net of allowances	7,963	8,849
Other Commitments [Line Items]
Mortgage loans, net of allowances	$ 7,963	$ 8,849